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DIRECTOR'S REPORT
The stereotype of the eccentric scientist, indifferent to
the world about him and motivated only toward the
intellectual advancement of his own field of research, is
convenient to perpetuate. For the academic, it provides
the perfect out from the more than occasional necessity
of appearing concerned with the many pressing prob-
lems of the imperfect societies in which we all live. A
monomania of one form or another is a prerequisite for
most intellectual achievements, and trying to do too
much all too often is a recipe for future lack of distinc-
tion. And even if we are no longer passionate about our
intellectual careers, we tend to be reluctant to announce
publicly that we are ready to help our neighbors. This
would imply that we frequently have ideas that have
social consequences. We need not be clever to realize
that the appearance of goodness is far from correlated
with the actual accomplishment of good works. Far
better to maintain the illusion that we always have
esoteric ideas in mind.
This way of proceeding is also not without its advan-
tages to our politicians, the ultimate source of almost all
money for science. They need to be seen as practical
leaders and do not want to be unfairly tagged as un-
worldly by too much association with minds who can-
not be counted on for reliably consistent answers. As the
leaders of our countries, they have to devote almost all
of their waking moments to today's decisions, leaving to
their dreams the long-term future. They know as ad-
ministrators that the problems of the immediate moment
cannot be pushed aside in favor of schemes that perhaps
should never have been generated. Most untested new
ideas never go anywhere, and old remedies, imperfect
as they may be, have that marvelous quality of being
apparently predictable. Inherently, none of us want to
live with too much uncertainty, yet we as research types
seem often to push for new approaches merely because
we are bored with the past.
Most new ideas of intellectuals have to be seen for
what they are, academic exercises usually put forward
without the thought that they might be taken seriously
by the outside world. Without the fear of visible failure,
the mind meanders faster and further, sometimes to-
ward more practical directions than initially perceived.
This is the way it should be. If we believe that our futures
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as viable societies demand infusions of the really new, it
makes sense, for the most part, to separate the genera-
tion of new ideas from the job slots where the conse-
quences of failure are too clearly seen. This is why
universities and institutes of pure research must exist as
partial oases from the real world. Only in somewhat
unhurried atmospheres will we take the time to assimi-
late the key features of other cultures or to scrutinize
carefully the tenets of the moment for their viability over
the foreseeable future.
There will thus, of necessity, always be a sense of
quiet unease in an academic-type environment. The
desire of the students and younger staff to reexamine, if
not overturn, the inadequate ideas of the past will often
be in conflict with the purposes of the more senior
members, who themselves, a generation before, may
have come to power through their ability to think differ-
ently. A major factor determining the quality of a given
institution is thus the ability of its faculty to reward
intellectual success even when it leads to the effective
academic redundancy of many of its older members.
Happily, the tradition of rewarding intellectual
novelty now dominates major universities in every
society-that is as long as the ideas promoted are not
thought to affect the political (social) stability of the
society concerned. Here we should not delude our-
selves that these exceptions are all that rare. No one, for
example, can imagine a promoter of Marxist economics
becoming a professor in today's Chile. And even at
Harvard, Marxist economists never seem to make it.
For the most part, however, natural science has been
allowed to evolve on its own terms. No society that
wishes to advance itself in the modern world can reject
scientific progress, and we now find, virtually indepen-
dent of the political system, that the content of science is
left to its practitioners and not imposed from above.
There is, for example, no capitalistic form of molecular
biology. No matter in which country we look, molecu-
lar biologists are apt to have the same common objec-
tives. To be sure, there have been serious efforts to turn
the clock back, as witnessed by the debasements of
Russian biology when Stalin decided that Mendelian
genetics posed a threat to communist doctrine as to why
different individuals have different potentials for future
principle, but usually reflects the perception, sometimes 
mistaken, that we do not have anything unique to offer 
the outside world. But when we feel that a new observa- 
tion has much wider application than a place in a scien- 
tific iQurnal, we are unlikely long to ignore the fact that 
we might enhance our careers, if not our fortunes, by 
moving ourfjifpughts to the outside world. To show this,
I can best draw on my experience in molecular biology, 
a field that until recently was thought to be one of the 
more esoteric ofelhe major sciences. Two major exam- 
pies stand out.
The genetic engineering of microorganisms to pro- 
duce medically useful hormones and drugs. The now 
over thirty years of intensive research on DNA, the 
chemical compound that carries the genetic informa- 
tion of our genes, and on the fundamental genetics of 
bacteria: has led recently to the development of new 
proceduresjl^yhich bacteria can be used as effective 
factories to produce large amounts of human proteins 
that now are dtfficultto prepare in medically satisfactory 
amounts (e.g., !he growth hormone and, hopefully 
soon, the infinitely more illusive antiviral compound 
interfeMtlp Although vague proposals for genetic en- 
gineering have been talked about ever since DNA was 
pinpointed as the genetic material in 1944, this field 
became technologically possibleonly following the un- 
expected isolationHfc the early 1960s of a new class of 
enzymes (the restriction enzymes). These catalysts cut 
DNA molecules atspecific sites and so allow the routine 
test-tube generation of "recombinant DNA" molecules, 
say partially of human origin and partially of bacterial 
origin. As first shown in 1963 by Herbert Boyer and 
Stanley Cohen, these hybrid molecules can then be put 
into receptive bacteria, where they multiply as func- 
tional minichromosomes and lead to the production of 
not only proteins of bacterial origin, but also those 
corresponding to the specific human genes from which 
they have been constructed. Already three human hor- 
mones (insulin, somatostatin, and pituitary growth! 
have been synthesized by these procedures, and over 
the next several years we should witness an explosion of 
such examples, many with great commercial signifi- 
cance. This is not the place; however, to give the techni- 
cal details of these procedures. Much more interesting 
are the facts that:
1. There is no way these procedures could have been 
worked out by applied scientists without prior intense 
development of pure molecular genetics and bacterial 
genetics.
/ 2. The first successful recombinant DNA experiments 
were carried out at two major academ ic sites (U n i versity 
of California Medical School at San Francisco and Stan- 
ford University Medical School) by scientists whose 
careers untMhen had been in pure science.
3. The first use of these procedures was to further our 
knowledge of pure science, and already several major 
advancesim understanding the structure and function of
success—or the much less successful attempt by the 
Nazis to label relativity research as Jewish science— and 
the rear-guard action by fundamentalist American reli- 
gious groups to prevent the teaching of Darwin's evolu- 
tionary theories.
All in all, however, the more meaningful fact is the 
paucity of such restrictive political actions du|j§g the 
development of modern science. The efforts of the 
Catholic Church to muffle Galileo in the 16th century 
fortunately have not had too many subsequent parallels. 
Since then, the growing, clear correlation between the 
existence of a vigorous free science and the generation 
of technological advances has led more and more na- 
tions to organize their support of science in ways that 
maximize their scientists' control over their own des- 
tiny.
Here we cannot overemphasize too much the neces- 
sity for the promotion of pure science. Through it are 
generated the unexpected new facts that later can lead 
to applied developments like high-speed computers 
and the drugs|J|at control our fertility. The outcomes of 
untried scientific experiments are remarkably unpre- 
dictable, and we are constantly amazed by how differ- 
ent nature is from what our experts of the past have 
prophesized. And despite more prognostication that the 
end of new knowledge is ■ plight,there  is general 
agreement that there has been no real slowing down of 
the rate at which important new scientific concepts are 
established. Most, of course, have no immediate practi- 
cal consequence. But when one does, say in the devel- 
opment of semiconductors by life solid-state physicists, 
the payoff may be large indeed.
Although for a short time a growing society may try to 
live off the new facts produced by others, this approach 
appears not to be a recipe for long-term worldwide 
leaderlpp. Witness that the United States only became 
a major world power when it was the undisputed leader 
of world science, and that the long-held conception in 
the United States and Europe that the Japanese get 
ahead by copying the West is almost certainly false, 
reflecting more our inability to speak their language 
than any critical evaluation of the way they educate 
their students and encourage the development of new 
ways of thinking.
What almost seems inescapable is that the deeper we 
understand the ways of nature, the more capable we are 
of using it for human benefit. Over and over, in retro- 
spect we see that we never had a realistic chance to 
solve an applied problem until our scientific base was 
raised. Only, for example, by discovering that there 
were three immunologically distinct forms of poliovirus 
could we move beyond the inadequate iron lungs and 
truly conquer polio.
We must also realize that pure scientists, almost 
without exception, have no reluctance to exploit their 
observations for practical use. The fact that most of us do 
not get involved in practical matters is; not a matter of
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ineffectively immortal and multiply without stop in cul- 
ture, a condition no doubt related to their cancerous 
state. Their existence, however, gave to George Kohler 
and Caesar MiIstein, working in Cambridge, England, 
the idea that rf they fused mouse myeloma cells with 
normal intibody-producing cells from the spleen of a 
mouse that had been immunized agamst sheep red 
blood cells, the resulting hybrid cells might continue to 
produce the desired antibody against sheep red cells, as 
well as become immortal. Five years ago, the first such 
successful experiments were done, giving rise to clones 
of mouse cells that provide antibodies of desired single 
specificity (monoclonal antibodies). Since then, mono- 
clonal antibodies have been made against large num- 
bers of different antigens, and this procedure, because it 
leads to highly reproducible antibodies of high specific- 
ity, may soon supplement all current commercial ways 
of making antibodies. Here it is relevant to emphasize 
that:
1. This technique could not have been developed 
without the past two decades of solid advances in un- 
derstanding the celkalar basis of the immune response. 
Equally necessary was the finding in the mid-1960s by 
the English cell biologists Harris and Watkins of routine 
ways for fusing cells.
2. All the key steps were done by pure scientists, this 
time working in a laboratory for pure molecular biology, 
supported by the British Medical Research Council.
3• The most important early uses have been in the 
area of pure immunobiology and cell biology, giving to 
these fields new armadas of specific antibodies directed 
against biologically important molecules on cell sur- 
faces.
4. The idea seemed so simple that no thought was 
given to patent protection until it was too late. Nonethe- 
less, the extraordinary power of the monoclonal anti- 
body procedure has quickly led to multiple commercial 
uses. As w l  recombinant DNA, several companies 
have quickly beenTormed to exploit it. The fact, how- 
ever, that most major pharmaceutical.Jnouses have 
m a jcrilh o use  immunological strength has quickly led 
to their movipg to improve their vaccine (medical tech- 
nology) capabilities through the monoclonal proce- 
dures.
Both of the examples cited here are textbook cases of 
where an advancement in pure science led inescapably 
to the public good through the production of products 
not previously effectively available. What is novel here 
%that molecular biology, prior to these discoveries, was 
regarded as one of the purest of the sciences. Until a 
year or so ago, almost none of our students ever thought 
about jobs in industry, nor were my peers boosting their 
incomes by being asked for their advice by industry. 
Now our lives are very different, and many of the peers 
for whom I have most regard as scientists are shuttling 
back and forth from their industrial backers. And, of 
course, they are no longer saying that the doers of
the genes of higher organisms have occurred that would 
have been impossible without recombinant DNA.
4. Thetfhitial developers of the recombinant DNA 
methodologies realized from the start that there could 
be major commercial applications and in due course 
became consultants and stockholders in several of the 
new companies that were formed to exploit the tech- 
nology. They also saw to it that patents were taken out 
by their respective universities to protect their rights, as 
well as their universities, in the development.
5. No major pharmaceutical company moved quick- 
ly into this work, in part because, on the whole, they had 
seen no need previously to emphasize applied devel- 
opments in either bacterial genetics or nucleic acid 
enzymology. So they didn't possess strong internal lob- 
bies to push the advantages of recombinant DNA. They 
were also afraid to be labeled as genetic engineers, 
knowing that the public badly confused work with bac- 
teria with actual experimentation on humafis. With the 
now much diminished public concern about recombi- 
nant DNA, however, we may expect the pharmaceuti- 
cal giants to try to catch up, often by buying up or into 
some of the newly formed recombinant DNA com- 
panies.
Growing industrial exploitation of monoclonal an- 
ti bodies. Until several years ago, antibodies either for
vaccine production or for medical testing or scientific 
research were made by injecting the appropriate anti- 
gens (e.g., diphtheria toxin) .into suitable laboratory 
animals (usually rabbits and guinea pigs, and when 
large vaccine amounts were needed, sheep and horses). 
All such resulting antisera are heterogeneous— con- 
taining antibodies of varying degrees of strength di- 
rected against different chemical groups on the surfaces 
of the respective antigens. Long desired, but not appar- 
ently easy, was a way to make preparations of identi- 
cally strong antibodies all directed against a single an- 
tigenic group. In the 1960s this goal began to look 
increasingly distant as we began to learn some of the 
basic facts about the cellular basis of the immunological 
response. In particular, the immunological response of a 
single animal usually involves the selective synthesis of 
large numbers of different lymphocytes, each of which 
makes its own unique type of antibody. Hence the 
heterogeneous nature of all available antisera.
It thus became obvious that the only way to produce 
single-specificity antibodies was somehow to find the 
conditions under which single-antibody-producing 
cells could grow in culture— like bacteria. By starting 
such cultures with single lymphocytes, all the resulting 
antibodies would be made by genetically identical lym- 
phocytes, and so possess identical antigen-combining 
sites. All such efforts invariably failed, however, telling 
us that normal antibody-producing cells lack the ability 
to multiply indefinitely. This is a great contrast to the 
behavior of the abnormal antibody-producing cells that 
generate the cancers we call myelomas. Such cells are
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applied sciences are no better than mercenaries for the
rich.
I therefore conclude that the main factor that keeps
academic thinkers aloof from the real world is not a
matter of principle, but the lack of common interest,
with most encounters likely to make both sides some-
what edgy. Whereas we as intellectuals have ideas as
our chief currency, those in industry or business or
agriculture must focus on the economic production of
the worldly goods without which our societies would
quickly crumble. Our short-term roles are thus so differ-
ent that very little good is likely to come through too
frequent intermixing.
On the other hand, when we do have relevant an-
swers, then we are not the impractical souls of common
perception and can make ourselves effectively heard.
Our physicists, for example, have never hesitated to
enter into inherently political battles about nuclear
weapons and how they may be controlled. They know
they will rise or fall along with the rest, and their appear-
ance of absentmindedness must necessarily be dropped
when they are needed.
At the same time, we must never forget what we can
do best. In our searching for ways to understand better
the world around us, we are a vital, if not the vital, key
for ensuring that the various civilizations of men can
long prevail over the inherent chaos of the physical
world about us. We thus have as much to lose from false
humility as from elitist arrogance. In working toward the
advancement of our civilization, we must never forget
that ideas are not only beautiful, but necessary.
Highlights of the Year
The Yeast Group confirms its cassette model for the
yeast mating-type genes
Almost four years ago, I received a letter from Ira
Herskowitz stating that two of his students at the Uni-
versity of Oregon, Jim Hicks and Jeff Strathern, would
profit by continuing their collaboration at Cold Spring
Harbor and that we should consider the possibility of
letting them work year-round in Davenport lab on the
genetics of yeast. Its space then was largely unused,
except during the teaching of our summer courses on
genetics. Exciting to Ira then was the cassette model that
Jim, Jeff, and he had devised for mating-type intercon-
version. This idea opened up a completely new way to
think about the control of gene action in yeast, if not in
all eukaryotic cells. Purely genetic considerations led
initially to the cassette proposal, and it could best be
confirmed by recombinant DNA procedures. Why not
here at Cold Spring Harbor, provided we continued our
habit of giving labs to younger scientists and encourag-
ing them to work at maximal speed?
Happily, Ira's advice was quickly seized upon, and
Jeff arrived in the fall of 1977, first working in Ray
Gesteland's lab until he moved to Davenport lab follow-
ing Jim Hicks's arrival six months later from Jerry Fink's
Cornell lab. There Jim had spent two postdoctoral years
helping to work out the yeast transformation system.
With Amar Klar's arrival from Berkeley, and with Jim
Broach also moving from Ray Gesteland's lab in Dem-
erec, Davenport was ready for the big push to clone
the mating-type genes to see whether the "silent" loci
predicted by the cassette model would be found. After
only six months effort, the first mating-type gene was
cloned in February, and by the summer's end the cor-
rectness of the cassette model was demonstrated at the
molecular level, not only from work here, but also
through similar experiments done in Seattle by Kim
Nasmyth, working in Ben Hall's laboratory.
Important as these results are, they should be seen as
opening up a field, not finishing it, and a bundle of new
experiments are awaiting to be done to try to work out
how the cassettes move from one spot to another. So the
fact that the Yeast group has almost to abandon research
during the summer course period is increasingly awk-
ward, if not downright depressing. This past fall, we thus
began talking about how we might put an addition onto
Davenport, and brought in our architects, Moore
Grover and Harper, to come up with an aesthetically
suitable addition. Now we have plans for an -3000 sq.
ft. addition in the form of a small colonial-type building
to the south, connected to Davenport on two levels,
with much underground space for biochemical in-
strumentation. We hope to start construction by early
June at the latest, with completion scheduled some ten
to eleven months later. The summer of 1981 can thus be
happily anticipated, knowing it will not force your yeast
geneticists into another enforced absence from real ex-
perimentation.
Receipt from NIH of a program-project grant to
support our Movable Genes effort
Strongly helpful, if not crucial to the success of our
efforts in tumor virology, has been the receipt for the
past nine years of a very large program-project grant
from NCI which covers the salaries and research monies
of key staff members who work on our SV40-adeno
projects. It gives us an ability to think big, both with
regard to the problems we choose, as well as the capac-
ity to recruit highly talented younger scientists to re-
place staff who have moved on to other institutions. The
value of a similar backing for our genetic's program has
long been obvious. It would help to formalize a long-
term commitment to genetics similar to that which
existed here between 1904 and 1963 under the aus-
pices of the Carnegie Institute of Washington. With the
creation of our Yeast Group and our already strong
programs in bacteriophage /.4., directed by Ahmad
Bukhari and David Zipser, we again felt strong enough
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in genetics to try for program-project support. In May,
under the title of "Movable Genes," we submitted a
heavy packet of material that proposed long-term sup-
port for the salaries and much of the research of our key
staff whose research centers on those genetic elements
that can move from one chromosomal site to another.
Happily, this proposal was well received, and in January
1980 the NIGMS Advisory Council approved our pro-
posal with a high priority. We thus have every confi-
dence that Cold Spring Harbor's long tradition of excel-
lence in fundamental genetics will be maintained.
Isolation of the chicken thymidine kinase gene
Among the most powerful tools now available for study-
ing the genes of higher vertebrates is the transfection
technique worked out in 1977 by Michael Wig ler and
Richard Axel at the College of Physicians and Surgeons.
Mike's arrival here in December of 1978 to head our
Mammalian Cell Genetics section quickly led to a rash
of experiments aimed at producing cloning vehicles
through which mammalian and avian genes can be
moved from one higher cell to another. Already there
has been one major achievement, the use of direct
selection procedures to isolate the cellular chicken
thymidine kinase gene on a bacterial plasmid, followed
by its subsequent reintroduction in a functional form
into mouse cells. Manuel Perucho and Doug Hanahan
played vital roles in pulling off this feat, which should be
reproducible for many vertebrate genes. In particular,
we shall seek ways of isolating the "cancer-causing
cells" in cells transformed by chemical carcinogens.
Use of recombinant DNA technology to understand the
integration of tumor viruses
Perhaps the most serious consequence of the harsh
regulations adopted for recombinant DNA was the vir-
tual prohibition of experiments in which the genes of
tumor viruses were inserted into E. coll. Yet, until this
technology was developed, there was, for example, no
realistic way to isolate specific regions of transformed
mouse cells which contained SV40 sequences. So for
more than two years, we felt totally frustrated by regula-
tions that at best could be thought of as well-meaning.
The first appearance of flexible rules occurred in Eng-
land, and to there (ICRF) Joe Sambrook and Mike
Botchan went in 1978 to do their first cloning exper-
iments on integrated genomes. By February of 1979 the
worst American rules were gone, and since then the
cloning of viral genomes has been most actively pur-
sued in James lab. Already we know the exact sequence
of one integrated SV40 genome, as well as the cloned
sequences of viral chromosomes generated when the
SV40 genome is placed in a permissive cell and some-
how comes out of the host chromosome. As a result,
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Botchan and Sambrook now can argue that excision
does not use virus-specific excision enzymes, but in-
volves a process involving replication of the integrated
viral DNA followed by an "illegitimate" genetic re-
combination event that releases the integrated se-
quences.
Our monoclonal-antibody effort takes of
In the fall of 1978, David Lane, a most-experienced
immunologist who trained in London under Av Mitchi-
son, came to James lab hoping to make a set of mono-
clonal antibodies against the SV40 large T antigen.
Using highly purified material made by Bob Tjian, this
past year he has not only generated a series of by-
bridomas of the required specificity, but shown that one
of the respective monoclonal antibodies reacts not only
with the SV40 T antigen, but also with a normal cellular
protein of -80,000 m.w. whose amount increases fol-
lowing cell transformation induced by a broad variety of
agents. The implications of this most unanticipated re-
sult are still open, with David now suspecting that the
normal protein may have a function like that of the large
T, thereby paralleling the relationship between the src-
gene product of Rous sarcoma virus and the very similar
protein found in smaller amounts in uninfected normal
cells.
Given one successful major monoclonal effort, we
have extended this technique to other antigens and
already have particularly encouraging results, with Jim
Lin using striated muscle fibers and myoblast cell
membranes to generate monoclonal antibodies of many
specificities, some of which we have not seen before.
And through immunization of a mouse with the nerve
cells of the leech, Ron McKay and Birgit Zipser have a
number of monoclonal antibodies that react in quite
specific ways to the leech nervous system.
Now we wish to increase still further our range of
hybridomas, but we are finding that we are badly short
of cell-culture facilities specifically set aside for this
purpose. So we have started to plan an addition to James
lab, to run to the north, which would be devoted exclu-
sively to the generation of the potentially thousands of
different hybridomas that are likely to be generated as
we immunize mice with the major classes of cells and
viruses. The resulting monoclonal antibodies may prove
invaluable as radioactive isotopes for the cell biology
research of the next several decades.
Our Symposium marks a milestone in tumor virus
research
It was easy to decide to hold this year's Symposium on
Viral Oncogenes. The tumor virus field is almost unrec-
ognizable from its state in 1974, when we held our first
Symposium on this topic. In this interval, much empha-
sis has shifted from the viruses themselves to the charac-
terization of those viral genes which directly promote
the transformed state. In particular, with the recent iso-
lation of the SV40 (polyoma) T antigens and of the Rous
src-gene product, the mechanisms of transformation
could for the first time be seriously discussed at the
biochemical level. Now, for example, many of us know
more about protein kinases than we ever thought
needed.
The Symposium opened with Howard Tem in giving a
typically eclectic talk that asked whether much human
cancer is, in fact, caused by tumor viruses. Ten years
ago, his answer of "no" could have badly disturbed
many tumor virologists and, if then commonly ac-
cepted, would most likely have kept the tumor virus
field from moving so rapidly. Now we see that, even
assuming that Howard's views are correct, the massive
monies spent on tumor viruses has been most well used,
giving us insights into cancer that never would have
been generated had, say, the Rous sarcoma virus not
been so well studied. Giving the summary this year was
Phil Sharp, who did a very neat job comparing the
oncogenic products of the DNA and RNA tumor viruses.
As with the past several Symposia, the number of
papers presented were virtually more than anyone
could absorb. Yet reflecting the high quality of this field
almost no one was complaining that we had let in
people to speak who had nothing to say. As in most
previous Symposia, the audience again exceeded by
almost two hundred the number of seats in our lecture
hall. Only through the use of our closed-circuit TV, most
ably supervised this year by Herb Parsons, could we
ever handle such a massive overflow. We clearly need
to expand our auditorium, but how to do so is still open.
We have considered a balcony, but fear it would be just
awful, and so, unlike our mood of a year ago, reluctantly
realize that probably only a completely new auditorium
will reflect the fact that the science that Cold Spring
Harbor has long focused upon is now at the center of
biology. It may now be almost impossible to hold an
interesting Symposium that does not generate an audi-
ence of three-hundred and fifty or so.
This being the case, we must somehow generate
funds that most certainly must exceed $750,000, if not a
million dollars. Probably only with such a large sum will
we have a building suitable for at least the next twenty-
five years (the Busch auditorium was built twenty-eight
years ago).
Major changes in our scientific staff
Unlike many Labs, a sizable fraction of our postdocs
stay on to become members of our staff, and by the time
they leave, we have virtually forgotten them as they
were upon arrival. They have become so indispensable
to our way of life that we cannot really believe that one
day, suddenly, they will be gone, and that we shall feel
Mike Botchan
so vacant. This year's staff loss has been particularly
noticeable, with Mike Botchan going to a tenured posi-
tion at Berkeley, Richard Gel inas to the Fred Hutchison
Cancer Center in Seattle, Ashley Dunn to the European
Molecular Biology Institute in Heidelberg, Sayeeda
Zain to the University of Rochester Medical School, Jim
Broach to join the Department of Microbiology at Stony
Brook, and Dietmar Kamp and Regine Kahmann to the
Max Planck Institute for Molecular Genetics in Munich.
Leaving us at the end of their postdoctoral positions
were Edmund Cheng to join Lan Bo Chen at the Sidney
Farber Center, Bill Gordon to go into business in
California, Marian Harter to take up a faculty position at
the College of Medicine and Dentistry of New Jersey,
Kajra Khatoon to return to her teaching position at
Karachi University, David Lane to take up his teaching
position at Imperial College in London, and Daniela
Sciaky to join the Biology Department at Brookhaven
National Laboratory.
Newly appointed this January to lead our Protein
Structure Group is John Smart, who first came here as a
visiting scientist from the Imperial Cancer Research
Laboratory. Yakov Gluzman, Jeff Strathern, and Jim Car-
rels have moved into Staff Investigator slots from their
postdoctoral positions, with Jim Hicks in turn moving up
to a Senior Staff Investigator position. And Stephen
Hughes has joined us as a Senior Staff Investigator in
James lab following his postdoctoral period in the
Bishop-Varmus group in San Francisco.
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Clockwise from top left: Alfred D. Her-
shey; Alan Garen, Rollin Hotchkiss,
Magda Hotchkiss; Hershey Building in-
terior view; exterior view; I.D. Watson,
Franklin W. Stahl, lames D. Ebert, Alfred
D. Hershey, Max Delbruck, Salvador E.
Luria
We have also successfully offered Senior Staff Inves-
tigator positions, to commence in mid-1980, to John
Fiddes, a former student of Fred Sanger at Cambridge
and now at UCSF with Howard Goodman, and to Fred
Heffron and Magdalene Y. H. So, both products of
Stanley Falkow's lab at the University of Washington
and now, also, at UCSF. All three have recently been
involved in very imaginative'gene-cloning experiments,
and their arrival here should further strengthen our po-
tentiality for high-powered molecular biology.
Promotion to the Senior Scientist position
Last year we created the position of Senior Scientist
whose holders have a continuing rolling commitment of
five years of salary support. Promotion to this rank is an
important event, since it signifies that we have faith that
the individual concerned is capable of a sustained,
high-level scientific future. Acting at their April meeting,
our Board of Trustees approved the well-deserved ad-
vancement to senior Scientist of Tom Broker, Louise
Chow, and Terri Grodzicker.
The Robertson Research Fund continues
to provide necessary flexibility
Funded in 1973 with a most magnificent capital gift
from our neighbor, Mr. Charles S. Robertson, the
Robertson Research Fund provides, each year, funds for
laboratory renovations, key equipment items, and
stipends for selected younger staff and postdoctoral fel-
lows. This year it was especially important in allowing
renovation of the ground floor of McClintock lab for our
expanding Cell Biology Group, as well as providing
funds for much of their needed major equipment and
supply monies to tide them over until they obtain ex-
panded grant support. We note here that this year, as in
the past, it has been the availability of Robertson Funds
that has allowed the creation of an entirely new effort by
the Laboratory. Besides ensuring the successful expan-
sion within McClintock of our Cell Biology Group, it has
been only through Robertson monies that we were able
to ensure that Michael Wigler's Mammalian Cell Group
could start up so effectively.
Dedication of the Alfred D. Hershey Building
Of the scientists who have worked at Cold Spring Har-
bor, none surpasses Al Hershey in the elegance of his
experimentation or the crisp clarity of his writing. Al-
ready Al's reseach on bacteriophage has generated
many honors including the Nobel Prize, which he
shared in 1969 with Max Delbruck and Salvador Luria.
There was no doubt that, with time, a building here
would bear his name. That occasion came formally to
pass on August 23, when the Alfred D. Hershey building
was dedicated before a large number of assembled
friends and admirers. The Hershey Building results from
a most imaginative rebuilding of the greenhouse and
potting sheds put up by the Carnegie Institute around
1910 for plant-breeding research. Long abandoned and
seemingly destined for total extinction, they have been
most cleverly reprogrammed into offices for scientists
working in Demerec laboratory, as well as space for
new machine and electronic shops, equipment repair,
our safety office, and receiving. The architects Moore
Grover and Harper of Essex, Connecticut, are to be
congratulated for combining style with simplicity, and
Jack Richards is again to be commended for overseeing
the not at all trivial construction process.
Among the many guests at the dedication ceremony
were Al's long-time close friends, Max Delbriick and
Salvador Luria, who joined Jim Ebert of the Carnegie
Institute of Washington and Frank Stahl of the University
of Oregon to give short speeches in honor of Al, who
graciously rose to the occasion by responding that he
now knows what Hershey heaven must be like. Follow-
ing a dinner on the lawn of the newly repainted Car-
negie Dorm, a square dance was held, bringing back my
fond memories of similar such dances conducted by
Carlton McDowell for over thirty years on the same
green summer lawn. To mark the occasion, a very
handsome booklet summarizing Al's career, together
with appropriate pictures from the past and present, was
put together by Tom Broker.
The Carnegie Dorm is now again in its original colors
The handsome Victorian house on the corner of
Bungtown Road and 25A was built by our founder, Mr.
John D. Jones, around 1875-1880 on the site of the
ancestral house where he was raised and which burned
down in 1862. As far as we can tell, Mr. Jones, the most
prominent member of the long-illustrious Cold Spring
Harbor Jones family, never lived in his newly built
Carnegie Dormitory
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house, living in another family house in Massapequa
when he was not in New York as President of the Atlan-
tic Mutual Insurance Company, the largest marine in-
surers that then existed in the United States. Early in its
existence, it was used by Mr. Fred Mather, the first
superintendent of the Fish Hatchery that Mr. Jones had
established around 1884. When Mr. Jones died in 1893,
his nephew, Townsend Jones, took up residence, stay-
ing there until 1904 when the Carnegie Institute's De-
partment of Experimental Evolution (later to be known
as the Department of Genetics) was established. Then its
Director, Charles Davenport, moved in to stay until
1932 when he retired as Director. It then served as a
residence for unmarried staff of the Department of Ge-
netics, and in this role became known as the Carnegie
Dorm, a designation that still holds today.
With time, its physical state, both outside and inside,
gradually declined, with its large size precluding the
possibility that any small monetary input would delay
the decay. Last summer, knowing that we had to act
firmly or totally lose what may well be one of the finest
Victorian houses on Long Island, we did extensive car-
pentry work on its complicated exterior, put on a new
roof, and repainted it in its original colors. Helping us
here was my wife, Liz, and Frank Matero, an expert in
paint analysis, who worked on Theodore Roosevelt's
home, Sagamore Hill. At first there were many outcries
that any color other than white was inappropriate for
our community, but as the painting came to a close, we
have found that most neighbors like what we have done,
and there is increasing enthusiasm for more such
examples of historic preservation. To help cover some
of the additional costs involved in the application of the
six original colors, a special paint fund was created, to
which myself, Edward Pulling, Mary Lindsay, Betty
Schneider, and Norris Darrell made donations.
Now we have started work on the interior, putting in a
new heating system, which should reduce greatly its
now not trivial heating bill. Much new wiring and
plumbing are also being installed, with the aim to have it
ready for our summer guests. Then in a greatly renewed
way, it can resume its necessary dormitory-like role.
A most major gift from the Fleischmann Foundation
When Max Fleischmann set up his very large Founda-
tion in 1952, he set a termination date of 1980. So
knowing that almost one-hundred million dollars were
to be distributed within just two years, we asked its
Trustees whether they would consider a serious pro-
posal from us for capital funds. To our joy they said yes,
and we sent in a formal proposal asking for matching
funds to complete the financing of our new Animal
Facility and of the Sammis Hall residence at the Banbury
Conference Center. We also requested more modest
funds to make our lecture hall more suitable for
closed-circuit TV. Happily our first two requests were
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granted in August, providing us with a most-needed
$350,000 for the Animal Facility and $225,000 for
Sammis Hall. This marvelous gift allowed us soon after
to sign a construction contract for Sammis Hall, which
initially we hoped to have ready this spring. Delays in
construction, however, have set back its timetable, with
our first use of it now being planned for late summer.
We have also experienced delays in obtaining the
final working drawings for the Animal Building. We
wanted to break ground early in the spring of this year
(1980), but now fear that it may be July 1 before this
happens. We are getting increasingly impatient as our
tiny mouse house becomes increasingly inadequate
with each passing month.
The largest number of visitors so tar
This past summer we welcomed over 2600 scientists to
our meetings and summer courses. With our nine sum-
mer meetings, twelve courses, and four workshops, we
were constantly seeing new faces depart before we
learned many of their names. The net effect on each of
us, however, was very beneficial, giving us many oppor-
tunities for establishing new scientific friendships, if not
col laborations.There was, in addition, the heavy stimu-
lation provided by the course lectures, for which many
of the world's most distinguished biologists came here
for a day or so to tell what they are doing to student
audiences many of whom have never seen the scientists
whose names are attached to the journal articles that
fascinate them. Happily, we are increasingly making
use of the Banbury Center, where two of our lecture
courses and one advanced workshop were held.
Unfortunately, we now have to send to nearby motels
many of our meetings' participants, and we were there-
fore most fortunate in having the opportunity, given to
us by the family of Mrs. Nan Wood, to use her most-
splendid home, Fort Hill, to house some of our guests.
Her father, the noted industrial chemist, William J.
Matheson, was President of our Board of Directors from
1904 to 1922, leaving upon his death in 1930 the then-
considerable $20,000 Matheson bequest to the Long
Island Biological Association.
The Yeast Course refuses to die
In planning last summer's program, we realized it would
be the tenth consecutive year in which we had given our
course on Yeast Genetics. Taught most ably by Fred
Sherman and Jerry Fink, it has trained a good fraction of
our younger generation of yeast molecular biologists,
and clearly we had made the right decision to start it up.
So why not stop when we were ahead, and we told Fred
and Jerry that this would be the last year they would be
needed here to teach. By the beginning of the summer,
however, we knew we had made the wrong decision, as
there had been a spectacular rise in the number of
applicants (more than double that of the previous year),
no doubt due to the yeasts increasing potential for re-
combinant DNA experimentation. So again in 1980,
and possibly for many years in the future, the Yeast
Course will continue.
Again we have solid support for our Neurobiology
Courses
This last year marked the ninth consecutive year that we
have mounted a major summer teaching effort in
Neurobiology. Sloan Foundation funds covered this
program for the first three years, until we obtained an
NIH training grant that covered the following three
years. We then got caught up in the dilemmas that
surrounded the payback provision of the new Training
Grant Law, and in 1976 and 1977, only through adroit
maneuvering by Bill Udry, and with much help from
concerned NIH, NIMH, and NSF administrators, did we
get some modest support. Only through monies pro-
vided to us by the Banbury Foundation, through the
creation of the Marie H. Robertson Fund for Neurobiol-
ogy, were we able to keep our core curriculum alive.
While increasingly nervous about the attitude of the
governmental granting agencies toward our neurobiol-
ogy summer teaching, we again applied in the fall of
1978 for a long-term commitment, asking NSF for sup-
port for our two CNS-related courses in Jones and NIH
to support our two Banbury lecture courses, as well as
two experimental (the Leech and Experimental Tech-
niques) courses taught in McClintock lab. Happily, al-
most all the support requested materialized, with NIH
early last June granting us all the funds we requested
from them. While NSF could grant us monies to support
only one of the courses in Jones, a most-appreciated,
last-minute grant from the Klingenstein Fund virtually
closed the gap, and all six of last summer's courses were
adequately funded.
An expanded program of Neurobiology Workshops
Several years ago a sizable Sloan Foundation grant let us
commence several summer reseach workshops to
complement our formal teaching courses. These were
so successful that we have continued them, seeking out
other funds to replace our now-expired Sloan grant.
Using funds from the Rita Allen Foundation, we had a
most exciting Pain Workshop in Jones, and the Digital
Equipment Corporation gave us one of their most ver-
satile MI NC computers so that our Synapse Workshop
could focus on the use of computers in analyzing
neurobiological electrical signals. Our Artificial Intelli-
gence Workshop was again supported by funds from the
Cognitive Science Program of the Sloan Foundation,
and the Limulus-focused workshop was made possible
using Marie H. Robertson funds.
A very successful year for publications
This was again a year in which we could be very proud
of our publications. At the opening of the year appeared
the latest volume in our monograph series, "The
Single-Stranded DNA Phages," edited by David Den-
hardt, David Dressler, and Dan Ray. It came out attwice
the initially projected size and so had to be priced at a
much higher figure than desired. But this large volume is
in no way padded, and it should prove increasingly
sought after as the M13 -like phages become a common
ingredient in DNA sequencing. The "Operon," edited
by Jeffrey Miller and Bill Reznikoff, has sold well
enough during its first year to cover its initial production
costs, and so we plan to bring out a much lower priced
paperback edition that should encourage its adOption in
molecular genetics courses.
The bringing out of the annual Symposia was again a
massive trick, with Volume 43 (DNA Replication and
Recombination) running to almost 1400 pages and re-
quiring a two-book set. Through much sustained effort,
we had it on hand just as this year's Symposium started.
Clearly, we would have liked to get it out quicker, but its
production being essentially a linear process, it is sub-
ject to so many potential delays that its appearance in
less than a year after the meeting is a real achievement
for Nancy Ford and her most-dedicated staff. Also most
impressive is this year's offering in the Cell Proliferation
Series, entitled "Hormones and Cell Culture." Ably
edited by Gordon Sato and Russell Ross, its initial sales
have been good, and its excellence combined with its
great topicality should ensure a wide distribution.
We, also, this year brought out a more polished form
of the lab manual for our course on the Transformed
Cell, entitled "Experiments with Normal and Trans-
formed Cells." It was assembled by Ruth Crowe, Harvey
Ozer, and Dan Rifkin.
The number of books, manuals, and abstracts sold
during 1979 was 17,800, to be compared with a 1978
figure of 16,300.
The Banbury Meeting House draws nothing but raves
When we acquired possession of Mr. Charles S.
Robertson's estate in the late spring of 1977, we had
high hopes for eventually using it in a most-imaginative
way. When that was to be was not obvious, however,
since we needed both a program to give it its own
uniqueness and a Director to carry it out. We also had to
somehow convert what was a perfect site for family
living into a complex that would successfully hold small
conferences in a fashion equal to that done so well in
London by the CIBA Foundation. Giving us a great head
start was our architects most imaginative transformation
of the former Georgian-styled garage into a meeting
center with a super central conference room of which I
have seen no visual equal. For this we owe Charles
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Moore and his colleagues a great debt. Equally impor-
tant was the recruiting of Victor Mc El heny to be its first
Director, and subsequently his ability to persuade the
Sloan Foundation to give us the needed seed monies to
begin a high-quality program of meetings on Biological
Risk Assessment. This enabled us to go to the NCI with
firm plans, and here we must acknowledge the great
help that they have given which has allowed us to start
up with the highest possible standards.
Already we are almost running at our maximum ca-
pacity of six yearly meetings, whose proceedings we
transcribe and quickly turn into useful books. That task,
combined with the holding of several more informal
workshops for journalists and congressional aides, gives
to Vic a position where boredom is impossible to imag-
ine.
LIBA never ceases to help us push for the best of science
Existing as we do almost an hour from any major site of
biological research, we are seemingly isolated in a
world that can know nothing of our virtues and at best
regards us with the latent suspicions that exist between
any two cultures that speak different languages. The
truth is fortunately just the opposite. Through the help
provided by our neighbors who comprise the Long Is-
land Biological Association (LIBA), we have firm, warm,
local support, which, if widely known, should create
envy in virtually every other serious research institution,
if not major private university. That we were in a true
sense founded by our community, of course, helps, but
the credit must go to the fact that we have always tried to
work hand-in-hand with our neighbors to solve our
common problems and, in doing so, have built up a
record of mutual trust that I find truly remarkable. We
also have been fortunate that LIBA has always been led
by men of such high character, and among these Ed
Pulling, in his ability to channel effective support for us,
has no peer.
Behind our scientists is a most effective
supportive and administrative staff
That we can do so much science so quickly owes much
to the fact that as an administrative entity we try to
function in a much more personal way than many other
institutions where the bureaucracy does not mesh well
with those they serve. Supervising that whole show now
for over nine years is Bill Udry, whose ability to intelli-
gently adapt to still one more crisis does much to keep
us on a steady upward course. Likewise, life without
Jack Richards, our super contractor in charge of all of
our building here, is just not imaginable. In April of this
year, Jack will have been here ten years, joining us just
in time to successfully preside over the construction of
the James Annex, the real turning point in making it
known that the Lab would not decay further, but would
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thoroughly transform itself into an institution with aspi-
rations for the very best.
Behind Bill and Jack stand so many competent people
that it is unfair to single out a few for special praise. I
should like, however, to mention the retirement of Julius
Ku lmayer, a carpenter of highest quality, who came to
us when Jack joined the Lab. Likewise, we are not the
same without Bruce DeTroy, who presided so much
over our shops for over eight years. And, regretfully, I
must note the sudden death of our grounds man, Car-
men Dewan, and the premature, sad loss of our most-
dedicated artist and photographer, Bob Yaffe. On the
more positive side I should mention our new cook,
Jim Hope, who has the talent to cheerfully serve five-
hundred perfectly cooked, warm lobsters, Stephen
Humenick in whom we have a most-innovative mind
for our electronic shop, Mike Ockler, who brings high
talent as a draftsman and photographer, Herb Parsons,
who gives us the audio-visual support we have so long
required, and Deborah Lukralle, who keeps our tiny
mouse house so effectively run.
A continued necessity for a strong Board of Trustees
Sitting here in our still semi-wild, almost pristine, envi-
ronment, it is very easy to concentrate inward and not
see ourselves as others must. We thus remain fortunate
that our Board of Trustees possesses such great strengths
in science, academia, law, and business, and is, there-
fore, able to give us invaluable counsel. Leading them is
Harry Eagle, rightfully known as both a scientist of the
highest order and one of the best administrators of sci-
ence that we have had in the United States over the past
three decades. He has been aided this year by a particu-
larly strong Executive Committee, which also includes
Edward Pulling, Clarence Galston, Bayard Clarkson,
Robert Cummings, and Vittorio Defendi. In this capacity
they must frequently meet here to give their approval for
new actions, and everyone on our staff is greatly indebt-
ed for the carefully wise way they commit us to action.
Because of a statutory limit on tenure of service, we
lost the services in October of Drs. Herman Eisen and
Rollin Hotchkiss, and Dr. Joseph Kates resigned as a
consequence of his move from Stony Brook to the
Scripps Institute in LaJolla. Arnold Levine, in his move
from Princeton to Stony Brook, now becomes our Stony
Brook Trustee. Elected to fill the Princeton position is
Abraham Worcel, a long-time friend and constant vis-
itor here. Also newly elected is Charles Stevens, chosen
by Yale University to represent them following their
decision to join our Participating Institutions. Chuck
knows us well through his participation in the Synapse
Course and gives to our Board of Trustees its first distin-
guished neurobiologist. We also welcome back Norton
Zinder as the Rockefeller Trustee, as well as Walter
Page, who has served previously between 1963 one
1969, and 1972 and 1978.
We must soon come to grips with the
fact that the forefront of much of our
science has commercial implications
Until the past year or so, most of our scientists had never
heard of an investment banker, much less met one. Now
we know several who say they can take dollars from
those fortunate souls who need tax losses and miracu-
lously promise fifteen dollars for every original one they
might entrust to our putative genius for manipulating
DNA for the benefit of mankind or for making anti-
bodies do tricks that until now only hotshot chemists
were capable of.
This most certainly is a new world for us, and joining
it has its perils to say the least. At the worst it would so
dilute our thinking about difficult science that we would
soon not be competitive with the best of our peers. Even
if we decided that money was the thing, our amateur
status could easily let us fail, leaving us with no true
home in either camp. At the best, some foresighted
industrial firm would give us piles of money to let us do
what we want to do anyway, say, to develop for use in
the mouse, if not human cells, the perfect cloning vehi-
cle that has a promoter which can maximally produce
any desired gene product. That would let us do wonders
scientifically, as well as more than interest those who
want to see whether large amounts of authentic interfer-
on would actually work in humans.
So there is no avoiding the fact that some of our most
sought after goals may also have a monetary figure
attached, and we would be naive not to realize that we
may have some bargaining chips. If we were Bell Lab's
subsidiary, all the profits would go to ATT, but we would
have guaranteed super working conditions, as well as
salaries superior to those in academia. But here, as in
almost every other research institution or university, we
cannot offer the long-term security to do unimpeded
research. As a tradeoff to our scientists, they are free to
consult with industry, if not to take an equity interest in a
new company designed to reap the commercial fruits of
molecular biology.
But if our individual staff can join forces with industry,
does it make sense for the Lab itself to continue to have a
hands-off attitude from any direct involvement in bring-
ing our ideas to the market world by not acquiring some
equity in any company that wishes to use our ideas. The
conventional response, that such a course is bound to
divert us as a lab from our real purpose of high-level
biology, may very well be right. Here we need badly the
wisdom of our Trustees to whom we have already re-
ferred this problem.
Financially we end the year in strong shape
Thanks in part to our large Fleischmann gift, our year-
end finances are stronger than at any time since I have
been Director. We have been running at more than full
utilization of our research and meeting facilities, and
none of our service and maintenance staff are under-
employed. Our Lab's productivity, seen from the econ-
omist's viewpoint, has been on an upward course,
which we hope to maintain by investing almost all the
free cash we generate into new laboratories and equip-
ment that will let us do even better science. We do this
believing that the safest way to protect our future is to
keep at the forefront of science, as opposed to the piling
up of a large reserve of cash to draw on in case our
nation's support of science badly stalls.
Here we are optimistic and assume that our country's
fortune will never fall so low that it loses the will to keep
itself scientifically strong. We are, of course, aware that
we are passing through a most hazardous economic
period for our nation, with no evidence that our current
government or plausible successor will do more than
parrot the slogan of the balanced budget to remedy the
fact that we are too much a nation of consumers and that
we must work more effectively and receive less in the
short term if we are to enter the twenty-first century as a
commanding power. Now our Lab should act, as we
hope our nation will, by looking to see where the future
is, not where the past was, and to maintain our long
tradition of staying ahead of the conventional wisdom
that worked for our predecessors, but is inadequate for
our successors. If we continue to be so regarded by
those who know us well, we shall continue to have a
meaningful future.
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17
TUMOR VIRUSES
From the research reports that follow, you can see that work on the molecular
biology of adenoviruses and SV40 continues to comprise a major portion of the
research effort at the laboratory. The several autonomous groups, whose work is
described below, although located in different buildings, continue to collaborate
in various ways. A major advantage of this form of organization is that different
groups are able to attack the same problem from different directions.
lames Laboratory
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MOLECULAR BIOLOGY OF TUMOR VIRUSES
J. SAMBROOK, B. Ahrens, P. Barkley, A. Barros, M. Botchan, J. Dorso, A. Dunn, R. Frisque, L. Garbarini,
Y. Gluzman, R. Greene, 7 Crodzicker, W Hoeffler, D. Holtzman, S.-L. Hu, R. Ketch, D. Klessig, D. Lane,
R. McGuirk, R. McKay, R. Pashley, C. Paul, M. Quinlan, S. Smith, D. Solnick, C. Stephens, N. Stow, J. Stringer,
W Topp, S. Weirich, I. Wendel, J. Wiggins, K. Willison
During the past year, the Tumor Virus Group has
continued its efforts to understand how the genomes of
viruses that malignantly transform cells are organized
and expressed. The topics investigated fall into six
major groups: (1) the organization of viral DNA se-
quences in malignantly transformed cells, (2) the ge-
netics of the transforming viruses SV40 and adenovi-
rus 2, (3) the properties of proteins coded by viral
genes which cause transformation, (4) the mechanism
of RNA splicing, (5) the properties of malignantly
transformed cells grown in culture, and (6) the inter-
action of SV40 with early mouse embryos.
The organization and expression of viral DNA




All cells transformed by adenovirus 2 (Ad2) carry viral
DNA sequences, which, being covalently joined to
those of the host, are passed on to the cells' descen-
though a good deal is known about the number of
integrated viral segments present in different cell lines
and their general organization, nothing is known
about the mechanism by which integration occurs, the
nature of the cellular attachment sites, the exact loca-
tions of the integration sites in the viral genome, or the
mechanism by which viral DNA sequences are ex-
pressed. Direct access to the three latter problems has
recently become possible with the development of
techniques to propagate segments of eukaryotic DNA
in prokaryotes. During the past year we have used
these techniques to clone from lines of adenovirus-
transformed cells the integrated viral DNA and its
flanking host sequences. We have used these clones to
understand in detail the organization of the integrated
viral segments and to determine the sequences that
connect the viral DNA to the cellular genome.
We have studied the viral sequences in two lines (F4
and F17) of rat embryo brain cells transformed by Ad2.
Both are part of an extensive collection isolated after
infection of brain cells of Sprague-Dawley embryonic
rats with viral particles. Like all other cells transformed
by adenovirus 2, F4 and Fl 7 contain only a fraction of
the viral genome. Cells of the Fl 7 line carry 3.5 copies
of the left-hand 14% of the viral DNA. This sequence is
common to all cells transformed as a consequence of
infection with adenovirus-2 particles: often (as is the
case with Fl 7 cells) it is the only viral sequence that is
present. Cells of the F4 line appear to be considerably
more complicated: they carry about 16 copies of the
segment of the viral genome that extends from the
left-hand terminus to about map position 63, as well as
a small stretch of sequences from the extreme right-
hand end of the viral DNA (Sambrook et al., Cold
Spring Harbor Symp. Quant. Biol. 39:615 [19751).
Thus, F4 cells contain a more extended set of se-
quences than is necessary to establish or maintain
transformation, and those sequences are present in
considerably higher copy number than usual. Never-
theless, the DNA of F4 cells after cleavage with EcoRl
yields only two fragments that contain Ad2 DNA se-
quences. These bands, whose approximate molecular
weights are 23,000 and 10,500, do not comigrate with
any known EcoRl fragment of Ad2 DNA. Thus, F4
cells, which carry a large number of copies of viral
sequences, are measured by renaturation kinetics and
display a simple distribution of viral DNA sequences
among the variously sized EcoRl fragments of cellular
DNA. The best explanation of this paradox is that all
16 viral insertions are identical, so that, high copy
number notwithstanding, the cell-virus junctions are
unique. This hypothesis is open to test. Accordingly,
we set about cloning into bacteriophage X the two
off-sized EcoRl fragments that contain adenoviral se-
quences, using standard methods. The starting mate-
rial was either F4 cellular DNA, digested to comple-
tion with EcoRl but not further fractionated, or similar
preparations of DNA that had been enriched for
adenoviral sequences by sedimentation through su-
crose density gradients. However, despite screening a
total of recombinant phages somewhat in excess of
10 x 10', we were unable to identify any that con-
tained adenoviral DNA sequences. The reason for this
failure is unknown. Forced to approach the problem
another way, we took advantage of an unpublished
method developed by Hanahan to generate and
screen by hybridization large numbers of recombi-
nants synthesized in vitro by ligation of DNA to the
plasmid pBR322. Fearing that insertion of the entire
integrated viral set would prove too great a burden for
the plasmid to carry efficiently, and hoping to gain
preliminary information about the organization of the
viral sequences, we used a combination of two re-
striction enzymes. F4 DNA was cleaved sequentially
with EcoRl and Hindlll and cloned in pBR322.
Eighty-six recombinants were obtained that contained
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Figure 1
The structure of adenovirus 2 DNA sequences integrated in f4 cells. The viral DNA sequences are represented by the
blocked areas: the flanking cellular sequences are shown as thin lines. The upper diagram shows the structure of a
tandem array of viral and host sequences; the lower diagram shows in more detail the structure of the junction
between cellular and viral sequences and of the inversion which connects the right and left ends of the adenovirus
genome.
adenoviral sequences. Their structures have been ana-
lyzed in detail by restriction endonuclease digestion,
hybridization, and DNA sequencing. From the results
of these experiments, it is possible to deduce an un-
viral sequences integrated
in F4 cells (see Fig. 1). Starting from the left-hand end
there occurs, in order, 1 kb of cellular sequence; a
tract of viral sequences approximately 1400 nu-
cleotides in length, beginning 2 nucleotides from the
right-hand end of the viral genome and terminating
soon after the Bglll site at map position 95.8; and,
finally, a tract of viral sequences approximately
21,000 nucleotides in length, beginning near the left-
hand end of the viral DNA and terminating at map
position 63.
As far as we can presently tell, the structure of each
of the 16 copies of the adenoviral sequences present in
F4 cells is identical. Furthermore, each appears to be
inserted into an identical sequence of cellular DNA. It
seems most likely to us that this situation arose as a
consequence of an amplification event that took place
after integration had been established. Experiments to
test this idea are in progress.
By reassociation kinetics, cells of the Fl 7 line have
'been shown to contain about 3.5 copies of only the
leftmost 14% of the Ad2 genome. When the products
of digestion of F17 DNA by endonuclease Hindi II are
assayed for their content of viral sequences, two bands
are detected. Because the segment of viral DNA pres-
ent in these cells contains only one site for endonu-
clease Hindi'', at map position 8.0, the results strongly
indicate that there is a single site at which viral se-
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quences are integrated. Consistent with this conclu-
sion is the observation that after cleavage with EcoRl,
F17 DNA yields only one band that hybridizes to Ad2
DNA. This fragment was cloned in bacteriophage
XgtWES XB by standard techniques. Its structure has
been partially elucidated by restriction endonuclease
cleavage and hybridization. As far as we can tell, the
cloned fragment contains a sequence of adenoviral
DNA that is colinear with the viral genome from a
point close to the left-hand end (between nucleotide 1
and nucleotide 188) to a point just after the Hindi!' site
at map position 17. Little more information is avail-
able, except that the host sequences flanking the viral
insert in F17 cells are different in their pattern of re-
striction from those flanking the viral sequences in F4
cells. This observation is consistent with the conclu-
sion that adenoviral sequences integrate in different






Stable transformation of cells by SV40 is accompanied
by integration of viral DNA into the cellular genome.
This endows the cell with a heritable source of virally
encoded tumor IT) antigen proteins that are involved
in the maintenance of the transformed state. The
mechanism by which integration occurs is not known;
however, at the level of analysis resolved by restriction
endonuclease digestion of total transformed-cell
DNA, it appears that integration is not site-specific
with respect to either cellular or viral chromosomes.
During the past year, we have been investigating
whether this apparent lack of specificity extends to the
level of nucleotide sequence or whether integrative
recombination is mediated by DNA sequence homol-
ogy. To this end, we have cloned in various lambdoid
phages DNA fragments that contain the integrated
SV40 DNA along with its flanking cellular DNA se-
quences. We have obtained cloned fragments from
the genomes of two transformed rat cell lines, 14B and
SVRE 17, both of which contain a single integrated
SV40 tract, and from closed circular molecules pro-
duced by excision of the integrated SV40 DNA follow-
ing fusion of 14B cells with monkey cells. We have
analyzed these clones by restriction endonuclease di-
gestion, heteroduplex formation, and DNA sequence
determination.
The structure of the integrated DNA in 14B cells is
somewhat complex. SV40 DNA is attached to cellular
DNA at nucleotide 850; it then proceeds as a continu-
ous tract colinear with the SV40 genome through the
origin of replication and the early region to nucleotide
2244. At th is point there are 40 nucleotides that are not
recognizable as SV40 DNA; these are followed by a
resumption of SV40 sequence beginning at nucleotide
857 and continuing to nucleotide 1656 where cellular
DNA resumes. This second stretch of SV40 DNA is
inverted with respect to the first SV40 DNA sequence.
The cause of this inverted arrangement of SV40 se-
quences is not known. It may be the result of either two
neighboring integration events or a rearrangement of
the viral genome during integration.
The role of sequence homology in the integration
event that gave rise to 14B cells will remain unre-
solved until the segment pf cellular DNA that took part
in the recombination event is sequenced. We have
cloned a 10-kbp fragment from untransformed rat
cells that is colinear with the cellular DNA on one side
of the SV40 DNA integrated in 14B cells. Interestingly,
the DNA sequences on the other side of the SV40 DNA
are not present in the 10-kbp fragment, suggesting that
some rearrangement, deletion, or insertion of cellular
sequences occurred during integration.
The structure of the integrated SV40 DNA in SVRE
17 cells is simpler than in 14B cells. Viral DNA is
present as a single tract colinear with the SV40 map
from 0.76 map units through the origin of replication
and early region around to a position somewhere be-
tween 0.98 and 0.95 map units. Sequence analysis of
the recombinant joint around 0.76 map units shows it
to be at nucleotide 518. This is clearly different from
any of the cell-virus junctions in 14B. Although the
other cell-virus joint in SVRE 17 has not yet been
completely sequenced, it is already clear that it is not
the same attachment site at nucleotide 1656 that is
found in 14B cells. The cellular sequences adjacent to
integrated SV40 in SVRE 17 are also different from any
of the flanking cell sequences in 14B. Furthermore, the
cellular DNA tracts in the cloned fragments from cell
line 14B and SVRE 17 do not cross-hybridize, indicat-
ing a lack of sequence homology within the cellular
DNA sequences flanking the integrated SV40 ge-
nomes.




The excision products found in 14B cells following
fusion with permissive monkey cells are heterogene-
ous in size and are composed of both viral and cellular
DNAs. Eight excision products formed after fusion of
14B cells with monkey cells have been cloned. They
range in size from 3 kbp to 10 kbp and are all structur-
ally related. All can be aligned with the same cell-virus
joint at nucleotide 850. The DNA sequence at this
joint has been determined in one of the cloned exci-
sion products and it is the same as that found in the
DNA cloned directly from the integrated 14B genome.
The cloned excision products contain various
amounts of viral and cellular DNAs, but all the viral
DNA tracts are colinear with one another and with the
viral DNA cloned directly from the 14B genome. The
simplest explanation of these structures is that they
were produced by recombination between cellular
DNA sequences flanking the SV40 insertion or be-
tween integrated SV40 DNA and flanking cell se-
quences. We have recently cloned from the genome of
14B cells another DNA fragment that overlaps the first
clone from 14B, described above. This clone will be
useful for further analysis of the cell sequences in the
rescued viral products.
The cloned excision products and the cloned inte-
grated DNA fragments obtained from 14B cells consti-
tute a set of parental sequences and recombinant
progeny sequences. Analysis of the DNA sequences
before and after excision will establish what role DNA
homology plays in the excision process.
We can conclude from our analysis of cloned DNA
fragments that the low level of specificity for integra-
tion holds true at the level of DNA sequence. We will
soon know whether DNA sequence homology
mediates integration and excision of SV40 DNA.
Transcription of integrated viral sequences
in transformed cells
S.-L. Hu
Much work has been focused on the expression of
viral sequences in transformed cells. Viral transcripts
from two single-copy lines of rat cells transformed by
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SV40 (SVRE 14B and SVRE 17) and one line trans-
formed by Ad2 (F4) have been studied according to the
method of Berk and Sharp (Cell 14:695 [1978]). In
general, cytoplasmic poly(A)-containing viral tran-
scripts from these transformants have the same topol-
ogy and splicing patterns as those found early in viral
lytic infection. The relative abundance of individual
species, however, may vary. In one of the lines investi-
gated, F4, two additional viral transcripts unique to the
transformed cells have been observed. These tran-
scripts contain sequences from both the left end and
the right end of the adenovirus-2 genome. They ap-
pear to originate from the early-region-4 promoter and
extend into the early region 1A, transversing the junc-
tion connecting the right and left end sequences.
These transcripts are terminated and spliced in the
same manner as that of normal transcripts from early
region 1A. Whether they code for any protein that is
responsible for any of the transformed properties of F4
is currently under investigation.
In all three lines of transformed cells investigated,
no transcripts from viral late promoters can be de-
tected. Whether this indicates a failure in the initiation
of these transcripts or some defects in their processing
is still not clear.
Another interesting observation concerns the exis-
tence of hybrid RNA molecules containing both viral
and cellular sequences in SVRE 14B. This transcript
appears to originate from the proximal cellular se-
quences, extend through the viral early region, and
terminate at the normal site for early SV40 mRNA. This
transcript is polyadenylated, but not spliced, and is
present only in the nucleus of the transformed cell.
Whether this hybrid transcript can serve as a precursor
to the spliced viral mRNA in the cytoplasm is not clear
at present. If such should be the case, the 5 'end of this
hybrid transcript must be processed so that it will
coincide with the 5' end of normal viral early mRNA,
since the structure of viral transcripts present in the
cytoplasm of SVRE 14B is indistinguishable from that
of normal early mRNAs. The availability of clones
containing the integrated viral genome together with
its flanking cellular sequences should allow us to study
the structure and the biosynthesis of these hybrid
transcripts in greater detail.
In summary, it appears that all transcriptional regu-
latory elements (promoters, splicing signals, ter-
minator sites, etc.) normally functional in early viral
infection are also operative in transformed cells.
However, because of the rearrangement of the viral
genome in the integrated state, some viral transcripts
produced in certain lines of transformed cells may not
be identical to those observed in lytic infection. Fi-
nally, in the nucleus of some transformed cells, we
have observed chimeric transcripts containing both
viral and cellular sequences.
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The genetics of the transforming viruses SV40
and adenovirus 2




Replication of SV40 DNA begins at a unique site on
the viral chromosome and proceeds bidirectionally
around the circular molecule. To understand the struc-
ture of the viral origin of replication and its role in the
expression of viral genes and in the mechanism of
transformation, we isolated a new set of noncondi-
tionally lethal origin-defective mutants. This class of
mutants cannot be complemented by any helper virus
in their conventional eukaryotic hosts. Therefore, the
isolation of these mutants was achieved by utilizing
SV40 DNA cloned in a plasmid vector and propagated
in Escherichia coli.
The mutations at the origin of viral DNA replication
were introduced at the 8g1I site (which is located at the
origin). Cloned DNA was cut with Bgll, and mutations
were introduced by treatment of the resulting linear
DNA with either single-strand-specific nuclease S1 or
DNA polymerase I. Mutated Bgll-resistant DNAs were
recloned and used for biological studies.
All Bgll-resistant SV40 DNAs were found to be
origin-defective mutants; however, the majority of
them were capable of synthesizing biologically active
T antigen in transfected mammalian cells. Thus, de-
spite the very close physical proximity of the putative
early promoter and the origin of DNA replication,
these two sites are functionallly separated. Origin-
defective mutants were able to transform rat cells with
efficiencies similar to that of wild-type SV40 DNA.
Thus, a functional origin of DNA replication is not
necessary for the maintenance of transformation. Be-
cause transformation was initiated by DNA transfec-
tion using the calcium phosphate precipitation
method, we can state that the origin of SV40 DNA
replication does not affect the efficiency of trans-
formation in this situation; however, whether the viral
origin is required for efficient transformation after in-
fection of cells by virions is still unresolved and is still
under investigation.
The origin-defective mutants were also used to
transform permissive monkey cells. The mutant DNA
expresses functional T-antigen; however, the lack of a
viral origin allows the permissive cells to survive in-
fection with mutant DNA and become transformed.
Because these cells were not selected to survive either
virion infection or uncontrolled viral DNA replication,
they possess a combination of very useful properties:
they are permissive to infection with SV40 and express
functional T antigen. We have shown that these two
properties allow replication of SV40 tsA virus at the
nonpermissive temperature. These cells can thus be
used as a host for SV40 vectors, which contain a viral
origin of DNA replication and an intact late region, but
have the early region replaced by different heterolo-
gous DNAs. This system has the advantage of allowing
the propagation of pure populations (without helper
viruses) of eukaryotic transducing viruses.
Cotransformation of adenovirus-2 DNA
and the herpes simplex virus I thymidine kinase
gene in human cells
T. Grodzicker
D. Klessig
We are deriving human cell lines that can express
different adenoviral genes by cotransformation of Ad2
restriction enzyme fragments with the herpes virus
thymidine kinase (tk) gene. We hope to use these lines
as host cells for various types of viral mutants, as well
as for studying the control and expression of viral
genes in the tk+ cells.
In collaboration with Michael Wigler, we have co-
transformed a tk- human cell line (obtained from
Carlo Croce, Wistar Institute) with large Ad2 fragments
(30% or 60% of the genome) and a cloned Bam frag-
ment carrying the herpes virus thymidine kinase gene.
tk+ cells were isolated after selection and maintenance
in HAT medium. The transformed lines were initially
screened to see if they are able to complement the
growth of Ad5A312, a deletion mutant lacking the
sequences between -1% and 4.5% of the viral
genome (Jones and Shenk, Cell 17:683[1979]). Sev-
eral lines were obtained that complement Ad5 5312,
some giving extremely high, and others intermediate,
levels of complementation. Some cell lines are also
able to complement the growth of Ad5 A313, a mutant
lacking sequences between positions -4% and 10%
of the viral genome.
Several of the cotransformants that complement the
mutants are quite stable, whereas others are fairly
unstable even when grown in the continuous presence
of HAT medium. Thus, some tic+ subclones comple-
ment Ad5A312 as well as the parental line, others give
reduced levels of complementation, and some fail to
support the growth of the mutant viruses. Analysis of
the adenoviral sequences in the transformed cells by
restriction enzyme analysis and Southern hybridiza-
tion showed that the amounts of viral DNA are the
same in all tk+ subclones regardless of their ability to
complement the mutants. Thus, tic+ subclones do not
lose viral DNA, but its expression is altered or re-
duced. This situation is also found in SV40-tk mouse-
cell cotransformants (D. Hanahan, M. Botchan, D.
Lane, L. Lipsich, M. Wigler, unpubl.).
All of the lines are unstable to some extent in the
absence of HAT, and therefore tk- revertants can eas-
ily be obtained. In this case, all of the tk- revertants
have lost all of the thymidine kinase and the adenovi-
ral DNA they had contained (see Mammalian Cell
Genetics Section for futher discussion of this phenom-
enon).
The amount and arrangement of viral sequences in
the transformed cell has been analyzed by blot hy-
bridization. Most of the cell lines contain a single
insertion of the herpes virus tk fragment and a single
insertion of adenoviral DNA. The adenoviral DNA is
composed of a segment from the left end of the
genome and extends for varying lengths in different
lines. However, one line (B1) contains about eight
different insertions, two of which are amplified. All of
the insertions in B1 are missing a small segment from
the extreme left-hand end of the genome, suggesting
that the final arrangement of viral DNA may have
arisen from recombination and amplification of an
initial set of viral sequences. Interestingly, this line
complements the growth of viral mutants the least,
even though it contains the most viral DNA, suggest-
ing that the viral sequences are poorly expressed. The
viral RNA in these lines is presently being analyzed.
Preliminary results indicate that the two lines (A2 and
A5) that complement very efficiently and contain a
single copy of the left end of the adenoviral genome
synthesize the early-region-1A and early- region -1 B
mRNAs. In contrast, the B1 cell line produces the
normal early- region -1 B mRNAs but not the early-
region-1A mRNAs. In addition, a prominent, un-
spl iced RNA that is encoded by the Hindlll C fragment
(coordinates 7.5-17) and may extend into the Hindlll
G fragment (coordinates 0-7.5) is found in the cyto-
plasm of B1 cells. The loss of the left-end viral DNA
sequences at least to coordinate 0.8, together with the
absence of normal early-region-1A mRNAs, suggests
that the promoter for this gene family may have been
lost or altered during the initial recombination event
that led to the formation of the B1 cell line.
New tk- lines are being constructed with different
viral fragments, as well as with plasmids containing
the thymidine kinase gene and various adenoviral
genes on the same molecule.
Suppression of Ad2+ ND1 nonsense mutants
T. Grodzicker
In collaboration with Jim Lewis, we have been study-
ing the use of antibiotics that cause misreading of
nonsense codons and suppression in mammalian
cells. We have isolated both amber and ocher muta-
tions in the SV40 segment of the hybrid virus
Ad2+ND1 and have shown that they can be suppres-
sed by yeast suppressor tRNAs when mRNA from the
mutants is translated in vitro, or in vivo when yeast
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suppressor tRNA is microinjected into mutant-
infected nonpermissive cells (Grodzicker et al., J.
Virol. 19:559 [1976]; Geste land et al., DNAs 74:4567
[1977]; A. Graessmann, R. Gesteland, and T. Grod-
zicker [unpubl.]).
Paromomycin is an aminoglycoside antibiotic that
has been shown to cause misreading of poly(U) in
several in vitro translation systems derived from a
variety of eukaryotic cells (see, for example, Wilheml
et al., Biochemistry 17:1143[1978]) as well as
phenotypic suppression of many yeast nonsense mu-
tants (Singh et al., Nature 277:146[1979]; Palmer et
al., Nature 277:148[1979]). We have translated
mRNA derived from two amber Ad2+ N D1 mutants in
a reticulocyte lysate translation system and have
shown directly that paromomycin causes suppression
of the nonsense mutation. In the presence of 4-30
µg /ml of paromomycin, mutant mRNA is translated to
yield the wild-type 30K protein in addition to the 19K
amber fragment normally produced by the mutants. At
60 gg/ml of the drug, protein synthesis is quite se-
verely inhibited. We plan to screen other putative
adenoviral nonsense mutants to see if they can be
suppressed by paromomycin. Preliminary evidence
suggests that the drug does not readily enter cells, even
when the cells are treated with a variety of reagents
that facilitate the uptake of various macromolecules.
We intend to test a series of related antibiotics to see if
they can be taken up more readily by mammalian
cells.
The role of adenoviral DNA-binding protein
in late gene expression
D. Klessig
T. Grodzicker
Five host-range mutants (Ad2hr400, hr401, hr402,
hr403, and Ad5hr404) of human adenovirus serotype
2 and 5 (Ad2 and Ad5) that overcome the block to
growth of wild-type adenovirus in monkey cells have
been isolated. They form plaques and multiply effi-
ciently in both monkey and human cells. The altera-
tion in each of these mutants allows the full expression
of all viral late genes, in marked contrast to the de-
pressed synthesis of many late proteins in monkey
cells infected with the parental Ad2 or Ad5. The al-
tered gene encodes a diffusible product, since the
mutation acts in trans to enhance the synthesis of
wild-type Ad3 late proteins during coinfections of
monkey cells with Ad2hr400 and Ad3. Restriction
enzyme analysis of the genomes of all host-range mu-
tants show that none of them contain major altera-
tions. In addition, earlier work (Klessig and Hassell, J.
Virol. 28:945 [1978]) indicated that Ad2hr400 does
not contain SV40 sequences, which in some adenovi-
rus-SV40 hybrids allows efficient multiplication in
monkey cells. The mutation responsible for the ex-
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tended host range has been physically mapped by
marker-rescue experiments using isolated restriction
enzyme fragments of the mutants to transfer the new
phenotype to wild-type adenovirus. The alteration in
each of the five mutants is located in a region (coordi-
nates 62-70.7; coordinates 62-68 for Ad5hr404)
which encodes predominantly the 72K DNA-binding
protein (DBP). More detailed mapping using Ad2
hr400 fragments places the mutation (coordinates
62.9- 65.6) entirely within the DBP gene.
Viral DNA replication that requires DBP occurs
normally in monkey cells infected with wild-type Ad2
or Ad5. Thus, DBP must have a second function that is
impaired in these abortive infections. The action of
DBP is probably mediated through its interaction with
host cell components. Thus, in infected human cells,
DBP interacts properly with all cellular proteins
needed for its functions in both early and late stages of
lytic infection. In monkey cells, however, DBP can
function with host proteins needed for viral DNA re-
plication, whereas it fails to interact correctly with
other host factors important for late gene expression. It
seems probable that the host-range mutations alter
DBP so that it can interact correctly with monkey as
well as human cell components.
Mutants in early region 1A of adenovirus 2
D. Solnick
Genetic experiments have been designed to further
our understanding of the adenoviruses of transforming
genes and their role in viral gene expression. We have
been isolating and characterizing early-region-1A mu-
tants generated by one of several site-directed
mutagenesis techniques. To date, eight point mutants
and six deletion mutants have been isolated. The point
mutants were obtained by nitrous acid mutagenesis of
the small Xbal restriction fragment (map position
0.0-3.8) from a phenotypically wild-type Ad5 variant
containing a single Xbal restriction site located at 3.8
map units. The mutagenized fragment was ligated to
the large Xbal fragment containing the remainder of
the viral genome, and the mixture was then transfected
onto human 293 cells. These Ad5-transformed per-
missive cells support the growth of viral mutants with
lesions at the left-hand end of the viral genome. The
resulting plaques were then checked for enhanced
plaguing efficiency on 293 cells relative to that on
HeLa cells. The deletion mutants were generated by a
modification of a technique developed by Tom Shenk
(Cell 13:181 [1978]), which selects for spontaneous
mutants lacking a particular restriction site. In this
case, the deletions remove the Sma I site located at 2.9
map units.
One of the point mutants has been partially charac-
terized. Interestingly, this mutant synthesized one, and
only one, of the two principal region-1A cytoplasmic
mRNAs, as determined according to the method of
Berk and Sharp (Cell 12:721 [1977]). In the wild-type
infection, these two mRNAs have each lost one inter-
vening sequence and are exactly or very nearly
coterm i nal. The right-hand boundaries of the interven-
ing sequences are coincident, whereas the left-hand
boundaries are different (Berk and Sharp, Cell 14:695
[1978]; Chow et al., 1. Mol. Biol. 139:265 [1979];
Perricaudet et al., Nature 281:694 [1979]). It is sus-
pected, therefore, that these two mRNAs are derived
either in sequence or in parallel from the unspliced
nuclear transcript detected by Berk et al. (Cell 17:935
[1979]). The mutant, then, may contain an altered
splicing signal required for one of the processing
pathways of the region-1A transcripts.
A second project involves the construction of an
adenoviral variant containing a second major late
promoter. Such a variant could be useful as a vehicle
for the expression of closed eukaryotic genes. We are
initially trying to obtain a virus that overproduces the
region-1A proteins. Both early region 1A and the
major late promoter have been separately cloned in E.
coli using the pBR322 vector. The appropriately
oriented ligation product from these two clones was
then recloned in pBR322. This final clone is now being
inserted into a nonessential region of the adenoviral
genome with the hope that the late promoter will
produce a functional transcript of region 1A.
Cloning of adenovirus-2 early cDNAs
N. Stow
The four major early regions of Ad2 encode a large
number of overlapping mRNAs that exhibit different
patterns of splicing and this considerably complicates
the analysis of their fine structures and biological
functions. One possible way of circumventing these
problems is to purify and amplify the mRNA se-
quences in the form of cloned cDNA copies.
Early in infection, Ad2-specific sequences consti-
tute only a small proportion of the total poly(A)-
containing RNA, and much time has been spent in
finding an efficient method of cloning cDNA copies of
these low-abundance species while maintaining their
structural integrity. Initial experiments with the more
abundant late Ad2 mRNAs indicated that maximum
cloning efficiencies are obtained by synthesizing
double-stranded cDNA copies (as opposed to DNA-
RNA hybrids) and inserting these by G/C tailing into
the Pstl site of the plasmid vector pBR322. Efficiencies
of 10' -10' colonies /µg double-stranded cDNA were
obtained by transforming E. coli x 1776, using a pro-
cedure developed by D. Hanahan.
This result suggested that it might be possible to
obtain cloned copies of early messages by employing
total poly(A)-containing RNA from infected cells as
template for the synthesis of double-stranded DNA.
This cDNA would then be used in a "shot-gun" trans-
formation of x1776, and colonies containing virus-
specific sequences could be identified by hybridiza-
tion. Starting with double-stranded cDNA, which had
been shown to be reasonably intact by blotting, 47
clones contai ning Ad2 DNA sequences were obtained
by using the approach outlined above. Hybridization
experiments indicated that sequences from early re-
gions 1A, 1 B, 2, 3, and 4 were represented, and several
clones are now being subjected to a detailed structural
analysis.
Restriction enzyme analysis and DNA sequencing
(in collaboration with Eric Lifsen and Daniela Sciaky)
are being used to correlate the structures of these
clones with previously described message species and
to identify protein coding regions, splice sites, and
polyadenylation signals.
Those clones containing the complete coding se-
quences for individual Ad2 early proteins will be used
in systems that allow their expression as an aid to
understanding the biological roles of these gene prod-
ucts.
The transforming proteins of SV40
Studies of SV40 tumor antigens
D. Lane
Three separate hybridoma cell lines have been de-
rived that secrete monoclonal antibody to the large T
antigen of SV40. The lines were derived from a fusion
between spleen cells from a mouse immunized
against the purified Ad2+1)2 hybrid virus T-
antigen-related protein isolated from infected HeLa
cells. All three lines have been through three separate
rounds of cloning in soft agarose and now appear to be
stable secretors. Clone 1 and clone 2 are being grown
in pristane-primed mice, and the ascitic fluid from
these hybridoma-bearing animals contains large
amounts of the monoclonal antibody. All three lines
grow well in mass culture and the media contains high
concentrations (1 -10 Ag/m1) of the antibody.
The binding site of clone 1 on the T-antigen protein
has been shown to be retained even after the antigen is
treated with boiling SDS and 0.1 M DTT. Furthermore,
the binding site has been localized on the T protein by
the finding that clone 1 does not bind the 30K
T-antigen-related polypeptide encoded by the Ad2+
ND1 virus but does bind the 56K and 42K polypep-
tides made by the Ad2+ND2 virus.
Clones 2 and 3 recognize binding sites on SV40 T
antigen that are not present on the T-antigen-related
polypeptides made by AD2+ND1 and AD2+ND2. In
both cases, the binding sites are sensitive to the de-
naturing effects of SDS. A large number of uses for
these monoclonal reagents are envisioned and their
further characterization is now in progress.
The host protein that binds to large T antigen has
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been characterized in a variety of different trans-
formed cells, in collaboration with William Topp. The
protein has been isolated preparatively from an
SV40-transformed rat cell line and used to immunize
rabbits. The relationship between the presence of the
protein and its association with large T antigen with
the transformed state of the cell has been studied in
both tsA-transformed and flat revertant cell lines. In
the flat revertant cell lines examined so far, no loss of
the host protein has been discovered and it is still
complexed to large T antigen. Thus, the presence of
the protein in a complex with large T antigen does not
automatically mean that the cell is transformed. Re-
sults with the tsA-mutant-transformed cells are more
complex, but preliminary data suggest that the ability
of the host protein to complex with large T antigen is
thermosensitive in these lines. It has also been noted
thatthe temperature sensitivity of the transformed state
in differenttsA-transformed cells is correlated with the
half-life of large T antigen in the cell.
An immunoassay for the interaction
of SV40 T antigen and DNA
R. McKay
Standard immunoassay procedures using monoclonal
antibodies have been adapted with the aim of monitor-
ing the binding of SV40 T antigen to DNA. Two advan-
tages of these procedures are foreseen: (1) The DNA
binding properties of the protein can be assessed at
very early stages of purification. (2) The assay proce-
dure can be used to obtain kinetic information on
protein-DNA interactions. An absolute binding con-
stant derived from a Scatchard plot depends on the
fulfillment of several criteria, namely, that (1) equilib-
rium is reached, (2) the reaction is fully reversible, (3)
bound and free forms can be measured without per-
turbing the equilibrium, (4) the protein is univalent, (5)
binding sites are independent, and (6) one of the reac-
tants is homogeneous. Some of these criteria are
known to be fulfilled by this assay, others may not be.
In particular, the independence of binding the three
tandem binding sites at the replication origin (Tjian,
Cell 13:165 [19781) may only be achieved using DNA
sequences that have been experimentally altered.
At the present time we have shown that there is a
protein complex in Ad2±D2-infected HeLa cells that
binds to the DNA restriction fragment containing the
SV40 origin up to 1000 times "better" than it does to
other DNA fragments. One assumes that this binding
activity is due to the active form of the T-
antigen-related protein found in these cells. Recovery
of the protein from the DNA fragments is required to
prove this assumption. This "high binding" complex
also binds preferentially to another site on SV40 DNA.
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The mechanism of splicing
Incomplete splicing of fiber mRNA
in monkey cells
D. Klessig
Monkey cells are nonpermissive hosts for human ad-
enoviruses due to a block in the synthesis of certain
late viral proteins. Analysis of the RNA produced in
abortively infected monkey cells indicated that the
depressed synthesis of many of the late proteins can be
ascribed to the reduced concentration of their corre-
sponding mRNAs (Klessig and Anderson, J. Virol.
16:1605 [1975]). An exception is the capsid polypep-
tide, fiber. Fiber RNA concentration is reduced 5- to
20-fold in monkey cells, whereas fiber protein syn-
thesis is depressed 100- to 1000-fold. In collaboration
with Louise Chow, experiments designed to detect
defects in the cytoplasmic fiber RNA that would ac-
count for its poor translatability have been conducted
and show that the RNA had a normal, capped tri-
partite leader at its 5' terminus. However, a large
proportion of these molecules contained long se-
quences between the tripartite leader and the main
body that failed to be spliced out of the initial tran-
script during maturation of the fiber mRNA. Similarly,
region-3 RNAs at late times also contained the same
long upstream sequences in abortive infections. In
contrast, few cytoplasmic fiber RNAs or region-3
RNAs from a productive infection with an Ad2 mutant
(Ad2hr400) which grows lytically in monkey cells re-
tained such long upstream sequences. The other late
RNAs from abortively or productively infected mon-
key cells had splicing patterns identical to those seen
in permissive human cells. These findings, together
with the observation that the host-range mutation in
Ad2hr400 is located in the DBP, suggest a role for this
protein in RNA processing in addition to its function in
viral DNA replication.
Attempts to achieve splicing in vitro
A. Dunn
We have continued our analysis of the transcription
of viral genes in human cells infected with the non-
defective hybrid virus Ad2+ND1dp2. Ad2+ND1dp2
contains two independent insertions of SV40 se-
quences that have replaced a 6% fragment of the Ad2
chromosome which is nonessential for lytic growth.
One of the SV40 insertions is located about 300 by
upstream from the beginning of the major late gene
which encodes the structural protein fiber. A conse-
quence of this arrangement is the synthesis, during the
late phase of productive infection, of viral mRNAs
containing covalently linked Ad2 and SV40 se-
quences. Previous work in our laboratory has shown
that the cytoplasm of infected cells contains large
quantities of two distinct and separable populations of
mRNAs that are associated with the SV40 sequences
proximal to the 3' end of the fiber sequences. These
mRNAs, which are under the control of the major late
adenoviral promoter, carry the traditional tripartite
leaders, but differ in the presence or absence of an
extra leader (the "y" leader) component located 2000
nucleotides downstream from the gene.
We have considered the possibility that the hybrid
mRNA carrying the y leader is the immediate precur-
sor to the mature mRNA containing only the tripartite
leader. These molecules might be a suitable and con-
venient choice as substrate for use in identifying and
isolating the enzymatic machinery responsible for re-
moval of intervening sequences in precursor RNAs in
eukaryotes. This choice of substrate offers several ad-
vantages including (1) the ability to isolate purified
''.2P-labeled precursor RNA in large quantities and (2)
the precursor and mature mRNA have unique and
diagnostic fingerprints which we have observed ex-
perimentally and which are predicted from the nu-
cleotide sequence analysis of a cloned copy of the
closely related Ad2 fiber mRNA, carried out in our
laboratory in the last year.
Initial experiments, carried out in collaboration
with Walter Keller at the University of Heidelberg,
have resulted in the demonstration of an activity, pres-
ent in both infected and uninfected cells, that reduces
the molecular weight of the supposed precursor to that
of the mature mRNA. This activity, which is dependent
on divalent cations, appears unstable under a variety
of storage conditions, and we have experienced great
difficulty in the day-to-day reproducibility of our as-
say. Nevertheless, we have shown that these semi-
purified fractions include a double-strand-specific
RNase which, on theoretical grounds at least, we be-
lieve to be a likely component of the splicing ap-
paratus. Interestingly, those same fractions do not ap-
pear to contain a T4-like ATP-dependent ligase.
Perhaps the covalent linkage between conserved se-
quences of mRNA is mediated by the joining of 5 '-OH
and 3' -PO4 groups, as has been convincingly shown
for the processing of tRNA in yeast.
We have also considered the possibility that RNA is
only spliced when it is in its natural environment as
part of a ribonucleoprotein complex. We are presently
isolating RNA complexes from the nuclei of infected
cells to determine whether they include all of the
processing machinery.
Finally, we are synthesizing viral RNA in the iso-
lated nuclei of virus-infected cells. The majority of this
RNA is unspliced and is initiated at the major late Ad2
promoter. Preliminary experiments suggest that this
same result can be obtained in lysed nuclei, thus pro-
viding a soluble system in which to demonstrate in
vitro splicing.




We have been involved in the study of how DNA
viruses transform cells in tissue culture and the rela-
tionship of this process to tumorigenicity. (1) We have
characterized cells transformed by the human
papovavirus JC. Although JC virus (JCV) is tumorigenic
in hamsters and owl monkeys, there have been no
reports until now of it transforming cells in vitro. An
analysis of the phenotype of JCV hamster brain trans-
formants suggests that they are quite similar to cells
transformed by SV40, showing good colonial growth
suspended in methylcellu lose. A number of the JCV
transformants are tumorigenic. However, JC trans-
formants are morphologically flatter and, in general,
retain the cytoplasmic actin networks characteristic of
normal cells. (2) The transforming ability of SV40 mu-
tants defective in the viral large (tsA) or small (c1154/59)
T proteins has also been investigated and the
phenotypes of transformed cells compared with those
of wild-type transformants. The large T protein ap-
pears to be involved in the maintenance of trans-
formation in both rat and hamster cells. However,
hamster embryo fibroblasts transformed by c1154/59
mutants were phenotypically indistinguishable from
their wild-type counterparts, indicating that the small
T protein is not required. This is in contrast to our
previous results with rat cells in which small T protein
was clearly required for full transformation. (3)
Replication-defective mutants of SV40 have recently
been isolated in our laboratory. SV40 DNA was
cloned in a plasmid vector, mutagenized at the origin
of DNA replication, and analyzed (see above). Many
of these mutants have very small deletions or substitu-
tions, induce T antigen in permissive and nonpermis-
sive cells, and complement tsA virus in lytic infection.
We find that these mutants give efficiencies of trans-
formation identical to those of wild-type SV40 when
rat cells are infected by coprecipitation with calcium
phosphate. This result argues strongly against the in-
volvement of viral DNA replication in the initiation of
transformation by this route. (4) We are beginning
studies related to adenovirus transformation. Because
of the confusing situation in Ad2 of overlapping genes
and numerous gene products, it has been difficult to
precisely define which DNA sequences and polypep-
tides are involved in transformation. We are attempt-
ing to introduce small mutations at specific sites (using
cleavage with restriction endonucleases) in cloned
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subgenomic species of Ad2 DNA containing the trans-
forming region. The transforming efficiencies of these
molecules relative to that of the parent will be used to
map functions important for transformation. Initial ex-
periments indicate that cloned adenoviral DNA frag-
ments are able to transform rat embryo fibroblasts.
Interaction of SV40 DNA and virus
with early mouse embryos
K. Willison
Preimplantation mouse embryos have been infected
with SV40 either by incubation of morulae with virus
or by microinjection of purified DNA into the blasto-
cyst. These infected embryos were implanted into
pseudopregnant foster mothers and live mice were
obtained. DNA was extracted from the tissues of these
mice and from the liver of the foster mothers. The
DNAs were then analyzed for the presence of SV40
sequences by Southern blotting.
Five litters were obtained after DNA injection. All
the members of two litters contained SV40 DNA
sequences in a form that comigrated with circular
SV40 DNA extracted from lytically infected CV-1
cells. The liver DNA of the foster mothers that carried
these two litters also contained free (nonintegrated)
SV40 DNA sequences. None of the members of the
other three litters that were analyzed contained free
SV40 DNA. One male mouse (1 of 12 analyzed),
however, did contain SV40 sequences in high-
molecular-weight DNA that was extracted from
somatic and germ line tissue. The arrangement of the
SV40 DNA has been examined using five different
restriction enzymes and the data suggest that it is
integrated. To prove that this is the case, experiments
are in progress to clone the integrated sequences using
the Charon 4A phage vector system.
Four litters were obtained after viral infection (the
infections were carried out by Francoise Kelly, Institut
Pasteur, Paris; DNA samples were analyzed at Cold
Spring Harbor Laboratory). DNA was extracted from
the livers and brains of some members of each litter
(nine animals analyzed). In no case could any free
SV40 DNA be detected by Southern blotting. How-
ever, two mice from different litters appeared to con-
tain integrated SV40 DNA sequences. A detailed re-
striction enzyme map is being constructed using
Southern blotting.
The aim of this work has been to find a method for
introducing DNA sequences into adult mice, and so
far the results are encouraging. The efficiency of inte-
gration is high (3 of 23 mice examined) and this en-
courages us to explore the possibility that SV40 could
serve as a useful vector for introducing genes into
living animals.
The presence of free SV40 DNA in two litters and
the foster mothers of these same litters is most readily
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explained as the result of a persistent viral infection.
No proof of virus production has been obtained as yet
nor have the cell type(s) infected been identified. This
observation warrants further attention in light of the
fact that all mouse cells in tissue culture are nonper-
missive for SV40 production. Perhaps some cells in the
developing mouse embryo, when infected early
enough, can support virus multiplication and hence -
start an infection in the mother.
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Following the discovery of RNA splicing in 1977, the
efforts of this laboratory have been directed toward the
determination of sequences within the adenovirus-2
(Ad2) genome that are involved in splicing. Initially,
our interest centered on those three regions of the Ad2
genome (coordinates 16.6, 19.6, and 26.6) that en-
code the three leader segments of the major late right-
ward transcription unit. However, it soon became ap-
parent that many other regions of the Ad2 genome give
rise to mRNAs that are processed by splicing. Clearly,
these regions also needed to be analyzed at the pri-
mary sequence level before a complete description of
Ad2 splicing would be possible. Consequently, during
the summer of 1978, it was decided to concentrate the
efforts of our laboratory on a project aimed at deter-
mining the complete primary sequence of the Ad2
genome. This sequence would not only provide a
basis for an understanding of RNA splicing, but also
could ultimately be linked to the plethora of biological
information being gathered by other groups at Cold
Spring Harbor Laboratory.
Ad2 sequencing
The basic strategy with which we have tackled this
project was outlined in last year's Annual Report and
has not changed significantly during the course of this
year. The large size of the Ad2 genome, which we now
believe to be in excess of 36,000 bp, has meant that
the work this year has been involved primarily with
data gathering. The present status of the information
available is shown in Table 1.
In brief, essentially complete sequence information
is available from at least one strand of the genome for
the region from 0% to 37.3% of the genome and from
89.7% to 100% of the genome. These sequences are
presently being confirmed by obtaining sequence data
from the complementary strand. This process is both
straightforward and efficient using the chain-
termination method because the map positions of ap-
propriate primers can be predicted from the first strand
sequence. The remaining regions of the genome still
require more data gathering before the first strand
sequence can be completed. The sequence from
coordinate 73.6 to coordinate 75.9 is a part of the
EcoRl F fragment whose sequence has already been
reported (Galibert et al., Gene 6:1 [19791).
More than 200,000 nucleotides of sequence have
been derived so far and have yielded more than
30,000 nucleotides of unique sequence. The manipu-
lation and analysis of this amount of data have re-
quried the use of computer methods and these are
described below. Although this year has mainly been
devoted to data collection, some analysis of these data
has already been possible. In particular, the three re-
gions of the Ad2 genome around coordinates 16.6,
19.6, and 26.6, which encode the major leader com-
ponents of late mRNAs, have been sequenced and the
positions of splicing within these sequences have been
determined. In the case of fiber mRNA, some mRNA
species have an extra leader component and the se-
quences surrounding its coding position have also
been deduced. It has been possible to locate and
sequence the region of the Ad2 genome encoding the
main body of fiber mRNA and to then locate the
position at which this main body becomes spliced to
either of the two leader conformations. By comparing
the genome sequence within this main body of fiber
with N-terminal protein sequence data (C.W. Ander-
son and J.F. Lewis, pers. comm.), we have located the
start of the fiber-protein coding sequence.
Like most other eukaryotic mRNAs, we have found
that the sequences at the splice points of Ad2 mRNAs
contain the dinucleotides GU at the 5' end of interven-
Table 1
Region of Ad2 genome I-strand sequence r-strand sequence
(coordinates) (%) (%)
Nina! G ( 0 - 7.9) 99.9 >50
HindlIl C ( 7.9 -17.0) 99.9 >80
HindlIl B (17.0 -31.5) 95.0 10
Hindi!! I (31.5 -37.3) 99.0
HindlIl I (37.3 -41.0) 80.0
HindlIl D (41.0 -50.1) 40.0
HindlIl A (50.1 -73.6) 10.0 >70
EcoRl D (75.9 -84.0) 0 >90
EcoRl E (84.0 -89.7) 0 >50
EcoRl C (89.7 -100) >50.0 99
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ing sequences and AG at the 3' end of intervening
sequences. There are no other obvious sequence
homologies around these splice points and, indeed,
the sequences surrounding these late Ad2 splice
points are considerably different from the "preferred"
sequence suggested by Chambon and his coworkers
(Proc. Natl. Acad. Sci. 75:4853 [1978]). We have also
examined the possible RNA secondary structures that
might be adopted by the RNA in the region of these
splice points. Although some interesting features have
emerged, there is as yet no conserved feature that
might suggest a molecular basis for the specificity of
splicing.
We have also examined the possibility, first sug-
gested by L. Phillipson (unpubl.), that VA RNA might
act as a template for the splicing process. We can find
no obvious homology between VA RNA and the splice
points, which would suggest a simple template func-
tion. Furthermore, again using computer predictions
of secondary structure, we find that VA RNA could
adopt a particularly stable secondary structure with
rather few single-strand regions present and available
for hybridization.
One early mRNA splice point is now known. N.
Stow (Tumor Virus Section) has partial sequence data
from a cloned cDNA copy of an early mRNA and, by
comparison with the genomic sequence present in
EcoRl fragment C, the splice point has been deduced.
This mRNA is from early region 4 and contains leader
sequences encoded around coordinate 99 that have
become joined to sequences beginning at coordinate
96. Although the sequences around the splice point
contain the usual GT, AG dinucleotides at their ends,
they bear little resemblance to any of the other junc-
tion sequences present in Ad2. The sequences present
in the leader around coordinate 99 do not contain an
AUG initiation codon and the first such codon appears
within the first 50 nucleotides beyond the splice point
at coordinate 96.
Computer programs
From the inception of this project, it was apparent that
the amount of data involved was too great to allow its
ready manipulations without automated methods. Be-
cause such computer methods were not available, we
Undertook to develop our own software specifically
designed to handle large amounts of sequence data.
We were fortunate to obtain the help of a professional
programmer, Mr. John Milazzo, who is a full-time
employee of the Computing Center at Stony Brook.
Much of his spare time over the last year has been
devoted to collaborating with us in the development of
computer strategies for the assembly and analysis of
DNA sequences. At the present time, sequences are
transcribed manually from the original autoradio-
grams and then entered manually into the computer.
Two copies are made within the computer, one enter-
ing a master archive and the other entering a working
file. As data accumulate within the working file, the
various strings of nucleotides can be compared and
searched for identical or complementary stretches.
Once such stretches have been identified, they can be
used to join together the original strings of nucleotides
and thus the original, short strings of nucleotides
gradually become fused into a long, continuous string
that ultimately will be the sequence of the entire Ad2
genome. A variety of subroutines are available to ma-
nipulate the various strings of nucleotides including,
for example, programs to locate restriction enzyme
sites.
Aside from the ease of manipulating large amounts
of sequence data by computer methods, the most sig-
nificant advantage of this approach is the fidelity with
which one can make copies of any given piece of
sequence information. Even the most careful individ-
ual makes errors when manually copying a sequence
from one place to another. From our own experience
we have found that, because of the manual steps in-
volved in transferring information from the original
autoradiograms into the computer, errors can ac-
cumulate at a rate of about 1 per 200 nucleotides. We
are presently exploring a method that we hope will
eliminate this source of error. This new method makes
use of a device called a "digitizing tablet" upon which
is placed the autoradiogram. The digitizing tablet is
connected electronically to a pen, such that when the
pen touches it, the x-y coordinates of the point of
contact are recorded. By then using the pen to touch
the individual bands within a sequencing gel, theirx-y
coordinates are recorded and can be translated into a
sequence by an appropriate program. Such a program
is being developed at the present time. In addition, a
number of modifications to the existing programs for
the assembly of DNA sequences will also be made in
the coming year so as to reduce the amount of manual
intervention necessary to convert primary data into a
complete sequence. The programs that we have writ-
ten so far are of general application and have been
made available to other members of the scientific
community.
Restriction endonucleases
The collection of restriction enzymes continues to
grow and more than 200 such enzymes are now
known and more than 70 different specificities are
represented. Among the new specificities, the recog-
nition sequences of Ddel (C1TNAG) and Xho I I
(PuiGATCPy) have recently been characterized in this
laboratory. In addition, we have shown that Bad and
Eccl, first isolated by H. Mayer, are isoschizomers of
Sacll (CCGCGG) and Msil is an isoschizomer of Xho I
(CTCGAG). We have also shown that three other en-
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zymes, Sbol and Sbrl, isolated by H. Takanami, and
Shyl, isolated by F. Walter, are isoschizomers of Xho I.
Finally, we have shown that Xnil is an isoschizomer of
Pvul(CGATCG).
Using recombinant DNA techniques, we have at-
tempted to transfer the genes for a number of restric-
tion endonucleases into Escherichia coli. Initially, we
hoped to transfer and select these genes directly; how-
ever, our experience would suggest that, in general,
this will not be possible. Presumably, this is because of
the acquisition of a powerful specific endonuclease,
which, even when accompanied by its cognate
methylase, still results in the destruction of the host
cell DNA. To try to overcome this difficulty, we have
now concentrated our attention upon the prior cloning
of the methylase genes. Consequently, we have car-
ried out a number of experiments to characterize the
patterns of methylation that serve to protect DNA
against the effects of certain restriction endonucleases.
Among enzymes that recognize sequences containing
the tetranucleotide GATC, we find that methylation of
the A residue within the sequence protects DNA
against the effects of Mbol (GATC), Bc11 (TGATCA),
and Cpe I (TGATCA). On the other hand, methylation
of the C residue within this sequence protects DNA
against the action of Bam I (GGATCC), Bgl II
(AGATCT), Pvul (CGATCG), Xholl (PuGATCPy), and
Sau3A (GATC). Thus, by cloning the genes for the
Sau3A methylase and the dam methylase of E. coli
(which methylates GATC), we should obtain hosts in
which it will be possible to clone all of these restriction
endonucleases. Recently, we have successfully iso-
lated clones containing the dam methylase of E. coli.
During the course of these studies of methylase
specificity, we have encountered an unusual situation.
It has previously been shown that the restriction en-
donuclease, Hpall, recognizes the sequence CCGG
but cannot cut at that sequence if the internal C residue
is methylated. However, if the external C residue is
methylated, or if neither C residue is methylated, the
enzyme will cleave that sequence. Another restriction
endonuclease, Mspl, also recognizes this same se-
quence. In contrast to Hpall, this enzyme will cleave
the sequence when the internal C residue is methy-
lated, and so it was assumed that protection would be
afforded by methylation of the external residue. This
turns out not to be the case. When DNA from the
Moraxella species, which is the source of Mspl, is
prepared, it is found to be resistant to the action of both
Mspl and Hpall. Because Hpall can cleave DNA in
which the external cytosine is methylated, we are
faced with the conclusion that the modification re-
sponsible for protecting Msp DNA against the action
of Mspl must involve either the methylation of both C
32
residues or some other kind of modification. In gen-
eral, relatively little is known about the types of modi-
fication that serve to protect the host DNAs against the
effect of their own restriction endonucleases, but in
those cases that have been studied, it has always been
found to involve methylation. It could be that Msp will
prove to be the first example of an organism using a
different kind of modification.
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The Electron Microscopy Section has continued to
study the transcription and splicing of adenoviral
RNAs and the replication and transposition of bac-
teriophage Mu DNA. In doing so, we have combined
electron microscopic analysis with the techniques of
DNA cloning, restriction enzyme mapping, and
polynucleotide sequencing. In addition, we have col-
laborated with others to align the physical maps of the
chromosomes with the genetic and functional maps.
Adenoviral RNA synthesis
Adenoviruses cause throat infections or conjunctivitis
in people and can grow lytically in human cell culture.
Although they are unable to complete the infectious
cycle in rat cells, the several classes of human adeno-
viruses elicit, to varying degrees, transformation of
these cells and tumorigenesis in rodents. Hence, they
are bona fide tumor viruses and have been studied
intensely in their own right and as model systems for
eukaryotic gene expression:
The human adenovirus-2 (Ad2) chromosome con-
sists of 36,500 by of DNA. After infection of permis-
sive cells, the viral genome is transcribed into different
sets of RNA molecules at early (1-8 hr), intermediate
(8-16 hr), and late (16-30 hr) times after infection.
For the past several years, we have been mapping the
chromosomal locations of the viral transcripts and,
together with others at Cold Spring Harbor and
elsewhere, we have found that almost all cytoplasmic
RNAs are derived from discontinuous segments of the
genome. This spliced structure is generated from con-
tinuous primary transcripts of DNA by the deletion of
intervening sequences and the religation of the con-
served segments that constitute functional RNAs.
The map coordinates, splicing patterns, and relative
abundances of the early, intermediate, and late RNAs
were described in previous Annual Reports. One of
the more interesting RNAs at intermediate times is an
r-strand transcript with main body sequences from
coordinates 30.5-39.0, which encodes a 52K protein
(J. Miller, R. Ricciardi, B. Roberts, B. Paterson, and M.
Mathews, pers. comm.; Lewis et al., Cold Spring Har-
bor Symp. Quant. Biol. 44:[1980]). This RNA has the
tripartite leader that is found on all the other products
of the r-strand transcription unit or, more frequently, a
four-part leader (Chow et al., 1979, 1980). This extra
segment, which we call the "i" leader, is derived from
genome coordinates 22.0-23.2, between the normal
second and third leaders (Fig. 1). The i leader can also
be found in all the other r-strand messages, especially
at intermediate times after infection.
In the presence of Ara C (an inhibitor of DNA repli-
cation), the production of the 52K transcript is dramat-
ically elevated, at the expense of the dozen other
possible products we have previously characterized
(Chow and Broker, Cell 15:497 [1978]). Furthermore,
about 85% of the 52K RNA and of the other r-strand
RNAs have the four-part leader. Molecules with this
extra leader might be RNA splicing intermediates. To
test this possibility, Kilpatrick has cloned short seg-
ments of the Ad2 chromosome that contain various
combinations of the coding regions for the late RNA
leaders. These will be hybridized to radioactively
labeled RNA synthesized in vivo to follow their kinet-
ics of appearance, interconversion, and turnover in an
attempt to define the precursor-product relationships.
Using cell-free translation of RNA, Jim Lewis and
coworkers identified a 13.6K protein that is made at
intermediate times and is encoded near map coordi-
nate 20. Extensive electron microscopic examinations
of the RNA by Louise Chow revealed that the only
likely segment that could be correlated with the 13.6K
protein was the i-leader segment. More recently, one
of Kilpatrick's cloned Ad2 segments containing the
coding sequences for the i leader (but no other leaders)
was used successfully by Lewis to select the 13.6K
RNA. This strongly supports the notion that the leader
is a message-a novel situation-and provokes specu-
lation about the role of the 13.6K protein in the early-
to-late transition in gene expression.
Ad2 RNA synthesis in monkey cells
Klessig and Anderson (J. Virol. 16:1650 [1975]) and
Farber and Baum (J. Virol. 27:136 [1978]) have shown
that the block to the growth of human Ad2 in monkey
CV-1 cells can be attributed, in part, to a reduced
concentration of certain late mRNAs in the cells. The
most severe reduction is in the mRNA for the fiber
protein; it seems to be anomalously affected because
the fiber protein level is even more reduced than that
of the RNA. The nature of this defect was examined by
electron microscopy of fiber (and other late) RNA in
collaboration with D. Klessig (Klessig and Chow,
1980). A major manifestation of the defect is evident at
the level of RNA splicing. About half of the fiber
transcripts are incompletely spliced and have long
RNA sequences remaining between the tripartite
leader and the main body of the fiber message (Fig. 2).
Because only the 5'-proximal message in polycis-
tronic eukaryotic RNA is translated (Kozak, Cell
15:1109 [1978]), such long fiber RNA would not be
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Heteroduplexes of single-stranded Ad2 DNA with late cytoplasmic RNAs having abnormal 5' leader segments. (a) A rare
cytoplasmic RNA with normal first and second leader segments. The sequence between the third leader and the main
body of the message has not been removed; thus, there are only two leader loops, 1 and 2. (b) An RNA (coordinates
30.5-39.0) for the 52K protein which has normal first and second leaders and a long third leader from coordinate 22.0 to
coordinate 26.8, forming leader loops 1, 2a, and 3. (c) An RNA with a normal first and second leader, an i leader, and a
longer-than-normal last leader (coordinates 24.0-26.8). The leader loops are labeled 1, 2a, 2c, and 3. The 5' end of the
main body of the RNA is located at coordinate 39.0 (d) An RNA for the 52K protein with a four-part leader 1, 2, i, and 3,
generating leader loops 1, 2a, 2b, and 3. (e) An RNA for the 52K protein which has a normal tripartite leader constraining
the DNA into leader loops 1, 2, 3. (f) Graphic representations of a through e.
Leader
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(HR400) that grows in monkey cells (Klessig, I. Virol.
21:1243 [1977]) shows almost normal production of
mature fiber RNA both in amount and in structure. The
HR400 mutation maps in or near the gene for the
DNA-binding protein (Klessig and Grodzicker, Cell
17:957 [1979]), implicating it in the RNA-splicing
process. The tenfold reduction in the amount of fiber
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message could be due to any of several defects: (1)
premature termination of transcription, (2) failure to
polyadenylate fiber transcript, or (3) instability of in-
completely spliced fiber message. In last year's Annual
Report, we presented some evidence suggesting that
the tripartite leader is transferred sequentially down
the primary transcript from the 5' end of one gene to
Figure 2
Heteroduplex of Ad2 DNA with incompletely spliced fiber
RNA isolated from monkey CV-1 cells. The coordinates of
the RNA are / 6.5- / 6.6/19.5- /9.7/26.5-26.8/72.5-73.5/
73.9-77.6/78.6-79.1/86.2-9 / .3. In the heteroduplex, the
seven conserved segments are separated by six deletion
loops corresponding to the intervening sequences. Leader
segments 1, 2, 3, and y are labeled, two small deletions
loops are indicated by arrowheads, and the 3' end of the
RNA is indicated by a dot. Mature fiber RNA contains only
four segments, the first three leaders and the main body
from coordinates 86.2-91.3.
the next. It appears that splicing to the leader to the
main body in monkey cells is very slow or is blocked in
the vicinity of the 100K-33K- pVIII gene family. This is
compatible with our splicing model.
RNA synthesis by class-B adenoviruses
Last year our laboratory showed that the late tran-
scripts of class-B adenoviral serotypes Ad3 and Ad7
have virtually the same coordinates as those mapped
for Ad2, a class-C adenovirus (Kilpatrick et al., 1979;
Chow and Broker, Cell 15:497 [1978]1. The leader
sequences of RNAs within the same class (Adl , Ad2,
Ad5, Ad6 or Ad3, Ad7) will anneal with DNA from
another member of the same class; however, they will
not anneal with DNA from another class, indicating
sequence divergence even though the locations of the
coding regions are highly conserved.
To examine these leader divergences in greater de-
tail, Engler and Kilpatrick have cloned DNA restriction
fragments of Ad3 and Ad7 into the pBR322 plasmid
vector. Engler has further characterized them by re-
cloning and by detailed restriction endonuclease
mapping. DNA sequence analysis of Ad3 and Ad7
clones containing the first leader coding sequences
has been carried out. Examination of the sequence
indicates an unexpectedly close homology with the
Ad2 sequence of the same region (Fig. 3). Green et al.
(Virology 93:481 [1979]1 have reported that Ad3 and
Ad7 share only about 15% homology with Ad2, based
on retention on hydroxyapatite after solution hy-
bridization. However, Engler finds that over 80% of
the nucleotides are identical. There are very few dele-
tions or insertions and most changes are transitions or
transversion. By analogy to the Ad2 sequence, the Ad3
and Ad7 DNA sequences coding for the first leader (41
nucleotides) have been recognized and there are six
differences between Ad2 and Ad7 or Ad3. The splice
junctions are identical, but differences are observed as
close as the third and fourth nucleotides into the inter-
vening sequence. The TAT(A,T) sequence indicative
of eukaryotic promoters (D. Hogness, pers. comm.) is
identical for the Ad2, Ad7, and Ad3 r-strand transcrip-
tion units.
An unexpected dividend of the few observed differ-
ences between the viruses comes from examination of
the potential secondary structures in the sequence. Ziff
and Evans (Cell 15:1463 [1978]) noted, in the single-
strand DNA, a potential stem-loop structure in the
vicinity of the promoter and the 5' end of the late Ad2
RNA. This cannot exist in Ad7 or Ad3 due to 8-bp
changes (Fig. 4). But a different stem-loop structure
can be drawn precisely between the promoter and the
5' end of the RNA (Fig. 4a). In fact, an analogous
structure also exists in the Ad2 DNA sequence (Fig.
-30 .20 -no
Ad2 5' GGGGGGCT ATAAAAGGGG GTGGSGGCSC GTTCGTCCTC 3.
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Figure 3
Comparison of the Ad7 and Ad2 DNA sequences in the vicinity of the major late promoter and the first leader segment
(coordinates 16.5 - 16.6). The Ad7 sequence was determined by Jeff Engler and the Ad2 sequence by Ziff and Baker (Cold
Spring Harbor Symp. Quant. Biol. 44 [1980]). Sequence differences are indicated by the shaded areas and reveal less than
20% divergence of the leader as well as of the flanking regions.
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G-T G-T tional leader regions from Ad3 and Ad7 will be de-G.G
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studies with other studies
Figure 4
The electron microscopic characterizations of thePotential stem-loop structures in the Ad7 and Ad2 DNA
structures and splicing patterns of the adenoviral RNAstrands homologous to the late mRNAs. The AT-rich se-
quence believed to constitute part of the promoter (dark transcripts present in the cytoplasm of infected cells
stippling) and the sequence corresponding to the 5' end of have provided a wealth of data for comparison with
the first leader segment of the late RNAs (light stippling) DNA and RNA sequences and proteins characterizedimmediately flank the stems. (a) The sequence determined
for Ad7. The nucleotides that differ from those of Ad2 are by other investigators. These have been discussed in
indicated by asterisks. (b) The comparable structure estab- detail by Chow et al. (1980) and by Chow and Broker
lished with the Ad2 DNA sequence. This is an alternative (1980a). Table 1 summarizes some of the biological
configuration to that proposed by Ziff and Evans (Cell 15: consequences of RNA splicing that can be inferred1463 [1978]).
from comparative analyses. Table 2 reviews many of
the rules for, or patterns of, RNA splicing inferred
4b). Examination of a broad spectrum of adenoviral primarily from our electron microscopic investiga-
early RNA regions and other eukaryotic genes has Lions.
revealed that similar, but generally somewhat less The coincidences of 5' promoters, 3' polyadenyla-
ideal, inverted duplications exist in the same location. tion sites, and upstream or downstream splicing junc-
Table 1
The biological consequences of RNA splicing
1. Establishes alternative deletions within the coding sequences of the same primary transcripts to produce sets of
related proteins differing in internal polypeptide composition (one gene-several proteins). (Early regions 1A, 1B, 4,
and possibly 3.)
2. Allows modulation of the relative abundances of the related messages. (Early regions 1A, 18, 3 and 4 and the major
late transcriptional unit.)
3. Bypasses protein termination codons to allow synthesis of longer polypeptides. (Early region 1A and possibly the
early region 4 and the messages for the IVa2 and 100K -33K proteins.)
4. Creates translation frameshifts to allow synthesis of longer polypeptides. (Early region 1A.)
5. Couples a protein initition codon AUG to an open translation frame to allow its expression. (Early-region-1A RNA.)
6. Couples a protein termination codon to an open translation frame to allow premature truncation of polypeptide
synthesis. (Early region 1B.) .
7. Allows utilization of a common promoter for coordinately expressed mRNAs. (Early regions 1A and 1B, 3, and 4 and
major late r-strand transcriptional unit.)
8. Provides translational access to interior messages in long primary transcripts. (Major late r-strand transcriptional unit
and possibly early regions 3 and 4.)
9. Places at the 5' end of RNAs a leader sequence which may be needed for ribosome binding through the 185
ribosomal RNA. (Early region 4 and major late r-strand transcriptional unit.)
10. Allows utilization of different promoters for the same message at early and late stages of infection. (Early regions 2
and 3.)
11. Deletes the promoter, cap site, and rRNA binding sequences from the main bodies of overlapping transcripts. (Early
region 1B and peptide-1X RNA.)
12. Enables, in an undefined way, transport of mRNAs to the cytoplasm.
These have been inferred by correlating RNA splicing patterns determined by electron microscopy, deoxyribonuclease
mapping, and RNA and cDNA nucleotide sequencing with the chromosomal DNA sequence and with studies of the sizes
and compositions of the encoded proteins and thus represent the collective efforts of numerous people, both at Cold
Spring Harbor Laboratory and elsewhere. References to the sequencing work appear in the footnote to Table 2, and
discussion of the proteins is reported by the Protein Synthesis Section in this Annual Report.
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Table 2
General patterns of adenoviral RNA splicing
1. Almost all mature mRNAs are derived from two or more discontinuous segments of the genome.
2. Splices may remove a few nucleotides (e.g., about 100 in early-region-1A and -1B RNAs) to many (21,700 between
the third consanguinous leader segment and the fiber message).
3. The first two nucleotides of a deleted intervening sequence are GU and the last two are AG, as in virtually all
eukaryotic RNA splicing (based on sequencing studies in many laboratories).
4. Splices are faithful to the nucleotide; they can correctly join coding regions. (Early regions 1A, 1B.)
5. Splices can also be upstream of coding regions (between leader segments) or downstream of the translated portion of
the message. (Early region 1B.)
6. Conserved segments are always in the same order as in the primary transcript of the genome, suggesting a directional,
intrastrand event.
7. Most, if not all, splicing occurs in the nucleus.
8. The capped 5' end and the polyadenylated 3' end of each primary transcript are conserved through all splicing
events, and all deletions are therefore internal.
9. The presence of the 5' cap nearby (within 50-100 bases) seems to potentiate certain splice sites; its absence seems
to disqualify sites that can otherwise be used. (The early and the late leaders of region-2 transcripts are usually not
present in the same mRNA.)
10. There are a number of early and late RNA families with common 3' ends. The sites of polyadenylation determine the
sets of product messages derived from the precursor transcript such that the 5' end of the primary transcript is spliced
to one of several sites relatively near the poly(A). (Early region 3, region-4- region-2 hybrid RNAs, and late r-strand
transcripts; see Figs. 5 and 6.)
11. A site that is a normal downstream junction site can be bypassed if poly(A) is not nearby. (Region -4- region -2 hybrid
RNAs.)
12. Segments that are conserved when present in one primary transcript may be spliced out when flanked by different 5'
and 3' ends. (Early-region-3 fiber, early -region -4- region -2, and late r-strand mRNAs from-different 3' families.)
13. Deletions are not necessarily processive in the 5'->3' direction; certain downstream splices can occur prior to other
upstream splices. (Early region 4, late r-strand leader segments, and fiber transcripts.)
14. Some multiple deletions may occur in alternative orders. (Early region 4, late r-strand leader segments, fiber
transcripts, and other late r-strand products.)
15. Splicing of certain segments does not necessarily occur in a single complete step, but can proceed by a series of
partial deletions. (Early region 4, late r-strand leader segments, fiber transcripts, and other late r-strand products.)
16. Late tripartite leaders appear to undergo a gene-to-gene transfer during coupling to distal coding regions in
polycistronic transcripts. The leaders are (apparently transiently) coupled to the 5' ends of upstream genes. (r-strand
transcripts.)
17. Leader sequences and main body sequences may be spliced somewhat independently; they can be at different stages
of maturation. (r-strand transcripts.)
18. Splice signals in separate transcription units can faithfully recombine if transcription readthrough puts them in the
same RNA molecule. (Region-4- region-2, region -1A- region -1B, and late r-strand-unit-early-region-3.)
19. Many splice junction sequences can have alternative 5' or 3' splice partners. (All early regions, and major late
r-strand transcripts; see Figs. 5 and 6.)
20. When a message switches from an early to a late promoter, splicing within the main body can continue in the same
pattern despite different leaders. (Early regions 2 and 3.)
21. Splices that occur efficiently in one host may be inefficient in another host. (Region 3 and fiber: HeLa vs monkey
cells.)
22. The rate or efficiency of splicing can depend on cellular growth conditions whether cells are grown in monolayers or
spinner cultures.
23. Cycloheximide, an inhibitor of protein synthesis, depresses the appearance of the more extensively deleted members
within a family of transcripts. (Early regions 1A, 1B, and 4.)
24. Adenoviral RNA splicing is catalyzed by host proteins, but some viral proteins play some role in the process at
intermediate to late times after infection.
25. The designations "intron" and "exon" are inappropriate for adenoviral transcripts since most segments can serve both
roles, depending on the message.
References to nucleotide sequence analyses: van Ormondt et al., Gene 4:309 (1978); Maat and van Ormondt, Gene 6:75
(1979); Maat et al., Gene 1980; Akusjarvi and Pettersson Cell 16:841 (1979); Zain et al., J. Mol. Biol. 135:473 (7979);
Perricaudet et al., Nature 281:694 (1979); Perricaudet et al. Proc. Natl. Acad. Sci. (1980).
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Figure 5:
Coincident RNA processing sites in the Ad2 chromosome between map coordinates 0.0 and 17.0. Arrows indicate the
direction of transcription along the r strand or I strand of the DNA. The conserved segments constituting early RNAs
(Chow et al., 1979) are depicted by thin arrows and those in late RNAs (Chow and Broker, Cell 15: 497 (1978]) by thick
arrows. Gaps in arrows represent intervening sequences removed from the mRNA5 by splicing. The short deletion in the
region-18 RNA was detected by Berk and Sharp (Cell 14: 695 f19781) using a nuclease-digestion assay. Short DNA or
RNA regions that serve multiple roles in the synthesis and splicing of different RNAs (derived from either the same strand
or opposite strands) are indicated by the stippled areas.
tions in various RNAs transcribed from the same strand between protein-coding regions. The promoters and
or from opposite strands were discussed by Broker and 5'-leader segments of the late RNAs for the 72K
Chow (1 979) and are emphasized in Figures 5 and 6. It single- stranded DNA-binding protein over lap
is remarkable that RNA synthesis and processing sig- protein-coding regions on the opposite strand, the first
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Figure 6
Coincident RNA processing sites in the Ad2 chromosome between map coordinates 60.0 and 100.0. The conventions
described for Fig. 5 are maintained. All late r-strand RNA5 have a tripartite leader (3) derived from genomic coordinates
16.5- 16.6/19.5 - 19.7/26.5 -26.8. The fiber RNAs have multiple forms that include the consanguinous tripartite leader
and all combinations of ancillary leaders x, y, and z, which coincide with segments in early-region-3 RNAs. The region-3
RNA5 originate from a promoter at coordinate 76.6 at early times and can be transcribed from the major late promoter
(coordinate 16.5) at late times. The single-stranded DNA-binding protein RNAs are transcribed from different promoters,
two active primarily at early-early times and two at intermediate to late times. Each DNA-binding-protein RNA can be
observed in an alternative form with a small splice at coordinate 66.3.
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Cloning and mapping of specific bacteriophage Mu
DNA restriction fragments
Partial correlations of genetic and physical maps of
bacteriophage Mu are obtained by determining the
Mu DNA segment present in XpMu transducing
phages (Magazin et al., Virology 77:677 [1977]) or by
defining the genetic markers in certain Mu DNA re-
striction fragments cloned into bacteriophage X or
plasmids (Moore et al., in DNA Insertion Elements,
Plasmids, and Episomes, p. 567, Cold Spring Harbor
Laboratory [1977]). To extend such correlations, Jeff
Engler has cloned EcoRl -BamHl restriction fragments
of Mu DNA. These clones have been characterized by
electron microscopic heteroduplex methods and by
restriction endonuclease digestion and gel elec-
trophoretic assays, as well as by genetic complemen-
tation tests. In collaboration with R. Forgie and M.
Howe, additional genetic markers were tested and the
two BamHI cleavage sites in Mu DNA have been
placed within cistrons E and F.
The relationships between bacteriophage Mu
and D108
Phage D108 is a Mu-like phage, but it is heteroim-
mune. It is closely related to Mu in both DNA se-
quence and genetic properties (Hull et al., J. Virol.
27:513 [1978]). By electron microscopic heterodu-
plex analysis, we have detected two regions of the
genomes which are nonhomologous, in addition to
three others previously described (Fig. 7). One of the
newly found nonhomologies is a 200-nucleotide-pair
substitution located in the invertible G segment,
which has been postulated to encode the tail fiber of
the phage. This sequence divergence might explain
the differences in the host ranges of Mu and D108
(Howe, Virology 55:103 [1973]; Hull et al., J. Virol.
27:513 [1978]. The other identified difference be-
tween the two genomes is an insertion of 0.5 kb in the
/3 segment of D108 relative to that of Mu. The genetic
consequence of this insertion is unknown.
Upon coinfection of sensitive cells with Mu and
Figure 7
Heteroduplexes of DNAs from phages Mu and D108. (Top) Three substitution loops near the left end of the genomes
at coordinates 0.3-4.1%, 13.1-13.5%, and 20.5-22.3%; (bottom)a substitution loop within the invertible G segment
in the (+) orientation at coordinates 89.6-90.1% and an insertion of 500 nucleotides in D108 (relative to Mu) in the
beta-region near the right (split) end at 99.7%.
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D108, only 0.5-4% of the progeny are Mu. This is
similar to the exclusion phenomenon observed with
the related T3 and T7 phages or the T-even phages.
However, when Mu-infected cells are superinfected
with D108 after a 5-minute delay, mixed bursts are
obtained in which 80-95% of the progeny are Mu.
The molecular basis for these observations is under
investigation.
We have also found that the replication-transposi-
tion system of D108 complements that of Mu poorly.
Cells harboring a mini-Mu genome (consisting of the
two terminal segments of Mu) replicate and transpose
only rarely when the host cells are superinfected by
D108. This mini-Mu has been shown to replicate and
transpose efficiently in the presence of a Mu helper (D.
Kamp, R. Kahmann, and L. Chow, unpubl.).
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In the past year, studies in the Protein Synthesis Labo-
ratory have concentrated on the proteins of the
adenoviral particle and of cells productively infected
by the virus or transformed by it. Several areas have
received special attention, including (1) the proteins
encoded by the left end of the viral genome, (2) the
interactions that contribute to the regulation of viral
gene expression, and (3) the properties of small virus-
coded RNA species. Identification of viral proteins and
correlation of the proteins with their cognate mRNAs
and genes is now well advanced, particularly in the
case of the structural components of the viral particle
produced late in infection. Extensive progress has also
been made in recognizing the viral products synthe-
sized in the early phase of the infectious cycle, before
viral DNA replication has occurred, but it is clear that
there is still some way to go before the catalog is
complete. Transformed cells need express only one or
two of the viral genes, although four early genes have
been found to exert at least some influence over the
transformation process. It is in this aspect of viral gene
expression that some of the most profound unan-
swered questions persist.
Our analyses are based on the translation of mRNA
from infected or transformed cells in vitro, using a
cell-free system from rabbit reticulocytes rendered
dependent on exogenous mRNA by treatment with
micrococcal nuclease. The mRNA is preselected by
molecular hybridization and/or by size fractionation
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permit correlation with RNA species characterized by
other means. The proteins generated in vitro are iden-
tified by SDS gel electrophoresis and compared with
their counterparts made in vivo by such methods as
peptide mapping, two-dimensional electrophoresis,
and immunoprecipitation.
Discovery of "new" viral proteins
Several additional virus-coded polypeptides have
come to light in the last year using theselechniques. It
is convenient to introduce the salient facts here be-
cause these products will figure in the subsequent
discussion.
El A-28K: The smallest of the El A proteins, with an
apparent molecular weight of 28,000, is translated
from the smallest mRNA from this region. It comes to
account for a substantial share of the early-region-1A
(El A) protein synthesized at late times in infection (see
Figs. 1 and 2).
El B-58 K: Under most conditions this is a minor in
vitro product, first seen by Halbert et al. If. Virol.
31:621 1197911, although in vivo it appears to be a
major component of T antigen. We are presently in-
vestigating its relationship to other viral proteins.
E1B-18K and 22K: These two polypeptides are
made in vitro in small amounts relative to the 15K
protein from the same region. Their mRNAs are
selected by hybridization to a DNA fragment from the















Adenoviral proteins synthesized in the absence of viral DNA replication. The conventional early gene blocks, El E4,
and the newly positioned E5 block which contains a conventional early gene, are shown as unshaded arrows. Stippled
arrows represent genes falling into the "intermediate" category. The direction of each arrow gives the polarity of
transcription in each gene block. Polypeptides translated in vitro from RNA deriving from each gene block are listed
above or below their point of origin. Parentheses and asterisks signify that precise map locations and polarity
assignments, respectively, have not yet been made in some instances. The circled numbers 1 3 mark the loci of the
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Figure 2
Coding assignments for early-region-1 mRNAs. The thick
lines represent the map locations of the sequences and
splices contained in the E1A and E18 mRNAs (drawn from
several sources). The proteins encoded by each RNA
species are indicated, and the boxed areas show the
likely extent of the coding regions.
about the size of the mRNA or the precise location of
its coding region.
16.5K and 17K: The RNAs encoding these polypep-
tides map within the region that codes for the IVa2
protein at 11-17 map units. The proteins have been
detected as in vitro translation products of RNA from
high-multiplicity infections made in the presence of
cytosine arabinoside (Ara C, an agent that blocks DNA
replication and prevents the appearance of the con-
ventional late mRNAs though not of IVa2 mRNA), but
not in preparations made in the presence of cyclohex-
imide (which blocks protein synthesis as well as DNA
replication and late RNA production). Neither the
precise location of the coding regions for these pro-
teins nor their relationship to each other and to com-
ponent IVa2 is known at present.
13.5K: This polypeptide is made from an r-strand
transcript selected by a DNA fragment located be-
tween 17 and 22 map units. It may represent the
leftmost protein encoded by the major late transcrip-
tion block running from map position 16.4 toward the
right end of the genome. The mRNA is selected by
DNA containing the tripartite leader sequence that is
present on most late mRNAs, but we do not yet know
whether the 13.5K protein RNA is initiated at the
promoter used by the major late block. It is found in
largest amounts in preparations isolated at late times
after infection and can be seen in many early RNA
preparations, including ones made from cells almost
totally blocked for protein synthesis.
85K: The DNA fragments located between 17-22
and 22-26.5 map units select RNA that is translated
into a polypeptide with a molecular weight of 85,000,
coincident with the late structural protein III (penton
base). Although the mRNA for the latter could hy-
bridize to the same fragments by virtue of its tripartite
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leader sequences, the 85K polypeptide is detected in
the translation products of early RNA, which fails to
evidence any of the other late proteins. Accordingly,
we consider the 85K early protein a likely candidate
for the gene product of the newly mapped early region
5, defined by mutants of the ts36 group (Galos et al.,
Cell 17:945 [1978]).
52K, 55K: This pair of closely related polypeptides
constitutes the leftmost product of the late gene block
as conventionally defined. The 52K, 55K-protein
mRNAs possess the tripartite leaders and map be-
tween 29 and 39 map units, with coding sequences
between about 30 and 34 map units. However, the
mRNA encoding these proteins is unconventional in
that it is readily detectable in preparations made in the
absence of viral DNA replication, whereas the other
mRNAs of the major late transcription unit remain
cryptic.
Early region "IA
Studies in other laboratories have shown that the
products of this region constitute the core of the trans-
forming potential of the virus (van der Eb et al., I.
Supramol. Struct. [Suppl. 3]: 128 [1979]) and also
(perhaps by related activities) act as positive effectors
to promote the expression of other early viral genes
(Berk et al., Cell 17:935 [1979]; Jones and Shenk,
Proc. Natl. Acad. Sci. 76:3665 [1979]). By cell-free
translation of RNA isolated from adenovirus-2 (Ad2)-
infected cells, we have identified five polypeptides
encoded in this region, with apparent molecular
weights of 58,000, 54,000, 47,000, 42,000, and
28,000. In the closely related Ad5 strain, the corre-
sponding polypeptides migrate with apparent molecu-
lar weights of approximately 2000 greater, but for
simplicity we will use the Ad2 designations through-
out this report. Translation of early RNA, made at 6
hours postinfection in the presence of cycloheximide
or at 16 hours in the presence of Ara C, yields predom-
inantly the four largest El A proteins and relatively little
of the 28K polypeptide. In contrast, late RNA made at
20 or 29 hours postinfection codes for reduced
amounts of the four large proteins, whereas the syn-
thesis of the 28K polypeptides rises to levels compar-
able with the other proteins from this block.
Electrophoresis through agarose gels in the pres-
ence of methylmercury hydroxide separates three size
classes of El A mRNAs. The largest species, centered at
1.05 kb, directs the synthesis of the 58K and 47K
polypeptides; the second largest species, 0.9 kb,
codes for the 54K and 42K polypeptides; and the
smallest RNA species, 0.6 kb, encodes the 28K
polypeptide. The observation that the four large pro-
teins are translated from only two size classes of RNA
is open to several interpretations. One possibility is
that there are indeed only two species of mRNAs, and
the pairs of polypeptides that derive from each one are
generated by anomalies in translation or by posttrans-
lation modification. Alternatively, both mRNA size
classes might contain two comigrating species each
coding for a unique polypeptide. We have not yet
arrived at a definitive resolution of this question, but
experiments with El A mutants (described below)
confirm the pairwise behavior of the proteins and
locate the source of the duality between 3.7 and 4.5
map units. This issue aside, the results from our trans-
lation experiments correlate readily with data from
this and other laboratories on the structures and kinet-
ics of appearance of E1A mRNAs, permitting assign-
ment of proteins to individual RNA species (see Fig. 2).
Mutant El A proteins
Two sets of mutants of adenovirus that are defective for
growth in HeLa cells contain lesions in the El A region
and give rise to aberrant proteins. RNA from cells
infected with the host-range mutant hrl (Harrison et
al., Virology 77:319 [19771) fails to produce the 58K
and 42K polypeptides from region El A, but directs the
synthesis of the 54K and 42K pair together with a
rather diffuse group of polypeptides with apparent
molecular weights of 26,000-28,000. The RNA
species encoding these shorter products correspond in
size to the mRNA that in wild-type infections codes for
the 58K and 42K proteins. Therefore, we conclude that
the hrl mutation has generated a nonsense condon in
the region between 2.8 and 3.2 map units that is
specific for the largest species of El A mRNA, resulting
in the truncation of its normal products (58K and 42K)
to 26K-28K.
Another group of host-range mutants contains vi-
ruses that carry deletions of the El A region (Jones and
Shenk, Cell 17:683 [19791). In the most severe case
(dI312) no viral messenger activity can be detected by
cell-free translation. This virus is missing almost all of
the El A region and, by physical criteria, all viral
mRNAs. The mutants d/311 and d1313 contain smaller
deletions of the E1A region and produce mRNAs that
encode altered proteins. Two polypeptides are made
in vitro in each case, of sizes 38K and 34K (dI311) and
40K and 36K (dI313), in place of the four normal
proteins of 42K-58K. Fractionation of the RNAs by
gel electrophoresis suggests that the polypeptides from
each mutant are made on separate mRNAs, corre-
sponding to the species that in wild-type infections
give rise to the four largest El A proteins. Both of these
mutants lack E1A sequences to the right of map posi-
tion 3.7 and their mRNAs produce two proteins in-
stead of two pairs of proteins. This suggests that the
feature that causes each RNA to make a pair of pro-
teins maps between 3.7 and 4.5 map units. In dI313,
the deletion fuses part of the El A and El B regions, with
the result that the El A mRNAs, and probably the pro-
teins for which they code, contain some sequences
from the El B region. Additional minor polypeptides
with molecular weights of 50,000-55,000 are seen in
some preparations of El A mRNA from d1311 and
dI313 infections, but the origin of these polypeptides,
which differ in the two viruses, is not understood.
Pleiotropic effects of El A products
The El A proteins have been clearly implicated in cell
transformation, and in the last year it was reported that
they also exert a controlling influence over the ex-
pression of other viral early genes. We have studied
this point using the in vitro translation technique to
estimate the amounts of viral mRNA present in HeLa
cells infected with mutant viruses or with wild-type
virus in the presence of inhibitors of protein synthesis.
In agreement with the results of others, we find that
the d1312 lesion produces the most severe obstruction
to viral gene expression, and we have not detected the
synthesis of any viral products whatsoever. The hrl
mutation, which foreshortens one of the two pairs of
El A proteins, leads to a reduction in the amounts of
mRNAs from the other early regions. In our hands the
effect is quantitatively variable but always less dramat-
ic than reported in the literature, the RNAs from re-
gions E2 and particularly E4 being affected to a greater
extent than those produced by the El B and E3 regions.
Therefore, it seems reasonable to conclude that the
El A region products include positive effectors re-
quired for the expression of the other early regions
El B, E2, E3, and E4. One tempting hypothesis that can
be framed around the data is the speculation that the
El A 58K and 47K proteins are primarily concerned
with the I-strand mRNAs of regions E2 and E4, whereas
the responsibility of the El A 54K and 42K products lies
with the El B and E3 r-strand products.
As far as this pleiotropic effect is concerned, the
functionally significant parts of the proteins would
seem to be encoded to the left of map position 3.7 on
the genome, because only minor reductions of early
mRNA concentrations are observed in cells infected
with the d/311 and dI313 mutants whose deletions are
to the right of this point. On the other hand, both of
these mutants are defective in viral DNA synthesis, so
the region lying between 3.7 and 4.5 map units pre-
sumably encodes a portion of the El A proteins in-
volved directly in replication.
The proposition that the El A proteins are "pre-
early" or "immediate early" viral products required to
actuate other early genes has been probed by exper-
iments using drugs to inhibit protein synthesis. Cyclo-
heximide, the drug conventionally used for this pur-
pose, gives rise to a pattern of gene expression not
differing greatly from that observed in the presence of
Ara C. However, as shown previously, it does marked-
ly affect quantitative representation of the various
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early mRNAs, the cellular concentration of many, but
not all, early viral mRNAs being augmented-perhaps
by interference with synthesis of a negative effector or
via stabilization of mRNA against degradation. How-
ever, cycloheximide is only 95-97% effective in
blocking protein synthesis in vivo and it could be that
the residual activity suffices to produce adequate
amounts of an immediate early protein. We have
therefore turned to anisomycin, a more potent in-
hibitor of protein synthesis, to investigate this ques-
tion. At 10 ,tn, anisomycin gives effects similar to
those observed with cycloheximide, but, at 100 gm,
protein synthesis is reduced to less than 1% of the
control level and the pattern of early mRNA expres-
sion is grossly altered. The concentrations of most
early RNAs, including those from region El A and es-
pecially those from regions E2 and E4, are severely
depressed, but the amounts of the mRNAs for the
13.5K and 52K, 55K polypeptides are unaffected. On
the basis of these experiments, these proteins would
be good candidates for immediate early status.
The "early-late switch"
Although the existence of a network of controls oper-
ating during the early phase has only recently been
recognized, the conventional distinction between
early and late stages of infection is well established.
The transition between these phases does not occur in
the absence of viral DNA replication, i.e., in the pres-
ence of inhibitors of early protein synthesis or of DNA
synthesis, in infections with defective viruses or of
nonpermissive cells, or simply chronologically prior
to replication in the normal infection cycle. However,
the nature of the link between replication and the
transcription of late genes is obscure. We have
employed a superinfection assay to examine the ex-
pression of viral genes introduced into cells already at
a late stage of a prior infection and the effects thereon
of metabolic inhibitors. This enables us to discriminate
between two classes of hypothetical linking mecha-
nisms: those that propose that the nature of the DNA
template is the determining factor and others that em-
phasize concurrent alterations in the transcriptional
apparatus of the cell.
In these experiments, we use a pair of closely related
viruses that cross-complement for all known adenovi-
ral functions, chosen such that the products of the
initial infection can be distinguished from those of the
superinfecting virus. The first virus is an Ad5 mutant,
ts125, conditionally defective in an early function,
and the superinfection is carried out with a variant of
Ad2, Ad2+ND1dp2, carrying two insertions of SV40
sequences, one of which is under early control and
and the other, under late control. These markers, and
other electrophoretic differences between the pro-
ducts of the two viruses, allow the expression of early,
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"intermediate" (see below), and late genes to be moni-
tored.
Upon superinfection of cells in the late phase of a
primary infection, both early and late products of the
superinfecting genome can be detected. However,
blockade of DNA replication from the time of the
superinfection prevents expression of the late genes of
the superinfecting genome, although active transcrip-
tion of the late genes of the first agent continues in the
same cells. Control experiments exclude several less-
interesting possible explanations of this finding, in
terms of gene dosage or serotype-specific effects, for
example, and we conclude that the mere presence in
the cell of the machinery for late transcription does not
secure the expression of late genes from unreplicated
viral DNA. Other data argue against the transient in-
volvement of unstable factors acting on the first
genome to activate its transcriptional capacity. It
seems, therefore, that only genomes which themselves
have undergone replication are available for late gene
expression, although ongoing replication is not ob-
ligatory. The nature of the replication-induced modifi-
cation is presently under investigation, and current
efforts are directed toward the isolation and definition
of the late template.
"Intermediate" phase of gene expression
These results notwithstanding, the demarcation be-
tween early and late genes has become less clear-cut
in recent months. Last year we demonstrated that viri-
on component IX, which is made in large amounts at
late times, is also produced in the absence of viral
DNA synthesis. Recently, we have extended this ob-
servation to include polypeptide IVa2, another con-
stituent of the viral particle, whose mRNA has now
been detected in cells that are blocked for DNA repli-
cation with Ara C and contain no other "true" late
RNAs. The mRNAs for polypeptides IX and IVa2 are
much less evident in preparations from cells held in
the early phase of infection by cycloheximide. These
observations suggest the existence of an "inter-
mediate" category of products expressed strongly at
late times, modestly in the absence of viral DNA repli-
cation, and only weakly in the absence of protein
synthesis.
It is perhaps not surprising that the genes for
polypeptides IX and IVa2 should be under separate
control from the majority of late genes, since they are
located outside the major late transcription unit and
have their own transcriptional promoters. However, it
was more surprising to discover that mRNA for the
52K, 55K polypeptides, which are encoded between
30 and 34 map units, is present in early RNA prepara-
tions that lack the other late species. The 52K, 55K-
protein mRNA, like other RNAs of the major or late
















Identification and mapping of late genes. The arrows indicate the map locations and direction of transcription of the
11 mRNAs, grouped in five families, comprising the major late block. The stippled portions mark the positions of the
protein-coding sequences. All these RNA species carry the same 5'- terminal tripartite leader sequence whose points
of origin are shown by the coded numerals.
fore presumably is also initiated at map position 16.4.
Consequently, it becomes necessary to postulate
modulation of transcription at the level of processing,
as well as at initiation, to explain how the 52K, 55K-
protein mRNA can be formed when other late mRNAs
are lacking.
The late gene block
In collaboration with Bruce Paterson (National Insti-
tutes of Health) and Bryan Roberts (Harvard Medical
School) and his coworkers, we have completed a
fine-structure analysis of the major late gene block
using cell-free translation in combination with three
other techniques: (1) gel electrophoresis of mRNA in
the presence of the denaturant methylmercury hy-
droxide to provide size estimates of the messages; (2)
hybridization selection to locate the genomic origins
of the mRNAs; and (3) hybrid-arrested translation to
map the protein-coding sequences. The diagram in
Figure 3 summarizes the main conclusions. In accord
with results from several sources, the late mRNAs are
arranged in five families of one to three mRNAs each,
all sharing the common tripartite 5'-leader sequence.
The RNAs of each family are also coterminous at their
3' ends and their coding sequences are invariably 5'
proximal. Our analysis revealed the existence of one
new gene, encoding the 52K, 55K polypeptide pair, at
the left end of the block, and we also resolved certain
anomalies in previous maps by establishing the order
of polypeptides111-pVII-V within the second family of
mRNAs. In addition, the data show that those mRNAs
containing extensive untranslated regions are prone to
lose these superfluous sequences and hence migrate
in the gel as a polydisperse streak. The mechanism
responsible for this phenomenon is being studied.
Protein structure studies
Partial protein sequence data, obtained in collabora-
tion with Carl Anderson (Brookhaven National Labo-
ratory), have allowed us to locate precisely the N
termini of four proteins with respect to the DNA se-
quence. Two of these are prominent late proteins,
hexon (II) and fiber (IV); the others are the El B 15K
protein and polypeptide IX, which are also relatively
easily obtained in a highly radioactive form. This ad-
vantage is not shared by many early proteins that, in
addition, often exist in a number of related forms.
Region El A codes for at least six polypeptides, with
molecular weights of 38,000-50,000, extractable
from infected cells. Three of these focus at an isoelec-
tric point of about 6.0 and exhibit molecular weights
of 50,000 (A), 46,000 (B), and 42,000 (C), whereas the
remaining three El A proteins focus at pH 5.9 and
exhibit molecular weights of 46,000 (D), 42,000 (E),
and 38,000 (F). In an attempt to further define the
relationships among these proteins, we have com-
pared the tryptic peptides of each of the species
labeled in vivo with ['H]proline. That all six species
are closely related is demonstrated by the detection of
at least six proline-containing peptides common to all
of the El A proteins.
The structures of the mRNAs from this region are
consistent with the hypothesis that some of the pep-
tides that occur in the larger El A proteins might be
absent from some of the smaller species. We have
observed a proline-containing peptide that occurs in
the El A proteins, A, B, D, and E, but is absent from the
smaller proteins C and F. This peptide is therefore a
potential candidate for a peptide derived from se-
quences that are "spliced out" of the mRNA(s) coding
for the smaller El A proteins C and F. These data also
suggestthat protein Cis more closely related to protein
F than to protein E and, therefore, that the three El A
proteins focusing at pH 6.0 might show a diagonal,
rather than a horizontal, molecular-weight relation-
ship to the three species focusing at pH 5.9. Such a
uniform shift of proteins A, B, and C to a more acidic
isoelectric point with a concomitant decrease in
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molecular weight might be accomplished by a post-
translational modification such as phosphorylation or
proteolytic removal of a basic portion of the
molecules. At least one distinct proline-containing
peptide occurs in proteins A, B, and C, but not in
proteins D, E, and F, and may represent a peptide that
has been modified or deleted posttranslationally.
Experiments are also in progress to define the rela-
tionship of these six El A proteins isolated from in-
fected cells to the El A 42K, 48K, 54K, and 58K species
synthesized in vitro.
Several other viral proteins have also been sub-
jected to peptide analysis. The data show that three
21K proteins and one 19K protein, all resolved by
two-dimensional gel electrophoresis of infected cell
extracts, are closely related to one another and to 21K,
19K, and 17K polypeptides made in vitro from early-
region-E4 mRNA. The 11K polypeptide from the same
region gives rise to different peptides and seems unre-
lated. Some of these peptides have been characterized
further by sequence analysis in order to correlate them
with the DNA sequence and ultimately to define the
complete sequence of amino acids in the original
proteins.
Small virus-coded RNAs
The two small noncoding VA RNAs still pose several
conundrums, and we have continued our investiga-
tions of their structure and function. Together with U.
Pettersson (University of Uppsala) and his coworkers
in Sweden, we have completed the DNA sequence
analysis of the VA RNA gene region and have iden-
tified the sequence of VA-RNA,, by combining this
information with RNA sequence data. Computer-
assisted model building predicts virtually identical
hairpinlike structures of considerable stability for both
VA RNAs. However, neither the structural sequences
themselves nor the sequences lying to their 5' side
(potential promoter sites) show much homology. We
have also begun to explore the range of variation
permissible in the sequence of VA-RNA,. Within
group-C adenoviruses, few base changes distinguish
the different serotypes: the VA-RNA, of Ad2 is identi-
cal to that of Ad6 and differs by 2 nucleotides from that
of Ad5 and probably by only 1 nucleotide from that of
Adl . One mutant, generated in collaboration with
Terri Grodzicker, contains a four-base insertion that,
like the natural variations, is located near the center of
the molecule. The mutation has little impact on its
probable secondary structure and is not associated
with any detectable physiological perturbation in the
infectious cycle.
A clue to their role in adenoviral infections may
emerge from experiments on binding of VA RNA to
mRNA. Under suitable conditions, we have been able
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to form complexes by hybridizing labeled VA-RNA, to
mRNA and to separate the complexes from unreacted
VA RNA by chromatography on oligo(dT)-cellulose.
RNA isolated from infected cells in the late phases is
more effective in binding VA RNA than is uninfected
cellular RNA. VA-RNA also appears to form similar
complexes, but these have not been extensively
studied. Further analysis of the complex is being car-
ried out with the aid of a plasmid containing a DNA
copy of fiber mRNA and of cloned fragments of the
viral genome, with a view to characterization of the
sequences in the VA RNAs and mRNAs that are in-
volved in the binding.
Sequence analysis of the mRNA coding for virion
component IX, carried out with Ulf Pettersson (Uni-
versity of Uppsala) and coworkers, and Daniel Klessig,
is now essentially complete. The RNA comprises 485
nucleotides, excluding the poly(A) tail and inverted
5'-terminal base, of which 420 nucleotides code for
amino acids. Identification of the 5 '-terminal se-
quence confirmed our expectation that this mRNA
(like the VA RNAs) is not spliced, and in this respect it
seems to be unique among adenoviral mRNAs. From
this observation, we deduce that whatever the role of
splicing is, it is not essential for messenger production.
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It has become evident in the last few years that spatial arrangements of genetic
material may undergo rapid changes and that different DNA segments may fuse or
dissociate by mechanisms occurring commonly in nature. These mechanisms can
now be given a general term, "specialized recombination". Movable genetic
elements, specific DNA sequences that undergo rapid rearrangements, are the
primary exponents of specialized recombination. The realization that movable
genetic elements occur commonly in nature is changing the way we think about the
evolution, organization, storage, reassortment and expression of genetic material.
Studies on movable genetic elements at Cold Spring Harbor are a continuation of
a long tradition of genetics. Barbara McClintock did her famous work on control-
ling elements in maize in the early fifties at Cold Spring Harbor. She proposed that
the variegated phenotype of kernels of corn (and that of corn plants themselves) is a
result of interaction of movable genetic elements with different genes and that this
interaction occurs by transposition of the controlling elements to, and excision
from, the affected loci. She further proposed that the process of transposition itself
could be controlled by a component of the transposable system. Later, the work on
bacteriophage lambda at Cold Spring Harbor helped to understand how one DNA
molecule is inserted into another.
The present era of movable genetic elements can be traced to the discovery of
bacteriophage Mu and bacterial transposable elements. The idea that Mu is a
prototype of transposable elements was mainly developed from studies at Cold
Spring Harbor. Transposition of Mu DNA and flip-flop of the G segment of Mu are
now well recognized processes of genetic rearrangements.
Recently, two groups of scientists studying genetic rearrangements have joined
the Cold Spring Harbor Laboratory. One group studies the molecular genetics of
yeast, with a focus on transposition of mating type genes in Saccharomyces
cerevisiae. The other group is studying the molecular genetics of mammalian cells;
in particular, the integration of exogenously added genes in the mammalian cell
genome. Thus, the Division of Movable Genetic Elements at Cold Spring Harbor
encompasses studies on prokaryotes, lower eukaryotes and higher eukaryotes.
These are exciting times in genetics. New technologies are making it easy to
analyze the structure and functioning of genes. The impact of studies on basic
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For the past two decades, a central theme of molecular
biology has been the study of gene expression. There is
no single mechanism for modulating the expression of
a gene. Control can occur at many levels ranging from
amplification of the number of DNA copies through
the synthesis, transport, or degradation of mRNA to the
transport, modification, and ultimately to the degra-
dation of proteins. Over the past year our laboratory
has been engaged in a variety of projects which were
motivated by a desire to understand various aspects of
the control of gene expression. An example is our
work on bacteriophage Mu-1. This bacteriophage in-
tegrates at random into its host chromosome and
causes mutations. It has a mechanism of DNA replica-
tion with features significantly different from other
known bacteriophages and also contains a variety of
interesting control systems. One, which has attracted
our attention most strongly, is the G-loop inversion
system. The G loop is a 3000-bp segment of DNA in
the Mu genome, which can exist in either of two
possible orientations. Mu possesses a function called
gin, which is absolutely essential for changing the
orientation of the G loop. It has now been established
that in one orientation the G loop allows Mu to infect
certain strains of Escherichia coli, whereas in the other
orientation efficient infection of other strains occurs
but the ability of Mu to grow on E. coli is virtually
eliminated. We are ultimately interested in developing
an in vitro system that will enable us to study the
mechanism by which the G loop is inverted. To do
this, we must obtain significant quantities of the gin
protein. This is necessary in order to identify the pro-
tein and to have it in high enough concentrations so
that the inversion reaction can be run at reasonable
efficiency in vitro. Our approach to identifyinggin and
obtaining it in large quantities has been to clone this
gene on a amplifiable plasmid. This approach had
previously enabled us to identify the repressor protein
of Mu and to map the Mu operator. The cloning ap-
proach we took made it worthwhile to clone the entire
Mu genome in small pieces. We used random shear-
ing and terminal transferase to construct our clones.
During this year we have isolated a large number of
plasmids, each containing a section of the Mu genome
of a few thousand base pairs. In addition to sections
containing the gin function, we have all the essential
genes of Mu cloned in this fashion. These clones have
been analyzed genetically and physically using re-
striction enzymes to determine which sections of Mu
DNA they contain, and they have been analyzed by
complementation to determine which gene products
they produce. We now have clones that produce all
the essential functions of Mu, together with thegin and
mom functions. We are focusing our attention on
clones that contain the proteins of the G-loop region
and the G loop itself, together with gin. Other people
have begun to use our clones to study a variety of
functions associated with Mu. To identify the gin pro-
tein, we have transferred the plasmid, which has been
shown by physiological analysis to make gin in large
quantities, to minicells. In these cells it is possible to
identify the products made by plasmids, since the
m in icel I mother cells bud off small enucleate cells that
contain no host DNA but do contain plasmid and
express only those proteins coded by the plasmid. This
is a well-worked-out technology that we have used in
identifying the Mu repressor. With it, this year, we
have been able tentatively to identify the gin protein,
together with several other proteins from the G loop in
both of its orientations. If our preliminary identifica-
tion of gin is correct, and this can only be proven by
further genetic analysis, then we are fairly lucky since
it is produced in large quantities and has a molecular
weight of about 15,000, which makes it quite easy to
separate from other proteins. We already have muta-
tions induced in the gin function on the cloned plas-
mid that should enable us to unambiguously confirm
that the protein we believe to be gin is in fact, that
function. This will lay the foundation for our further
work on the in vitro system.
As mentioned above, one of the important features
in controlling the expression of genes is to be able to
destroy the products of those genes when they are no
longer needed. This is often done by protein degrada-
tion. This year we have continued our study of the Ion
protein degradation system of E. coli. This system is
quite specific and has the interesting feature that pro-
tein degradation is in some way energy-dependent.
One of our important findings this year is that the Ion
system works on the soluble form of proteins and
probably not on the insoluble form, which sometimes
occurs with aberrant proteins. We were able to de-
termine this by cloning a mutant of /3- galactosidase,
X90, which produces a large fragment that is rapidly
degraded by the Ion system under normal circum-
stances. However, when this mutant was cloned on a
multicopy plasmid, the fragment was synthesized in
huge quantities, on the order of 50% of the cell pro-
tein. Somewhat to our surprise, the fragment that was
normally rapidily degraded had become completely
stabile. We were able to analyze the reason for this
and it became clear that stability was associated with
precipitation of the protein; at these huge concentra-
tions apparently protein-protein interactions oc-
curred, leading to insolubility. We found the X90
fragment present in a low-speed centrifuge pellet in
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strains producing it at extremely high levels, whereas it
was always present in the soluble fraction under nor-
mal conditions. A variety of restriction enzyme analy-
ses and suppressibi I ity tests indicated that we were in
fact dealing with genuine X90. From this we con-
cluded that the highly multimeric form of this protein
which led to insolubility, also made it resistant to
degradation by the Ion proteases.
E. coli has a lot of proteolytic enzymes, most of
which are not energy-dependent. The presence of
these enzymes has greatly complicated the study of
the energy-dependent enzyme, and this year we have
managed to identify and purify to homogeneity one of
the important energy-independent proteases of E. coli,
which we have called protease III. We have also been
able to isolate mutations in the protease-III gene and
map them. These protease-III- mutants lack one of the
major energy-independent proteases of E. coli and are
excellent vehicles for clarifying the study of the more
complex energy-dependent protein-degradation sys-
tems, since they eliminate one of the spurious sources
of substrate degradation.
Prior to this year, the Molecular Genetic Section had
concentrated almost entirely on prokaryotic systems.
This year we began a collaboration with M. Wigler,
who is now next door to us at the animal cell facility.
Dr. Wigler brought from Columbia a marvelous new
system for the transformation of animal cells. This new
technique allows virtually any exogenous DNA to be
introduced into cultured mouse cells. This means that
the expression of DNA in eukaryotic cells can be
studied in great detail using genetic-engineering
techniques on cloned DNA outside the host and then
introducing the DNA into mouse cells. The collabora-
tive projects we have initiated this year involve such
techniques as introducing lac operon genes from bac-
teria into animal cells to determine what features of
DNA structure are required for their expression there.
We have started a project to introduce dihydrofolate
reductase genes from bacteria into animal cells to
construct a positively selectable universal vector that
would be able to have a basis for selection in trans-
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formation of both bacteria and cultured animal cells.
In addition, we have started to transfer many of the
thymidine kinase genes, which have been cloned from
animal cells into bacteria, to find out what modifica-
tions of them are necessary for their expression in
bacteria. In this way we also hope to develop vectors
that are selectable in bacteria and animal cells both of
which have selective techniques for thymidine kinase.
An additional collaborative project involves a detailed
genetic analysis of the thymidine kinase gene of her-
pesvirus to map the sites required for its transforma-
tion, transcription, and control within animal cells.
This project is based on our ability to create a large
library of deletions in cloned thymidine kinase genes
using currently available genetic-engineering tech-
niques.
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INSERTION ELEMENTS AND PLASMIDS
A.I. BUKHARI, G. Chaconas, M. Dubow, D. Evans, R.M. Harshey, K. Messina, N. Sarvetnik
The transposable genetic elements in prokaryotes fall
in two main groups. One group causes duplications of
9 host base pairs at sites of insertion, whereas the other
group generates 5-bp duplications. The 5-bp group
includes Tn3, bacteriophage Mu, IS2, and the y8 se-
quence. A remarkable recent event in molecular ge-
netics is the demonstration that the phenomenon of
5-bp duplication transcends the prokaryote-eukaryote
boundary. G. Fink and coworkers at Cornell Univer-
sity have found that a transposable element in yeast
causes a 5-bp duplication; G. Rubin at Sydney Farber
Institute in Boston has reached a similar conclusion for
an element in Drosophila. Thus, it would seem that the
process of bacteriophage Mu DNA transposition has
even wider applicability than was thought previously.
During the past year, our efforts to dissect the mecha-
nism of Mu transposition were focused on examining
the behavior of small plasmids containing either
whole Mu or internally deleted Mu's (called mini-
Mu's).
Construction of mini-Mu plasmids
All of the plasmids used for studies on Mu replication
and transposition were derived from a 9.09 kb plasmid
pSC101. We removed from a pSC101 plasmid con-
taining the whole Mu genome the central 27-kb Pstl
fragment of Mu DNA. This prototype mini-Mu con-
tains 1.6 kb from the left end of Mu and about 7.5 kb
from the right end, including the invertible G segment.
Within this mini-Mu, we cloned various selectable
markers such as the entire lac operon of Escherichia
coli, a gene for ampicillin resistance (encoding
/3- lactamase), and a gene for kanamycin resistance.
The prototype mini-Mu was further manipulated by
first recombining the gene for ampr at the right ex-
Table 1
Plasmids Containing Mu DNA
tremity of the G segment. (This was done by a genetic
cross involving the Mu amp previously isolated by D.
Leach and N. Symonds, at the University of Sussex.)
Since the ampr gene contains a Pstl cleavage site, we
were able to cut out the G segment, removing all but
the 1.6-kb segment of Mu DNA at the right end. In
addition, we cloned the lac operon and the ampr gene
within this 3.2-kb mini-Mu. Many of the important
plasmids constructed by us during the past year are
shown in Table 1.
These plasmids provide us with valuable tools with
which to dissect the process of Mu transposition and
replication. We can study the various events during
the life cycle of Mu by monitoring the markers we have
inserted within the ends of Mu.
Replication and transposition of mini-Mu sequences
By genetic, biochemical, and electron microscopic
methods, we have shown that the mini-Mu sequences
carried in our plasmids undergo Mu-mediated trans-
position, replication, and packaging when provided
with Mu helper functions in trans. When a phage
lysate is prepared from a strain containing mini-Mu
and a helper Mu phage, 5 - 20% of the phage particles
carry mini-Mu sequences, indicating that mini-Mu se-
quences increase in number during Mu growth. Figure
1 shows a packaged mini-Mu that was heteroduplexed
with wild-type Mu DNA.
The replication of mini-Mu is shown directly by
assaying the activity of f3-lactamase for mini-Muamp
and the activity of f3-galactosidase for mini-Mu/ac.
When these mini-Mu's are provided with normal Mu
functions, the levels of the enzymes begin to increase.
This increase is in good agreement with the previously
reported kinetics of wild-type Mu DNA replication.









































All mini-Mu's contain the immunity gene c and only the beginning of the A gene. The left and right ends of Mu are denoted byc
and S, irrespective ol the extent of DNA present at the ends.
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Figure 1
A packaged mini-Mu sequence. Mini-Mu DNA in a transducing lysate is heteroduplexed with wild-type Mu DNA. A large
loop near the left end (c end) represents the deletion in mini-Mu. An underwound G segment can be seen. The arrow
indicates a normal split end and a very long split end, indicating the packaging of extra-long host DNA attached to the
mini-Mu sequence.
The replication of mini-Mu requires both functional A
and B genes of Mu.
High-efficiency transposition of mini-Mu se-
quences has been shown by a genetic assay that in-
volves integration of the mini-Mu sequences into a
conjugally transferable plasmid such as F'prolac. Fol-
lowing induction of a strain containing a Mu prophage
and mini-Muamp, mini-Mu/ac, or mini-Mukan the
mini-Mu sequences appear in about one in ten trans-
ferred episomes. Many of these mini-Mu sequences
still have the plasm id attached to them; the integrated
DNA has the structure mini -Mu- plasmid- mini -Mu.
This type of structure has been seen with all transpos-
able elements and is referred to as a cointegrate.
Behavior of Mu- and mini-Mu-containing plasmids
during transposition
A singularly important advantage of using small
plasmids with Mu insertions is that the plasmid
molecules can be separated from the chromosomal
DNA and their different forms can be differentiated by
agarose gel electrophoresis. In a series of experiments,
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we extracted the DNA from strains containing the Mu
or mini-Mu plasmid and subjected it to elec-
trophoresis in low-percentage-agarose gels followed
by transfer of the DNA to nitrocellulose paper. Sepa-
rate hybridizations with 32P-labeled pSC101 and Mu
DNA revealed the position of the plasmids and the
replication of Mu DNA. We found that the plasmids
are not cleaved to generate either a linear form or
smaller products; instead, they migrate with E. coil
DNA. This interaction of the plasm ids with the host
chromosome is of two types: (1) formation of cointe-
grates of the structure Mu- plasmid -Mu and (2) associ-
ation of circular plasmids with the chromosomal
DNA.
Analysis of cointegrates
That some of the plasmid DNA migrating with the host
DNA after induction represents cointegrates has been
shown by restriction, blotting, and hybridization of
DNA. When the DNA was digested with Kpn I, which
cleaves only once within Mu or mini-Mu sequences,
linear plasmids of the original size were released.
When the DNA was cut with Xhol, which cuts the
plasm id DNA once but does not cut the Mu se-
quences, a smear of plasmid DNA was generated. This
would be expected if Mu-plasmid-Mu sequences had
integrated at different sites in the host DNA.
As mentioned above, we have studied the cointe-
grates genetically by inserting them in conjugally
transferable plasmids. As much as 90% of the inte-
grated Mu sequence can be in the form of cointegrates.
The cointegrates are resolved in rec+ cells, generating
the original Mu plasmid and a copy of Mu (or mini-
Mu) on the conjugal plasmid. This resolution is much
reduced in recA- cells. It has yet to be determined
whether there is a Mu function that will resolve coin-
tegrates slowly in a recA- background. We have also
studied the cointegrates by transduction experiments.
When Mu lysates are used for transduction of plasmid
markers, we can recover the original plasmid in the
recipient cells. This can only happen if cointegrates
are packaged in the phage particles and are then re-
solved in the recipient cells. The packaging of cointe-
grates is being examined carefully.
Electron microscopy of plasmid-host association
Electron microscopy of mini-Mu plasmids after Mu
induction showed that many circular plasm ids were in
contact with the host DNA. About 20% of the observ-
able plasmids were seen associating with the host
chromosome in this manner. This association requires
functioning of theA and B genes of Mu. Figure 2 shows
examples of such association. These structures appar-
ently represent either intermediates in the transposi-
tion process or the end products of transposition.
Figure 2
Mini-Mu plasmids in contact with the chromosomal DNA during transposition.
Analysis of the nature of the contact between the
plasmids and the host DNA promises to provide im-
portant clues to the mechanism of transposition.
The Mu transposition problem in 1980
The results discussed above, i.e., plasmids that contain
Mu sequences remain intact during Mu replication
and associate with the host chromosome in their en-
tirety, lend further support to the replication -
integration hypothesis that we proposed a few years
ago. It was proposed in this hypothesis that the pre-
dominant event during Mu transposition is replication
of Mu DNA in situ to generate integrative inter-
mediates. The results further strengthen the assump-
tion that the ends of Mu DNA are the primary deter-
minants of replication and transposition. The A-gene
and B-gene proteins of Mu evidently act upon these
ends to trigger the twin processes of transposition and
replication.
Cointegrate formation appears to be a prominent
feature of the process of Mu transposition and, indeed,
of all other prokaryotic transposable elements. Oc-
currence of cointegrates in response to Mu induction
has been seen in at least two other laboratories work-
ing on Mu. It has yet to be determined whether the
cointegrates are obligatory intermediates in transposi-
tion.
Flip-flop control of gene expression in Mu
One experiment on the expression of genes within the
3-kb invertible G segment of Mu is noteworthy. In this
experiment, we inserted the IacZ gene without its
promoter into the G segment as follows. We cut
Mrplac phage DNA (Xtrp/acW205, provided by W.
Reznikof, in which the IacZ gene is fused to trp and is
under trp promoter control) with Hindi II and Kpn I. The
Ninal cut is in the trpB gene and the Hindlll -Kpn
fragment contains a part of trpB, trpA, IacZ and a part
of the lacY gene. The Kpn cut is very close to the end of
lac DNA. To put this fragment into a Kpn I site within
the G segment, we used a Hindlll -Kpn I linker of about
500 by derived from the adenovirus-2 DNA, since this
purified fragment was readily available at Cold Spring
54
Harbor. The cloning was done in mini-Mu pSC101.
We have put this plasmid in the trpA-, Aprolac
strain and have shown that the cells switch back and
forth from the Lac-Trp- phenotype to the Lac+Trp+
phenotype. If we use ampicillin selection for enriching
Trp cells, we get colonies that are Trp-Lac-. Using
the Lac-Trp- cells, on the other hand, we can directly
select Trp+. By screening for colonies that have be-
come fixed in one G orientation, we can isolate gin-
mutants. A by-product of this work is the potential for
the study of Mu promoters, using lac and trp as indi-
cators of promoter activities. We can also test whether
the G segment can be transposed by examining for lac
transposition.
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DNA-PROTEIN INTERACTIONS
D. KAMP, R. KAHMANN
For the past year, we have extended our studies on
site-specific recombination with the main focus on the
integration/transposition process of bacteriophage Mu
DNA and the inversion system of the G segment of Mu
DNA.
Integrative recombination of bacteriophage Mu
The heterogeneous host DNA sequences attached to
the ends of bacteriophage Mu DNA have been dem-
onstrated directly by the dideoxy chain-terminating
sequencing method of Sanger et al. (Proc. Natl. Acad.
Sci. 74:5463[19771) These experiments have con-
firmed our previously determined position of the
crossover sites and, furthermore, have shown that the
host DNA sequences immediately adjacent to the
attachment sites are not randomly distributed but re-
producibly contain a certain set of predominant
nucleotides (Fig. 1), which we shall call the host
attachment site. In view of the very low insertion spec-
ificity of bacteriophage Mu, this result was quite unex-
pected. It seems to indicate that Mu insertion does not
occur at randomly distributed sites, as was thought
previously, or alternatively it could mean that the Mu
packaging machinery preferentially encapsidates Mu
prophages inserted next to a specific host DNA se-
quence. A comparison of the preferential sequences at
the two ends revealed that these sequences do not
reflect a 5-bp duplication of host DNA (5-bp duplica-
tions of host DNA have been found to flank the two
prophage junctures analyzed). We have inferred from
this result that in mature Mu DNA, not all molecules
contain the duplicated host sequences. An integration
model for Mu was developed that accommodates
these findings.
We have extended our investigation of the Mu
transposition process. The multicopy plasmid pTM2,
which contains only the extreme ends of a Mu
prophage (called TnM1) and which does not express
any Mu functions,,was exposed to a Mu helper phage
in vivo, and the phage progeny derived from such an
infection was analyzed biologically and physically.
About 10-20% of the phage progeny contain the
entire pTM2 plasm id. After digestion with restriction
enzymes, all pTM2 plasmid fragments appear in their
relative intensities, indicating that the integration of
the pTM2 plasmid did not occur via a Campbell-type
mechanism. We have also eliminated the possibility
that multimeric forms of pTM2 are packaged or that
dimeric forms of pTM2 are the required substrate for
transposition. The structure of those molecules con-
taining the entire TnM1 sequence was shown by re-
striction enzyme analysis to be a cointegrate TnM1-
pBR322-TnM / -host DNA. The presence in these
molecules of a direct repeat of the TnM1 sequences
was substantiated by the finding that a bacteriophage
Mu lysate propagated on a strain containing pTM2 is
capable of transducing pTM2 with very high fre-
quency (2 x 10-1) into a rec.+ host. Under recA condi-
tions, the transduction frequency is greatly reduced,
indicating that recombination between the direct re-
peats of TnM1 sequences within the cointegrate struc-
ture is essential for the resaturation of the pTM2 plas-
mid.
This very sensitive transduction assay was also
employed to study the biological activity (e.g., trans-
position of the entire plasmid and formation of coin-
tegrate structures) of recombinant plasm ids containing
either only Mu attL (pLM445) or Mu attR (pRM445),
respectively. The transduction frequencies observed
were 7 x 10 -'for pLM445 and 1 x 10 -'for pRM445.
These values are very low relative to pTM2 transduc-
tion frequencies, but are significantly higher than
those of a pBR322 control (6 x 10-9). Quite surprising
is that pRM445 is transduced at all since the transduc-
tion assay requires not only transposition to the host
chromosome but also packaging; the latter is believed
to be initiated exclusively at the left end of the Mu
DNA molecule. Using this transduction assay, we
have further shown that D108, a Mu-related phage,
can be used as a helper for the transposition and
cointegrate formation of pTM2. However, the fre-
quency is about 100-fold reduced compared to a Mu
helper phage. We are currently sequencing the D108
attachment sites to determine whether this reduced
complementation can be attributed to sequence dif-
ferences of the Mu and D108 attachment sites.
Inversion of the G segment of bacteriophage Mu
DNA
In continuation of our studies on the invertible G
segment of Mu, the puzzle of the noninfectious GI -)
phage particles has been resolved. The original obser-
vation was that a phage mutant Mu 445-5 G( -) is
noninfectious for Escherichia coli K12. However,
when Mu 445-5 G( -) phage is grown on an E. coli K12
strain containing the recombinant plasmid pGM1,
which expresses the Gin function, a few plaque-
forming phages are released. The same result is ob-
tained when the pGM1-containing host for propaga-
tion of the G(-) phage has a mutation conferring
resistance to Mu infection. The plaque-forming
phages released were propagated and it was shown by
restriction enzyme analysis that they were Mu 445-5
G( +). This indicated that whatever prevented the Mu
445-5 G( -) phage from entering a cell could be over-
come in a few rare cases and could become visible by
inverting the G segment of the entering G(-) phage
back to the G(+) orientation.
These results tempted our search for a bacterial host
fully sensitive to Mu 455-5 G(-) infection. In the
beginning, bacteria were isolated from soil samples
and tested for their sensitivity to G( +) and G( -)
phages, respectively. The results were, however, am-





















Autoradiograph of sequence gel from the left Mu-host DNA juncture (- ). The lower diagram shows schematically
the relative position of hybridization of the restriction fragment used as primer (D) and the direction of synthesis by









Host range of bacteriophage Mu. Bacteriophage Mu 445-5 G( +) and Mu 445-5 G( -) lysates propagated on E. coli K12
were spotted in serial dilutions on plates seeded with E. coli K12, Enterobacter cloacae, and Serratia marcescens,
respectively. Phage growth results in clearing of the lawn at high phage concentrationsand in the appearance of single
plaques at low phage concentrations.
concentrations, but were unable to detect single
plaques. We therefore resorted to at least partially
characterized strains. Of those tested, Serratia mar-
cescens and Enterobacter cloacae were sensitive to
infection by Mu 455-5 G( -), but insensitive to infec-
tion by Mu 445-5 G(+) phage (Fig. 2). Mu 445-5 G( -)
phage can lysogenize both strains, and phage lysates
derived from Enterobacter or Serratia have a plating
efficiency of 1 on their respective hosts, but they plate
on an E. coli K12 r-m- host with an efficiency of 10-7.
This indicates that the Mu 445-5 G(-) phage has
maintained its G(-) phenotype through propagation
on Serratia and Enterobacter. Since the Mu 445-5
phage has a mom- phenotype, the plating efficiencies
of Mu morn+ and Mu mom- phage lysates were de-
termined in control experiments. Both values are
identical, eliminating the possibility that the Mu-
encoded DNA-modification function Mom is in-
volved in any of the effects observed. We can thus
conclude that through inversion of the G segment of
bacteriophage Mu an alteration of the phage host-
range specificity is achieved. This raises the interesting
possibility that E. coli K12 may not be the natural host
for Mu and that, instead, soil bacteria such as Serratia
could potentially be carriers of Mu or Mu-related
prophages that so far have gone undetected.
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I.B. HICKS, I. BROACH, A. KLAR, I. STRATHERN, S. Ismail, C. McGill, I. McIndoo, C. Michels, I. Wood
The Yeast Genetics Group in Davenport laboratory
was formed in the spring of 1978, with the specific
objective of characterizing the genetic switch that
controls mating type in yeast cells and, in addition, to
establish an ongoing research effort at Cold Spring
Harbor Laboratory in the rapidly expanding area of
yeast molecular biology. Previous studies by ourselves
and others have shown that this genetic process may
involve an extremely specific rearrangement of the
cell's DNA and that it has implications for the study of
growth and development in higher animals and plants.
We therefore brought our independent research proj-
ects together to attack this problem.
Traditionally, Davenport laboratory has been the
site of summer courses and workshops and has a rich
heritage of research in molecular genetics. The sum-
mer courses continue, but now, for the first time,
Davenport is being used full time all year round. The
dual use of the building created some problems. We
had no sooner arrived at the laboratory in April 1978
when we had to pack up and move out to make room
for the summer courses. In September, we moved back
into Davenport laboratory to begin our first full year of
research, and it was a very successful year for all of us.
Thanks to the Robertson Fund, we were able to equip
and supply the laboratory until Federal grant money
became available. Research grants were awarded to
us by the National Science Foundation and the Na-
tional Institutes of Health, and once our research be-
gan, the inconvenience of moving was forgotten and
we found Davenport to be a warm and pleasant place
to work. We continued our genetic analysis of the loci
involved in the control of cell type and developed a
yeast DNA cloning vector that allowed us to isolate the
DNA from the mating-type locus and to determine the
nature of the DNA alteration associated with the
changes in cell type.
By the spring of 1979, several of our immediate
research goals had been achieved, but it was time to
move out for the summer courses once again. This
time, space was made available in Demerec labora-
tory for a limited continuation of research. The sum-
mer of 1979 was a hectic one and included the organi-
zation of a large and productive meeting on yeast
molecular biology, attended by over 400 scientists
from around the world. We also began the organiza-
tion of a book for the Cold Spring Harbor Monograph
Series, which will provide an overview of yeast
molecular biology, including many of the observa-
tions presented at the yeast meeting.
Active research in Davenport began again in Sep-
tember, but without the presence of Jim Broach, who
left Cold Spring Harbor Laboratory to take a faculty
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position at the State University of New York, Stony
Brook. Happily, we have maintained a strong collab-
oration between our groups and expect to continue
working together in the future. This fall also marked
the initiation of plans to make a structural addition to
the Davenport building in order to provide office and
laboratory space for the yeast group during the sum-
mer months. We look forward to this addition and to
the continuation of our work at Cold Spring Harbor.
Research Summary
The genes that control the cell type in yeast reside in
transposable genetic elements, the a and a cassettes
that occupy three different loci on chromosome III. At
HML and HMR the cassettes are normally silent. The
cassette residing at MAT (MATa or MATa) is expressed
and controls the cell type by regulating the expression
of a- and a-specific mating functions encoded
elsewhere in the genome. Homothallic yeast can
change efficiently (about 50% of the cell divisions)
between the a and a mating types and does so in an
orderly pattern in cell pedigrees. These changes of cell
type reflect interconversion of the MATa and MATa
alleles and, as described below, involve replacing the
cassette at MAT with a replica of the unexpressed
cassette at HML or HMR (Fig. 1). The genetic and
physical experiments supporting these conclusions
are described below.
Switching can heal mat mutations
The cassette model was based on the pattern of in-
volvement of the various HML and HMR alleles and on
the observation that mutants of MAT (matal ) could be
switched to MATa and then to MATa. Most laboratory
strains have the HMLa allele that provides a function
required for the switch from MATa to MATa and it was
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Figure 1
Schematic diagram of yeast chromosome III showing the
cassette model for mating-type switching. Heavy lines indi-
cate the a and a mating-type cassettes, which are sequen-
tially transposed from the silent HML and HMR loci to MAT
under the influence of the HO (homothal I ism) gene. Only the
cassette occupying the MAT locus is expressed (wavy arrow)
in normal strains.
proposed that HMLa was the site of unexpressed a'
information (an a cassette) that could be transposed to
MAT as part of the switching-and-healing process.
Similarly, most laboratory strains have the HMRa al-
lele that provides a function required for switching
MATa to MATa, the a cassette. The transposition-
substitution process includes a replication step, i.e.,
the HML and HMR alleles are not altered or consumed
by the switching process. A prediction of this cassette
model is that all mar mutations in the transposable
part will be healable. We were able to confirm this
prediction both for additional mate mutants and for
mata mutants (Strathern et al., Proc. Natl. Acad. Sci.
76:3425 [1979]; Klar et al., Genetics 92:159 [1979]).
The MAR1 hypothesis and the isolation of mutations
of the HML and HMR loci.
On the basis of genetic studies, a locus designated
MARI (mating-type regulator) has been proposed to
act as a repressor of the HML and the HMR loci (Klar et
al., Genetics [1979]). The mating phenotype of a strain
containing the mutant marl - allele depends on the
genetic content of the HML, HMR, and MAT loci, i.e.,
a strain of genotype HMLa MATa (or MATa) HMRa
marl - is nonmater, a phenotype similar to that of the
MATa/MATa diploids. On the other hand, a strain
HMLa MATa HMRa marl expresses an a phenotype
and a strain HMLa MATa HMRa marl expresses an a
phenotype. It was suggested that in cells containing
themarl mutation all copies of the mating-type alleles
are expressed, including the ordinarily silent informa-
tion proposed to exist at HML and HMR. The nonmat-
ing phenotype of marl HMLa MATa HMRa provided
us with a novel selection for mutations in the a infor-
mation at HMRa, since elimination of a should make
such a cell mate as an a. Likewise, selection of
mating-type-a cells from sterile HMLa MATa HMRa
marl should yield mutations in the a information ex-
pressed at HML. Using this scheme, we have obtained
a large number of mutations, including the nonsense
amber and ocher types, of the HML and HMR loci.
Transposition of genetic information from HMR and
HML to MAT during switching.
A critical prediction of the specific cassette model is
that strains with mutations in the "storage" loci HML
and HMR should generate correspondingly defective
MAT alleles during the switching process. We ob-
served that strains containing the amber and ocher
mutations within the HMRa locus yield corresponding
amber and ocher mutant mata- loci (Fig. 2). Similarly,
the hmla- mutant strain generates mate- mutant al-
leles, i.e., specific mutations from the HMRa and
HMLa are transmitted to MAT (Klar, Genetics [1980]).
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Figure 2
Selected transposition of mutant a information from HMR to
MAT showing that, during switching, the MAT DNA se-
quence is replaced by an exact copy of the cassette at HMR.
fore, a replica of the mating-type information originat-
ing from these loci is transmitted to MAT where it
replaces the existing information.
Recombination between MAT and HML or HMR.
In many yeast strains, the MATa and MATa alleles
(and hence the a and a cell types) are very stable. In
these stable, or heterothallic, strains, switches from
MATa to MATa occur at rates of about 10-6 per cell
division. At similar rates, rearrangements of chromo-
some III occur, resulting in a change of cell type but
creating a recessive lethal at MAT. We had proposed
that the switch from MATa to lethal MATa was the
result of an intrachromosomal recombination be-
tween MAT and HMRa deleting the a cassette and the
portion of chromosome III between MAT and HMRa
and activating the a cassette. Similarly, we interpreted
the switch from MATa to lethal MATa as an intra-
chromosomal recombination between MAT and
HMLa to form a ring chromosome with an activated a
cassette. The genetic analysis was consistent with this
interpretation. Furthermore, we were able to identify
and isolate this ring chromosome, thus providing the
first physical evidence supporting the cassette model
(Strathern et al., Cell 18:309 [1979]).
Transformation and DNA cloning vectors for yeast
The ability to establish the biological function en-
coded by a piece of DNA by cloning it and reintroduc-
ing it into the organism opens particularly powerful
forms of genetic and physical analysis. These tech-
niques, as applied to yeast, were in their fledgling
stages when we first came to Cold Spring Harbor. To
exploit more fully the ability to transform yeast, we
constructed a series of cloning vectors that were hy-
brids between the bacterial vector pBR322 and the
selectable yeast gene LEU2. The particularly useful
vector yep13 combines pBR322, LEU2 and an origin
of replication from the yeast plasmid (2-gm circle or
Scpl). The yep13 plasmid can replicate in yeast or
bacteria, has markers that can be selected in yeast
(LEU2) and bacteria (amp' and ter), and has unique
59
restriction sites into which additional DNA to be tested
for function can be placed. From a collection of yepl 3
clones containing additional yeast DNA, we were able
to identify several DNAs carrying genes for nutritional
enzymes, the arginine permease (Broach et al., Gene,
8:121 [1979]) and the a cassette as described below.
The 2-Am circle
The construction of these vectors and the develop-
ment of transformation not only provided a means to
isolate MAT, it also provided an opportunity to study
the replication of and the functions provided by the
2-pm circle plasmid. In this context, hybrid 2-
pm-circle:LEU2 plasmids were introduced into a
leu2- strain that did not contain the normal plasmid.
The ability of these hybrid plasmids to replicate was
dependent on the portion of 2-pm plasmid included.
In this fashion, the origin of replication was defined as
the region required in cis for the replication of the
hybrid. In addition, we identified a function encoded
by 2-gm plasmid required for the replication of the
hybrid but which can be supplied in trans.
The 2-pm circles have the interesting property of
existing in two forms that can interconvert by an inter-
nal recombination in a region of repeated DNA. The
transcription map is consistent with a requirement for
both forms to express all of the messages. This site-
specific recombination-mediated activation of genes
has intellectual similarity to interconversion of MAT.
The isolation of the a cassette
We surveyed 7000 BamHI restriction endonuclease
fragments of yeast DNA for having a functional a
cassette by transforming those DNAs (cloned in
Yep13) into a mat- leu2- strain. These transformants
were screened for having obtained the a phenotype.
One of these transformants clearly had the a pheno-
type and that phenotype was dependent on the pres-
ence of the plasmid. We isolated this plasmid from
yeast and showed that it could again confer this
phenotype when again introduced into a mat- strain.
We found that the portion of the DNA that conferred
this a phenotype hybridized to only three of the
HMLcr
thousands of fragments produced by restriction en-
donuclease cleavage (EcoRI, BamHI, Hindi!, or Pst) of
the whole yeast genome. Using natural variants of the
genomic fragment sizes, we were able to identify these
bands as HML, HMR, and MAT. Using the a clone as a
probe, we were able to show that the a cassette is
larger than the a cassette; HMLa, HMRa, and MATa
are all approximately 150 by larger than their respec-
tive alleles HMLa, HMRa, and MATa. Furthermore,
we were able to demonstrate that, as predicted by the
cassette model, the switch from MATa to MATa in a
homothallic strain involves replacing the a cassette at
MAT with a replica of a cassette from HMLa or HMRa
(Hicks et al., Nature 282:478 [1978]).
Details of the switching process
The cross-homology between the a clone and
genomic HMLa, HMLa, HMRa, HMRa, MATa, and
MATa sequences enabled us to use it as a probe to
screen phage or plasmid libraries of yeast DNA and to
isolate clones carrying each of the genes. The identifi-
cation of the clones was made on the basis of restric-
tion endonuclease mapping done on whole genomic
DNA probed with a clone.
To examine the nature of the homology between
HMLa, HMLa, HMRa, HMRa, MATa, and MATa,
electron microscopic analyses of heteroduplexes
formed between cloned DNA fragments correspond-
ing to these loci were made. The a and a cassettes
differ by a DNA substitution corresponding to about
600 by in a and about 750 by in a. This difference was
observed at HML, HMR, and MAT. Flanking these
substitutions are DNA sequences shared by all alleles
of HML, HMR, and MAT corresponding to about 700
by on one side and 250 by on the other (Strathern at
al., Proc. Natl. Acad. Sci. [1980]). There are additional
regions of homology between HML and MAT, so that
the long homology extends to about 1450 by and the
short homology is about 300 by (Fig. 3). The function
of this structural difference between HML and HMR is
not yet understood. It is tempting to invoke a role for
this difference in defining the pattern of cell-type
switches in pedigrees of homothallic cells.
The mechanism of cassette transposition is still un-
MATa HMRa
Ya
88111 Hill RI RI BRIR HIIIPst
Figure 3
Partial restriction map of the mating-type cassettes showing their orientation on the chromosome. (0) Sequences common to
more than one locus (W, X, and Z); the W region is lacking at HMR in all strains tested so far. f. . . Sequences unique to a
and a cassettes, respectively.
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known. We know that DNA sequences from HMR and
HML must be replicated and eventually substituted for
the sequences at MAT. This could be accomplished by
replication of diffusible cassettes from HML and HMR
followed by a substitution reaction at MAT. Alterna-
tively, substitution might be accomplished by homol-
ogous pairing of HML or HMR with MAT followed by
transfer of a strand from the storage loci to MAT. The
heteroduplex formed at MAT would be resolved in the
direction of the donated strand and the gap at the
donor locus would be filled in by replication. The
regions of homology between MAT and HML or HMR
on each side of the transposed region provide an op-
portunity to initiate and terminate the recombination
events required in either mechanism. Which mecha-
nism is involved has not yet been determined. How-
ever, we have not detected sequences homologous to
the cassettes that are not associated with the chromo-
somes. Furthermore, we have shown that pairing and
reciprocal recombination occur between these loci to
form chromosome rearrangements at low frequency in
heterothallic strains. It is therefore reasonable that
such pairing followed by nonreciprocal gene conver-
sion could occur at high frequency in the presence of a
site-specific recombination enzyme in HO strains.
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MAMMALIAN CELL GENETICS
M. WIGLER, D. KURTZ, C. Fraser, M. Hallaran, D. Hanahan, D. Levy, L. Lipsich, C. Nicodemus, C. Perucho, M.
Perucho
Certain cultured cell lines can readily be transformed
by exogenous DNA when given as a calcium phos-
phate coprecipitate. Although stable transformants,
detected by biochemical selection, can arise from ex-
posure of 10" cells to as little as 50 pg of a purified
gene, such efficient gene transfer requires the use of
vast excesses of carrier DNA. Cells that incorporate a
selectable marker, such as thymidine kinase, are also
likely to incorporate significant amounts of carrier
DNA, a process we have called cotransformation. By
adding well-defined DNA sequences to the carrier, it
is possible to construct cell lines containing virtually
any defined DNA sequence. This method is a poten-
tially powerful tool in the study of animal cell genetics
and gene expression. In our laboratory we are attempt-
ing to increase our understanding of this tool. To
exploit this understanding in specific ways, we are (1)
attempting to determine the physical state of trans-
forming elements in the transformed host, (2) design-
ing more general animal cell vectors, (3) studying the
expression of transforming elements, (4) collaborating
with the Tumor Virology Section to engineer new
mutant-specific host cells that will be useful in the
development and analysis of new viral mutants, and
(5) utilizing the method of plasmid rescue to isolate
cellular genes coding for selectable markers.
Transfer and amplification of an altered dhfr gene
Successful transfer of the cellular genes coding for
thymidine kinase (tk) and adenine phosphoribosyl
transferase (aprt) has been demonstrated using total
genomic DNA from vertebrate species as donor.
Isoelectric focusing of enzymatic activity in trans-
formants has shown this activity to be donor-derived.
These findings suggest that it may now be possible to
transfer any cellular gene that codes for a selectable
marker. More recently, we have demonstrated the
transfer to mouse cells of a mutant gene from hamster
cells (A29), which codes for a dihydrofolate reductase
(dhfr) with altered binding affinity of methotrexate
(Mtx). This gene confers resistance to high concentra-
tions of Mtx. Murine recipients were shown to contain
the hamster dhfr gene by blot hybridization, using as
probe a cDNA clone of dhfr mRNA (kindly provided
by R. Schimke, Stanford University). When the Mtx
concentration was raised slowly from 0.1 ktg/mIto 10
,ag/ml, the hamster dhfr gene resident in surviving
mouse cells was shown to undergo a commensurate
increase in copy number (amplification). Moreover, if
genomic A29 DNA is ligated to a defined genetic
element prior to transformation and the transformants
62
are subsequently amplified, the ligated genetic marker
is also often amplified. In this way we have con-
structed mouse cells containing up to 50 copies of a
yeast suppressor tRNA gene (see below).
Cloning the HSV-1 tk gene
Herpes simplex virus type 1 (HSV-1) codes for a thy-
midine kinase activity that can complement tk- ani-
mal cells. We have cloned the HSV-1 tk gene as a
3.5-kb fragment inserted into the Baml site of the
prokaryotic plasmid pBR322. This prokaryotic/eu-
karyotic chimeric molecule (ptk-2) transforms tk- mu-
tant mouse cells (Ltk-) with the same efficiency as the
HSV tk gene purified from viral DNA. When ptk-2 is
cotransformed into Ltk- aprt- cells in a nonselective
manner (using a cellular aprt gene as the selectable
marker), eight of nine cotransformants express tk, sug-
gesting that the cloned HSV-1 tk gene carries its own
promoter.
Plasmid rescue
It is possible to cotransform animal cells with the
prokaryotic antibiotic resistance plasmid
These bacterial sequences are found integrated into
the high-molecular-weight nuclear DNA of the host.
The integrated pBR322 sequences often include a
contiguous origin of plasmid replication and an anti-
biotic resistance factor. In such cases, we have dem-
onstrated that the pBR322 sequences can act as a
transducing element from the animal host to Esch-
erichia coli. Host DNA is digested with restriction
endonucleases and the resulting restriction fragments
are then ligated with T4 DNA ligase under cyclization
conditions. Those cyclized molecules containing
pBR322 and its flanking host sequences can be used
to transform E. coli to antibiotic resistance. We refer
to this process as plasm id rescue.
Cointegration of cotransforming DNA
Cotransforming elements become genetically linked
in the transformed host. This has been demonstrated in
a variety of ways. We have used prokaryotic se-
quences such as pBR322 and thX174 RF DNA as the
cotransforming markers and ptk-2 as the selectable
marker. tk- revertants can be selected from tk' trans-
formants. Revertants that have deleted the tk gene will
also often delete the cotransforming markers as well.
In addition, when the tk gene resident in a transformed
host is transferred to tk- recipient cells by chromo-
some-mediated transfer, cotransforming markers are
also cotransferred. Finally, when cells are transformed
with A29 dhfr and cotransformed with pBR322 de-
rivatives, amplification of the dhfr gene will often re-
sult in amplification of pBR322 sequences. We used
the method of plasmid rescue to demonstrate that the
flanking sequences of cotransforming pBR322 derive
not from the endogenous host sequences but rather
from carrier sequences. These observations have led
us to hypothesize that transforming elements do not
integrate directly into the chromosomes of the host
cell but, rather, are first ligated to carrier DNA into a
single unit, which we have called the pekelasome. We
do not know at present if pekelasomes are sometimes
or usually stably integrated into host chromosomes.
Thus, the picture that emerges of transformation in
animal cells differs markedly from that in yeast or
bacteria.
Expression of rat a2 globulin gene in rat hepatoma
cells
The cqu globulin is a protein with a molecular weight
of 20,000 that is synthesized in the liver of mature
male rats, secreted into their serum, and excreted in
their urine. The hepatic synthesis of this protein is
under complex hormonal control involving the par-
ticipation of the sex hormones, glucocorticoids,
thyroid hormone, and pituitary growth hormone. The
cDNA for this protein has been cloned into pBR322,
and this clone is being used to screen a genomic rat
library. Several library isolates have been obtained
that show nucleotide homology to the probe, but they
have not yet been mapped. At the same time, a rat
hepatoma cell line has been obtained that synthesizes
cqu, and its hormonal responses have been charac-
terized. Using this cell line and DNA-mediated trans-
formation, it may be possible to localize genomic
sequences responsible for hormonal control by site-
specific mutagenesis of the gene and insertion into an
expressing cell.
Expression of transformed genetic elements in host
cells
Work in progress in our laboratory and in others indi-
cates that the phenotypic pattern of expression of
transformed elements in genetically transformed cells
is very complex. In collaboration with M. Botchan and
D. Lane of the Tumor Virology Section, we have used
the method of cotransformation to examine the ex-
pression of SV40 T antigen in mouse cells transformed
nonselectively with the early region of SV40 DNA.
Some transformants express T antigen constitutively.
With other transformants, subclones arise spontane-
ously, at high frequency, and do not express T antigen.
These subclones, in turn, can spontaneously give rise
to cells that express T antigen. Despite this varied
phenotypic expression, the genotypic content of these
cells remains constant as determined by Southern
blotting. Several transformants were obtained that
contain multiple copies of the entire SV40 early region
but express no detectable T antigen. This perhaps
represents an example of either cis- or trans-acting
coordinate regulation.
Construction of mutant-specific host cells
Much effort in viral genetics centers around the isola-
tion of conditional lethal mutants. For animal cells,
temperature sensitivity is the most commonly used
conditional selection, whereas host range is used
much less frequently. In collaboration with T. Grod-
zicker and D. Klessig of the Tumor Virology Section,
we have constructed a number of human cell lines that
have stably incorporated various regions of the
adenoviral genome. These cells can now complement
adenovirus mutations that map at those loci. The use
of these cells should greatly facilitate the development
and analysis of new adenoviral mutants. In addition, in
collaboration with J. Broach, now at the State Univer-
sity of New York, Stony Brook, we have constructed
mouse cell lines with greater than 50 copies of a
specific yeast suppressor tRNA gene. We are prepar-
ing to examine this mouse cell line for the proper
expression of these genes. Suppressor animal cells
provide another avenue to the development of
mutant-specific host cells.
Isolation of cellular genes coding for selectable
markers by the method of plasmid rescue
We have previously demonstrated that cellular genes
coding for selectable markers can be transferred to
appropriate recipient cells using total genomic DNA
as donor. We have coupled this observation with the
method of plasmid rescue to devise a means for the
cloning of the cellular gene coding for thymidine
kinase on bacterial plasmids. To this end we ligate
restriction-endonuclease-cleaved, total genomic
DNA to bacterial plasmid pBR322 prior to trans-
formation of tk- animal cells. DNA from transformed
animal cells is then used to transform E. coli to am-
picillin resistance. The chicken tk gene is now the first
vertebrate gene isolated by purely genetic means. It
also represents the first "household" gene cloned. Our
isolation scheme can be applied equally as well to any
dominant-acting gene coding for a selectable marker.
Included in this category are various "putative" genes
that code for the malignant phenotype, as well as a
variety of biochemically well-defined genetic loci.
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CELL BIOLOGY
After several years of being scattered throughout the Cold Spring Harbor Labora-
tory, the groups working on motility, architecture, and protein composition of
animal cells are now united in the McClintock building. Remodeling of the various
laboratories, offices, and cold rooms in this building was essentially completed by
the summer of 1979; after moving into this new facility, the groups began to operate
again. Naturally, there was inevitable interruption and disturbance of each group's
work, causing some delay in progress; however, we are now fully operational.
We gratefully acknowledge the financial support received from the National
Science Foundation and the Robertson Research Fund. Jack Richards, head of
the Lab's Building and Grounds Department, and his crew are thanked for the
excellent work they put into our building. We also extend to all the other groups at
Cold Spring Harbor Laboratory our appreciation of their tolerance and patience
during this time, when Laboratory funds and manpower were largely occupied by
our reorganization.
Dr. William Gordon left the group and science altogether in January 1979. We
lost in him a quite promising young cell biologist who had already contributed
significant work on animal cell architecture.
Newcomers to our group are Dr. E. Birgitte Lane, Dr.- Jim Lin, and Dr. James
Feramisco. We were happy to have with us Dr. Ian Buckley, from the John Curtin
School of Medical Research, Canberra, Australia, who spent last year on sabbatical
with our group.
The detailed report on published work by the groups is outlined below.
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CELL MOTILITY
G. ALBRECHT-BUEHLER, S Blose, I. Buckley, A. Bushnell, A. Calasso, E. B. Lane, T. Lukralle, M. Schwartz, M.
Szadkowski
The ultrastructure of primary cilia in quiescent 3T3
cells
Primary (rudimentary, solitary) cilia and their biologi-
cal function are still an enigmatic and often unknown
aspect of animal cell physiology. They are defined as
single cilia that grow out of one of the centrioles during
interphase in otherwise unciliated animal cells. Before
mitosis, the cilium shaft is disassembled and only un-
ciliated centrioles are found at the spindle poles. Many
of the primary cilia remain, for the most part, inside the
cell body. In contrast to normal, motile cilia with the
well-known 9 + 2 pattern, primary cilia show a 9 + 0
pattern. Although discovered in 1898, primary cilia
were first carefully investigated in 1961 and 1962 by
Barnes and Sorokin, who described them in mouse
hypophysis, as well as in fibroblasts and smooth mus-
cle cells of neonatal chicken (Barnes, J. Ultrastr. Res.
5:453 [1961]; Sorokin, . Cell Biol. 15:363 [1962]). By
1967, Scherft and Daems (1. Ultrastr. Res. 19:546) had
listed 36 avian and mammalian tissues containing
primary cilia. In 1971 Wheatley (J. Anat. 105:351)
described such cilia in cultured cell lines such as
BHK-21 and 3T6. It seems, therefore, that primary
cilia are quite common centriolar specializations in
vivo and in vitro.
The biological function of primary cilia is unknown.
Since retinal rods, olfactory flagellae, and kinocilia
may be considered specializations of primary cilia,
even though only retinal rods show the 9 + 0 pattern,
one may suspect them of having a sensory function,
perhaps that of a chemoreceptor. It was also noted
that ciliation of centrioles correlated with a reduction
of mitotic activity. Furthermore, it was found that
blocking mitosis with Colcemid induced primary cilia
in CHO cells. These findings led to the suggestion that
primary cilia may be involved in control of the cell
cycle, although this interpretation has been chal-
lenged.
Aside from these possibilities, using indirect im-
munofluorescence, we recently found that the primary
cilia in migrating 3T3 cells were oriented parallel to
the substrate and predominantly pointing in the direc-
tion of migration. In addition, we found in migrating
3T3 cells one centriole oriented preferentially paral-
lel, and another oriented perpendicular, to the sub-
strate. The parallel centriole could be ciliated and,
thus, was easily observable by immunofluorescence.
It seems that these observations add an aspect of spa-
tial directionality to the suspected sensory function of
primary cilia.
Electron microscopy was used to investigate pri-
mary cilia in quiescent 3T3 cells. As in the case of
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primary cilia of other cell types, their basal centriole
was found to be a focal point of numerous cytoplasmic
microtubules that terminate at the basal feet. There are
also intermediate filaments that appear to converge at
the basal centriole. Cross-striated fibers of microtubu-
lar diameter, reminiscent of striated rootlets of ordi-
nary cilia, appear associated with the proximal end of
the basal centriole. Usually less than nine cross-
banded feet surround the basal centriole in a well-
defined plane perpendicular to the centriolar axis. The
ciliary shaft was found to be entirely enclosed in the
cytoplasm of fully flattened cells. In rounded cells, it
could be found extending to the outside of the cell.
Periodic striations along the entire shaft were ob-
served. The tip of the shaft showed an electron-dense
specialization. Several unusual forms of primary cilia
were observed, reminiscent of olfactory flagella or
retinal rods.
Through the use of tubulin antibody for indirect
immunofluorescence, a fluorescent rod is visible in
the cells, which we demonstrate is identical to the
primary cilium.
The relationship of 10-nm filaments and
microtubules in interphase cells and during mitosis
Guinea pig vascular endothelial cells in culture ar-
range the majority of their 10-nm filaments into a
perinuclear ring (Blose and Chacko, 1. Cell Biol.
70:459 [1976]; Blose et al., Proc. Natl. Acad. Sci.
74:662 [1977]). This arrangement greatly facilitates
the observation of these filaments during mitosis. We
have recently shown that the array of 10-nm filaments
remains stable during mitosis, and that cytokinesis is
needed to cleave the filaments into daughter cells
(Blose, Proc. Natl. Acad. Sci. 76:3372 [1979]). Obser-
vations from this study have demonstrated that during
mitosis the spindle was contained within the 10-nm
filament ring. This raised the following questions: (1)
Does the spindle apparatus insert into the 10-nm fila-
ment ring? (2) In interphase cells, how does the cyto-
plasmic microtubule network structure itself relative
to the 10-nm filament ring? To answer these questions,
a double-label immunofluorescence study was con-
ducted to simultaneously visualize 10-nm filaments
and microtubules in the same cell. Antibodies against
chick brain tubulin were made in guinea pigs, and the
previously described (Blose, Proc. Natl. Acad. Sci.
76:3372 119791) rabbit anti-10-nm antibody was
employed. Endothelial cells were fixed and stained
simultaneously with antitubulin and anti-10-nm fila-
ment antibodies, followed by staining with fluorescein
isothiocyanate (FITC)-labeled goat anti-rabbit IgG and
tetramethylrhodamine isothiocyanate (TMRITC)-
labeled goat anti-guinea pig IgG. In interphase cells,
the cytoplasmic microtubules radiate away from the
juxtanuclear cytocentrum and extend to the cell's
border. The cytocentrum is located within the ring of
10-nm filaments. As cells enter mitosis, the most strik-
ing change is observed in the microtubu le pattern. The
cytoplasmic microtubules disassemble and reappear
in the mitotic spindle. Throughout mitosis the spindle
poles remain in the same plane and closely applied to
the 10-nm filament ring. As shown in Figure 1 a -c the
10-nm filaments are excluded from the spindle.
The immunofluorescent pattern of microtubules
throughout mitosis is very similar to previous reports
on cultured cells. However, the relationship between
the 10-nm filaments and microtubules during mitosis
seems special: (1) The organizing centers for micro-
tubules, i.e., the cytocentrum in interphase cells, or
the spindle poles in mitosis, remain within the ring of
10-nm filaments. (2) The spindle poles are in the same
approximate plane and in close apposition to the
10-nm filament ring. (3) The 10-nm filaments precede
and are excluded from the spindle during mitosis. This
relationship suggests that the spindle poles might be
suspended from the 10-nm filament scaffold during
mitosis. This could aid in orienting the spindle ap-
paratus and the whole process of mitosis parallel to the
substrate. The overall consequence of this orientation
might be to direct both daughter cells to remain at-
tached to the substrate during mitosis. In vivo, this
would have an advantage of assuring that daughter
cells remain attached to the vessel wall and not be
swept away in the bloodstream. From these and ear-
lier studies, it was found that the 10-nm filament ring
moves ahead of the spindle. The motive force that
moves these filaments remains obscure, although two
possibilities are entertained: (1) The 10-nm filaments
generate the motive force for their movement, or (2)
the mitotic spindle apparatus pushes the filaments into
daughter cells.
This study illustrates the divergent behavior of two
elements of the cytoskeleton during mitosis. The
10-nm filaments remain intact and the microtubules
recycle. We have recently suggested (Blose, Proc.
Figure 1
Phase (a) and fluorescence micrographs of the same dividing endothelial cell in metaphase stained for 10-nm
filaments with antibodies labeled with fluorescein (b) and for tubulin with antibodies labeled with rhodamine (c). The
chromosomes have migrated to the equatorial plate (dotted line; a and c). The 10-nm filaments remain assembled (b)
and contain the mitotic spindle (c). The spindle poles (arrows, band c) are in close apposition to the filament ring. In
situ staining (d -f) of the inner surface of the guinea pig aorta with antibodies to 10-nm filaments reveal intact
perinuclear rings.
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Natl. Acad. Sci. 76:3372 [1979]) that the 10-nm fila-
ments provide topological information about the rela-
tive position of fibrous structures and organelles
within the microtrabecular lattice. It is possible that
these filaments provide a framework for orienting the
assembly of the mitotic spindle and cytocentrum in
newly restructuring daughter cells. Current studies are
directed at determining if this association might occur
through the centriole region.
In situ demonstration of the endothelial 10-nm
filament cytoskeleton
Studies now in progress seek to correlate the perinu-
clear ring of 10-nm filaments found in cultured guinea
pig endothelial cells to their in vivo counterparts.
Guinea pigs, 1 month old and 1 year old, were sac-
rificed and their thoracic aortas were rapidly removed.
After the blood was washed away, vessels were
opened along their longitudinal axis; the endothelial
surface was pinned down face up and fixed with 3.7%
Formal in in buffered saline for 30 minutes. The vessels
were extracted in absolute acetone at -20°C, and the
surface endothelium stained with antibodies to 10-nm
filaments. When the surface endothelium was exam-
ined by epifluorescence, 70% of the cells exhibited
intact perinuclear rings of 10-nm filaments (Fig. ld-f).
The other 30% were either very distorted or did not fall
in the plane of focus, hence making observation of the
ring impossible. This exciting observation confirms
our in vitro findings. Future studies are directed at
determining how widespread the ring of 10-nm fila-
ments is in blood vessels of various species, including
man.
Monoclonal antibodies to study the cytoskeleton
In the last few years the contribution of immunological
markers to the study of cell motility systems has been
prodigious, and a large part of our present understand-
ing of actomyosin systems, microtubules, and inter-
mediate filaments comes directly from immuno-
fluorescence studies. Some aspects of this field of re-
search, however, are not approaching limits imposed
by ancillary technology; with a long-term view to
expanding these technological limits, a project has
been initiated to raise monoclonal antibodies to
cytoskeletal components. Based on the cell hy-
bridization procedure of Kohler and Milstein (Eur. I.
lmmunol. 6:511 [1976)), plasma cells of an im-
munized mouse are immortalized by fusion to a
myeloma cell line, and the resulting "hybridoma" cell
lines secrete immunoglobulin of a definable specific-
ity in theoretically unlimited quantities. From such
fusions involving mice immunized with crude epithe-
lial cytoskeleton preparations, we have obtained and
stabilized, by repeated cloning, several cell lines, rec-
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ognizing different aspects of tonofilament proteins, or
cytokeratins, as well as a number of other previously
unidentified antigens. The various monoclonal an-
tibodies give different immunofluorescent staining
patterns (Fig. 2) which, although subtle in the original
antigenic epithelial cell line, are often striking in other
cell lines; the patterns obtained by immunoauto-
radiography on SDS-PAGE of the immunizing antigen
(Burridge, Proc. Natl. Acad. Sci. 73:4457 [1976]) sug-
gest that these antibodies might be alternately recog-
nizing sites in either constant or variable regions of
tonofilament protein molecules, in keeping with the
structure proposed for keratin molecules by Steinert 11.
Mol. Biol. 123:49 [1978]).
These monoclonal antibodies are proving to be ex-
cellent for use as intracellular markers, giving a very
low background, and in view of their cross-reactivity
with different epithelial cell types (in which the
cytokeratins appear to have different molecular
weights), they may become useful as standardized
reagents, providing a more functional framework for
defining cytoskeletal components. This approach is
expected to be particularly powerful when combined
with high-resolution two-dimensional gel and elec-
tron microscope technology in this laboratory.
Organelle movements and the distribution of
filamentous actin in nonmuscle cells
It has for a long time been known that, although the
cortical cytoplasm of nonmuscle cells is rich in thin
filaments that bind heavy meromyosin (HMM), the
subcortical cytoplasm contains few of these HMM-
binding thin filaments. Here in this deeper cytoplasm,
the predominating fi lament type is intermediate in size
and fails to bind HMM. It thus appeared possible that
the subcortical cytoplasm (where organelles reside
and move) contained too little filamentous actin to
provide for an actin/myosin-based system of organelle
movement. As an alternative interpretation, it had to
be considered whether these intermediate-size fila-
ments contained filamentous actin closely associated
with proteins that could block the binding of HMM.
Investigating this possibility, various types of cultured
cells (that had been extracted with glycerol) were
treated with low doses of trypsin before being labeled
with HMM. Initially, these cells were prepared for
electron microscopy as either negatively stained or
critical-point-dried whole-cell mounts. In such prepa-
rations, all filaments remaining after trypsin treatment
labeled clearly with HMM; in control preparations
that had had the trypsin but not the HMM, it appeared
that most intermediate filaments had survived the
trypsin treatment. From this it was initially concluded
that most intermediate filaments of the subcortical
cytoplasm contained a central core of filamentous
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Figure 2
(a) Staining of spreading ptK1 cell margins by a monoclonal antibody. (b) Detergent -soluble (1) and insoluble (2) (= immunizing antigen) fractions of PtK1 cells and binding of this
monoclonal antibody to two gel bands (3,4) on the same gel revealed by autoradiography. Staining of HeLa cells by the same antibody is heterogeneous (c).(d) Phase contrast
of same field as c.
cells were prepared for electron microscopy by resin
embedding and sectioning, it became clear that the
effect of the trypsin was to largely eradicate the pre-
dominating intermediate filaments of the subcortical
cytoplasm. Further analysis of these sectioned cells
suggested that the seemingly positive results from the
whole-cell-mount preparations were due to the occur-
rence of arrays of converging and closely apposed thin
filaments that, surviving the trypsin treatment and
labeling with HMM, were able to simulate the HMM
labeling of what seemed to be typical intermediate
filaments. It thus appears that the predominating
intermediate-size filaments of the subcortical cyto-
plasm are devoid of filamentous actin and that there
may indeed be very little of this form of actin available
to generate the motion of cytoplasmic organelles.
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CELL BIOCHEMISTRY
K. BURRIDGEJ Feramisco, J. Lin, L. McCullough
The efforts of our group are primarily directed toward
understanding the functions and interactions of struc-
tural proteins in higher cells, particularly those pro-
teins involved in generating cell movements.
a-Actinin in nonmuscle cells
One protein that continues to command our attention
is a-actinin. Originally it was found in striated skeletal
muscle where it was localized exclusively to the Z-line
structures. It is into these regions that actin filaments
insert, and because a-actinin will bind actin in vitro, it
has seemed likely that it is involved in the attachment
of actin to these structures. With the discovery of
a-actinin in nonmuscle cells several years ago, it was
suggested that a-actinin might function similarly and
mediate the attachment of actin to membranes. By
immunofluorescence microscopy, it has been found
in locations that are consistent with such a function. In
last year's report we described some preliminary ex-
periments testing whether a-actinin does function in
the attachment of actin to plasma membranes. We
demonstrated that a-actinin is a prominent compo-
nent of the plasma membranes isolated from several
different cell types, but our attempts to extract selec-
tively either a-actinin or actin were inconclusive.
More recently, we have found relatively mild condi-
tions of ionic strength and pH that favor the preferen-
tial release of a-actinin from membrane preparations.
After several cycles of extraction, we have obtained
membranes almost devoid of a-actinin but still rich in
actin. Such experiments strongly suggest that a-actinin
does not function in linking actin to the plasma mem-
brane, although it may function indirectly to promote
or stabilize attachments as a result of its ability to
cross-link actin filaments.
We have continued to study the biochemistry of
both muscle and nonmuscle a-actinins. A traditional
problem in working with a-actinin has been that it is
difficult to purify, and the conventional procedures are
very time-consuming. Realizing the need for a better
and more rapid purification, we have developed a
new procedure that is both fast and simple (Feramisco
and Burridgei. Biol. Chem., in press [1980]). Besides
its relative convenience, our new purification scheme
has several advantages. One of these has been that
when applied to smooth muscle it also gives rise to
pure filamin and a protein with a molecular weight of
130,000. This 130K protein is most interesting and will
be described in more detail below. With minor modi-
fications, the purification of a-actinin has been
applied to smooth and skeletal muscles as well as to
nonmuscle tissues. This has permitted us to study the
nonmuscle form of a-actinin and compare its structure
and biochemistry to the muscle types. The nonmuscle
form is a distinct protein, although definite regions of
homology are conserved and shared particularly with
the a-actinin from smooth muscle.
Microinjection of fluorescently labeled proteins into
living cells
During the last 5 years, the localization of structural
proteins within cells has been revolutionized by the
use of specific antibodies against these proteins and by
the technique of immunofluorescent microscopy. This
powerful technique, however, requires that the cells
be fixed and permeabilized -procedures that prevent
the observation of living cells. To overcome this prob-
lem and as a complementary approach to immuno-
fluorescence, we have used the technique of microin-
jection to introduce into living fibroblasts fluores-
cently labeled structural proteins. This approach to
studying the distribution and behavior of structural
elements in higher cells such as fibroblasts has been
developed independently in our laboratory
(Feramisco, Proc. Natl. Acad. Sci. 76:3967 [1979])
and by others (Kreis et al., Proc. Natl. Acad. Sci.
76:3814 H9791) and derives from the work of Taylor
and Wang (Proc. Natl. Acad. Sci. 75:857 [1978]), who
microinjected fluorescently labeled structural proteins
into comparatively large protozoans. The very flat
cells we have been using have well-organized stress
fibers (unlike the large amoebae injected by Taylor
and Wang), and as such they provide a better system
for high-resolution analysis of the location of injected
proteins within the living cells.
Because of our interest in the protein a-actinin, it
was the first protein we studied by microinjection.
When the native protein was covalently labeled with a
fluorescent dye and microinjected into living fibro-
blasts, the fluorescent protein incorporated into the
actin microfilament bundles and polygonal networks
of the living cells (Feramisco, Proc. Natl. Acad. Sci.
76:3967119791) (Fig. 1). On the other hand, when the
a-actinin was first denatured by boiling and then in-
jected, it incorporated into vesicular structures (prob-
ably lysosomes) around the nucleus. Further analysis
of the injected "native" a-actinin in fibroblasts in
relation to other endogenous structural proteins
(viewed by conventional immunofluorescence)
showed that the injected protein was (1) incorporated
at least everywhere that the cells' endogenous
a-actinin was found, (2) distributed along virtually all
discernible actin bundles, and (3) found in antiperi-
odic arrangement with respect to tropomyosin along
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Figure 1
Incorporation of rhodamine-labeled a-actinin into a living
fibroblast. A fully spread gerbil fibroma cell was microin-
jected with rhodamine-labeled a-actinin and photographed
16 hr later with fluorescence optics. Note the periodicities of
the injected protein along the actin microfilament bundles.
the actin bundles. These results suggest that the in-
jected native protein will incorporate faithfully into
the supramolecular structures of the living cell.
An interesting sidelight of this study showed that the
distribution of fluorescently labeled a-actinin seen in
the living cell was not significantly altered by chemi-
cal fixation and permeabilizaton of the cells-treat-
ments that are normally used for the preparation of
cells for immunofluorescent localization of many pro-
teins. This information combined with our observation
that, in the fixed and permeabilized cell, the distribu-
tion of the injected a-actinin was virtually identical to
the distribution of a-actinin as seen by immuno-
fluorescence in the same cell offers, for the first time,
some evidence indicating the validity of the immuno-
fluorescence technique in the localization of a-actin in
in cultured cells.
Microinjection affords us a unique opportunity to
follow specific proteins within the living cell. We have
recently succeeded in injecting simultaneously two
different proteins, each labeled with a different
fluorescent dye, into the same cell. Also, we have
connected a highly light-sensitive television camera
to our fluorescence microscope, which will let us
record the dynamics of the fluorescently labeled pro-
teins within the cell as movement occurs. It is hoped
that studies of this kind will help us unravel some of the
complex molecular events and interactions of cell
moti I ity.
A new structural protein
In developing the new purification scheme for
a-actinin from smooth muscle, we also obtained a
pure protein with a molecular weight of 130,000
(Feramisco and Burridge, j. Biol. Chem., in press
11980]). We were studying the interactions of this pro-
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tein with other structural proteins, such as actin, when
we learned at the Cold Spring Harbor meeting on the
cytoskeleton this summer that the same protein had
also been isolated by Geiger, who had localized it to
the tips of actin microfilament bundles by immuno-
fluorescence (Geiger, Cell 18:193 [1979]). Clearly,
this was an interesting protein, and we decided to study
its behavior and distribution both by microinjection
into living cells and by immunofluorescence. Visu-
alization of fluorescence in living fibroblasts 2-4
hours after microinjection of the protein conjugated
with a fluorescent dye revealed two major distribu-
tions (Burridge and Feramisco, Cell, in press [1980]).
One distribution was as bright, focal patches on the
lower surface of the cells, similar to the distribution de-
scribed by Geiger using immunofluorescence. This
prominent focal distribution prompted Jim Watson to
name the protein "Focin," a name that we now use in
the laboratory and that we have proposed for the pro-
tein (Burridge and Feramisco, Cell, in press [1980]).
Double-label fluorescent microscopy of cells injected
with the protein and stained for actin by indirect im-
munofluorescence 2 hours later has confirmed that this
focal distribution is at the ends of actin microfilament
bundles. A second major distribution has also been
seen for the injected protein with a streaky or fibrillar
appearance more commonly on the top of the cells,
but sometimes also on the bottom. This distribution
was reminiscent of the patterns of fibronectin on the
cell surface. Using antibodies against fibronectin and
double-label fluorescence microscopy, we have
shown that the distribution of the injected protein does
indeed correlate closely with the distribution of sur-
face fibronectin on these cells (Burridge and Feramisco,
Cell, in press [19801) (Fig. 2). Where the fibronectin
extended beyond a cell, the 130K protein remained
strictly cellular and often appeared concentrated as if
in an anchorage point. The distribution of this protein
both at the tips of the actin microfilament bundles and
underlying the matrix of fibronectin suggests that it
may be one element involved in the linkage between
the actin cytoskeleton and the extracellular matrix.
Monoclonal antibodies
Specific antibodies have been powerful tools for
analyzing the distribution of structural proteins in
higher cells. However, to raise an antiserum by con-
ventional means, it is usually necessary to have a pure
protein for immunization. This is a major limitation
since many potentially interesting proteins are difficult
to purify or cannot be obtained in sufficient quantity
for immunization. The production of monoclonal an-
tibodies can eliminate this problem since immuniza-
tion can be with a crude antigenic mixture and there
can be subsequent selection of cells producing a pure
antibody by cell cloning. Since his arrival in the labo-
Figure 2
Phase and fluorescent micrographs of a fibroblast microinjected with the gizzard 730K protein labeled with fluorescein and
indirectly stained for fibronectin with antibodies labeled with rhodamine. Two hours after the living cell was microinjected
with the labeled 130K protein, it was fixed and stained for fibronectin. (D) Phase micrograph of the cell; (E, F) fluorescent
micrographs viewing the fluorescein and rhodamine fluorescence, respectively; (E) two distributions of the microinjected
protein can be seen: one appears as "focal" patches of fluorescence on the bottom of the cell and the other appears as a
fibrillar or streaky distribution (marked with arrows). This fibrillar distribution coincides with the distribution of fibronectin on
the surface of the cell revealed in F.
ratory, J. Lin has begun to apply this strategy to raise
antibodies against the cytoskeleton, with the aim to
raise monoclonal antibodies against minor or previ-
ously unidentified components that by other means
could not be approached immunologically. Anti-
bodies against such components will be powerful re-
agents and will also provide a potential means of
purifying the target proteins through the use of affinity
chromatography on the immobilized antibodies. Al-
though this work is still at an early stage, already
several interesting monoclonal antibodies have been
raised that react with components of the microfila-
ment bundles or with intermediate filaments. The pro-
teins binding these antibodies are currently being
identified by antibody staining of SDS gels.
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QUEST-2D GEL LABORATORY
J. GARRELS, C. Burwell, J. Farrar, E. Kelly, T. Kelly
In the past year, we have designed and set up a new
laboratory for analyzing the proteins of the cell by
two-dimensional gel electrophoresis. We have also
developed computer programs for quantitation of the
proteins detected by this method and for assigning a
set of standard coordinates to each detectable protein.
The name we use to describe our new laboratory and
computer facility stands for QUantitative Elec-
trophoresis STandardized in 2 Dimensions (QUEST-
2D).
Our aim has been to make the detection and quanti-
tation of several thousand proteins from any cellular or
subcellular sample an easy and routine procedure. At
the same time, we want to ensure that our gels will
have consistently high resolution and reproducibility
so that we can use our computer to automatically
match the proteins of each new gel to a standard
protein map stored in the computer. The proteins de-
tected on each new gel will be assigned standard map
coordinates and will be stored along with their inten-
sities in a computer data bank. This data bank should
within a few years contain information about the oc-
currence of thousands of proteins in cells of many
differentiated types and states of growth. This infor-
mation will be searched and correlated in many ways
to determine which proteins are found in all cells,
which are tissue-specific, which are growth-specific,
and which are abnormal in particular conditions of
disease or transformation. We also hope to use these
methods to determine the rates of synthesis, rates of
degradation, posttranslational modifications, and
subcellular localizations for thousands of proteins in
muscle cells as they undergo differentiation in culture.
These studies should help us to determine which of the
many unknown proteins we should focus on in future
efforts to purify and characterize proteins that regulate
gene expression.
The new laboratory
It was clear to us from the start that a specialized
laboratory would be needed if we expected to pro-
duce enough two-dimensional gels for in-depth analy-
ses of differentiation in cultured cells. It was also clear
from previous work that to consistently produce gels of
high resolution and high reproducibility the whole
procedure should be as convenient and routine as
possible. The lab that was designed and built during
1979 provides for a throughput of 24 two-dimensional
gels each day. The steps that must be carried out each
day include the casting and loading of first-dimension
gels; running of the first-dimension gels; removal of
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first-dimension gels from their tubes, equilibration,
and placement onto the second-dimension gels; run-
ning the second-dimension gels; processing the
second-dimension gels in stains or chemicals for
fluorography; drying the gels; exposure of gels to film;
and film development. To make these steps easier and
more reproducible, we have designed and built the
following pieces of equipment: (1) A simple plastic
apparatus has been built for casting many first-
dimension gels quickly and reproducibly. (2) A simple
clamping and sealingdevice has been built for holding
and casting the large slab gels. (3) Special sink/
benches have been installed for slab gel elec-
trophoresis. Each sink is covered with a porous grating
so that after electrophoresis, the large gel apparatus
can be washed in place using sprayer hoses mounted
on the wall nearby. (4) Electrode buffer, which is used
in large amounts, is pumped through filters from a
central reservoir to an outlet near each gel bench. (5)
Special microprocessor-controlled power supplies
allow any current-voltage scheme to be prepro-
grammed such as constant wattage). During the run,
current and voltage are monitored and logged and the
power is automatically shut off when the ion front
passes through the gel. (6) A dipping system has been
installed for automatic staining and destaining of gels
and for automatic processing of gels through chemi-
cals for fluorography. This apparatus, which is en-
closed in a hooded floor-sink, consists of a mechanical
assembly for lifting and transporting the dipping bas-
kets, the dipping baskets themselves, and large chemi-
cal tanks. Each aluminum dipping basket holds 36
perforated metal shelves on which the gels are placed.
The baskets are lowered and gently agitated up and
down in the tanks by the lifting mechanism. The elec-
tronic controls (microprocessor-based) provide for au-
tomatic transfer of the dipping baskets from one tank to
another. (7) Large gel dryers have been built with
integral heaters and with a connection to a high-
vacuum system. These dryers can dry all 24 gels at
once. (8) Special light-tight boxes have been built for
holding the gels next to film for the duration of the
exposure period. Films are developed with our auto-
matic X-Omat film processor.
None of the above equipment could have been built
without the help of the lab shop personnel, namely,
Gus Dulis, Rocco Soccolich, and Steve Humenick.
Gus built all the electrophoresis chambers, the gel
dryers, the gel-casting apparatus, and numerous other
useful items. Rocco did all the machine work for the
dipping baskets and the lifting mechanism. Steve de-
signed and built all the electronic controls.
Midway through the year, Tom Kelly joined us and
began training as the technician in charge of daily
operation of the gel lab. He also has participated in its
construction and has become experienced in its op-
eration.
Carter Burwell, normally in the computer room, has
also helped to get the gel lab ready for operation. He
has written a set of programs that are run from a
computer terminal in the gel lab to help us keep track
of all the samples, gels, and films we produce. Since
quality control is so important, we will also use these
programs to keep careful records of each solution that
we make for gel electrophoresis, including lot num-
bers, exact formulation, pH, and conductivity.
The computer facility
The development of the gel lab has gone hand-in-hand
with the development of a set of computer programs
for the analysis of our gels. Our computer and scan-
ning equipment were installed on the second floor of
the library at the end of 1978 (see the Annual Report
for that year). During 1979 we were able to write a set
of basic programs for scanning and aligning the film
images, for subtraction of background streaks and film
noise, for merging data from different exposures of the
same gel, and for automatically matching the pattern
of spots on each new gel to a standard spot pattern.
John Farrar, who has written many of our basic
scanning and display programs, as well as our
background subtraction routine and our backup pro-
grams, left in August to return to medical school. Car-
ter Burwell, who joined us in January, has developed
our alignment and merging programs and matching
programs, and he has considerably enhanced our
data-display programs. As mentioned above, Carter
has also written a powerful record-keeping system that
will be used not only to record laboratory data, but
also to keep records on the scanning and calibration of
each film.
In the design of our image-processing programs, we
have put primary emphasis on rigorous matching of
data from many different gels. We want of establish a
standard may in which a unique set of coordinates are
assigned to each detectable protein within a species,
such as rat or mouse. The proteins of each new pattern
will then be matched to the proteins of the standard
map. Since the patterns become quite crowded after
long exposures, we know that we cannot describe
each protein unambiguously by only the two coordi-
nates of size and charge. Fortunately, we can use our
gel system to obtain more information about each
protein, and our matching programs have been de-
signed to make use of this additional information.
Our major source of additional information for
identification of the proteins will come from double-
label experiments. Many of the cells we study will be
labeled with two radioactively labeled amino acids,
one containing 5H and the other containing 355. The
gels obtained by electrophoresis of these double-
labeled samples will be exposed soon after they are
run and again 4 -6 weeks later, when a substantial
amount of the 35S will have decayed. By scanning both
exposures and asking the computer to compare the
two images, we can obtain the ratio of the two amino
acids across the entire gel. Within a protein spot the
amino acid ratio is constant, but between neighboring
spots, the ratio of amino acids, such as methionine and
proline, can vary considerably. If we display this ratio
information in terms of color on our TV display, we
will be able to visualize the three parameters of size,
charge, and amino acid ratio. In the matching pro-
grams, the ratio information will be considered as well
as size and charge in determining which spots should
be matched.
In addition to the amino acid ratio data, there is
another source of additional information that we will
often use for more rigorous matching. We know that if
we compare the pattern of spots detected on a 7.5%
second-dimension gel and the pattern detected on a
10% second-dimension gel, there are numerous small
shifts in the relative positions Of the spots. This occurs
because the relationship between mobility and pore
size is slightly different for each protein. Therefore,
once we know where a protein runs at two different
slab gel concentrations, we can look for it in both types
of gels before we confirm its identity in a new sample.
This parameter will also help us to detect proteins that
are overlapped by neighboring spots at one acryla-
mide concentration, but not at another. Our matching
programs have been designed to take into account this
type of information for samples that have been run at
two or more acrylamide concentrations.
In the programs that have been written during the
past year, we have tested the basic concepts and have
found that our approach is feasible. What remains for
us to do in the future is to refine these programs and to
connect them together into a finished system for
routine gel scanning. With the development work
nearly complete, we will in the next year begin to
establish our data base for the proteins in differentiated
cells and to pursue our special interests into the details
of muscle differentiation as a model system.
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NEUROBIOLOGY
The Neurobiology Section has progressed from just a summer program into a
year-round activity at Cold Spring Harbor Laboratory. Not only does research
continue all year long, but meetings and workshops also occur during the spring,
autumn, and winter months. Some of this off-season activity reflects the old spirit of
Cold Spring Harbor, when scientists visited the laboratory for a few weeks or
months to do experimental work. A good example is George Augustine. After taking
the Synapse Course in 1978, George came back the following spring with Linda
Beres, Bill Higgins, Patrick Riordan, Cynthia Scott, and Winsor Watson to collabo-
rate on common projects.
The number of our neurobiology courses has been steadily increasing since
1972, and we now have a total of seven courses projected for 1980. Of the six
courses given in 1979, a new one, the Neurobiology of Behavior, was taught by Eric
Kandel, John Koester, Fernando Nottebohm, and Keir Peirson. The Mammalian
Central Nervous System Course had a radical change in leadership, with only Peter
Kirkwood continuing on as instructor and David Hubei, Joseph Malpeli, and Helen
Sherk as new instructors. The Leech Course, taught for many years by John Nicholls
and Ken Muller, gained ltzack Parnas as a new instructor. Courses that continued
largely under their old leadership were Electrophysiological Methods for Cellular
Neurobiology, taught by Jacsue Kehoe, Dante Chiarandini, Enrique Stefani, and
Ray Kado, and Synaptic Structure and Function, taught by Rami Rahamimoff, U.
Jack McMahan, Charles Stevens, and Dale Purves. We would like to thank Jennifer
and Matthew La Vail for developing the Neuroanatomical Methods Course; this
course will have new leadership in 1980.
Every year, new concepts are taught in our courses and new technologies are
incorporated. Two examples for 1979 were (1) the immunocytochemical tech-
niques introduced by Ellyn Glazer and Allan Basbaum into the Neuroanatomical
Methods Course and the Pain Workshop and (2) the principles of the use of digital
computers in data collection and analysis taught by Rami Rahamimoff in the
Exploratory Synapse Workshop. Workshops involving a MINC computer (donated
by the Digital Equipment Corporation) will also become part of the 1980 Synapse
Course curriculum.
During the past year, much effort was put into acquiring fellowship moniesfor
the participants in our summer courses. In previous years, half the students in each
course received half-fellowships deriving largely from the Marie Robertson Fund
and a National Institutes of Health grant. In addition, for the next three years, we are





The Neurobiology Laboratory uses the leech as a
model system to study the nervous system. The advan-
tage of using an invertebrate preparation like the leech
lies in the possibility of studying identified neurons
rather than a large population, which is usually what is
done with vertebrate brains. The importance of work-
ing with precisely identified neurons becomes obvi-
ous if one realizes that the two nociceptive (or N) cells
in a leech ganglion, with their similar axoneuritic
geometries and electrophysiological properties, are
functionally different. The N cell sensing pain in the
leech belly has different membrane receptors and in-
tegrates into different neural networks than the N cell
that senses pain in the leech back.
During the past year, we worked on the following
three different projects using the leech nervous sys-
tem: (1) the neural network subserving mating behav-
ior, (2) an analysis of the mode of action of the opioid
peptide enkephal in, and (3) the isolation of hy-
bridomas producing monoclonal antibodies against
the leech nervous system.
Neuronal interactions in the mating network
The basic unit of the leech central nervous system is a
400-neuron ganglion that is repeated 34 times to in-
0.1 mm
nervate the animal's segmental body. The total num-
ber of leech nerve cells exceeds 34 x 400 because
extra neurons are added to a few ganglia to subserve
such specialized functions as reproductive behavior.
In the Haemopis leech, the sex ganglia, 5 and 6, are
almost twice as large as the standard midbody gan-
glion. This size increase is due, in part, to the addition
of two pairs of large neurons.
Much of our past work centered on these two large,
easily identified pairs of neurons. This year a number
of other sex neurons have been mapped by nerve
backfilling, which we recently were able to adapt to
the leech. Backfilling a nerve permits the identification
of neuronal elements that project their axons through
this common pathway. If the nerve subserves a spe-
cialized function, as is true for the male sex-nerve
feeding into ganglion 6 (Fig. 1), the backfil I can reveal
major sensory and motor neurons. The smaller cells
seen in Figure 1 are all newly identified neurons,
whereas, of the three large cells, the middle one is the
serotonergic Retzius cell and the other two are the two
motor neurons, the R and L cells, that we originally
studied.
The two motor neurons interact electrotonically
across a high junctional resistance. In spite of this
relative electrical insulation, a strong voltage coupling
Figure 1





Electrical interactions between L and R motor neurons
Action potentials in an L cell (upper trace) elicit depolariz-
ing synaptic potentials in an R cell (lower trace.).
exists for low-frequency depolarizing of potential
changes transmitted from the L cell to the R cell. The
explanation lies in the voltage-dependent membrane
resistance of the R cell. The input resistance of the R
cell increases tenfold as its membrane is depolarized
from resting potential to threshold. The resulting elec-
trotonic interactions are asymmetrical, almost like a
unidirectional chemical synaptic transmission.
The L cell also excites the R cell by means of a fast
electrotonic postsynaptic potential (PSP). The
stoichiometry of the PSP generation led to the hypoth-
esis of a pair of interneurons connecting the R and L
cells electrically. The data are as follows: An L-cell
action potential can evoke PSPs of two discrete ampli-
tude distributions in the other L cell and in the pair of R
cells. Since the smaller PSP is half the size of the larger
one, they are considered to be single and double
events. Synchronous action potentials occurring in
Figure 3
Localization of a bilateral pair of neurons
through fluorescent-dye coupling.
both L cells similarly only elicit single- or double-size
PSPs or failures, but not events that are three- or four-
fold in size. PSPs that are blocked by Tedrotoxin are
explained as reflections of action potentials from a pair
of interneurons connecting symmetrically to the L and
R cells via gap junctions.
The hypothetical interneurons appear to be key
decision-making elements in the network, since L cells
can only fire R cells with the help of the electrotonic
PSPs. If the single- and double-size PSPs are generated
with a high probability, the L cells can assume a wavy
bursting pattern (Fig. 2), which is characteristic of
vertebrate and invertebrate neuron-activating behav-
iors.
Further evidence for the existence of the interneu-
rons came from an experiment in which the L cells
were injected with Lucifer yellow, a fluorescent dye
that crosses gap junctions (Fig. 3). A bilateral pair of
small neurons (arrows) that lie in a different focal plane
than the brightly fluorescent L cell showed more dye
coupling than did the homologous L or the pair of R
cells. This raises the possibility that even the low-
frequency electrotonic coupling might occur via the
interneurons.
Opioid peptides
The small endogenous peptides, Met and Leu en-
kephal ins, bind to the same specific receptors as
opiate analgesics. They, together with the larger en-
dorphin peptides, have been widely found in mam-
mals, where they appear to play a significant role in
neuronal pathways mediating pain and emotional be-
havior. The earthworm is the only invertebrate pres-
ently known to have enkephalinlike substance.





Identification of a specific leech neuron immunoreactive
to enkephalin.
in the leech nervous system using immunocytochemi-
cal techniques (Fig. 4). Rabbit antienkephalin that had
reacted with leech tissue was linked to a peroxidase-
antiperoxidase complex (PAP; Sternberger) which
then produced an insoluble brown reaction product
upon the addition of 3,3'-diaminobenzidine and H2O,.
We learned this immunocytochemical technique at
the Cold Spring Harbor Neuroanatomy Course last
summer.
We are now in the process of studying further the
enkephalin-containing neuron. Its cell body invari-
ably appears between a pair of neurons called the
"nuts" and the giant serotonergic Retzius cell as a
member of a small set of three to four neurons with
30-,am somatas. Since all leech neurons have their
particular electrical parameters, it should be possible
to reliably characterize the enkephalin-containing
neuron electrophysiologically.
Monoclonal antibodies against the leech nervous
system
In collaboration with Ron McKay, monoclonal an-
tibodies against the leech nervous system are being





A monoclonal antibody reacting with a small subset of
cells in a 400-neuron midbody ganglion.
shows a leech ganglion reacted with our first interest-
ing monoclonal antibody. On the ventral surface (see
Fig. 5), nine cell bodies are stained to various degrees
by an HRP reaction product obtained by linking
mouse antibodies with protein A to the PAP complex.
Eight of the stained somatas seem to be bilaterally
symmetrical, whereas the ninth soma lies medially on
top of stained axons running vertically across the gan-
glion. The medial glial package to which this neuron
belongs has identified unilateral cells, whereas the
lateral glial package to which the other neurons be-
long contains bilaterally symmetrical sensory and
motor neurons.
Publications
Zipser, B. 1980. Horseradish peroxidase nerve back -
filling in leech. Brain Res. (in press).
1980. Identification of specific leech neu-
rons immunoreactive to enkephalin. Nature (in
press).
1979. Identifiable neurons controlling
penile eversion in the leech. Neurophysiol.
42:455.
1979. Voltage-modulated membrane resis-
tance in coupled leech neurons. 1. Neurophysiol.
42:465.
1979. Quantal electric psps. In Abstracts of
Society for Neuroscience Ninth Annual Meeting.
INVERTEBRATE NEUROBIOLOGY WORKSHOP, March 12 - March 31
ORGANIZER
Augustine, George J., B.S., University of Maryland, College Park
Many nervous system functions are performed by discretely localized networks of neurons. These networks,
although presumed to occur in all animals, are frequently studied in the somewhat simpler nervous systems
of invertebrates. In the winter workshop this year, the participants examined how the properties of localized
neural networks of several invertebrates could be influenced by neurotransmitters, neurohormones, and
other exogenous influences.
Experiments were performed on three different systems; the cardiac ganglion of the horseshoe crab
Limulus polyphemus, the penile eversion network of the leech Haemopis marmorata, and the visceral
ganglion of the soft-shell clam Mya arenaria. Most attention was focused on the Limulus cardiac ganglion.
W. Watson and G. Augustine examined the efferent innervation of the ganglion to determine the structure
and physiological properties of the neurons responsible for modulating its rhythmic output. W. Higgins and
C. Scott determined the action of putative neurotransmitters and neurohormones on the ganglion and the
possible mediation of the long-lasting effects of these substances via cyclic nucleotides. P. Riordan, B.
Zipser, and G. Augustine developed a modified technique for labeling cardiac ganglion neurons with the
electron-dense marker horseradish peroxidase, and they used this technique to examine the anatomy of
these neurons with light and electron microscopy.
In the leech, W. Higgins and B. Zipser considered how several neurotransmitters could interact to regulate
the activity of muscles responsible for copulation. L. Beres worked with the clam nervous system, to
determine how the salinity of the clam's environment could alter the characteristics of its nervous system.
PARTICIPANTS
Augustine, George, J., B.S., University of Maryland, College Park
Beres, Linda S., B.S., University of Maryland, College Park
Higgins, William J., Ph.D., University of Maryland, College Park
Riordan, G. Patrick, M.S., Georgetown University, Washington, DC
Scott, Cynthia, B.S., University of Maryland, College Park
Watson, Winsor H., Ph.D., University of New Hampshire, Durham
EXPLORATORY SYNAPSE WORKSHOP, July 24 - August 22
ORGANIZER
Rahamimoff, Rami, M.D., Hebrew University Medical School, Jerusalem, Israel
The purpose of the Exploratory Synapse Workshop was to teach electrophysiological and computational
methods while at the same time examining new approaches and techniques in the study of the cellular basis of
neuronal function. Workshop participants learned how to program a small lab computer for On-Line data
collection and analysis using the muscle endplate potential as a neurobiological signal.
The projects were:
1. the use of MINC-11 digital computer for On-Line Data Acquisition and analysis (Maehlen, McManus,
Meiri, Pickett, Rahamimoff, Stewart)
2, the use of heavy water in a study of subthreshold and suprathreshold synaptic potentials (Maehlen,
Pickett, Rahamimoff)
3. time series analysis of electromyographic data of patients with muscle weakness (Pickett)
4. the action of purified small neurotoxins on neuromuscular transmission (McManus)
5. generic and environmental control over shape and electrical behavior on nerve cells (Feder, Stewart),
6. oscillations in evoked release and neuronal facilitation (Meiri, Pickett)
7. the action of the sodium ionophore monensin on transmitter release (Meiri, Erulkar, Rahamimoff)
8. catecholamine modulation of tetanic potentiation (Nussinovitch)




Erulkar, Sol, D.Sc., Ph.D., University of Pennsylvania Medical School, Philadelphia
Feder, Ned, M.D., National Institutes of Health, Bethesda, Maryland
Maehlen, Jan, University of Oslo, Norway
McManus, Owen, B.A., University of Utah Medical School, Salt Lake City
Meiri, Halina, Ph.D., Hebrew University Medical School, Jerusalem, Israel
Nussinovitch, Itzhak, M.Sc., Hebrew University Medical School, Jerusalem, Israel
Pickett, Jack, M.D., University of California, San Francisco
Rivera, Amelia, M.S., University of Puerto Rico Medical School, San Juan
Rahamimoff, Rami, M.D., Hebrew University Medical School, Jerusalem, Israel
Stewart, Walter, B.A., National Institutes of Health, Bethesda, Maryland
COMPUTER MODELING OF SPECIFIC NEURAL NETWORKS, August 5 - August 11
ORGANIZER
Zipser, David, Ph.D., Cold Spring Harbor Laboratory, New York
The building of models holds a central position in the explanation of natural phenomena. Models enable
science to relate masses of complex data at one level of organization to processes at another. Nowhere is
this more clearly needed than at the interface between neuro and cognitive science. This year's workshop
was devoted to the problems of constructing and understanding computer models of neuronal phenomena.
The goal of the workshop was to examine some of the existing neuro models, see how they might be
expanded to meet more significant challenges, and examine in detail their structure and logical significance.
While computer modeling was emphasized and the computer was hovering in the background at all times,
many of the models were conceptual or mathematical.
The general organization of the workshop involved first investigating techniques that could be applied to
relatively simple, usually invertebrate systems in which neural network architecture is well known. We then
discussed a variety of intermediate systems, moving on finally to presentations related to eye movement. The
eye movement system is perhaps the most tractable neurobiology area involving the interface between
cognitive and neurophysiological studies. The system involves the ability to trace processes from input
through output in a complex neuromuscular system in which the cognitive correlates can be derived from
behavior in a fairly straightforward fashion. The whole operation takes place in the head, thus circumventing
a good deal of complexity usually brought in by spinal processing.
Although our workshop was only a beginning, barely scratching the surface of many of these problems, it
demonstrated the rich rewards to be obtained by an intensive study of neuro modeling paradigms.
PRESENTATIONS
Bahill, T., Carnegie Mellon University, Pittsburgh, Pennsylvania: Validation, linearization, and sensitivity analysis of
homomorphic model for eye movement control system.
Eckmiller, R., University of Dusseldorf, Germany: New models of the neural control system for pursuit eye move-
ments.
Edwards, D., Stanford University, California: Formulating and organizing computer models of neuronal systems.
Feldman, J., University of Rochester, New York: Computer-science-motivated approaches to representing neural
network function.
Friesen, 0., University of Virginia, Charlottesville: Analysis of rhythm generation in leech swimming with analog
circuits.
Just, M., Carnegie -Mellon University, Pittsburgh, Pennsylvania: Eye movements and psychological processes.
Lara, R., University of Massachuestts, Amherst: Visual motor coordination in the frog and toad.
Llinas, R., New York University School of Medicine, New York: Use of models in neurobiology.
Merickel, M., Baylor College of Medicine, Houston, Texas: Motivation and techniques for modeling a neural network.
Mulloney, B., University of California, Davis: Cellular and synaptic basis of stomatogastric motor patterns: What and
when is enough?
Optican, L., National Institutes of Health, Bethesda, Maryland: Adaptive control mechanisms for saccadic eye
movements.
Pellionisz, A., New York University School of Medicine, New York: A model of the cerebellum.
Raphan, T., Mt. Sinai School of Medicine, New York: The role of the integrator in modeling the visual-vestibular
interaction.
Stark, L., University of California, Berkeley: Modeling neurological generation of controller signals for eye movements.
Von der Malsburg, C., Max-Planck-Institut fur Biophysikalalische Chemie, Gottingen, Germany: Self organization in
the visual system.
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PAIN WORKSHOP, August 1 - August 30
ORGANIZER
Basbaum, Allan I., Ph.D., University of California, San Francisco
ASSISTANT
Goldstein, Ron, B.S., Columbia University, New York
Because analysis of the mechanisms of pain generation and modulation inherently requires an interdiscipli-
nary approach, pain itself is an ideal topic for a workshop that brings together physiological, anatomical,
and behaviorial approaches to solving a common problem. The Pain Workshop at Cold Spring Harbor
Laboratory was specifically organized to include researchers from several disciplines, each of whom has a
long-standing interest in the problems of pain and pain control. The physiological focus was provided by
Gary Bennett and Ron Dubner, who made intracellular recordings from "pain-responsive" neurons of the
primate spinal cord. These neurons were intracellularly marked for subsequent anatomical reconstruction.
Tissue of one animal was examined by both immunohistochemical and autoradiographic procedures for
localizing CNS amines and peptides (including the endogenous opiate leucine enkephalin). Of particular
interest were the interactions that apparently take place between these compounds and how this might
underlie some endogenous pain-control mechanisms. Additional anatomical studies of the pain pathways
were examined with transport methods using horseradish peroxidase (HRP) and various lectins. The
anatomical studies were carried out by Ellyn Glazer, Joe Coulter, Susan Hockfield, and M.A. Ruda. A more
global analysis of the neural substrate of pain included the use of the 2-deoxyglucose method to map the
CNS metabolic changes generated by a pain-producing stimulus. The latter studies, under the direction of
Peter and Carol Hand, were directed toward locating the heretofore elusive thalamic and cortical structures
that subserve the perception of pain. In addition, guest lectures by Ann-Judith Silverman and Tom Jessel
contributed to the scientific interchange that was an important part of the workshop. It is our hope that the
results of these studies will bring fresh approaches to the problem of pain, a problem that clearly will not be
solved without similar interactions.
PARTICIPANTS
Basbaum, Allan, Ph.D., University of California, San Francisco
Bennett, Gary, Ph.D., National Institutes of Health, Bethesda, Maryland
Coulter, Joe, Ph.D., Marine Biomedical Institute, Galveston, Texas
Dubner, Ronald, Ph.D., National Institutes of Health, Bethesda, Maryland
Glazer, Ellyn, Ph.D., University of California, San Francisco
Hand, Carol, B.S., University of Pennsylvania, Philadelphia
Hand, Peter, Ph.D., University of Pennsylvania, Philadelphia
Hockfield, Susan, Ph.D., University of California, San Francisco
Ruda, M., Ph.D., National Institutes of Health, Bethesda, Maryland
PRESENTATIONS
Jesse', Tom, M.D., Harvard University, Cambridge, Massachusetts




A computer-enhanced color display of
[2=14,d deoxyglucose (2DG) metabolic
labeling in a transverse section of the
medulla oblongata of the rhesus monkey.
Color differences indicate optical densities
of labeling and thus of differences in glu-
cose utilization and neural activity. In this
awake, flaxedilized animal (RD1), which
was under nitrous oxide analgesia, noxious
heat (40-50°C) was pulsed through a probe
applied to the left upper lip. Observe the
two foci of increased 2DG labeling in the
left spinal trigeminal subnucleus caudalis
(N. tr. sp. Vc). The spot labeled I (arrow) is
localized to the maxillary representation in
lamina I and the larger area labeled to
lamina V of N. tr. sp. Vc.
Figure 2
A computer-enhanced color display of 2DG
labeling in a transverse section of the
medulla oblongata of the rhesus monkey.
The level of this section was similar to that
in Fig. 1. In this animal (RD2), under the
same experimental conditions as RD1, a
heat probe was placed on the left upper lip,
but no thermal stimulus was applied. Note
that labeling was most dense in the left N.
tr. sp. Vc (arrow) and was not focalized as in
RD1.
Figure 3
A color display of 2DG labeling in a trans-
verse section of the right thalamus of RD1,
which had noxious heat applied to its left
upper lip (see Fig. 1). At this thalamic level,
dense labeling is observed in the following
contralateral nuclei; parafascicularis (pf);
centrum medianum (CM); medialis dorsalis
(MD); lateralis posterior (Ip). Labeling in the
subthalamic nucleus (SN) appears not to be
specific to the noxious heat stimulus, as it






VIRAL ONCOGEN ES, May 30-June 6
In the early days of tumor virus research, few people had any illusions
that any final answers would soon be forthcoming. The nature of
viruses themselves was still in doubt, and the necessity of working with
living animals meant that many months, if not years, would be needed
to carry out successfully a given experiment. Then, in the early 1960s,
Temin, Rubin, Dulbecco, Sachs, and Stoker successfully brought cell
culture into tumor virology, and for the first time, thinking at the
molecular level could begin. Cell culture procedures, however, are
necessarily expensive, and the prospect of doing extensive studies on
molecular biology of any tumor virus seemed to demand amounts of
money that only a few lucky labs might be able to command.
And so, when in 1969 research on SV40 commenced here, we saw a
long uphill fight to achieve meaningful answers at the DNA level.
Fortunately, however, we did not long remain effectively bored, as the
discovery of the restriction enzymes, together with the newer meth-
odologies for separating DNA fragments and blotting them to RNA, led
to an explosion of meaningful facts about the genomes of the DNA
tumor viruses. Simultaneously, through the discovery of reverse
transcriptase, the RNA tumor viruses also were open to meaningful
analysis. By 1974 we could hold our June Symposium on tumor
viruses, and though long and trying, it was at all times exciting.
Since then, the pace of tumor virus research has quickened even
further. The arrival of the recombinant DNA technology, together with
powerful new ways of sequencing DNA, allows us now to directly
focus on those viral genes that are directly involved in the conversion
of normal cells into their malignant counterparts. "Viral oncogenes"
are no longer theoretical construals but real objects of intensive re-
search, which soon should profoundly affect the way we think about
cancer cells.
We thus felt it appropriate again to bring together for a Symposium
the now frequently separate worlds of the DNA tumor viruses and the
RNA tumor viruses. In doing so, we hoped that many key insights
might turn out to be common to both disciplines. In arranging this
Symposium, Joe Sambrook, Mike Botchan, and I called many friends
for advice, and, in particular, we thank David Baltimore, Mike Bishop,
and Phil Sharp for providing lists of key speakers. Again limitations in
time kept us from inviting all we wished, and the formal program was
necessarily somewhat arbitrary. However, we did have about 140
scheduled speakers and a number of short, impromptu presentations.
Our audience was correspondingly large, with a registration of 411.
We acknowledge the much needed financial support given by the
National Institutes of Health, the National Science Foundation, and the Department ofEnergy. It allowed us to
provide the travel expenses of many foreign visitors, in addition to covering the costs of all our invited speakers
while they were at Cold Spring Harbor.
Welcoming Remarks: J. D. WATSON, Cold Spring Harbor Laboratory
Opening Address: H. TEMIN, McArdle Laboratory, University of Wisconsin, Madison
Session 1
L. CRAWFORD, Imperial Cancer Research Fund, London, England: Synopsis-The transforminggenes of DNA
tumor viruses.
P. DUESBERG, University of California, Berkeley: Synopsis-The transforming genes of retroviruses.
Session 2: DNA Tumor Viruses-Early RNAs and Early Proteins
Chairperson: P. BERG, Stanford University, California
M. PIATAK,* P. K. GHOSH,' V. B. REDDY,* J. SWINSCOE,* P. LEBOWITZ,, J. MERTZ,t T. SHENK,§ K. N.
SUBRAMANIAN,' and S. M. WEISSMAN,* *Department of Human Genetics, and ',Department of Internal
Medicine, Yale University School of Medicine, New Haven, Connecticut; ,McArdle Laboratory, Univer-
sity of Wisconsin, Madison; §Microbiology Department, University of Connecticut Health Center,
Farmington; #Microbiology Department, University of Illinois Medical Center, Chicago: The structure ofSV40 mRNA.
G. KHOURY, J. C. ALWINE, R. DHAR, P. GROSS, C. -J. LAI, S. SEGAL, and I. SEIF, NCI, National Institutes of
Health, Bethesda, Maryland: Regulation of SV40 gene expression through RNA splicing.
R. KAMEN, J. FAVALORO, J. PARKER, L. LANIA, and A. MELLOR, Imperial Cancer Research Fund, London,
England: Comparison of polyoma virus early gene expression in productively infectedmouse cells and
transformed rodent cell lines.
M. GRIGORYAN, P. CHUMAKOV, and E. LUKANIDIN, Institute of Molecular Biology, USSR Academy of Sciences,
Moscow: Transcription of SV40 DNA in transformed rat cells.
S. J. FLINT, G. A. BELTZ, J. STADLER, J. LIESCH, and H. W. WEINTRAUB,* Department of Biological Sciences,
Princeton University, New Jersey; *Fred Hutchinson Cancer Research Center, Seattle, Washington:
Mechanisms of expression of viral genes in cells transformed by SV40 and adenovirus type 2.
R. TITAN and A. ROBBINS, Department of Biochemistry, University of California, Berkeley: The SV40 tumor
antigen is an enzyme.
D. LIVINGSTON, J. GRIFFIN, D. SHALLOWAY, and G. SPANGLER, Sidney Farber Cancer Institute and Harvard
Medical School, Boston, Massachusetts: Enzymatic and DNA binding properties of large SV40 T antigen.
C. PRIVES, M. OREN, D. GIDONI, H. SHURE, and Y. BECK, Weizmann Institute of Science, Rehovot, Israel:
Interactions of SV40 T antigen with DNA.
W. ECKHART, M. A. HUTCHINSON, and T. HUNTER, Tumor Virology Laboratory, Salk Institute, San Diego,
California: Polyoma T antigens.
A. SMITH, R. SMITH, B. GRIFFIN, and M. FRIED, Imperial Cancer Research Fund, London, England: Protein
kinase activity associated with polyoma virus middle-T.
Session 3: src. I.
Chairperson: D. BALTIMORE, Massachusetts Institute of Technology, Cambridge
R. L. ERIKSON, M. S. COLLETT, E. ERIKSON, J. S. BRUGGE, and A. F. PURCHIO, Department of Pathology,
University of Colorado Medical Center, Denver: The transforming protein of avian sarcoma viruses and
its homolog in uninfected cells.
J. M. BISHOP, G. CALOTHY,* A. D. LEVINSON, L. LEVINTOW, H. OPPERMANN, D. SHEINE55, R. SWANSTROM, and H.
E. VARMUS, University of California, San Francisco; *Institut Curie, Orsay-Paris, France: The origin and
function of avian retrovirus transforming genes.
T. HUNTER, B. SEFTON, and K. BEEMON, Tumor Virology Laboratory, Salk Institute, San Diego, California:
Analysis of avian sarcoma virus pp605,c.
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J. M. BUCHANAN, W. H. BERG, J. G. BURR, J. KAMINE, S.-R. LEE, and M.-H. PARK, Department of Biology,
Massachusetts Institute of Technology, Cambridge: Studies on the characterization, processing and
isolation of transformation-specific proteins.
P. MANESS, H. ENGESER, M. GREENBERG, M. O'FARRELL, and G. M. EDELMAN, Department of Developmental
and Molecular Biology, Rockefeller University, New York, New York: Isolation and assays for activity of
the src gene product.
E. T5EN, B. DAMIANI, P. HSIEH, M. WALSH, and L. B. CHEN, Sidney Farber Cancer Institute, Harvard Medical
School, Boston, Massachusetts: Inhibitors for protein kinase activity associated with src gene product.
R. RADKE and G. S. MARTIN, Department of Zoology, University of California, Berkeley: Synthesis and
phosphorylation of cellular polypeptides in chick embryo fibroblasts transformed by Rous sarcoma virus.
C. CALOTHY, POIRIER, and B. PESSAC, Institut Curie-Biologie, Orsay, France: Expression of viral oncogenes in
differentiating chick embryo neuroretinal (NR) cells infected with avian tumor viruses.
Session 4: T Antigens
Chairperson: B. HIRT, Swiss Institute for Experimental Cancer Research, Lausanne
Y. ITO and N. SPURR, Imperial Cancer Reserach Fund, London, England: T-antigens expressed in polyoma-
vi rus-transformed cells.
P. TEGTMEYER and T. SPILLMAN, Department of Microbiology, State University of New York, Stony Brook,
New York: Purification of SV40 small-T antigen.
F. MCCORMICK, F. CHAUDRY, A. E. SMITH, and E. PAUCHA,* Translation Laboratory, Imperial Cancer Research
Fund, London; *Department of Biochemistry, Imperial College, London, England: Characterization of
different tumor antigens present in cells transformed by SV40.
L. V. CRAWFORD, D. P. LANE,* D. T. DENHARDT, E. E. HARLOW, P. M. NICKLIN, K. OSBORN, and D. C. PIM,
Imperial Cancer Research Fund, London, England; *Cold Spring Harbor Laboratory, New York: Charac-
terization of the complex between SV40 large-T antigen and the 53K host protein in transformed mouse
cells.
P. MAY, M. KRESS, M. LANGE, and E. MAY, Institut de Recherches Scientifiques sur le Cancer, Villejuif, France:
Study of the 55K protein(s) expressed in SV40-transformed cell lines and immunoprecipitable by an
anti-SV40 tumor serum.
J. A. MELERO, D. S. GREENSPAN, S. TUR, K. MUELLO, and R. B. CARROLL, Department of Pathology, New York
University School of Medicine, New York: T antigen-associated proteins, which are induced by SV40
transformation.
D. I. H. LINZER, W. MALTZMAN, and A. J. LEVINE, Princeton University, New Jersey: Characterization of a
murine cellular SV40 tumor antigen in SV40 transformed cells and uninfected embryonal carcinoma
cells.
W. DEPPERT* and R. HENNING,t *Max-Planck-Institute for Biophysical Chemistry, Gottingen; tDepartment
of Biochemistry, University of Ulm Medical School, Germany: SV40 T-antigen related molecules on the
surface of adenovirus 2-SV40-hybridvirus-infected He La cells and on SV40 transformed cells.
S. S. TEVETHIA, R. S. GREENFIELD, D. FLYER, and M. J. TEVETHIA, Department of Microbiology, Pennsylvania
State University College of Medicine, Hershey: SV40 transplantation rejection antigen-Relationship to
SV40 specific proteins.
G. KLEIN, Department of Tumor Biology, Karolinska lnstitutet, Stockholm, Sweden: Transformation by
lymphotropic herpesviruses-Nuclear antigen studies.
Session 5: The Genomes and Proteins of Retroviruses. I.
Chairperson: R. WEISS, Imperial Cancer Research Fund, London, England
D. DONOGHUE, M. GOLDFARB, C. TRENT, and R. A. WEINBERG, Department of Biology and Center for Cancer
Research, Massachusetts Institute of Technology, Cambridge: Transformation by Moloney sarcoma virus.
S. AARONSON, E. CANAANI, K. ROBBINS, P. ANDERSEN, and S. TRONICK, NCI, National Institutes of Health,
Bethesda, Maryland: Cellular origin of the transforming gene of Moloney murine sarcoma virus.
G. VANDE WOUDE, M. OSKARSSON, L. ENQUIST, P. FISCHINGER, W. MCCLEMENTS, S. NOMURA, D. BLAIR, and M.
SULLIVAN,* NCI and *NICHD, National Institutes of Health, Bethesda, Maryland: Characterization of
integrated proviruses of Moloney sarcoma viruses and host flanking sequences cloned in bacteriophage X.
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T. G. W000,* J. P. HORN,* D. G. BLAIR,t J. ROBEY,t and R. B. ARLINGHAUS,* *University of Texas System
Cancer Center, M.D. Anderson Hospital and Tumor Institute, Houston; +NCI, National Institutes of
Health, Bethesda, Maryland: Detection of a 85,000-dalton polypeptide at the permissive temperature in
transformed cells infected with a mutant murine sarcoma virus (MuSV) that is temperature sensitive for
transformation.
L.-H. WANG, P. SNYDER, T. HANAFUSA, C. MOSCOVICI,* and H. HANAFUSA, Rockefeller University, New York,
New York; *Tumor Virus Laboratory, Veterans Administration Hospital, Gainesville, Florida: Compari-
son of cellular and viral transforming sequences by oligonucleotide fingerprinting.
R. E. KARESS, W. S. HAYWARD, and H. HANAFUSA, Rockefeller University, New York, New York: Transforming
protein encoded by the cellular information in the genome of recovered avian sarcoma virus.
H. M. TEMIN, E. KESHET, S. WELLER, I. CHEN, and J. O'REAR, McArdle Laboratory, University of Wisconsin,
Madison: Relationship of numbers and structures of avian retrovirus DNAs to virus production and cell
killing.
E. M. SCOLNICK, H. A. YOUNG, and T. Y. SHIH, NCI, National Institutes of Health, Bethesda, Maryland:
Different rat-derived transforming retroviruses code for an immunologically related intracellular phos-
phoprotein.
H. W. SNYDER, JR., M. ESSEX,* A. H. Sus KO W. D. HARDY, JR.,' and J. RFilm,, *Harvard University School of
Public Health, Boston, Massachusetts: +National Institutes of Health, Bethesda, Maryland; +Memorial
Sloan-Kettering Cancer Center, New York, New York: Feline oncornavirus-associated cell membrane
antigen.
Session 6: The Transforming Genes of DNA Tumor Viruses and Their Arrangement in Transformed Cells
Chairperson: M. BOTCHAN, Cold Spring Harbor Laboratory, New York
L. VISSER, M. VAN MAARSCHALKERWEERD, T. H. ROZIJN, A. WASSENAAR, A. REEMST, and J. S. SUSSENBACH,
Laboratory for Physiological Chemistry, State University of Utrecht, The Netherlands: Presence and
expression of viral sequences in 15 adenovirus-transformed cell lines.
W. DOERFLER, S. STABEL, R. NEUMANN, D. SUTTER, H. IBELGAUFTS, J. GRONEBERG, R. DEURING, and U.
WINTERHOFF, Institute of Genetics, University of Cologne, Germany: Selectivity in the integration of
adenovirus DNA in infected and transformed cells.
J. SAMBROOK, J. STRINGER, S.-L. Hu, R. GREENE, and M. BOTCHAN, Cold Spring Harbor Laboratory, New York:
The arrangement and expression of integrated sequences of SV40 and adenovirus DNA.
M. A. MARTIN, M. A. ISRAEL, K. CHOWDHURY, J. M. RAMSEUR,* and W. P. ROWE,* NIAID, National Institutes
of Health, Bethesda, Maryland: Characterization of the polyoma virus DNA and polyoma virus proteins
present in hamster tumors induced by virions and viral DNA.
L. LANIA, D. GANDINI-ATTARDI, and M. FRIED, Imperial Cancer Research Fund, London, England: The structure
and function of polyoma virus DNA in transformed and normal cells.
A. GRAESSMANN, M. GRAESSMANN, and C. MUELLER, Institut fLir Molekularbiologie and Biochemie der Freien
Universitat, Berlin, Germany: Transformation of monkey and rat cells by microinjection of an early SV40
DNA fragment.
B. BASILICO, D. ZOUZIAS, S. GATTONI, G. DELLA VALLE, V. COLANTUONI, and R. FENTON, Department of
Pathology, New York University School of Medicine, New York: Integration and excision of polyoma
virus genomes.
E. WINOCOUR,* M. F. SINGER:, and E. L. KUFF,t *Department of Virology, Weizmann Institute of Science,
Rehovot, Israel; +NCI, National Institutes of Health, Bethesda, Maryland: Host-substituted SV40 variants.
G. R. REYES, R. LAFEMINA, S. D. HAYWARD, and G. S. HAYWARD,* Department of Pharmacology, Johns
Hopkins Medical School, Baltimore, Maryland: Evidence for two distinct transforming regions in the
DNA of herpes simplex virus.
Session 7: Proviruses and Their Expression
Chairperson: J. M. BISHOP, University of California Medical Center, San Francisco
S. H. HUGHES,* P. K. VOGT,t E . STUBBLEFIELD,t H. ROBINSON,§ J. M. BISHOP,* and H. E. VARMUS,*
*Department of Microbiology, University of California, San Francisco; +Department of Microbiology,
University of Southern California, Los Angeles; +Department of Biology, University of Texas Cancer
Center, Houston; §Worcester Institute for Experimental Biology, Shrewsbury, Massachusetts: Organiza-
tion of endogenous and exogenous avian viral and linked nonviral sequences.
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J. M. TAYLOR, T. W. Hsu, C. YEATER, and W. S. MASON, Institute for Cancer Research, Fox Chase Center,
Philadelphia, Pennsylvania: Avian RNA tumor virus DNA.
A. SKALKA, W. MCCLEMENTS, P. DEBONA, and F. HISHINUMA, Roche Institute of Molecular Biology, Nutley,
New Jersey: Avian endogenous proviral DNA-relationship between structure and expression.
S. M. ASTRIN,* H. L. ROBINSON,' L. B. CRITTENDEN, and W. S. HAYWARD,§ *Institute for Cancer Research,
Philadelphia, Pennsylvania; tWorcester Foundation for Experimental Biology, Shrewsbury, Mas-
sachusetts; fRegional Poultry Research Laboratory, East Lansing, Michigan; §Rockefeller University,
New York, New York: Ten genetic loci in the chicken that contain structural genes for endogenous avian
leukosis viruses.
W. S. HAYWARD, S. B. BRAVERMAN, and S. M. ASTRIN,* Rockefeller University, New York, New York;
*Institute for Cancer Research, Philadelphia, Pennsylvania: Transcriptional products of endogenous and
exogenous oncovirus genes.
H. L. ROBINSON and M. N. PEARSON, Worcester Foundation for Experimental Biology, Shrewsbury, Mas-
sachusetts: Subgroup E avian leukosis virus associated disease in chickens.
D. R. Lows, E. RANDS, S. K. CHATTOPADHYAY, and G. R. HAGER, NCI, National Institutes of Health, Bethesda,
Maryland: Molecular cloning of infectious integrated AKR murine leukemia virus DNA genomes.
G. L. HAGER, L. A. DONEHOWER, D. S. BERARD, and R. G. WOLFORD, NCI, National Institutes of Health,
Bethesda, Maryland: Construction and characterization of molecular clones containing integrated mouse
mammary tumor virus sequences.
N. E. HYNES and B. GRONER, Swiss Institute for Experimental Cancer Research, Lausanne, Switzerland:
Genomic integration sites of endogenous and acquired MMTV proviral genes.
G. M. COOPER, N. G. COPELAND, A. D. ZELENETZ, and T. KRONTIRIS, Sidney Farber Cancer Institute, Boston,
Massachusetts: Transformation of mouse cells by avian retrovirus DNAs.
Session 8: The Genetics of Transformation by DNA Tumor Viruses
Chairperson: P. TEGTMEYER, State University of New York, Stony Brook
T. BENJAMIN, B. S. SCHAFFHAUSEN, and G. CARMICHAEL, Pathology Department, Harvard Medical School,
Boston, Massachusetts: The hr-t gene of polyoma virus.
B. E. GRIFFIN, Y. ITO, N. SPURR, U. NOVAK, S. DILWORTH, and N. SMOLAR, Imperial Cancer Research Fund,
London, England: Early mutants of polyoma virus which have altered transformation properties.
J. M. PIPAS, S. P. ADLER, S. LAZAROWITZ, K. PEDEN, D. SHORTLE, and D. NATHANS, Department of Microbiology,
Johns Hopkins University School of Medicine, Baltimore, Maryland: Mutants of SV40 that affect the
structure or synthesis of viral tumor antigens.
G. DIMAYORCA,* D. PINTEL,* N. BLOUCK,* B. SWERDLOW,' and T. E. SHENK' *Department of Microbiology,
University of Illinois Medical Center, Chicago; 'Department of Microbiology, University of Connecticut
Health Center, Farmington: dIA 1499 is a new early region mutant of SV40 which is heat sensitive for
lytic growth and cold sensitive for transformations.
R. G. MARTIN, V. P. SETLOW, A. B. CHEPELINSKY, and R. SEIF, NCI, National Institutes of Health, Bethesda,
Maryland: Roles of the tumor antigens in transformation by SV40.
R. J. FRISQUE, W. C. ToPP, and D. B. RIFKIN,* Cold Spring Harbor Laboratory; *Department of Cell Biology,
New York University Medical School, New York: The genetics of transformation of nonpermissive cells
by SV40.
M. RASSOULZADEGAN, E. MOUGNEAU, B. PERBAL, F. BIRG,* and F. CUZIN, Centre de Biochimie du CNRS, Nice;
*Unite 119 INSERM, Marseille, France: Analysis of a homogeneous set of polyoma and SV40 trans-
formed rat cells-temperature dependence of tsA transformants, integration sites, levels of expression of
the transformed phenotype.
J. HISCOTT, M. STEINBERG, and V. DEFENDI, Department of Pathology, New York University School of
Medicine, New York: Viral and cellular control of the transformed phenotype.
J. WILLIAMS,* R. S. GALOS,* M. H. BINGER,' and S. J. FLINT,' *Department of Biological Sciences,
Carnegie-Mellon University, Pittsburgh, Pennsylvania; 'Department of Biochemical Sciences, Princeton,
New Jersey: Location of additional early sequences within the left quarter of the adenoviral genome.
T. SHENK, N. JONES, and W. COLBY, Department of Microbiology, University of Connecticut Health Center,
Farmington: Adenovirus type 5 deletion mutants defective for transformation of rat embryo cells.
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Session 9: The Transformed Phenotype and Differentiation
Chairperson: M. LINIAL, Fred Hutchinson Cancer Center, Seattle, Washington
N. M. TEICH, M. Boss, T. CURRAN, and T. M. DEXTER,* Imperial Cancer Research Fund, London; *Paterson
Laboratories, Manchester, England: Murine leukemia viral gene expression in transformed hematopoietic
cells.
D. HOUSMAN, R. LEVENSON, V. VOLLOCH, A. TSIFTSOGL011, J. GUSELLA, D. PARKER, J. KERNEN, A. MITRANI, V.
WEEKS, 0. WITTE, and P. BESMER, Biology Department and Center for Cancer Research, Massachusetts
Institute of Technology, Cambridge: Control of proliferation and differentiation in Friend virus trans-
formed cells.
W. C. RASCHKE, Developmental Biology Laboratory, Salk Institute, San Diego, California: Transformation by
Abelson leukemia virus-Properties of the transformed cells.
R. RISSER, D. GRUNWALD, P. JELEN, and C. SINARKO, McArdle Laboratory for Cancer Research, University of
Wisconsin, Madison: Cell surface antigens of Abelson or Friend MuLV and of hematopoietic differentia-
tion.
C. MORONI, J. STOYKE, J. DELAMARTER, F. JAY, J. JONGSTRA, and G. SCHUMANN,* Friedrich Miescher-lnstitut,
Basel; *Pharmaceuticals Division, Ciba-Geigy Ltd., Basel, Switzerland: Correlation of endogenous
C-type virus expression and B-cell differentiation-Implications for immune cell function and leuke-
mogenesis.
D. STEHELIN, S. SAULE, M. ROUSSEL, C. LAGROU, and C. ROMMENS, INSERM, Pasteur Institute, Lille, France:
Three new types of transforming genes in acute defective avian leukemia viruses. I. Specific viral
nucleotide sequences correlating with distinct phenotypes of virus-transformed cells.
T. GRAF, H. BEUG, A. V. KIRCHBACH, and M. HAYMAN,* Deutsches Krebsforschungszentrum, Heidelberg,
Germany; *Imperial Cancer Research Fund, London, England: Three new types of transforming genes in
acute defective avian leukemia viruses. II. Biological, genetical, and biochemical evidence.
R. EISENMAN, M. GROUNDINE, and M. LINIAL, Fred Hutchinson Cancer Research Center, Seattle, Washington:
Analysis of avian oncovirus-related polyproteins in uninfected hematopoietic cells and in cells trans-
formed by the acute leukemia viruses MC29 and AEV.
D. BOETTIGER and E. DURBAN, Department of Microbiology, University of Pennsylvania, Philadelphia:
Infection and transformation of progenitor cell populations by Rous sarcoma virus and avian myeloblas-
tosis virus.
Session 10: The Genomes and Proteins of Retroviruses. II.
Chairperson: T. AUGUST, Johns Hopkins University, Baltimore, Maryland
P. nLESBERG,* K. BISTER,* L. EVANS,* C. Moscovici,+ P. VOGT,t D. TROXLER,§ and E. SCOLNICK,§ *Depart-
ment of Molecular Biology, University of California, Berkeley; +Veterans Administration Hospital,
Gainesville, Florida; *Department of Microbiology, University of Southern California, Los Angeles;
§NCI, National Institutes of Health, Bethesda, Maryland: Gene structure of avian and murine leukemia
viruses.
K. TOYOSHIMA,* T. KAMAHORA,* H. SUGIYAMA,* M. OWADA,* A. NOMOTO," and M. YOSHIDA,t *Research
Institute for Microbial Diseases, Osaka University: +School of Pharmaceutical Sciences, Kitasato Univer-
sity, Tokyo; *Cancer Institute, Tokyo, Japan: Analysis of RNA specific for the transforming agent of R
strain of avian erythroblastosis virus.
D. BALTIMORE, A. SHIELDS, G. OTTO, and S. GOFF, Center for Cancer Research, Massachusetts Institute of
Technology, Cambridge: Structure of the A-MuLV genome.
0. N. WITTE,* N. E. ROSENBERG,' and D. BALTIMORE,* *Massachusetts Institute of Technology, Cambridge;
Tufts University School of Medicine, Boston, Massachusetts: Syngeneic tumor regressor serum reactive
with the unique region of the Abelson MuLV p120 protein recognizes a normal cellular protein in
hematopoietic tissues.
N. ROSENBERG,* 0. N. WITTE, and D. BALTIMORE, Massachusetts Institute of Technology, Cambridge; *Tufts
University School of Medicine, Boston, Massachusetts: Characterization of A-MuLV isolates differing in
p120 expression.
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J. R. STEPHENSON, W. J. M. VAN DE VEN, A. S. KHAN, and F. H. REYNOLDS, JR., Frederick Cancer Research
Center, National Cancer Institute, Frederick, Maryland: Mammalian RNA type C transforming viruses-
Characterization of viral-coded polyproteins containing phosphorylated nonstructural components with
possible transforming function.
Y. IKAWA,* M. YOSHIDA,* M. OBINATA,* F. HARADA,t and H. YOSHIKURA,F *Department of Viral Oncology,
Cancer Institute, Tokyo; +Virology Division, National Cancer Center Research Institute, Tokyo; +De-
partment of Genetics, Institute of Medical Science, University of Tokyo, Japan: RNA sequences and
proteins specific to Friend strain of spleen focus-forming virus (SFFV).
A. S. BERKOWER, R. KAUL, F. LILLY, F. PLATA, R. SOEIRO, and R. A. STEEVES, Departments of Genetics and
Medicine, Albert Einstein College of Medicine, Bronx, New York: Progressive shutdown of viral gene
expression in Friend virus-induced erythroleukemia cells.
T. W. MAK,* A. BERNSTEIN,* C. GAMBLE,* M. MACDONALD,* and P. BRANTON, + *Ontario Cancer Institute,
University of Toronto; +McMaster University, Ontario, Canada: Genetic control of the expression of
Friend erythroleukemia virus-specific sequences in normal and leukemic mouse tissues.
R. C. NOWINSKI, Fred Hutchinson Cancer Research Center, Seattle, Washington: Monoclonal antibodies
against murine leukemia viruses.
Session 1 1: The Transforming Genes of Adenoviruses and Their Expression
Chairperson: P. GALLIMORE, University of Birmingham, England
A. J. VAN DER EB, P. I. SCHRIER, H. VAN ORMONDT, H. JOCHEMSEN, J. MAAT, P. J. VAN DEN ELSEN, J. H. LUPKER, R.
DUKEMA, R. J. DELEYS, C. P. VAN BEVEREN, and A. DE WAARD, Sylvius Laboratories, University of Leiden, The
Netherlands: Organization and structure of the transforming genes of human adenoviruses.
L. T. CHOW, J. B. LEWIS, and T. R. BROKER, Cold Spring Harbor Laboratory, New York: The spliced RNAs of
adenovirus-2 early regions 1A and 2B.
C. C. BAKER and E. B. ZIFF, Department of Molecular Cell Biology, Rockefeller University, New York: 5'
termini or Ad2 early messenger RNAs.
P. A. SHARP, A. J. BERK, F. K. LEE, J. WILLIAMS, and T. HARRISON, Center for Cancer Research, Massachusetts
Institute of Technology, Cambridge: Regulation of early adenovirus mRNA synthesis.
D. J. SPECTOR, D. N. HALBERT, L. D. CROSSLAND, and H. J. RASKAS, Department of Pathology, Washington
University School of Medicine, St. Louis, Missouri: Expression of genes from the transforming region of
adenovirus.
M. C. WILSON and J. E. DARNELL, Department of Molecular Cell Biology, Rockefeller University, New York:
Metabolism of viral mRNA5 in Ad2-transformed and lytically infected cells.
M. GREEN, W. S. M. WOLD, K. BRACKMANN, and M. CARTAS, Institute for Molecular Virology, St. Louis
University School of Medicine, Missouri: Studies on human adenovirus early and transformation proteins.
N. J. LASSAM,* S. T. BAYLEY,* and F. L. GRAHAM,* t Departments of *Biology and +Pathology, McMaster
University, Hamilton, Ontario: Transforming proteins of human adenoviruses-Studies with infected and
transformed cells.
J. B. LEWIS, J. SMART, M. HARTER, H. ESCHE, and M. B. MATHEWS, Cold Spring Harbor Laboratory, New York:
Studies of mRNAs and proteins encoded by the leftmost 30 percent of the genome of group C
adenovi ruses.
S. KVIST, H. PERSSON, L. OSTBERG, O. KAMPE, P. PETERSON, and L. PHILIPSON, Department of Cell Research,
Wallenberg Laboratory, and Department of Microbiology, Biomedical Center, Uppsala University,
Sweden: Molecular association between transplantation antigens and the early adenovirus glycoprotein
E3-19K.
K. FUJINAGA,* Y. SAWADA,* Y. UEMIZU,* H. SHIMOJO,t K. SHIROKI,t H. SUGISAKI,F and M. TAKANAMI,t
*Cancer Research Institute, Sapporo Medical College; +Institute of Medical Science, University of Tokyo;
+Institute for Chemical Research, Kyoto University, Japan: Transforming DNA sequences of highly
oncogenic human adenovirus type 12-Their integrations and transcriptions in transformed cells.
K. SHIROKI,* K. SEGAWA,* I. SAITO,* H. SHIMOJO,* K. FUJINAGA,t Y. MAETA,t and C. HIMADA,t *Institute of
Medical Science, University of Tokyo; +Sapporo Medical College; +Niigata University School of Medi-
cine, Japan: Products of the adenovirus 12 transforming genes and their functions.
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Session 12: src. II.
Chairperson: R. ERIKSON, University of Colorado, Denver
A. R. GOLDBERG, J. G. KRUEGER, and E. WANG, Rockefeller University, New York, New York: Localization
and characterization of the transforming protein of Rous sarcoma virus.
R. R. FRIIS, B. BOSCHEK, B. JOCKUSCH,* A. ZIEMIECKI, H. RUBSAMEN, and H. BAUER, Institut fur Virologie,
Giessen; *European Molecular Biology Laboratories, Heidelberg, Germany: Microfilaments as immediate
targets of the RSV src gene product.
L. R. ROHRSCHNEIDER, Fred Hutchinson Cancer Research Center, Seattle, Washington: Localization of pp605r.
in NRK cells infected with temperature-sensitive mutants (t-class) of Rous sarcoma virus.
I. PASTAN, M. C. WILLINGHAM, N. REICHERT, P. DAVIES, and G. JAY, NCI, National Institutes of Health,
Bethesda, Maryland: Ultrastructural localization of the src gene product to the plasma membrane and
characterization of the immune complex kinase from Schmidt-Ruppin avian sarcoma virus-transformed
cells.
D. ANDERSON,* L. ROHRSCHNEIDER," and M. WEBER,* tFred Hutchinson Cancer Center, Seattle, Washington;
*Department of Microbiology, University of Illinois, Urbana: Properties of some new transformation
mutants of Rous sarcoma virus.
F. LIPMANN and S. DECKER, Rockefeller University, New York, New York: Isolation of a glucose transport
protein from normal chicken fibroblasts that is two to three times more abundant in Rous sarcoma
virus-transformed cells.
M. L. BREITMAN, R. VIGNE, and P. K. VOGT, Department of Microbiology, University of Southern California
School of Medicine, Los Angeles: Focus formation by src deletion mutants of avian sarcoma viruses.
A. LAU,* M. COLLETT,t R. KRZYZEK,* R. ERIKSON,' and A. FARAS,* *Department of Microbiology, University
of Minnesota Medical School, Minneapolis; tDepartment of Pathology, University of Colorado Medical
School, Denver: Biologically active src gene product is present in morphological reverted yet
tumorigenic Rous sarcoma virus-transformed field vole cells.
J. A. WYKE,* J. A. BEAMAND,* and H. E. VARMUS,t *Imperial Cancer Research Fund, London, England;
tuniversity of California Medical School, San Francisco: Factors affecting transformation of rat cells by
avian sarcoma virus and their subsequent reversion.
ASH, R. C. CARROLL, and E. BALL, Department of Biology, University of California, San
Diego: The reversibility of the transformed phenotype in cells infected with a temperature-sensitive Rous
sarcoma virus.
Session 13: The Transformed Cell
Chairperson: L. B. CHEN, Sidney Farber Cancer Center, Boston, Massachusetts
G. J. TODARO and J. E. DE LARCO, NCI, National Institutes of Health, Bethesda, Maryland: Mouse sarcoma
virus (MSV)-transformed cells produce a polypeptide hormone, sarcoma growth factor (SGF), that specifi-
cally binds to membrane receptors for epidermal growth factor (EGF).
D. R. SENGER, D. F. WIRTH, C. BRYANT, and R. 0. HYNES, Department of Biology and Center for Cancer
Research, Massachusetts Institute of Technology, Cambridge: Transformation-dependent secretion of
specific proteins, phosphoproteins, and protein kinase.
G. JAY,* A. B. DELEo,t E. APPELLA,* L. W. LAW,* G. KHOURY,* and L. J. OLD,t *NCI, National Institutes of
Health, Bethesda, Maryland; tMemorial Sloan-Kettering Cancer Center, New York, New York: A com-
mon transformation-related protein in murine sarcomas and leukemias of different etiologies.
D. B. RIFKIN, New York University Medical School, New York: Studies on the control of plasminogen
activator production by transformed cells.
W. F. MANGEL, D. C. LIVINGSTON,* J. R. BROCKLEHURST,* H.-Y. Liu, G. A. PELTZ, J. F. CANNON, S. P. LEYTUS, J.
A. WEHRLY, B. L. SALTER and J. L. MOSHER, Department of Biochemistry, University of Illinois, Urbana;
*Imperial Cancer Research Fund, London, England: A new assay for the plasminogen activator activity of
transformed cells.
R. E. POLLACK, B. M. STEINBERG, and A. Lo, Department of Biological Sciences, Columbia University, New
York, New York: The in vitro tumorigenic syndrome.
K. K. JHA,* E. G. GURNEY,' L. A. FELDMAN,' and H. L. OZER,* *Hunter College, City University of New
York, New York; tDepartment of Biology, University of Utah, Salt Lake City; *Department of Microbiol-
ogy, College of Medicine and Dentistry of New Jersey: Expression of transformation in cell hybrids.
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S. SHIN, A. S. KLEIN, P. KAHN, and R. SIMON, Department of Genetics, Albert Einstein College of Medicine,
Bronx, New York: Tumor formation in nude mice by transformed cells.
P. H. GALLIMORE and C. PARASKEVA, Department of Cancer Studies, University of Birmingham Medical
School, England: A study to determine the reasons for differences in the tumorigenicity of adenovirus 2
and adenovirus 12 transformed rat cell lines.
Session 14: Viruses of Thymic Leukemia
Chairperson: E. SCOLNICK, National Institutes of Health, Bethesda, Maryland
P. V. O'DONNELL, E. STOCKERT, Y. OBATA, A. B. DELEO, and L. J. OLD, Memorial Sloan-Kettering Cancer
Center, New York, New York: MuLV-related cell surface antigens as serological markers of AKR
ecotropic, xenotropic, and dualtropic MuLV.
W. P. RowE, M. W. CLOYD, and J. W. HARTLEY, National Institutes of Health, Bethesda, Maryland: Status of
the association of MCF viruses with leukemogenesis.
M. Li LNG,* J. ROMMELAERE,* N. HOPKINS,* J. W. HARTLEY,' and W. P. ROWE,t *Biology Deparment and
Center for Cancer Research, Massachusetts Institute of Technology, Cambridge; ±National Institutes of
Health, Bethesda, Maryland: Analysis of the genomes of MCF viruses-A progress report.
J. G. SUTCLIFFE, T. M. SHINNICK, R. A. LERNER, and I. VERMA,* Department of Cellular and Developmental
Immunology, Scripps Clinic and Research Foundation, La Jolla; *Salk Institute, San Diego, California: The
nucleic acid sequence of parental and recombinant retroviral envelope (env) genes.
E. FLEISSNER, N. FAMULARI, J.-S. TUNG, and P. V. O'DONNELL, Laboratory of Viral Oncology, Sloan-Kettering
Institute for Cancer Research, New York, New York: Murine leukemia virus env gene expression in
preleukemic thymocytes and leukemia cells of AKR mice.
M. S. MCGRATH, E. PILLEMER, E. PILLEMER, D. A. KOOISTRA, and I. L. WEISSMAN, Department of Pathology,
Stanford University Medical Center, California: Thymotropic MuLV's and T-cell receptors.
Summary: P. SHARP, Massachusetts Institute of Technology, Cambridge
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SUMMER MEETINGS
PDXVIRUS-FROGVIRUS 3, April 23 - April 26
arranged by
Allan Granoff, St. Jude Children's Research Hospital, Memphis, Ten-
nessee
Enzo Paoletti, New York State Department of Health, Albany
40 participants
Session 1: DNA Structure
Chairperson: C.C. RANDALL, University of Mississippi, Jackson
D.L. PANICALI and E. PAOLETTI, New York State Department of
Health, Albany: Heterogeneity in the DNA content of vaccinia
virus (WR strain).
C.F. GARON, E. BARBOSA, and B. Moss, NIAID, National Institutes of
Health, Bethesda, Maryland: Analysis of the DNA sequence
heterology among several poxvirus genomes.
M. MACKETT and L.C. ARCHARD, Department of Virology, St. Mary's
Hospital Medical School, London, England: Restriction endonu-
clease analysis of orthopoxvirus genome structure.
R. WITTEK, H. CHAN, and B. Moss, NIAID, National Institutes of
Health, Bethesda, Maryland: Cloning of vaccinia virus DNA
restriction fragments in col iphage lambda.
E. VIrSUELA, J. KUZNAR, J. ORTIN, M.L. SALAS, A.L. CARRASCOSA, and L.
ENJUANES, Centro de Biologia Molecular (CSIC), Universidad Au-
tonoma, Madrid, Spain: StrOctural components of African swine
fever (ASF) virus.
Session 2: DNA Replication
ig Chairperson: J.R. KATES, State University of New York, Stony Brook
B.G.T. POGO and M. O'SHEA, Center for Experimental Cell Biology,
Mount Sinai School of Medicine, New York, New York: Studies on
vaccinia DNA replication.
G. MCFADDEN and S. DALES, Department of Microbiology and Im-
munology, University of Western Ontario, Canada: Biogenesis of
vaccinia: Characterization of DNA-ts vaccinia mutants.
Session 3: DNA Replication
Chairperson: J.R. KATES, State University of New York, Stony Brook
M.D. CHALLBERG and P.T. ENGLUND, Department of Physiological Chemistry, Johns Hopkins University
School of Medicine, Baltimore, Maryland: Vaccina virus DNA polymerase.
J.A. HOLOWCZAK, College of Medicine and Dentistry, Rutgers Medical School, Piscataway, New Jersey:
Electron microscopic and biochemical studies of Milker's nodule virus.
D. FOGELSONG, E. RESSNER, J. KATES, and W. BAUER, School of Basic Health Sciences, State University of New
York, Stony Brook: Purification and characterization of a vaccinia virus topoisomerase.
D. WILLIS, R. GOORHA, and A. GRANOFF, Division of Virology, St. Jude Children's Research Hospital,
Memphis, Tennessee: Nongenetic reactivation of purified frog virus 3 DNA.
Session 4: Transcription
Chairperson: W.J. JOKLIK, Duke University, Durham, North Carolina
E. BARBOSA, C.F. GARON, and B. Moss, NIAID, National Institutes of Health, Bethesda, Maryland: Transcrip-
tion of the terminal repitition in vaccinia virus DNA.
E. PAOLETTI and B.R. LIPINSKAS, Division of Laboratories and Research, New York State Department of Health,
Albany: Synthesis of low-molecular weight RNA molecules by vaccinia virus in vitro.
Session 5: Transcription
Chairperson: W.J. JOKLIK, Duke University, Durham, North Carolina
E. SPENCER, D. LORING, and J. HURWITZ, Albert Einstein College of Medicine, Bronx, New York: The role of
ATP in RNA synthesis by permeabilized vaccinia virus.
B.M. BAROUDY and B. Moss, NIAID, National Institutes of Health, Bethesda, Maryland: Purification
characterization of DNA-dependent RNA polymerase from vaccinia virions.
S. VENKATESAN and B. Moss, NIAID, National Institutes of Health, Bethesda, Maryland: Modification of the
5'-end of mRNA: Association of RNA triphosphatase activity with purified vaccinia virus RNA
guanylyltransferase-RNA (guanine-7-)-methyltransferase complex.
M. SILVER, G. MCFADDEN, and S. DALES, Department of Microbiology and Immunology, University of
Western Ontario, Canada: Biogenesis of vaccinia: A host transcriptional function is essential for produc-
ing mature virus.
D.E. HRUBY and J.R. KATES, Health Sciences Center, State University of New York, Stony Brook: Vaccinia
virus replication requires active involvement of the host cell nucleus.
R. GOORHA, St. Jude's Childrens Research Hospital, Memphis, Tennessee: Frog virus 3 requires RNA
polymerase II for its replication.
Session 6: Translation
Chairperson: B. Moss, National Institutes of Health, Bethesda, Maryland
D.E. HRUBY, D.L. LYNN, and J.R. KATES, Health Sciences Center, State University of New York, Stony Brook:
Identification of a viral-coded protein in the nucleus of vaccinia virus-infected cells.
R.M. ELLIOTT and D.C. KELLY, NERC Unit of Invertebrate Virology, Oxford, England: Induction and subcellu-
lar location of frog virus 3 specific polypeptides.
R.M. ELLiorr and D.C. KELLY, NERC Unit of Invertebrate Virology, Oxford, England: Cascade regulation of
frog virus 3 induced polypeptides.
D.C. KELLY, R. BRAVO, and R.M. ELLIOTT, NERC Unit of Invertebrate Virology, Oxford, England: Acidic and
basic two-dimensional gel electrophoresis of frog virus 3 induced polypeptides.
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A.N. AUBERTIN, 0. CORDIER, and A. KIRN, INSERM U 74 and Laboratory of Virology, Strasbourg, France:
Influence of temperature on polypeptide synthesis in frog virus 3 infected CHO cells.
R. RAGHOW and A. GRANOFF, Division of Virology, St. Jude Children's Research Hospital, Memphis,
Tennessee: Translation regulation of frog virus 3 mRNAs in vitro.
K. ESSANI and S. DALES, Department of Microbiology and Immunology, University of Western Ontario,
Canada: Biogenesis of vaccinia: Evidence for more than 100 polypeptides in the virion.
J. COOPER and B. Moss, NIAID, National Institutes of Health, Bethesda, Maryland: Characterization and
gene mapping of RNA from vaccinia virus-infected cells by translation in vitro.
Session 7: Genetics
Chairperson: S. DALES, University of West Ontario, London, Canada
R.W. MOYER, Microbiology Department, Vanderbilt University, Nashville, Tennessee: Genetic and biochem-
ical examination of the "white pock" host range mutants of rabbitpox virus.
D.E. HRUBY,* D.L. LYNN,* R.C. CONDIT,t and J.R. KATES,t *Health Sciences Center, State University of New
York, Stony Brook; tSchools of Medicine and Dentistry, State University of New York, Buffalo: Studies on
the mechanism of host range restriction of vaccinia virus.
M.J. ENSINGER, College of Physicians and Surgeons, Columbia University, New York, New York: Isolation and
complementation analysis of temperature-sensitive mutants of vaccinia virus.
R. DRILLIEN, F. KOEHREN, and A. KIRN, INSERM U 74 and Laboratory of Virology, Strasbourg, France:
Preliminary characterization of conditional lethal mutants of vaccinia virus.
Session 8: Virus-Cell Interactions/Miscellaneous
M. SCHROM* and R. BABLANIAN,f *Department of Microbiology and Immunology, Albany Medical College,
New York; 1-Department of Microbiology and Immunology, Downstate Medical Center, State University
of New York, Brooklyn: Studies on the inhibition of protein synthesis by vaccinia virus.
E. PETERHANS, D. SCHUMPERLI, and R. WYLER, Institute of Virology, University of Zurich, Switzerland: Ion
regulation in poxvirus-infected cells.
L.G. PAYNE, Virusinstitutionen, Karolinska Institutet, Stockholm, Sweden: The biology of extracellular vac-
cinia virus.
J. ESPOSITO, E. PALMER, J. OMSK], E. BORDEN, A. HARRISON, and F. MURPHY, Center for Disease Control,
DHEW, Atlanta, Georgia: Studies on the poxvirus cotia.
C. elegans, May 10 - May 13
arranged by
Robert Edgar, University of California, Santa Cruz
Robert Herman, University of Minnesota, St. Paul
John E. Sulston, Medical Research Council, Cambridge, England
William B. Wood, University of Colorado, Boulder
128 participants
Opening Remarks: J. E. SULSTON, Medical Research Council, Cambridge, England
Session 1: Genes and Development. 1.
Chairperson: H. R. HORVITZ, Massachusetts Institute of Technology, Cambridge
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E. SCHIERENBERG and G. VON EHRENSTEIN, Department of Molecular Biology, Max-Planck-Institute for Exper-
imental Medicine, Gottingen, Germany: Embryonic cell lineages and development in C. elegans.
R. CASSADA, E. ISNENGHI, M. CULOTTI, E. SCHIERENBERG, and G. VON EHRENSTEIN, Department of Molecular
Biology, Max-Planck-Institute for Experimental Medicine, Gottingen, Germany: Some recent results with
is embryonic mutants.
E. SCHIERENBERG, J. MIWA, and G. VON EHRENSTEIN, Department of Molecular Biology, Max-Planck-Institute for
Experimental Medicine, Gottingen, Germany: Cell lineages and developmental defects of temperature-
sensitive embryonic arrest mutants in C. elegans.
P. BAZZICALUPO, J. LAUFER, and W. B. WOOD, Department of Molecular, Cellular and Developmental
Biology, University of Colorado, Boulder: The mosaic nature of early development in C. elegans.
Session 2: Genes and Development. II.
Chairperson: R. H. WATERSTON, Washington University School of Medicine, St. Louis, Missouri
J. KIMBLE, I. SULSTON, and J. WHITE, MRC Laboratory of Molecular Biology, Cambridge, England: Regulation
in post-embryonic lineages.
M. CHALFIE,* H. R. HORVITZ,' and J. E. Suts-roN,* *MRC Laboratory of Molecular Biology, Cambridge,
England; ,Department of Biology, Massachusetts Institute of Technology, Cambridge: Mutations which
cause reiteration in cell lineages.
C. FERGUSON and H. R. HORVITZ, Department of Biology, Massachusetts Institute of Technology, Cambridge:
Vulva development in C. elegans.
J. Cox, M. KUSCH, J. POLITZ, and B. EDGAR, Thimann Laboratories, University of California, Santa Cruz:
Biochemical and genetic studies of the C. elegans cuticle.
M. HUSTA and R. M. HECHT, Department of Biophysical Sciences, University of Houston, Texas: Gene-
enzyme systems in C. elegans.
M. M. SWANSON and D. L. RIDDLE, Division of Biological Sciences, University of Missouri, Columbia:
Temperature-sensitive periods of dauer constitutive mutants.
P. M. MENEELY and R. K. HERMAN, Department of Genetics and Cell Biology, University of Minnesota, St.
Paul: X-linked lethals, steriles and deficiencies.
Session 3: Poster Session
N. ABDULKADER and J. BRUN, Laboratoire de Genetique Physiologique et Nematologie, Universite Lyon-I, and
Departement de Biologie Generale et Appliquee, CNRS, Villeurbanne, France: Mutations affecting the
caudal extremity of the C. elegans hermaphrodite.
Y. ARGON, G. NELSON, T. ROBERTS, and S. WARD, Carnegie Institution of Washington, Baltimore, Maryland:
Genetics and morphology of fer mutants sperm.
D. L. BAILLIE, T. M. ROGALSKI, and R. ROSENBLUTH, Department of Biological Sciences, Simon Fraser
University, Burnaby, British Columbia, Canada: Genetic organization in C. elegans:-Lethal analysis of
the unc-23 region.
J. A. BOLLINGER and J. D. WILLETT, Chemistry Department, University of Idaho, Moscow: Establishing age
synchrony in xenic populations of C. elegans-Problems and solutions.
U. CERTA, Department of Molecular Biology, Max-Planck-Institute for Experimental Medicine, Gottingen,
Germany: Changes in metabolism of C. elegans from egg to adult.
M. CHALFIE and J. N. THOMSON, MRC Laboratory of Molecular Biology, Cambridge, England: Microtubule
organization in C. elegans neurons.
J. G. DUCKETT,* R. K. HERMAN+ and R. L. RUSSELL,* *Department of Biological Sciences, University of
Pittsburgh, Pennsylvania; Department of Genetics and Cell Biology, University of Minnesota, St. Paul:
Gene dosage and dosage compensation effects studied with mutations affecting acetylcholinesterase.
D. B. DUSENBERY, School of Biology, Georgia Institute of Technology, Atlanta: Responses of C. elegans to
controlled chemical stimulation.
M. K. EDWARDS and W. B. WOOD, Department of Molecular, Cellular, and Developmental Biology,
University of Colorado, Boulder: In situ hybridization techniques.
A. FODOR, P. DEAR, and I. Kiss, Institute of Genetics, Biological Research Center of Hungarian Academy of
Sciences, Szeged: Competition of insect juvenoid ZR515 and precocene 2 in C. elegans.
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A. FODOR and P. DEAK, Institute of Genetics, Biological Research Center of Hungarian Academy of Sciences,
Szeged: Isolation of new balancer chromosomes of C. elegans.
P. GOLDSTEIN, Department of Genetics, North Carolina State University, Raleigh: Nematode chromosome
analysis by 3-D reconstruction of serial sections and electron microscopy.
P. GOLDSTEIN, Department of Genetics, North Carolina State University, Raleigh: Molecular characterization
of Ascaris suum DNA and of chromatin diminution.
L. GOSSETT and R. M. HECHT, Department of Biophysical Sciences, University of Houston, Texas: Squash
technique for visualization of individual nuclei during embryogenesis.
I. GREENWALD and H. R. HORVITZ, Department of Biology, Massachusetts Institute of Technology, Cambridge:
E1500-A new muscle mutant with unusual genetic properties.
J. S. HAEMER, Department of Molecular, Cellular, and Developmental Biology, University of Colorado,
Boulder: New map distances from old map data.
E. HEDGECOCK, J. SULSTON, M. CHALFIE, and M. DEW, MRC Laboratory of Molecular Biology, Cambridge,
England: Fluorescence microscopy of plant lectin receptors in C. elegans.
B. HENNIG and G. VON EHRENSTEIN, Department of Molecular Biology, Max-Planck-Institute for Experimental
Medicine, Gottingen, Germany: Two isocytochromes c in C. elegans.
R. K. HERMAN,* R. L. RUSSELL,' M. R. CuLcirri,, and J. G. CULOTTI *Department of Genetics and Cell
Biology, University of Minnesota, St. Paul; +Department of Biological Sciences, University of Pittsburgh,
Pennsylvania: Identification of the ace-1 gene by recombination away from a simultaneously occurring
unc-3 allele.
E. J. HESS and H. R. HORVITZ, Department of Biology, Massachusetts Institute of Technology, Cambridge:
Mutants defective in the migrations of the ventral cord precursor cells.
H. R. HORVITZ, Department of Biology, Massachusetts Institute of Technology, Cambridge: Suppression
studies of cell lineage mutants.
E. ISNENGHI, R. CASSADA, M. CULOTTI, E. SCHIERENBERG, and G. VON EHRENSTEIN, Department of Molecular
Biology, Max-Planck-Institute for Experimental Medicine, Gottengen, Germany: Further characterization
of temperature-sensitive embryonic arrest mutants of C. elegans (G set).
T. E. JOHNSON, M. MCAFEE, and W. B. Wool:), Department of Molecular, Cellular, and Developmental
Biology, University of Colorado, Boulder: The generation of genetic mosaics.
I. S. KASS, J. P. WALROND, A. 0. W. STRETTON, and C. C. WANG,* Department of Zoology, Madison,
Wisconsin; *Merck Institute, Rahway, New Jersey: The action of avermectin Bla on Ascaris.
F. R. KHAN and B. A. MCFADDEN, Program in Biochemistry/Biophysics, Washington State University,
Pullman: The glyoxylate cycle in C. elegans.
R. G. KNOWLTON, M. LAUTH, and W. B. W000, Department of Molecular, Cellular, and Developmental
Biology, University of Colorado, Boulder: cDNA probes for C. elegans messenger RNA sequences.
N. C. Lu, G. M. BRIGGS, and E. L. R. STOKSTAD, Department of Nutritional Sciences, University of California,
Berkeley: "Two-carbon" fragments as a growth factor for C. elegans in a completely chemically defined
medium.
J. MADL and B. HERMAN, Department of Genetics and Cell Biology, University of Minnesota, St. Paul:
Polyploids and sex determination.
D. MITCHELL, R. ROSENBERG and L. KOUMIIAN, Boston Biomedical Research Institute, Boston, Massachusetts:
Effects of X-irradiation on longevity and X-ray resistance in C. elegans.
I. MIWA, E. SCHIERENBERG, and G. VON EHRENSTEIN, Department of Molecular Biology, Max-Planck-Institute for
Experimental Medicine, Gottengen, Germany: Genetics, parental effects, and terminal phenotypes of
temperature-sensitive mutations arresting embryonic development in C. elegans.
J. RAND, Department of Biological Sciences, University of Pittsburgh, Pennsylvania: Choline acetyl-
transferase mutants of C. elegans.
D. RIDDLE, Division of Biological Sciences, University of- Missouri, Columbia: A search for cold-sensitive
dauer-constitutive mutants.
D. RIDDLE, M. M. SWANSON, and P. S. ALBERT, University of Missouri, Columbia: Summary of mapped
dauer-constitutive and dauer-defective genes.
T. ROBERTS, Y. ARGON, and S. WARD, Carnegie Institution of Washington, Baltimore, Maryland: Monoclonal
antibodies against surface antigens on C. elegans sperm.
R. L. RUSSELL, C. D. JOHNSON, M. R. CULOTTI, and J. G. CuLoui, Department of Biological Sciences,
University of Pittsburgh, Pennsylvania: Procedure for enzymatic assays with small numbers of worms.
M. SAMOILOFF,* D. BURKE,' S. SCHULZ,* K. DENICH,* and Y. JORDAN,* *Department of Zoology, University
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of Manitoba, Winnipeg, Canada; +Department of Biology, Johns Hopkins University, Baltimore, Mary-
land: The X-chromosome of P. redivivus.
D. SCHMITT, B. YODER, T. COLE, C. KRIEG, E. SCHIERENBERG, R. CASSADA, and G. VON EHRENSTEIN, Department
of Molecular Biology, Max-Planck-Institute for Experimental Medicine, Gottengen, Germany:
Computer-aided analysis for combining light- and electron microscopic data.
D. SCHOMER, J. ORO, E. V. HUNGERFORD,* A. BARTEL, and R. M. HECHT, Departments of Biophysical Sciences
and *Physics, University of Houston, Texas: Zygote defective mutants studied with the flow micro-
fluorometer.
S. S. SIDDIQUI,* G. VON EHRENSTEIN,* and P. BABU,t *Department of Molecular Biology, Max-Planck-
Institute for Experimental Medicine, Gottingen, Germany; +Molecular Biology Unit, Tata Institute of
Fundamental Research, Bombay, India: Genetic mosaics in C. elegans using fluorescent mutants.
S. S. SIDDIQUI,* G. VON EHRENSTEIN,* and P. BABU,t *Department of Molecular Biology, Max-Planck-
Institute for Experimental Medicine, Gottingen, Germany; +Molecular Biology Unit, Tata Institute of
Fundamental Research, Bombay, India: Fluorescent mutants as a tissue specific marker for the intestinal
cells of C. elegans.
T. TRANQUILLA, R. CORTESE, D. MELTON, and J. D. SMITH, MRC Laboratory of Molecular Biology, Cambridge,
England: Cloning and characterization of nematode tRNA.
R. H. WATERSTON and T. R. LANE, Departments of Anatomy and Neurobiology and of Genetics, Washington
University School of Medicine, St. Louis, Missouri: Suppressors in C. elegans.
B. M. ZUCKERMAN and M. A. GEIST, Laboratory of Experimental Biology, University of Massachusetts, East
Wareham: Influence of cultural regime on development and aging of C. briggsae and C. elegans.
Session 4: Sex
Chairperson: D. L. RIDDLE, University of Missouri, Columbia
J. HODGKIN, MRC Laboratory of Molecular Biology, Cambridge, England: Sex determining genes in C.
elegans.
J. B. KIRSCHBAUM, K. K. LEW, and T. 0. Fox, Department of Neuropathology, Harvard Medical School, and
Department of Neuroscience, Children's Hospital Medical Center, Boston, Massachusetts: Steroid hor-
mones and C. elegans.
D. G. ALBERTSON,*' 0. C. NWAROGU,t and J. E. SULSTON,* *MRC Laboratory of Molecular Biology,
Cambridge, England; +Department of Clinical Veterinary Medicine, University of Cambridge, England;
*Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder: Sex
determination by chromatin diminution in Strongyloides papillosus.
S. WARD, Department of Embryology, Carnegie Institution of Washington, Baltimore, Maryland: The acqui-
sition of cellular asymmetry.
G. NELSON, Carnegie Institution of Washington, Baltimore, Maryland: Motility studies of C. elegans sperm.
Y. ARGON, Carnegie Institution of Washington, Baltimore, Maryland: Lectin interaction with sperm.
M. R. KLASS, Department of Molecular, Cellular, and Developmental Biology, University of Colorado,
Boulder: A developmentally regulated sperm protein in C. elegans.
Session 5: Neurobiology
Chairperson: D. G. ALBERTSON, University of Colorado, Boulder
H. R. HoRvrrz,* J. SULSTON,t and J. WHITE,* *Department of Biology, Massachusetts Institute of Technol-
ogy, Cambridge; 5MRC Laboratory of Molecular Biology, Cambridge, England: The structure and
function of the C. elegans egg-laying system.
J. A. LEWIS, Department of Biological Sciences, Columbia University, New York: Levamisole-resistant
mutants.
J. E. DONMOYER, P. A. DESNOYERS, and A. 0. W. STRETTON, Department of Zoology, University of Wisconsin,
Madison: Synaptic interactions in the ventral nerve cord of Ascaris.
J. P. WALROND, J. E. DONMOYER, P. A. DESNOYERS, and A. 0. W. STRETTON, University Of Wisconsin,
Madison: How single excitatory motorneurons control zones of inhibition.
C. D. JOHNSON, Department of Zoology, University of Wisconsin, Madison: Localization of separable forms
of acetylcholinesterase in Ascaris tissues.
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C. D. JOHNSON and D. WHEATON, Department of Zoology, University of Wisconsin, Madison: Localization of
choline acetyltransferase in Ascaris tissues.
J. G. CULOTTI,* C. D. JOHNSON,' R. L. RUSSELL,' and G. VON EHRENSTEIN,* *Department of Molecular
Biology, Max-Planck-Institute for Experimental Medicine, Gottingen, Germany; +Department of Life
Sciences, University of Pittsburgh, Pennsylvania: Acetylcholinesterase mutants of C. elegans.
R. L. RUSSELL, J. B. RAND, J. G. DUCKETT, W. M. BLACKBURN, and J. G. CULOTTI, Department of Biological
Sciences, University of Pittsburgh, Pennsylvania: Further genetic and physical separation of multiple
acetylcholinesterase forms.
Session 6: Muscle
Chairperson: D. B. DUSENBERY, Georgia Institute of Technology, Atlanta
R. H. WATERSTON,* S. PLEURAD,* and J. N. THOMSON,' *Departments of Anatomy and Neurobiology and of
Genetics, Washington University School of Medicine, St. Louis, Missouri; +MRC Laboratory of Molecular
Biology, Cambridge, England: Genes affecting muscle structure.
R. H. WATERSTON and K. C. SMITH, Departments of Anatomy and Neurobiology and of Genetics, Washington
University School of Medicine, St. Louis, Missouri: Organization of the unc-54 I myosin heavy chain
gene.
J. M. ZENGEL, S. HOUTS, D. C. REIN, and H. F. EPSTEIN, Department of Neurology, Baylor College of Medicine,
Houston, Texas: A genetic analysis of 118 new body-wall muscle-defective mutants of C. elegans.
P. ANDERSON and S. BRENNER, MRC Laboratory of Molecular Biology, Cambridge, England: A positive
selection for unc-54 myosin heavy chain mutants-Deletion analysis of the surrounding chromosomal
region.
D. G. MOERMAN, D. POPHAM, and D. L. BAILLIE, Department of Biological Sciences, Simon Fraser University,
Burnaby, British Columbia, Canada: An analysis of the unc-22 region in C. elegans.
A. M. ROSE and D. L. BAILLIE, Department of Bioscience, Simon Fraser University, Burnaby, British Columbia,
Canada: Analysis of the region around the gene for paramyosin.
Session 7: DNA and RNA
Chairperson: D. L. BAILLIE, Simon Fraser University, Burnaby, British Columbia, Canada
S. EMMONS and M. KLASS, Department of Molecular, Cellular, and Developmental Biology, University of
Colorado, Boulder: Comparison of DNA sequences from C. elegans var Bristol germ-line and somatic
line cells, and from C. elegans var Bergerac and C. briggsae.
S. EMMONS, S. CARR, K. JOHNSON, and D. HIRSH, Department of Molecular, Cellular, and Developmental
Biology, University of Colorado, Boulder: Placing restriction fragments on the genetic map.
J. KARN, S. BRENNER, and G. CESARENI, MRC Laboratory of Molecular Biology, Cambridge, England: Con-
struction of phage and plasm id libraries representing the C. elegans genome.
J. FILES, Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder:
Ribosomal DNA of C. elegans.
A. R. MACLEOD and J. KARN, MRC Laboratory of Molecular Biology, Cambridge, England: Characterization of
the unc-54 myosin heavy chain messenger RNA.
M.-A. GIBERT and J. STARCK, Laboratoire de Genetique Physiologique et Nematologie, and Departement de
Biologie Generale et Appliquee, CNRS, University Lyon-I, Villeurbanne, France: RNA synthesis during C.
elegans oogenesis.
THE CYTOSKELETON: MEMBRANES AND MOVEMENT, May 16 May 20
arranged by
John Condeelis, Albert Einstein College of Medicine, New York, New York
Peter Satir, Albert Einstein College of Medicine, New York, New York
Keith Burridge, Cold Spring Harbor Laboratory, New York
255 participants
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Session 1: Dynein and Ciliary Motility
Chairperson: P. SATIR, Albert Einstein College of Medicine, New York, New York
F. D. WARNER and D. R. MITCHELL, Department of Biology, Syracuse University, New York: Dynein cross
bridges and force production in Tetrahymena cilia.
Y. YANO, H. MOHRI,* and T. MIKI-NOUMURA, Department of Biology, Ochanomizu University, Tokyo;
*Department of Biology, University of Tokyo, Japan: Recovery of tubule-extrusion ability in the
axonemes recombined with extracted dynein 1 after removal of outer arms or both arms.
J. J. BLUM and M. HINES, Department of Physiology, Duke University School of Medicine, Durham, North
Carolina: Some properties of a self-consistent three-state model of dynein cross bridges.
V. PALLINI, Institute of Zoology, University of Siena, Italy: Studies on mammalian dynein.
B. BACCETFI, Institute of Zoology, University of Siena, Italy: Comparative study of the relationship between
dynein HMW polypeptides and axonemal structures.
R. HIEBSCH and D. MURPHY, Department of Cell Biology and Anatomy, Johns Hopkins Medical School,
Baltimore, Maryland: Evidence for a dynein-like ATPase on cytoplasmic microtubules.
E. T. ROSENTHAL* and R. W. Li Nact *Cell and Developmental Biology Program, and tDepartment of
Anatomy, Harvard Medical School, Boston, Massachusetts: Sequence-specific patterns of doublet micro-
tubule sliding in dynein-mediated disintegration of rat sperm flagella.
K. TAKAHASHI, S. KAMIMURA, and Y. MOGAMI, Zoological Institute, University of Tokyo, Hongo, Japan:
Cinematographic analysis of microtubule sliding in cilia and flagella.
S. F. GOLDSTEIN, C. BESSE, and J. SCHRLVEL, Laboratoire de Zoologie et Biologie Cellulaire et SGMEAB,
Poitiers Cedex, France: Motility of a "6 + 0" flagellum.
S. TAMM, Laboratory of Molecular Biology and Department of Zoology, University of Wisconsin, Madison:
Calcium-dependent ciliary reversal in ctenophore larva-Relation to axonemal structures.
C. K. OMOTO and C. KUNG, Laboratory of Molecular Biology, University of Wisconsin, Madison: Central
pair of microtubules in paramecium cilia-Evidence for rotation and twist during the beat cycle.
R. W. TUCKER and A. B. PARDEE, Sidney Farber Cancer Institute, Boston, Massachusetts: Centriole ciliation is
related to quiescence and DNA synthesis in 3T3 cells.
D. SANDOZ, E. BOISVIEUX-ULRICH, and B. CHAILLEY, Centre de Cytologie Experimentale, CNRS, Ivry, France:
Cytochemical characterization of intramembrane parcticles associated with microfilaments linked to
microtubules in cilia.
Session 2: Microtubules-Polarity and Nucleation
Chairperson: B. R. BRINKLEY, Baylor College of Medicine, Houston, Texas
J. C. BULINSKI and G. G. Bo Rim, Laboratory of Molecular Biology, University of Wisconsin, Madison:
Comparison of microtubule protein in mitotic and interphase cells.
T. C. S. KELLER III and L. I. REBHUN, Department of Biology, University of Virginia, Charlottesville: Studies of
tubulin from mitotic apparatuses isolated with and without glycerol.
M. DE BRABANDER,* G. GEUENS,* J. DE MEY,* and M. JoNi AO- *Janssen Pharmaceutica, Beerse; 1-Catholic
University of Leuven, Kortrijk, Belgium: Nucleated assembly of microtubules in living mitotic PTK2-cells.
L. G. BERGEN, R. KURIYAMA, and G. G. BORISY, Laboratory of Molecular Biology, University of Wisconsin,
Madison: Polarity of centrosomal microtubules.
B. R. BRINKLEY, S. M. Cox, and D. A. PEPPER, Department of Cell Biology, Baylor College of Medicine,
Houston, Texas: Cytoplasmic microtubule assembly sites in mammalian cells.
B. M. SPIEGELMAN,t M. LOPATA,* D. RING,* and M. KIRSCHNER,* *Department of Biochemistry and Biophysics,
University of California, San Francisco; +Department of Biology, Massachusetts Institute of Technology,
Cambridge: Initiation sites for microtubule assembly in interphase mammalian cultured cells.
R. VALLEE, Worcester Foundation for Experimental Biology, Shrewsbury, Massachusetts: Isolation of the
portion of map-2 that promotes microtubule assembly.
A. H. LOCKWOOD, Cancer Research Center and Department of Anatomy, Cell Biology Laboratories, Univer-
sity of North Carolina Medical School, Chapel Hill: Purification and relationship of several assembly
proteins present in microtubules.
R. L. MARGOLIS and L. WILSON, Department of Biological Sciences, University of California, Santa Barbara:
Regulation of the microtubule steady state in vitro by ATP.
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P. B. SCHIFF and S. B. HORWITZ, Departments of Cell Biology and Molecular Pharmacology, Albert Einstein
College of Medicine, Bronx, New York: Taxol stabilizes cytoplasmic microtubules in mouse fibroblasts.
J. M. CARON and R. D. BERLIN, University of Connecticut Health Center, Farmington: Interaction of
microtubule proteins with phospholipid vesicles.
I. GOZES and U. Z. LITTAUER, Neurobiology Department, Weizmann Institute of Science, Rehovot, Israel: The
a-subunit of tubulin is preferentially associated with brain synaptic membranes.
D. SOIFER and H. CZOSNEK, Institute for Basic Research in Mental Retardation, Staten Island, New York:
Tubulin synthesis on membrane-bound polyribosomes-Incorporation of newly synthesized tubulin into
microsomal membranes.
Session 3: Actin Polymerization
Chairperson: F. 00SAWA, Osaka University, and Institute of Molecular Biology, Nagoya University, Japan
J. PARDEE and J. A. SPUDICH, Sherman Fairchild Center, Stanford University School of Medicine, California:
Role of ions and nucleotide in the conformation and assembly of actin from Dictyostelium discoideum.
H. HARRIS, J. BAMBURG, and A. G. WEEDS, MRC Laboratory of Molecular Biology, Cambridge, England:
Depolymerization of actin filaments by extracellular and intracellular proteins.
L. CARLSSON, F. MARKEY, I. BLIKSTAD, T. PERSSON, and U. LINDBERG, Wallenberg Laboratory, Uppsala Univer-
sity, Sweden: Reorganization of actin in platelets stimulated by thrombin, as measured by the DNase
inhibition assay.
L.-E. NYSTROM, B. MALM, and U. LINDBERG, Wallenberg Laboratory, Uppsala, Sweden: Properties of the
profi I in:actin complex.
S. LIN, Department of Biophysics, Johns Hopkins University, Baltimore, Maryland: Motility-related high-
affinity cytochalasin binding complexes are powerful inducers of actin polymerization.
M. GRUMET, Department of Biophysics, johns Hopkins University, Baltimore, Maryland: Regulation of actin
polymerization induced by high affinity cytochalasin binding complex from platelets.
Session 4: Actin Cytoskeleton
Chairperson: K. R. PORTER, University of Colorado, Boulder
K. T. EDDS, Marine Biological Laboratory, Woods Hole, Massachusetts: Coelomocyte cytoskeletons vs egg
actin gels-Similar components?
R. R. WEIHING, Worcester Foundation for Experimental Biology, Shrewsbury, Massachusetts: Cytoskeletal
proteins and plasma membranes of He La cells.
J. CONDEELIS, Department of Anatomy, Albert Einstein College of Medicine, Bronx, New York: Isolation of
two gelation factors from the amoeboid stage of Dictyostelium discoideum.
M. H. ELLISMAN* and K. R. PORTER,' *Department of Neurosciences, University of California, San Diego;
"Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder: New
techniques for revealing the cytoskeleton of axoplasm and the effects of CA++ upon its organization.
W. IP and D. A. FISCHMAN, Department of Anatomy and Cell Biology, State University of New York
Downstate Medical Center, Brooklyn: Analysis of cytoskeletal networks by high resolution scanning
electron microscopy.
J. M. MACKENZIE, JR. and H. F. EPSTEIN, Departments of Neurology and Biochemistry, Baylor College of
Medicine, Houston, Texas: A novel approach to electron microscopy of myosin filaments.
J. HEUSER* and M. KIRSCHNER,t *Department of Physiology, and "Department of Biochemistry and
Biophysics, University of California, San Francisco: 3D visualization of the filamentous cytoskeleton in
triton-extracted freeze dried fibroblasts.
R. D. ALLEN, L. R. ZACHARSKI, S. WIDIRSTKY, and L. ZAITLIN, Department of Biological Sciences, Dartmouth
College, Hanover, New Hampshire: Cytoskeletal structure and platelet motility.
N. S. ALLEN and G. C. RUBEN, Department of Biological Sciences, Dartmouth College, Hanover, New
Hampshire: Cryopreservation of the cytoskeleton of Nitella furcata.
S. HIGASHI-FUJIME, Institute of Molecular Biology, Nagoya University, Japan: Active movement in vitro of
.
cytoplasmic fibers isolated from Nitella.
F. OOSAwA, Department of Biophysical Engineering, Osaka University, and Institute of Molecular Biology,
Nagoya University, Japan: Motility of actin filaments.
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I. M. HERMAN, N. CRISONA, and T. POLLARD, Department of Cell Biology and Anatomy, Johns Hopkins
University Medical School, Baltimore, Maryland: Simultaneous localization of actin and myosin by
double antibody staining.
D. DRENCKHAHN, Department of Anatomy, University of Kiel, Germany: Immunocytochemical localization
of myosin and tropomyosin in various epithelial cells of ectodermal and entodermal origin.
J. R. FALLON and V. T. NACHMIAS, Department of Anatomy, University of Pennsylvania School of Medicine,
Philadelphia: Skeletal and cytoplasmic myosins in myotubes.
Session 5: Regulation of Cytoplasmic Structure
Chairperson: M. CLARKE, Albert Einstein College of Medicine, New York, New York
J. M. SCHOLEY and I. KENDRICK-JONES, MRC Laboratory of Molecular Biology, Cambridge, England: Myosin
linked regulation of actin-myosin interaction in bovine thymus and thymocytes.
S. CHACKO, Department of Pathobiology, University of Pennsylvania, Philadelphia: Phosphorylation and
actin-activated ATPase activity of vascular smooth muscle myosin.
A. SEN and G. J. TODARO, National Cancer Institute, Bethesda, Maryland: Mouse sarcoma virus particles
contain a low molecular weight (-15K) protein kinase that is cAMP-independent and that binds to actin.
L. J. VAN ELDIK, Rockefeller University, New York, New York: Phosphorylation and calmodulin-stimulated
activities.
D. K. JEMIOLO, T. C. S. KELLER III, W. H. BURGESS, and L. I. REBHUN, Department of Biology, University of
Virginia, Charlottesville: Tubul in-CDR interactions.
W. H. BURGESS, D. K. JEMIOLO, and R. H. KRETSINGER, Department of Biology, University of Virginia,
Charlottesville: Interaction of calmodulin and Cat, in the presence of SDS.
M. CLARKE, S. C. KAYMAN, and W. L. BAZARI, Department of Molecular Biology, Albert Einstein College of
Medicine, Bronx, New York: Isolation and characterization of a calcium-dependent regulator protein
from Dictyostelium discoideum.
W. DRABIKOWSKI and J. Ku2NlicKi, Department of Nervous System and Muscle, Nencki Institute of Exper-
imental Biology, Warsaw, Poland: Characterization of calmodulin from Physarum polycephalum.
E. ZUBRZYCKA, L. KuZt-iicKi, and W. DRABIKOWSKI, Nencki Institute of Experimental Biology,
Warsaw, Poland: Properties of microsomal fraction from Physarum polycephalum.
M. S. RUNGE,* P. B. HEWGLEY,' D. PUETT,' and R. C. WILLIAMS, JR.,* *Department of Molecular Biology, and
'Department of Biochemistry, Vanderbilt University, Nashville, Tennessee: Cyclic nucleotide phos-
phodiesterase activity in neurofilament preparations from bovine brain.
W. W. SCHLAEPFER, Department of Pathology, University of Pennsylvania, Philadelphia: The breakdown of
mammalian neurofilaments and its mediation by calcium and a soluble tissue factor.
P. A. M. EAGLES and D. S. GILBERT, Kings College, London University, England: The phosphorylation of
neurofilament proteins.
F. CABRAL and M. M. GOTTESMAN, National Institutes of Health, Bethesda, Maryland: Phosphorylation of 10
nm filament protein in CHO cells.
Session 6: Poster Sessions
Actin Cytoskeleton
P. J. ANDERSON, Department of Biochemistry, University of Ottawa, Ontario, Canada: Determination of actin
and tubulin in cells and tissues.
R. A. BADLEY, J. R. COUCHMAN and D. A. REES, Unilever Research, Colworth House, Bedford, United
Kingdom: Cytoskeletons, adhestion, and cell locomotion.
R. D. GOLDMAN and J. TALIAN, Department of Biological Sciences, Carnegie-Mellon University, Pittsburgh,
Pennsylvania: Adhesion plaques of nonmuscle cells are analogous to z-lines-The localization of an
a-actinin-like protein.
A. MILSTED, S. E. HITCHCOCK, and R. D. GOLDMAN, Department of Biological Sciences, Carnegie-Mellon
University, Pittsburgh, Pennsylvania: Alterations in contractile protein organization and cell locomotion
in aging cells.
S. S. BROWN and J. A. SPUDICH, Sherman Fairchild Center, Stanford University School of Medicine, Califor-
nia: Role of ATP in the nucleation of actin assembly by polylysine-coated beads.
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P. B. BELL, JR. and J.-P. REVEL, Division of Biology, California Institute of Technology, Pasadena: Cytochala-
sin-B-induced changes in the distribution of the triton-insoluble cytoskeleton.
S. T. BRADY,* and W. 0. MCCLURE,t *Department of Anatomy, Case Western Reserve University, Cleve-
land, Ohio; tDepartment of Biological Sciences, University of Southern California, Los Angeles: An-
timitotic drugs and axonal transport in the absence of microtubules.
F. C. S. RAMAEKERS,* A. M. E. SELTEN-VERSTEEGEN,* E. KATZ,t and H. BLOEMENDAL,* *Department of
Biochemistry, University of Nijmegen, The Netherlands; 'Department of Biology, University of Stony
Brook, New York: Cytoskeletal elements in elongating cultured bovine lens cells-Structural and
biosynthetic aspects.
M. PEARL,* and A. TAYLOR,' *Department of Physiology, Mt. Sinai School of Medicine; tDepartment of
Physiology, Cornell Medical College, New York, New York: Actin-like protein in toad bladder epithelium
and in situ labeling with HMM.
D. PAULIN and M. YANIV, Institut Pasteur, Paris, France: Changes of cytoskeleton organization upon
differentiation of mouse embryonic cells in vitro and in vivo.
J. TANNENBAUM, Biology Department, Massachusetts Institute of Technology, Cambridge: Effect of
cytochalasin D (CD) on the distribution of cytoskeletal proteins in chick embryo fibroblasts (CEF).
R. W. RUBIN, R. H. WARREN, and C. L. LEONARDI, Department of Anatomy, University of Miami, Florida:
Cytoskeleton-associated proteins in normal and transformed cells.
E. BELL, C. MERRILL, and B. IVARSSON, Department of Biology, Massachusetts Institute of Technology,
Cambridge: A tissue-equivalent assay system for studying fibroblast contractility.
T. M. PRESTON and C. A. KING, Department of Zoology, University College London, England: The use of
reflexion interference microscopy in the study of amoeboid locomotion and cell-substrate interactions.
D. E. KELLY and A. M. KUDA, Department of Anatomy, University of Southern California School of Medicine,
Los Angeles: Freeze-fracture analysis of desmosomal and triadic junctions.
Y. FUKUI and J. T. BONNER, Department of Biology, Princeton University, New Jersey: Dimethyl-sulfoxide-
induced multinucleation and novel nuclear division in Dictyostelium cells.
M. WALSH, L. JOHNSON, and L. B. CHEN, Sidney Farber Cancer Institute, Harvard Medical School, Boston,
Massachusetts: Use of Rhodamine-mit, a mitochondria-specific probe, to reflect possible cytoskeletal
alteration in living cells.
K. WANG, Clayton Foundation Biochemical Institute and Department of Chemistry, University of Texas,
Austin: Novel myofibrillar proteins of striated muscles.
Genetic Approaches and Morphogenesis
J. M. ZENGEL, S. Hours, D. C. REIN, and H. F. EPSTEIN, Department of Neurobiology, Baylor College of
Medicine, Houston, Texas: 118 body-wall muscle-defective mutants of C. elegans.
F. CABRAL and M. M. GOTTESMAN, National Institutes of Health, Bethesda, Maryland: 13- tubulin mutants of
CHO cells.
B. R. OAKLEY and N. R. MORRIS, Department of Pharmacology, Rutgers Medical School, Piscataway, N6w
Jersey: Genetic evidence that nuclear movement in Aspergillus is microtubule-dependent.
N. R. MORRIS, Department of Pharmacology, Rutgers Medical School, Piscataway, New Jersey: The genetics
of resistance to antimitotic drugs in Aspergillus nidulans.
D. L. KIRK, Department of Biology, Washington University, St. Louis, Missouri: Cytoskeletal mediation of
morphogenesis in Vo lvox-I. Introduction.
K. J. GREEN, Department of Biology, Washington University, St. Louis, Missouri: Cytoskeletal mediation of
morphogenesis in Volvox -II. Cleavage.
G. I. VIAMONTES, Department of Biology, Washington University, St. Louis, Missouri: Cytoskeletal mediation
of morphogenesis in Volvox-III. Inversion.
W. S. LYNN, C. MUKHERJEE, and B. FREEMAN, Department of Biochemistry, Duke University, Durham, North
Carolina: Hydrophobic anion transport and leukocyte motility.
G. THOMAS, M. SIEGMANN, A. M. KUBLER, J. GORDON, and L. JIMINEZ DE ASUA, Friedrich Miescher-Institut,
Basel, Switzerland: Ribosomal protein S6 phosphorylation, protein synthesis and cAMP.
Intermediate Filaments
E. FUCHS and H. GREEN, Department of Biology, Massachusetts Institute of Technology, Cambridge: Multiple
keratins of cultured human epidermal cells are translated from different messenger RNA molecules.
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M. S. RUNGE,* W. W. SCHLAEPFER,t and R. C. WILLIAMS, JR.,* *Department of Molecular Biology, Vanderbilt
University, Nashville, Tennessee; +University of Pennsylvania, Philadelphia: Isolation of neurofilaments
from mammalian brain.
F.-C. CHID, B. KOREY, J. E. GOLDMAN, and W. T. NORTON, Albert Einstein College of Medicine, Bronx, New
York: Intermediate filament proteins from mammalian nervous system.
E. WANG and S. C. SILVERSTEIN, Rockefeller University, New York, New York: The distribution of 10 nm
filaments and lysosomes in phorbal myristrate acetate treated mouse peritoneal macrophages.
E. BORENFREUND, P. J. HIGGINS, and A. BENDICH, Memorial Sloan-Kettering Cancer Center, New York, New
York: In vitro studies of a cytoskeletal abnormality in rat liver cells induced in vivo by a carcinogen.
B. ASCH,* C. LEONARDO N. BURSTEIN,* and R. RUBINT *Department of Pathology, Beth Israel Hospital, and
Harvard Medical School, Boston, Massachusetts; +Department of Anatomy, University of Miami School
of Medicine, Florida: Are cytoskeletal models from different nonmuscle cell types identical or unique?
K. RYBICKA, Cardiology Department, US Public Health Service Hospital, Staten Island, New York: Associa-
tion of 100 A filaments with glycosomes in the heart.
H. CZOSNEK, D. SOIFER, and H. M. WISNIEWSKI, Institute for Basic Research in Mental Retardation, Staten
Island, New York: The biosynthesis of filamentous proteins in rabbit spinal cord: Cell-free and in vivo
studies.
D. L. GARD, P. B. BELL, and E. LAZARIDES, Division of Biology, California Institute of Technology, Pasadena:
Coexistence of desmin and the fibroblastic intermediate filament subunit in muscle and nonmuscle cells:
Identification and comparative peptide analysis.
Tubulin
M. M. BLACK and L. A. GREENE, Department of Neuroscience, Children's Hospital Medical Center, Boston,
Massachusetts: Tubulin accumulation and organization in chick sympathetic neurons during nerve-
growth-factor-stimulated neurite outgrowth.
K. A. ROGERS, C. R. RUDD, J. G. KAPLAN, and D. L BROWN, Department of Biology, University of Ottawa,
Canada: Colchicine effects on microtubules and commitment of lymphocytes.
I. II and L. I. REBHUN, Department of Biology, University of Virginia, Charlottesville: Regulation of
polymerizability of tubulin via a mixed disulfide of tubulin-SH with glutathione.
L. I. REBHUN and R. WANG, Department of Biology, University of Virginia, Charlottesville: Reversible
inhibition of tubulin polymerization by formation of intrasubunit disulfides.
H. KIM and L. I. REBHUN, Department of Biology, University of Virginia, Charlottesville: Further analysis of
MAP2:tubulin interaction in brain microtubule assembly in vitro.
M. CAPLOW, B. ZEEBERG, and L. JAMESON, Department of Biochemistry, University of North Carolina, Chapel
Hill: Quantitative analysis of GDP and GTP involvement in microtubule assembly and disassembly.
R. A. B. KEATES and G. B. MASON, Department of Chemistry, University of Guelph, Ontario, Canada:
Analysis of the kinetics of inhibition of microtubule polymerization by colchicine and griseofulvin.
E. MANDELKOW and E. MANDELKOW, Max-Planck-Institute for Medical Research, Heidelberg, Germany:
Correlation between structural polarity and polarity of assembly of tubulin.
F. GASKIN, Department of Pathology, Albert Einstein College of Medicine, Bronx, New York: In vitro tubulin
assembly regulation by divalent cations and nucleotides.
J. MOLE-BAJER and A. S. BAJER, Department of Biology, University of Oregon, Eugene: Experimental modifi-
cation of microtubule assembly-disassembly as reflected in chromosome movements and spindle fine
structure.
B. S. ECKERT, S. J. KOONS,* and A. W. SCHANTZ, Department of Anatomical Sciences and *Department of
Biophysical Sciences, School of Medicine, State University of New York, Buffalo: Cytoskeleton-
associated proteins in cultured mammalian cells.
W. D. COHEN, Department of Biological Sciences, Hunter College, New York, New York: Cytoskeletal
structure in anucleate nonmammalian erythrocytes.
R. B. LUFTIG, B. MILES, D. LEAFFER, J. A. WEATHERBEE, and R. R. WEIHING, Worcester Foundation for
Experimental Biology, Shrewsbury, Massachusetts: Adenovirus and reovirus associations with mi-
crotubules inside infected cells.
K. R. HINDS and N. W. SEEDS, Department of Biochemistry, Biophysics and Genetics, University of Colorado
Medical Center, Denver: Characterization of the microtubule assembly-promoting factor in differentiated
neuroblastoma cells.
105
R. WEISENBERG, Department of Biology, Temple University, Philadelphia, Pennsylvania: Cooperative
oligomer addition model for microtubule assembly.
D. A. PEPPER and B. R. BRINKLEY, Department of Cell Biology, Baylor College of Medicine, Houston, Texas:
Site-specific microtubule nucleation in lysed mitotic cells-Inhibition by tubulin antibody.
Session 7: Cell Surface Dynamics
Chairperson: J. CONDEELIS, Albert Einstein College of Medicine, New York, New York
R. G. W. ANDERSON,* J. L. GOLDSTEIN,t and M. S. BROWN,t Department of Cell Biology, and +Department of
Molecular Genetics, University of Texas Health Science Center, Dallas: Relationship of low density
lipoprotein binding sites to the distribution of coated surface regions of membrane in human fibroblasts.
W. S. BLoom,* K. L. FIELDS,T S. H. YEN,T W. SCHOOK,* and S. PuszKIN,* *Department of Pathology, Mount
Sinai School of Medicine, City University of New York; +Department of Pathology, Albert Einstein
College of Medicine, Bronx, New York: Brain clathrin-Immunofluorescent studies on fibroblasts, brain
tissue sections and brain cell cultures.
P. DAVIES, D. DAVIES, F. MAXFIELD, A. LEVITZKI, P. MILHAUD, M. WILLINGHAM, and I. PASTAN, NCI, National
Institutes of Health, Bethesda, Maryland: Receptor-mediated endocytosis, transglutaminase and the
microfilament mat.
J. SALISBURY, J. CONDEELIS, and P. SATIR, Department of Anatomy, Albert Einstein College of Medicine, Bronx,
New York: Isolation of structures involved in capping and endocytosis of lg-lgM complexes in cultured
human B lymphocytes.
K. BURRIDGE, J. FERAMISCO, and S. BLOSE, Cold Spring Harbor Laboratory, New York: Association of a-actinin
and clathrin with the plasma membrane.
T. F. ROTH, M. P. WOODWARD, and C. LINDEN, Department of Biological Sciences, University of Maryland
Baltimore County, Catonsville: Coated vesicles-Subcellular organelles involved in vectorial movement
of sequestered proteins.
W. SCHOOK, E. FEAGESON, W. S. BLOOM, C. ORES, and S. PUSZKIN, Department of Pathology, Mount Sinai
School of Medicine, City University of New York: Properties of the clathrin complex that forms in vitro
ultrastructural assemblies of baskets And filamentous bundles.
B. M. JOCKUSCH, European Molecular Biological Laboratories, Heidelberg, Germany: Association of a-
actinin with cell membranes.
G. GABBIANI,* D. HOESSLI,* E. RUNGGER-BRANDLE,* and B. M. fOCKUSCH,T *Department of Pathology,
University of Geneva, Switzerland; +European Molecular Biology Laboratories, Heidelberg, Germany:
Lymphocyte a-actinin-Relationship with cell membrane and co-capping with surface receptors.
K. L. CARRAWAY, R. C. Doss, J. W. HUGGINS, and C. A. CAROTHERS, Department of Biochemistry, Oklahoma
State University, Stillwater: Effects of cytoskeletal perturbants on the cooperativity of the inhibition of
ecto 5'-nucleotidase by concanaval in A in 13762 ascites rat mammary adenocarcinoma cells.
R. M. EVANS,* D. C. WARD,* and L. M. FINK,' *Department of Human Genetics, Yale University School of
Medicine, New Haven, Connecticut; +Department of Pathology, University of Colorado Medical School,
Denver: Characterization of transmembrane proteins in phagolysosomes prepared from cultured mouse
L-929 cells.
D. A. M. MESLAND and U. W. GOODENOUGH, Department of Biology, Washington University, St. Louis,
Missouri: Flagellar tip activation during Chlamydomonas mating.
R. A. BLOODGOOD, Department of Anatomy, Albert Einstein College of Medicine, Bronx, New York: Effect of
inhibition of protein synthesis on Chlamydomonas flagellar adhesiveness and flagellar surface motility.
Session 8: Intermediate Filaments
Chairperson: R. D. GOLDMAN, Carnegie-Mellon University, Pittsburgh, Pennsylvania
W. W. FRANKE,* E. SCHMID,* M. OSBORN,t K. WEBER,t C. FREUDENSTEIN,* and B. APPELHANS,* *Division of
Membrane Biology and Biochemistry, Experimental Pathology, German Cancer Research Center, Heidel-
berg; +Max-Planck-Institute for Biophysical Chemistry, Gottingen, Germany: Occurrence and modes of
arrangement of different types of intermediate-sized filaments in tissues and cells.
T.-T. SUN,* A. VIDRICH,* C. SHIH,T and H. GREEN,T *Departments of Dermatology and of Cell Biology and
Anatomy, Johns Hopkins Medical School, Baltimore, Maryland; +Department of Biology, Massachusetts
Institute of Technology,-Cambridge: Keratin cytoskeletons in epithelial cells of internal organs.
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R. K. H. LIEM, J. F. LETERRIER, and M. L. SHELANSKI, Department of Pharmacology, New York University School
of Medicine, New York: Interactions between neurofilaments, microtubules and microtubule-associated
proteins.
B. H. ANDERTON,* R. THORPE,* J. COHEN,t and P. WOODHAMS,' *Chelsea College, University of London;
+University College London; 5MRC Developmental Neurobiology Unit, Institute of Neurology, London,
England: Identity of neurofilament polypeptides.
J. R. MORRIS and R. J. LASEK, Department of Anatomy and Neurobiology Center, Case Western Reserve
University, Cleveland, Ohio, and Marine Biological Laboratory, Woods Hole, Massachusetts: Differential
solubilities of cytoskeletal proteins in squid axoplasm.
E. D. FRANK,* G. P. TUSZYNSKI,T and L. WARREN,* *Wistar Institute, Philadelphia; +Thrombosis Center,
Temple University, Philadelphia, Pennsylvania: Classes of 10 nm filament proteins.
K. L. FIELDS* and S.-H. YEN,t *Departments of Neurology, Neuroscience and +Pathology, Albert Einstein
College of Medicine, Bronx, New York: Antibodies to neurofilament, glial filament and fibroblast
intermediate filament proteins bind to different cell types of the nervous system.
V. I. KALNINS, L. SUBRAHMANYAN, A. PORIETIS, and A. 0. JORGENSEN, Department of Anatomy, University of
Toronto, Canada: Distribution of 54,000 m.w. protein of 10 nm filaments isolated from calf brain.
S. H. BLOSE, Cold Spring Harbor Laboratory, New York: 10 nm filaments and mitosis-Maintenance of
structural continuity in dividing endothelial cells.
H. HOLTZER, Y. TOYAMA, G. BENNETT, S. FELLINI and C. WEST, Department of Anatomy, University of
Pennsylvania School of Medicine, Philadelphia: Changes in kind and distribution of the 100 A filaments
in developing muscle.
I. K. BUCKLEY,* M. STEWART,*T D. 0. IRVING,* T. R. RAIu,* and W. E. GORDON,' *John Curtain School of
Medical Research, Australian National University; +Division of Computing Research, CSIRO, Canberra,
Australia; +Cold Spring Harbor Laboratory, New York: Organelle movements, intermediate filaments and
actin.
R. V. ZACKROFF and R. D. GOLDMAN, Department of Biological Sciences, Carnegie-Mellon University,
Pittsburgh, Pennsylvania: In vitro assembly of intermediate filaments from BHK-21 cells.
L. M. MILSTONE, Department of Dermatology, Yale University, New Haven, Connecticut: Calf esophagus
contains two abundant proteins which form 10 nm filaments.
T. W. HUIATT, R. M. ROBSON, J. M. O'SHEA, M. K. HARTZER, and M. H. STROMER, Muscle Biology Group, Iowa
State University, Ames: Self-assembly of 10 nm filaments from highly purified desmin.
Session 9: Cell Shape and Migration
Chairperson: R. D. ALLEN, Dartmouth College, Hanover, New Hampshire
L. MAREK and E. BELL, Department of Biology, Massachusetts Institute of Technology, Cambridge: Time-lapse
films of fibroblasts in the polarized light microscope.
G. ALBRECHT-BUEHLER, Cold Spring Harbor Laboratory, New York: Group migration of the PtK1 cells.
E. B. CRAMER, L. C. MILKS, and G. K. OIAKIAN, Department of Anatomy and Cell Biology, State University of
New York Downstate Medical Center, Brooklyn: An in vitro model system of transepithelial migration of
human polymorphonuclear leukocytes (PMN's).
C. A. KING, R. H. MILLER, P. DONOVAN, and T. M. PRESTON, Zoology Department, University College,
London, England: Reflexion interference microscopy studies on the loss of membrane material (-trailing)
during amoeboid locomotion of free living amoebae and human neutrophil leucocytes.
C. H. DAMSKY, R. DORIO, and C. A. BUCK, Wistar Institute, Philadelphia, Pennsylvania: Manipulation of
cell-cell and cell-substrate interactions in mammary epithelial cell lines by antisera against surface
glycoproteins.
T. P. FITZHARRIS* and R. R. MARKWALD,T *Department of Anatomy, Medical University of South Carolina,
Charleston; +Texas Tech University School of Mddicine, Lubbock: Modification of matrix ordering during
in vivo cell movement.
A. ZURN and F. SOLOMON, Center for Cancer Research, Massachusetts Institute of Technology, Cambridge:
Cellular specification of morphology.
E. REPASKY and B. S. ECKERT, Department of Anatomical Sciences, State University of New York School of
Medicine, Buffalo: Cytoskeletal and contractile elements during maturation of mammalian erythroid
cells.
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V. BENNETT and P. J. STENBUCK, Department of Molecular Biology, Wellcome Research Laboratories,
Research Triangle Park, North Carolina: Ankyrin, the membrane attachment protein for spectrin, is linked
to band 3 in human erythrocyte membranes.
M. P. SHEETZ, Department of Physiology, University of Connecticut Health Center, Farmington: Internal
membrane protein interactions with triton cytoskeletons of erythrocytes.
S. L. BRENNER and E. D. KORN, NHLBI, National Institutes of Health, Bethesda, Maryland: The interaction of
spectrin with actin.
Session 10: Brush Border and Microfilament Organization
Chairperson: H. HUXLEY, MRC Laboratory of Molecular Biology, Cambridge, England
M. S. MOOSEKEe* and R. E. STEPHENS,' tMarine Biological Laboratory, Woods Hole, Massachusetts;
*Department of Biology, Yale University, New Haven, Connecticut: Brush border a-actinin?
A. BRETSCHER and K. WEBER, Max-Planck-Institute for Biophysical Chemistry, Gottingen, Germany: Analysis
of the major cytoskeletal components of chicken intestinal brush borders and their distribution between
the microvilli and terminal web region.
S. W. CRAIG and C. L. LANCASHIRE, Department of Physiological Chemistry, Johns Hopkins University School
of Medicine, Baltimore, Maryland: Evidence for lack of homology between alpha actinin and brush
border 100K polypeptide.
P. MATSUDAIRA and D. BURGESS, Department of Biology, Dartmouth College, Hanover, New Hampshire:
Helical arrangement of lateral arm projections and their removal from microvillar core microfilaments.
D. F. ALBERTINI and K. FUIIWARA, Department of Anatomy and Laboratory of Human Reproduction and
Reproductive Biology, Harvard Medical School, Boston, Massachusetts: Membrane-cytoskeletal interac-
tions during hormone and mitogen-induced cellular rounding.
T. J. BRADLEY and P. SATIR, Department of Anatomy, Albert Einstein College of Medicine, Bronx, New York:
Microfilament-associated mitochondrial movement.
B. GEIGER and S. J. SINGER, Department of Biology, University of California, San Diego: A 130K-protein
isolated from chicken gizzard-Its localization at the termini of stress fibers, in areas of cell-substrate and
cell-cell contact.
J. R. FERAMISCO, Cold Spring Harbor Laboratory, New York: Microinjection of fluorescently labeled a-actinin
into living fibroblasts.
A. B. FULTON, J. PRIVES, F. FARMER, and S. PENMAN, Massachusetts Institute of Technology, Cambridge: Transient
instability of skeletal framework and its surface lamina during myoblast fusion.
R. E. POLLACK,* K. SMITH,* N. SPURR,' and Y. Ito,t *Department of Biological Sciences, Columbia Univer-
sity, New York; tlmperial Cancer Research Fund, London, England: A polyoma virus mutant, DL-23, is
defective in changing the cytoskeletal actin pattern of infected cells.
A. M. (Duo, A. ZUMBE, L. J. GIBSON, A.-M. KUBLER, and L. JIMENEZ DE ASUA, Friedrich Miescher-Institut, Basel,
Switzerland: Cytoskeleton-disrupting drugs enhance the initiation of DNA synthesis stimulated by growth
factors.
MEMBRANE BIOGENESIS, May 22 May 27
arranged by
Gunter Blobel, Rockefeller University, New York, New York
David Sabatini, New York University Medical Center, New York
206 participants
Welcoming Remarks: D. D. SABATINI, New York University Medical Center, New York
Session 1: Introductory Session
G. PALADE, Department of Cell Biology, Yale University, New Haven, Connecticut: Membrane
biogenesis-Past and perspectives.
J. BECKWITH, Harvard Medical School, Boston, Massachusetts: Genetics of protein secretion in bacteria.
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V. MARCHES!, Yale University, New Haven, Connecticut: Proteins that make channels across membranes.
D. D. SABATINI, T. MORIMOTO, M. ADESNIK, and G. KREIBICH, Department of Cell Biology, New York
University School of Medicine, New York: Functions of membrane-bound ribosomes in eukaryotic cells.
Session 2A: Synthesis of Secretory, Membrane, and Lysosomal Proteins in the Rough Endoplasmic Re-
ticulum. I.
Chairperson: G. BLOBEL, Rockefeller University, New York, New York
Y. BURSTEIN, 0. WOLF, and I. SCHECHTER, Weizmann Institute of Science, Rehovot, Israel: Structure and
function of immunoglobulin precursors.
D. SHIELDS, Department of Anatomy, Albert Einstein College of Medicine, Bronx, New York: In vitro
synthesis, processing and segregation of secretory glycoproteins by heterologous microsomal membranes.
E. C. HEATH and T. H. HAUGEN, Department of Biochemistry, University of Iowa, Iowa City: Cell free
synthesis, processing, and glycosylation of an active RNase precursor.
T. MORIMOTO, Department of Cell Biology, New York University School of Medicine, New York: Functional
binding of ribosomes to rat liver endoplasmic reticulum membranes in vitro.
G. KREIL, C. MOLLAY, and L. HAIML, Institute of Molecular Biology, Austrian Academy of Sciences, Salzburg:
Melittin-A soluble peptide in search of a membrane.
J. R. LINGAPPA, V. R. LINGAPPA, and G. BLOBEL, Department of Cell Biology, Rockefeller University, New
York, New York: A competitive inhibitor of nascent chain translocation across microsomal
membranes-A tryptic putative signal peptide from chicken ovalbumin.
A. H. ERICKSON and G. BLOBEL, Rockefeller University, New York, New York: In vitro synthesis of
/3-glucuronidase by rat liver and preputial gland RNA.
M. ROSENFELD, G. KREIBICH, D. POPOV, and D. D. SABATINI, Department of Cell Biology, New York University
Medical Center, New York: Site of synthesis and processing of g-glucuronidase in rat liver and preputial
gland.
H. F. LODISH, W. BRAELL, M. PORTER, and A. ZILBERSTEIN, Massachusetts Institute of Technology, Cambridge:
Biosynthesis of a viral and a cellular glycoprotein.
H. P. GHOSH,* F. TONEGUZZO,* R. IRVING,* J. CAPONE,* and T. HOFMANN,* *Department of Biochemistry,
McMaster University, Hamilton, Ontario, Canada; ',Department of Biochemistry, University of Toronto,
Ontario, Canada: Membrane biogenesis-Synthesis, glycosylation, insertion into membrane and topol-
ogy of a viral transmembrane glycoprotein.
H. GAROFF, K. SIMONS, and B. DOBBERSTEIN, European Molecular Biology Laboratory, Heidelberg, Germany:
Structure and assembly of the Semliki Forest virus membrane.
S. BONATTI and G. BLOBEL, Laboratory of Cell Biology, Rockefeller University, New York, New York: Sindbis
virus glycoprotein PE' lacks an amino terminal cleavable signal sequence.
Session 26: Synthesis of Secretory, Membrane, and Lysosomal Proteins in the Rough Endoplasmic Re-
ticulum. 11.
Chairperson: T. OMURA, Kyushu University, Fukuoka, Japan
H. PLOEGH,* H. ORR,* E. CANNON,* and J. L. STROMINGER,* *The Biological Laboratories, Harvard University,
Cambridge; *Department of Biology, Brandeis University, Waltham, Massachusetts: Biosynthesis of
HLA-A and HLA-B antigens.
B. DOBBERSTEIN,* H. GAROFF,* G. WARREN,* and P. J. ROBINSON,* *European Molecular Biology Laboratory;
*Institute for Immunology and Genetics, German Cancer Research Center, Heidelberg, Germany: Cell-
free synthesis and membrane insertion of mouse H-2Dd histocompatibility antigen and /32- microglobulin.
I. D. ALGRANATI, A. ZIEGLER, and C. MILSTEIN, MRC Laboratory of Molecular Biology, Cambridge, England:
Regulation of biosynthesis and expression of human major histocompatibility antigens.
D. S. PAPERMASTER,** B. G. SCHNEIDER,* Y. BURSTEIN,, and I. SCHECTER,* *Department of Pathology, Yale
Medical School, New Haven, Connecticut; Departments of ,Organic Chemistry and tChemical Im-
munology, Weizmann Institute of Science, Rehovot, Israel: Biosynthesis of rhodopsin-Involvement of
Golgi in transport of a membrane protein synthesized without a short-lived NH H2-terminal peptide.
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E. SABBAN, D. SABATINI, M. ADESNIK, and V. MARCHESI,* Department of Cell Biology, New York University
School of Medicine, New York; *Department of Pathology, Yale University School of Medicine, New
Haven, Connecticut: Biosynthesis of murine erythrocyte membrane protein band 3.
Session 3A: Role of Endoplasmic Reticulum in Protein Biosynthesis and Processing. I.
Chairperson: G. KREIBICH, New York University Medical Center, New York
G. KREIBICH, New York University Medical Center, New York: Proteins associated with ribosomal binding
sites in the rough endoplasmic reticulum.
R. A. RACHUBINSKI, D. P. S. VERMA,* and J. J. M. BERGERON, Departments of Anatomy and *Biology, McGill
University, Montreal, Canada: Synthesis of rat liver microsomal cytochrome b5 by free ribosomes.
Y. OKADA, D. D. SABATINI, and G. KREIBICH, New York University School of Medicine, New York: Sites of
synthesis of rat liver cytochrome b5 and NADPH cytochrome P-450 reductase.
T. OMURA, Department of Biology, Kyushu University, Fukuoka, Japan: Role of free polyribosomes in the
biosynthesis of membrane proteins in hepatocytes and in adrenocortical cells.
Session 3B: Role of Endoplasmic Reticulum in Protein Biosynthesis and Processing.
Chairperson: J. D. JUDAH, University College Hospital, Medical School, London, England
S. BAR-NUN, G. KREIBICH, M. ADESNIK, L. ALTERMAN, M. NEGISHI, and D. D. SABATINI, New York University
School of Medicine, New York: Synthesis and insertion of cytochrome P-450 into endoplasmic reticulum
membranes.
N. BORGESE and J. MELDOLESI, CNR Center of Cytopharmacology and Department of Pharmacology, Univer-
sity of Milan, Italy: Biogenesis and turnover of NADH cytochrome b5 reductase, a membrane protein
with multiple localization in rat hepatocytes.
A. AMAR-COSTESEC, H. BEAUFAY, and C. DE DUVE, Universite de Louvain and International Institute of Cellular
and Molecular Pathology, Brussels, Belgium: The distribution of enzymes in subcellular membranes from
rat liver.
R. C. JACKSON* and G. BLOBELL," *Department of Biochemistry, Dartmouth Medical School, Hanover, New
Hampshire; +Department of Cell Biology, Rockefeller University, New York, New York: Post-translational
processing of full-length presecretory proteins with canine pancreatic signal peptidase.
M. ZIMMERMAN,* R. A. MUMFORD,* G. KREIBICH," and A. W. STRAUSS,' *Merck Institute for Therapeutic
Research, Rahway, New Jersey; +Department of Cell Biology, New York University, New York; +Depart-
ment of Biological Chemistry, Washington University, St. Louis, Missouri: Characterization of a mem-
brane endopeptidase possibly involved in pre-protein processing.
M. CZAKO-GRAHAM, D. D. SABATINI, E. BARD, and G. KREIBICH, New York University School of Medicine,
New York: Specific binding of secretory polypeptide precursors to reconstituted rat liver rough mi-
crosomal membranes.
P. WALTER and G. BLOBEL, Laboratory of Cell Biology, Rockefeller University, New York, New York: Tryptic
dissection and reconstitution of the translocation activity for nascent presecretory proteins across mi-
crosomal membranes.
G. VON HEIJNE and C. BLOMBERG, Department of Theoretical Biophysics, Royal Institute of Technology,
Stockholm, Sweden: Extrusion of nascent polypeptides through a lipophilic membrane-An energy
analysis.
J. D. JUDAH, Department of Experimental Pathology, University College Hospital Medical School, London,
England: Membrane function in the secretion of albumin.
C. M. REDMAN, D. BANERIEE, and S. Yu, Lindsley F. Kimball Research Institute of the New York Blood Center,
New York: Precursor processing of rat serum albumin in liver and Morris hepatomas 5123C and 7800.
L. GERACE and G. BLOBEL, Department of Cell Biology, Rockefeller University, New York, New York: A
model for the reversible mitotic disassembly of the higher eukaryotic nuclear envelope.
M. BUDARF, P. ROSA, and E. HERBERT, Chemistry Department, University of Oregon, Eugene: Effect of
tunicamycin on the synthesis and processing of pro-ACTH-endorphin.
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Session 4: Synthesis of Secretory and Membrane Proteins in Prokaryotic Cells. I.
Chairperson: J. BECKWITH, Harvard Medical School, Boston, Massachusetts
J. BECKWITH, P. BASSFORD, A. SARTHY, B. WANNER, T. SILHAVY, and H. INOUYE, Department of Microbiology
and Molecular Genetics, Harvard Medical School, Boston, Massachusetts: Genetics of secretion of
periplasmic proteins in E. coli.
C. N. CHANG and G. BLOBEL, Department of Cell Biology, Rockefeller University, New York, New York:
Processing and segregation of E. coli periplasmic enzyme alkaline phosphatase.
W. P. SMITH, Vick Divisions Research and Development, Mt. Vernon, New York: Co-translational secretion
of diphtheria toxin and alkaline phosphatase in vitro-Involvement of membrane protein(s).
B. D. DAVIS, W. P. SMITH, and P.-C. TAI, Harvard Medical School, Boston, Massachusetts: Protein secretion
in bacteria.
M. SARVAS,* K. P. HIRTH,t E. FUCHS,' and K. SIMONS,* *European Molecular Biology Laboratory, Heidelberg;
tlnstitut fur Molekulare Genetik, Universitat Heidelberg, Germany: Secretion of the penicillinase of
Bacillus licheniformis.
J. B. K. NIELSEN,* C. N. CHANG,t K. lzui,* G. BLOBEL,t and J. 0. LAMPEN,* *Waxman Institute of Microbiology,
Rutgers University, Piscataway, New Jersey; +Rockefeller University, New York, New York: Stages in the
biosynthesis of penicillinase in Bacillus licheniformis 749.
V. G. WILSON and R. W. HOGG, Department of Microbiology, Case Western Reserve University, Cleveland,
Ohio: Sequence studies of the precursor form of the arabinose binding protein.
D. L. OXENDER, C. I. DANIELS, R. LANDICK, and J. J. ANDERSON, Department of Biological Chemistry, University
of Michigan, Ann Arbor: Precursor forms of the periplasmic leucine binding proteins in E. coli K12.
K. ITo, G. MANDEL, P. HEARNE, and W. WICKNER, Department of Biological Chemistry and Molecular Biology
Institute, University of California, Los Angeles: Synthesis, assembly and processing of a precursor of the
M13 coat protein, an integral membrane protein.
C. N. CHANG, P. MODEL, and G. BLOBEL, Rockefeller University, New York, New York: Asymmetric insertion
of an integral transmembrane protein into the membrane is coupled to translation.
B. L. WANNER,* A. SARTHY,t and J. R. BECKWITH,t *Department of Biology, Massachusetts Institute of
Technology, Cambridge; +Department of Microbiology and Molecular Genetics, Harvard Medical
School, Boston, Massachusetts: An E. coli pleiotropic mutant defective in the synthesis of periplasmic and
outer membrane proteins.
J. J. C. LIN and H. C. Wu, Department of Microbiology, University of Connecticut Health Center, Far-
mington: Biosynthesis and assembly of murein lipoprotein in E. coli.
S. D. EMR and T. J. SILHAVY, Department of Microbiology and Molecular Genetics, Harvard Medical School,
Boston, Massachusetts: An analysis of signal sequence mutations in the gene coding for the X receptor,
an outer membrane protein of E. coli.
Session 5: Synthesis of Secretory and Membrane Proteins in Prokaryotic Cells. II
Chairperson: T. SILHAVY, Harvard Medical School, Boston, Massachusetts
L. MINDICH, R. HUANG, and B. STITT, Public Health Research Institute of the City of New York, New York: 46
mutants that synthesize temperature sensitive P12-A protein necessary for phage membrane assembly.
G. BREWER, Department of Microbiology, University of Southern California School of Medicine, Los Angeles:
Assembly of the membrane of bacteriophage PM2.
M. INOUYE, J. DIRIENZO, T. MAEDA, K. NAKAMURA, R. PIRTLE, I. PIRTLE, R. MOVVA, and E. WURTZEL, Department
of Biochemistry, State University of New York, Stony Brook: Biosynthesis and assembly of outer
membrane proteins of E. coli.
G. FERRO-LUZZI AMES, Department of Biochemistry, University of California, Berkeley: Interaction between
membrane and periplasmic proteins is a requisite for transport.
D. J. WAXMAN and J. L. STROMINGER, The Biological Laboratories, Harvard University, Cambridge, Mas-
sachusetts: Structure of the COOH-terminal hydrophobic region of a penicillin-sensitive bacterial
D-alanine carboxypeptidaSe.
M. ACHTMAN, P. A. MANNING, R. THOMPSON, C. EDELBLUTH, and P. HERRLICH, Max-Planck-Institute fOr
Molekulare Genetik, Berlin, Germany: E. coli cell envelope proteins encoded by the F sex factor.
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U. HENNING and C. P. HOLLENBERG, Max-Planck-Institute fOr Biologie, Tubingen, Germany: Cloning of
structural genes for integral E. coli membrane proteins.
C. LAZDUNSKI, J. M. PAGES, M. PIOVANT, S. VARENNE and D. BATY, Centre de Biochimie et Biologie
Moleculaire du CNRS, Marseille, France: Synthesis and export of alkaline phosphatase across the
cytoplasmic membrane of E. coli-Importance of the membrane fluidity, inhibition by procaine, effect of
antibiotics of low polarity.
V. ZOGBI and D. P. S. VERMA, Department of Biology, McGill University, Montreal, Canada: Homologies
between the plasma membrane and the membrane envelope enclosing the bacteroids in soybean root
nodules.
J. P. ROSENBUSCH, Department of Microbiology, University of Basel, Switzerland: Reconstitution of matrix
protein (porin) in single bilayer lipid membranes.
Session 6A: Glycosylation and Synthesis of Membrane Proteins of Enveloped Viruses. I.
Chairperson: S. KORNFELD, Washington University, St. Louis, Missouri
S. KORNFELD, I. TABAS, M. MICHAEL, and A. CHAPMAN, Washington University School of Medicine, St. Louis,
Missouri: Oligosaccharide processing during glycoprotein biosynthesis.
P. ROBBINS, Massachusetts Institute of Technology, Cambridge: Synthesis and processing of cell surface
glycoproteins.
J. R. ETCHISON and D. F. SUMMERS, University of Utah Medical Center, Salt Lake City: Structure and
processing of glycoprotein oligosaccharides in two lectin-resistant CHO cell lines.
R. G. SPIRO and M. J. SPIRO, Harvard Medical School, Boston, Massachusetts: Role of glucose-containing
oligosaccharide-lipids in glycoprotein biosynthesis.
S. SCHLESINGER, R. GIBSON, and S. KORNFELD, Washington University Medical School, St. Louis, Missouri: The
role of glycosylation of G protein in the replication of VSV.
G. HART, J. HANOVER, U. CZICHI, and W. J. LENNARZ, Department of Physiological Chemistry, Johns Hopkins
University School of Medicine, Baltimore, Maryland: Glycosylation of asparagine-linked
glycoproteins-Regulation, role, and subcellular localization.
D. S. BAILEY, Biology Department, McGill University, Montreal, Canada: Early events in membrane glyco-
protein assembly-In vitro and in vivo synthesis of lipid intermediates.
I. BOIME and M. BIELINSKA, Department of Pharmacology, Washington University School of Medicine, St.
Louis, Missouri: Processing of the mannose-rich glycosylated a subunit of human chorionic gonadotropin
in ascites tumor cell-free lysates.
H. BEAUFAY, D. GODELAINE, M. WIBO, and J. PAIEMENT, University de Louvain and International Institute of
Cellular and Molecular Pathology, Brussels, Belgium: Functional and structural changes induced by GTP
in stripped rough microsomes from rat liver.
R. W. COMPANS, J. A. GRIFFIN, M. G. ROTH, and J. P. FITZPATRICK, University of Alabama Medical Center,
Birmingham: Studies on the assembly of enveloped viruses.
A. SCHEID, M.-C. HSU, C. D. RICHARDSON, and P. W. CHOPPIN, Rockefeller University, New York, New York:
Studies on the structure and function of paramyxovirus membrane glycoproteins..
L. KAARIAINEN, C.-H. VON BONSDORFF, K. HASHIMOTO, S. KERANEN, and J. SARASTE, Department of Virology,
University of Helsinki, Finland: Transport of Semliki Forest virus envelope glycoproteins in infected cells.
Session 68: Glycosylation and Synthesis of Membrane Proteins of Enveloped Viruses. II.
Chairperson: H. LODISH, Massachusetts Institute of Technology, Cambridge
R. ROTT, Institut fur Virologie, Justus-Liebig-Universitat, Giessen, Germany: Biological significance of pro-
teolytic cleavage of the HA glycoprotein of influenza viruses.
H.-D. KLENK, Institut fur Virologie, Justus-Liebig Universitat, Geissen, Germany: Defective processing of a
viral membrane glycoprotein.
M. J. SCHLESINGER and M. F. G. SCHMIDT, Department of Microbiology and Immunology, Washington
University School of Medicine, St. Louis, Missouri: Evidence for covalent binding of fatty acids to viral
membrane glycoproteins.
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R. GREEN and E. RODRIGUEZ BOULAN, New York University School of Medicine, New York: The role of
glycosylation in the biogenesis of epithelial polarity.
Session 7A: Gogh Apparatus-Role in Secretion and Membrane Dynamics. I.
Chairperson: M. FARQUHAR, Yale University, New Haven, Connecticut
M. G. FARQUHAR, Section of Cell Biology, Yale University School of Medicine, New Haven, Connecticut:
Traffic flow and membrane specialization in the Golgi complex.
J. J. M. BERGERON* and B. I. POSNER,t Departments of *Anatomy and *Medicine, McGill University,
Montreal, Canada: Role of the Golgi apparatus in the elaboration and recycling of the insulin and
prolactin receptors of hepatocytes.
D. J. MORRE, Department of Medicinal Chemistry and Pharmacognosy and Department of Biological
Sciences, Purdue University, West Lafayette, Indiana: Sites of synthesis of membrane constituents within
the endomembrane system of rat liver.
C. C. WIDNELL,*T Y.-J. SCHNEIDER,t and A. TROUET,T tUniversite Catholique de Louvain and ICP, BruxelleS,
Belgium; *University of Pittsburgh School of Medicine, Pennsylvania: Evidence for an internal pool of
membrane in rat fibroblasts which exchanges with the cell surface.
Session 7B: Golgi Apparatus-Role in Secretion and Membrane Dynamics. II.
Chairperson: G. DALLNER, University of Stockholm, Sweden
G. DALLNER, Institute of Biochemistry, University of Stockholm, Sweden: Transport and glycosylation of
microsomal membrane proteins in rat liver.
B. FLEISCHER, Department of Molecular Biology, Vanderbilt University, Nashville, Tennessee: Orientation
and distribution of some components of rat liver Golgi membranes.
L. H. ROME, E. F. NEUFELD, and A. HASILIK, Genetics and Biochemistry Branch, NIAMDD, National Institutes
of Health, Bethesda, Maryland: Biosynthesis and transport of lysosomal enzymes in cultured human
fibroblasts.
M. GRATZL,* R. EKERDT,* and G. DAHL,t *Department of Physiological Chemistry, University of Saarland,
Homburg, Germany; t Department of Physiology and Biophysics, University of Miami, Florida: Mem-
brane fushion studied with isolated secretory vesicles.
E. J. PATZER and J. E. ROTHMAN, Department of Biochemistry, Stanford University Medical Center, California:
Reversible dissociation of polypeptides from coated vesicles.
R. S. GAROFALO, J. K. C. KNOWLES, and B. H. SATIR, Department of Anatomy, Albert Einstein College of
Medicine, Bronx, New York: Calmodulin and secretory mutants.
P. NOVICK and R. SCHEKMAN, Department of Biochemistry, University of California, Berkeley: Secretion and
cell surface growth are blocked in a temperature sensitive mutant of S. cerevisiae.
D. DOYLE, H. BAUMANN, and R. WARREN, Department of Molecular Biology, Roswell Park Memorial Institute,
Buffalo, New York: Metabolism of surface membrane proteins of rat hepatoma and primary liver cells in
culture.
D. BOK, B. MATSUMOTO, and D. DEFOE, Department of Anatomy and Jules Stein Eye Institute, University of
California, Los Angeles: Cytological events in the renewal of vertebrate rhodopsin.
A. MERCURIO and E. HOLTZMAN, Department of Biological Sciences, Columbia University, New York, New
York: Agranular reticulum and membrane genesis in frog retinal photoreceptors.
J. H. KEEN, I. PASTAN, and M. C. WILLINGHAM, NCI, National Institutes of Health, Bethesda, Maryland:
Clathrin-coated vesicles-Dissociation and reconstitution of the basket structure.
Session 8: Plasma Membranes-Structure and Biosynthesis
Chairperson: J. SINGER, University of California, San Diego
M.S. KRANGEL,* D. Pious,t and J. L. STROMINGER,* *The Biological Laboratories, Harvard University,
Cambridge, Massachusetts; tDepartments of Pediatrics and Genetics, University of Washington, Seattle:
Assembly of HLA-A and HLA-B antigens in vivo.
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L.-N.L. CHAN * and J. DELENICK,T *Department of Human Biological Chemistry and Genetics, University of
Texas Medical Branch, Galveston; *Department of Biology, Yale University, New Haven, Connecticut:
Plasma membrane biogenesis in embryonic chick red blood cells.
F. R. LANDSBERGER and L. D. ALTSTIEL, Rockefeller University, New York, New York: Structural changes in
plasma membranes induced by enveloped viruses.
J. D. JAMIESON,* M. P. SARRAS, JR.,* and M. F. MAYLIE- PFENNINGER,t *Yale University Medical School, New
Haven, Connecticut; *Columbia University, New York, New York: Developmental regulation of expres-
sion of pancreatic cell surface glycoconjugates.
F. RIEGER, Departement de Biologie et Pathologie Neuromusculaires, INSERM, Paris, France: Regulation of
biosynthesis and cellular localization of the multiple molecular forms of acetylcholinesterase-In vivo
and in vitro synapse formation.
R. B. KELLY, S. S. CARLSON, J. A. WAGNER, J. W. DEUTSCH, and R. VON WEDEL, Department of Biochemistry
and Biophysics, University of California, San Francisco: The membranes of purified synaptic vesicles.
K. H. PFENNINGER, R. SMALL, and M.-F. MAYLIE-PFENNINGER, Department of Anatomy, Columbia University,
New York, New York: Insertion of membrane components during plasmalemmal growth in neurons.
C. PERACCHIA, Department of Physiology, University of Rochester Medical Center, New York: Gap junction
crystallinity and cell coupling.
M. FINBOw, B. YANCEY, R. JOHNSON, and J. P. REVEL, Division of Biology, California Institute of Technology,
Pasadena: Identification of the protein component of mammalian gap junctions.
S. RAZIN, A. AMAR and S. ROTTEM, Biomembrane Research Laboratory, Hebrew University-Hadassah Medical
School, Jerusalem, Israel: Is the vertical disposition of mycoplasma membrane proteins affected by
membrane fluidity?
W. FRANKE,* J. KARTENBECK,* G. KROHNE,* J. STADLER,* C. FREUDENSTEIN,* and T. W. KEENAN,t *Division of
Membrane Biology and Biochemistry, Experimental Pathology, German Cancer Research Center, Heidel-
berg; *Department of Animal Sciences, Purdue University, Lafayette, Indiana: Membrane-associated
insoluble plaque structures.
Session 9: Plasma Membrane Differentiation
Chairperson: J. JAMIESON, Yale University, New Haven, Connecticut
E. B. GRIEPP, W. J. DOLAN, E. S. ROBBINS, and D. D. SABATINI, Department of Cell Biology, New York
University School of Medicine, New York: Studies on the development of tight junctions in epithelial
cells.
E. B. GRIEPP, N. L. SHINOWARA, A. S. HUDSPETH, and J.-P. REVEL, Division of Biology, California Institute of
Technology, Pasadena: Gap junction formation in beating embryonic heart cells.
E. RODRIGUEZ BOULAN and M. PENDERGAST, New York University School of Medicine, New York: Polarized
distribution of viral envelope proteins in infected epithelial cells.
L. LOUVARD, European Molecular Biology Laboratory, Heidelberg, Germany: Immunofluorescent studies on
the polarity of the epithelial cells.
J. BRUNNER,* H.-P. HAURI,t and G. SEMENZA,* *Department of Biochemistry, Swiss Institute of Technology,
Zurich; *Massachusetts General Hospital, Boston: Sucrase-isomaltase (SI), a "stalked" intrinsic plasma
membrane protein of intestinal brush borders (BB), is anchored to the membrane via a hydrophobic
segment of the N-terminal region of the I-subunit-Biosynthetic implications.
Session 10: Biogenesis of Chloroplasts
Chairperson: N. H. CHUA, Rockefeller University, New York, New York
A. GROSSMAN, S. BARTLETT, G. SCHMIDT, and N.-H. CHUA, Rockefeller University, New York, New York:
Post-translational transport of a cytoplasmically-synthesized protein into chloroplasts.
G. W. SCHMIDT,* A. R. CASHMORE,* *M. K. BROADHURST,' S. BARTLETT,* and N.-H. CHUA,* *Rockefeller
University, New York, New York: *Applied Biochemistry Division, DSIR, Palmerston North, New
Zealand: Biosynthetic precursors of integral chloroplast membrane proteins.
M. EDELMAN, A. REISFELD, H. HOFFMAN, and Z. E. KAHANA, Department of Plant Genetics, Weizmann Institute
of Science, Rehovot, Israel: Synthesis, processing and control of P-32000, the major membrane protein
translated within the chloroplast.
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C. A. Price, A. Watanabe, and R. E. Z ielinski, Waksman Institute of Microbiology, Rutgers University, 
Piscataway, New Jersey: Synthesis and assembly of chloroplast membrane proteins— Cytochrome 6559 
and coupling factor 1.
L. Bogorad, A. Grebanier, G. Link, L. Mc Intosh, and K. Steinback, Department of Biology, Harvard 
University, Cambridge, Massachusetts: The photogene for a maize chloroplast membrane protein.
L. A. Staehelin, D. P. Carter, A. Mc Donnel, and S. Spath, Department of Molecular Cellular, and 
Developmental Biology, University of Colorado, Boulder: In vivo and in vitro manipulation of the 
supramolecular organization of chloroplast membranes.
K. R. Miller, J. R. Ellenson, R. A. Cushman, and G. F. Cox, Harvard University, Cambridge, Massachusetts: 
A study of individual components of the photosynthetic membrane in model systems.
J. K. Hoober, Department of Biochemistry, Temple University Medical School, Philadelphia, Pennsylvania: 
The major polypeptides of Chlamydomonas reinhardtii thylakoid membranes— Properties and control of 
synthesis.
C. J. Arntzen, K. Leto, J. Mullet, and K. Steinback, Department of Botany, University of Illinois, Urbana: 
Regulation of stoichiometry of chloroplast membrane constituents.
R. K. Togasaki and M. O. Hudqck, Department of Biology, Indiana University, Bloomington: Analysis of 
photosynthetic competence during the early zygote maturation period in Chlamydomonas reinhardtii.
M. M. Margulies and J. W. Weistrop, Radiation Biology Laboratory, Smithsonian Institution, Rockville, 
Maryland: A sub-thylakoid fraction containing ribosomes.
I. O had,* J. G ershoni,* S. Shochat,*, and S. Malkin, ־1־ *Department of Biological Chemistry, Hebrew 
University of Jerusalem: 1־Department of Biochemistry, Weizmann Institute of Science, Rehovot, Israel: 
Stepwise synthesis and assembly of photosynthetic reaction centers and chlorophyll-protein complexes in 
algae.
Session 11: Biogenesis of Mitochondria and Peroxisomes
Chairperson: R. O. Poyton, University of Connecticut Health Center, Farmington
R. O . Poyton, C. George-Nascimento, K. Sevarino, AND S. Power, University of Connecticut Health 
Center, Farmington: Synthesis and assembly of yeast cytochrome c oxidase, an oligomeric membrane 
protein.
M.-L. Maccecchini, University of Basel Biocenter, Switzerland: Energy-dependent import of proteins into 
mitochondria.
W. Neupert, M. A. Harmey, E. M. Neher, and R. Z immermann, Physiologisch-Chemisches Institut der 
Universitat, Gottingen, Germany: Precursors of mitochondrial proteins.
S. Matsuura,* T. Morimoto,* D. Sabatini,* and E. Margoliash,+ *Department of Cell Biology, New York 
University School of Medicine, New York, 1־Department of Biochemistry and Molecular Biology, North- 
western University, Evanston, Illinois: Synthesis of cytochrome c in rat liver free polysomes and in vitro 
transfer into mitochondria.
I. Z. Ades and R. A. Butow , Biochemistry Department, University of Texas Health Science Center, Dallas: 
Fate of products synthesized by the mitochondria-bound cytoplasmic polysomes in yeast.
H. R. Mahler,* D. Hanson,* J. Johnson,* P. S. Perlman,1־ and N. Alexander,1־ *Department of Chemistry, 
Indiana University, Bloomington; 1־Department of Genetics, Ohio State University, Columbus: 
Mitochondrial biogenesis— Organization, expression and regulation of mitochondrial genes.
B. M. Goldman and G. Blobel, Rockefeller University, New York, New York: Biogenesis of peroxisomes—  
Intracellular site of synthesis of catalase and uricase.
P. B. Lazarow, Rockefeller University, New York, New York: Biogenesis of peroxisomes in rat liver.
Summary: G. Blobel, Rockefeller University, New York, New York
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Session 1: Mating Type
Chairperson: I. HERSKOWITZ, University of Oregon, Eugene
H. LIAO and J. THORNER, Department of Microbiology and Immunology, University of California, Berkeley:
The mating pheromone a-factor inhibits membrane-bound adenylyl cyclase in S. cerevisiae.
R. BETZ and W. DUNTZE, Institut fur Physiologische Chemie, Ruhr-Universitat Bochum, Germany: Isolation of
mating hormones produced by S. cerevisiae strain X2180-1A.
G. F. SPRAGUE, JR., J. RINE, and I. HERSKOWITZ, Institute of Molecular Biology and Department of Biology,
University of Oregon, Eugene: Structure and function of the mating type locus.
J. RINE and I. HERSKOWITZ, Institute of Molecular Biology and Department of Biology, University of Oregon,
Eugene: Regulation of cryptic mating type loci expression.
A. J. S. KLAR, J. HICKS, J. STRATHERN, and J. BROACH, Cold Spring Harbor Laboratory, New York: Interconver-
sion of yeast mating types by mobile genes.
J. E. HABER, D. W. MASCIOLI, W. T. SAVAGE, and L. B. ROwE, Rosenstiel Center, Brandeis University,
Waltham, Massachusetts: Mechanism of mating type gene transpositions in yeast.
R. E. MALONE and R. E. ESPOSITO, Chairman of Biology and Committee on Genetics, University of Chicago,
Illinois: The rad52 gene product is required for mating type switching in S. cerevisiae.
R. EGEL, Institute of Genetics, Copenhagen, Denmark: Reduced rates of mating-type switching and site-
specific mitotic recombination in homothallic fission yeast.
M. CRANDALL, School of Biological Sciences, University of Kentucky, Lexington: Induction of asco-
sporogenesis in the yeast Hansenula wingei by maltose and starvation for nitrogen.
Session 2: Cell Cycle, Sporulation, and Morphogenesis
Chairperson: H. 0. HALVORSON, Brandeis University, Waltham, Massachusetts
B. SLOAT, R. WATER, A. ADAMS, K. COLEMAN, and J. PRINGLE, Division of Biological Sciences, University of
Michigan, Ann Arbor: Cellular morphogenesis in the cell cycle of S. cerevisiae.
R. SCHEKMAN, P. NOVICK, C. FIELD, S. FRIED, and S. FERRO, Department of Biochemistry, University of
California, Berkeley: Secretion and cell surface growth are blocked in a temperature-sensitive mutant of
S. cerevisiae.
G. P. SAMOKHIN, L. V. LIZLOVA, M. I. TITOV, and V. N. SMIRNOV, USSR Research Center of Cardiology,
Moscow: The effect of a-factor on transition probability in yeast.
A. KLAR, Cold Spring Harbor Laboratory, New York: Mating type functions for meiosis and sporulation act
through cytoplasm.
S. DUTCHER and L. HARTWELL, Department of Genetics, University of Washington, Seattle: Cytoplasmic
location of karl gene product.
D. SCHILD* and B. BYERS,' *Department of Biophysics and Medical Physics, University of California,
Berkeley; tDepartment of Genetics, University of Washington, Seattle: Diploid spore formation and other
meiotic effects of cdc5 and cdc14 in S. cerevisiae.
D. Santo,* H. N. ANANTHASWAMY," and R. K. MORTIMER,* *Department of Biophysics and Medical Physics,
University of California, Berkeley; tCancer Biology Program, Frederick Cancer Research Center, Mary-
land: An endomitotic effect of cdc31-2.
S. KLAPHOLZ,* and R. E. ESPOSITO,*t *Committee on Genetics and tDepartment of Biology, University of
Chicago, Illinois: Genetic analysis of two meiotic mutants that undergo a single nuclear division and
produce asci containing two diploid spores.
G. S. ZUBENKO and E. W. JONES, Carnegie-Mellon University, Mellon Institute, Pittsburgh, Pennsylvania:
Protein degradation and sporulation in proteinase deficient mutants of S. cerevisiae.
C. FIELD and R. SCHEKMAN, Department of Biochemistry, University of California, Berkeley: Localized
secretion of acid phosphatase reflects the pattern of yeast cell surface growth.
Session 3: Poster Session
F. HILGER,* R. CONTOPOULOU,t and R. MORTIMER,t *Faculte des Sciences Agronomiques de L'Etat,
Gembloux, Belgium; tDepartment of Biophysics and Medical Physics, University of California, Berkeley:
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S. cerevisiae has seventeen chromosomes again - Mapping of argl and arg8 on the left arm of
chromosome XV.
D. CAMPBELL, J. DOCTOR, J. FEUERSANGER, and M. DOOLITTLE, Department of Biology, Holy Cross College,
Worcester, Massachusetts: Aneuploid tolerance and stability in yeast.
R. K. CHAN and C. A. OTTE, Department of Microbiology, University of Cincinnati College of Medicine,
Ohio: Isolation and characterization of yeast mutants supersensitive to a factor.
E. CIEJEK and J. THORNER, Department of Microbiology and Immunology, University of California, Berkeley:
Recovery of S. cerevisiae a cells from G1 arrest by a-factor pheromone requires endopeptidase action.
Y. JONES-BROWN and J. THORNER, Department of Microbiology and Immunology, University of California,
Berkeley: a-Factor biosynthesis-Immunological detection of mutants deficient in the elaboration of
extracellular pheromone.
L. M. MELNICK and J. BLAMIRE, Department of Biology, Brooklyn College, New York: A gene involved in
mating type regulated sporulation in S. cerevisiae.
I. EDELMAN,* M. CULBERTSON,* and J. B. HICKS,T *Laboratories of Molecular Biology and Genetics, University
of Wisconsin, Madison; tCold Spring Harbor Laboratory, New York: Heterothallic mating type intercon-
version.
J. BLAMIRE and L. M. MELNICK, Department of Biology, Brooklyn College, New York: Analysis of the results of
homozygous MATa rare mating events that produce modifications of chromosome III.
J. H. MCCUSKER and J. E. HABER, Rosenstiel Center, Brandeis University, Waltham, Massachusetts: Unstable
intermediates of chromosome loss induced in heterothallic and homothallic strains.
J. E. HABER, Rosenstiel Center, Brandeis University, Waltham, Massachusetts: Control of the direction of
mating type conversions by mating phenotype.
L. C. BLAIR and I. HERSKOWITZ, Institute of Molecular Biology, University of Oregon, Eugene: Isolation of hma
and hma alleles from HO HMa HMa homothallic spores.
P. KUSHNER, L. BLAIR, and I. HERSKOWITZ, Institute of Molecular Biology, University of Oregon, Eugene:
Mutant alleles of MATa produced by switching of HMa mutants.
G. KAWASAKI and D. HAWTHORNE, Department of Genetics, University of Washington, Seattle: Mapping HO
and a translocation of mating type by chromosome loss induced in yeast cell cycle mutants.
W. L. WHELAN, R. M. PARTRIDGE, and P. T. MAGEE, Michigan State University, East Lansing: Evidence for
heterozygosity and mitotic segregation in Candida albicans.
P. L. SKATRUD, E. J. KOT, and J. R. HELBERT, Miller Brewing Company, Milwaukee, Wisconsin: Fusion of
brewer's yeast.
G. KAWASAKI, Department of Genetics, University of Washington, Seattle: The cdc19 mutation of S.
cerevisiae is a temperature-sensitive defect for the glycolytic enzyme, pyruvate kinase.
J. PRINGLE, S. PARIS, A. TSCHUNKO, and A. ADAMS, Division of Biological Sciences, University of Michigan,
Ann Arbor: Isolation and characterization of temperature-sensitive cell cycle mutants of S. cerevisiae.
R. A. SINGER, D. BEDARD, and G. C. JOHNSTON, Faculty of Medicine, Dalhousie University, Halifax, Nova
Scotia, Canada: Nalidixic acid causes a transient G1 arrest in the yeast S. cerevisiae.
G. C. JOHNSTON and R. A. SINGER, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada:
Ribosomal RNA transcription and progression through G1 in the yeast S. cerevisiae.
K. NASMYTH, S. REED, and B. HALL, Department of Genetics, University of Washington, Seattle: The
molecular cloning of a yeast cell cycle "start" gene by transformation -Isolation by genetic complemen-
tation and identification by genetic mapping.
J. BOSSINGER,* N. -H. XUONG,t # and E. P. GEIDUSCHEK,* Departments of *Biology, tChemistry, and *Physics,
University of California, San Diego: Two dimensional protein patterns of yeast cell division cycle
mutants.
D. G. KAY, R. A. SINGER, and G. C. JOHNSTON, Faculty of Medicine, Dalhousie University, Halifax, Nova
Scotia, Canada: Ornithine decarboxylase activity as a marker of cell cycle arrest in the yeast S.
cerevisiae.
E. KRAIG and J. E. HABER, Rosenstiel Center, Brandeis University, Waltham, Massachusetts: A comparison of
protein synthesis in vegetative and sporulating yeast.
N. J. PEARSON and J. E. HABER, Rosenstiel Center, Brandeis University, Waltham, Massachusetts: Regulation
of ribosomal protein synthesis during sporulation.
M. PASTORCIC, J. E. GOLIN, and M. S. ESPOSITO, Department of Biology and Committee on Genetics,
University of Chicago, Illinois: Spontaneous mitotic recombination in cdc9-1/cdc9-1 diploids of S.
cerevisiae.
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K. WOLF, Genetisches Institut der Universitat Munchen, Germany: Uniparental inheritance is promoted by
delayed cell division of the zygote in the fission yeast Schizosaccharomyces pombe.
E. R. UNGER,* B. TUNG,* B. LEVIN:, and G. S. GETZ,* Department of *Pathology and tMedicine, University of
Chicago, Illinois: Influence of fatty acyl chain steriosomerism on the respiratory activity of an unsaturated
fatty acid auxotroph of S. cerevisiae.
N. NELSON and T. MASON, Biozentrum, University of Basel, Switzerland: The cytoplasmically-made cyto-
chrome c oxidase subunits V and VI each accumulate as larger forms under conditions of mitochondria!
ATP-depletion.
R. MOROSOLI and C. V. LUSENA, Division of Biological Sciences, National Research Council of Canada,
Ottawa: Endonuclease M from yeast mitochondria.
R. MATNER and F. SHERMAN, Department of Radiation Biology and Biophysics, University of Rochester
School of Medicine, New York: The presence of an apo-protein of cytochrome c in a cytochrome c
deficient mutant of yeast.
B. C. HYMAN and T. W. JAMES, Department of Biology, University of California, Los Angeles: Visualization
and analysis of mitochondrial DNA in Wickerhamia fluorescens.
S. F. COTTRELL, Department of Biology, Brooklyn College, New York: Variations in mitochondria! DNA
concentration as a function of different growth conditions in S. cerevisiae.
S. ULASZEWSKI, J. KoLopserIsKI, T. M. LACHOWICZ, and Z. KOTYLAK, Department of Genetics, Institute of
Microbiology, Wroclaw, Poland: Attempts of localization mit_ mutations responsible for resistance to
visible light on mitochondria! DNA in baker's yeast.
M. MISIEWICZ, T. M. LACHOWICZ, and Z. KOTYLAK, Department of Genetics, Institute of Microbiology,
Wroclaw, Poland: The map of deletion mutants in the OXI3 region.
K. WAKABAYASHI, Faculty of Medicine, University of Tokyo, Japan: Inversions in mitochondria! erythromycin
resistance gene.
G. GROSCH, A. HAID, C. SCHMELZER, R. J. SCHWEYEN, and F. KAUDEWITZ, Genetisches Institut der Universitat
Munchen, Germany: The COB/BOX region on mit DNA. II. Genetic/physical map and transcripts.
D. K. HANSON,* H. R. MAHLER,* J. A. JOHNSON,* and M. CLAISSE,t *Department of Chemistry, and Molecular,
Cellular and Developmental Biology Program, Indiana University, Bloomington; tCentre de Genetique
Moleculaire du CNRS., Gif-sur-Yvette, France: Nature and origin of novel polypeptides accumulating in
intron mutants in the COB-BOX region of the mitochondria! genome.
C. JACQ, J. LAZOWSKA, L. GIRALDINO-ROBAINA, and P. P. SLONIMSKI, Centre de Genetique Moleculaire, Centre
National de la Recherche Scientifique, Gif-sur-Yvette, France: Physical studies of the mutations in the
yeast mosaic cytochrome b gene.
A. HALBREICH, P. PAJOT, M. FOUCHER, C. GRANDCHAMP, and P. P. SLONIMSKI, Centre de Genetique
Moleculaire, Centre National de la Recherche Scientifique, Gif-sur-Yvette, France: An analysis of mtRNA
species from yeast mitochondria! petite mutants which complement box3 mutants.
G. DUJARDIN, 0. GROUDINSKY, P. PAJOT, and P. P. SLONIMSKI, Centre de Genetique Moleculaire, Centre
National de la Recherche Scientifique, Gif-sur-Yvette, France: Specific control circuits within the
mitochondria! genome and between the mitochondrial and nuclear genomes.
H. BLANC, B. DUJON, C. GRANDCHAMP, and P. P. SLONIMSKI, Centre de Genetique Moleculaire, Centre
National de la Recherche Scientifique, Gif-sur-Yvette, France: Hyper-suppressive "petites" replicate
preferentially their mit DNA and share a common sequence.
C. JACO,* F. CARON,* and J. RouvitkE-YAKiv,t *Centre de Genetique Moleculaire, Centre National de la
Recherche Scientifique, Gif-sur-Yvette; tInstitut Pasteur, Paris, France: Characterization of a histone-like
protein extracted from yeast mitochondria.
J. KREIKE,* H. BECHMANN,t F. J. VAN HEMERT,* P. H. BOER,* R. J. SCHWEYEN,t F. KAUDEWITZ,t and G. S. P.
GROOT,* *Department of Molecular Biology, University of Amsterdam, The Netherlands; t Department
of Genetics, University of Munich, Germany: The identification of cytochrome b as a mitochondrial gene
product in yeast.
P. H. BOER, E. ROOSENDAAL, G. J. B. VAN OMMEN, M. DE HAAN, and L. A. GRIVELL, Laboratory of Biochemis-
try, University of Amsterdam, The Netherlands: The gene for cytochrome b on yeast mtDNA.
Session 4: Mitochondria. I.
Chairperson: P. PERLMAN, Ohio State University, Columbus
N. J. ALEXANDER,* D. K. HANSON,t H. R. MAHLER,t and P. S. PERLMAN,* *Ohio State University, Columbus;
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tlndiana University, Bloomington: Further studies of the mosaic structure of the mitochondrial cob-box
gene in S. cerevisiae.
G. J. B. VAN OMMEN, L. A. GRIVELL, and G. S. P. GROOT, Laboratory of Biochemistry, University of
Amsterdam, The Netherlands: Mitochondrial transcription and splicing in different wild-type and mutant
yeast strains.
M. Souoz, Biocenter, University of Basel, Switzerland: Effect of intron and exon mutations in the
mitochondrial cytochrome b gene on the cytochrone b apoprotein.
A. LAMOUROUX,* A DE KOCHKO,, P. BAJOT,* A. M. COLSON,t and P. P. SLONIMSKI,* *Centre de Genetique
Moleculaire, Centre National de la Recherche Scientifique, Gif-sur-Yvette, France; tLaboratoire
d'Enzymologie, Universite de Louvain, Belgium: Complementation between exons and introns within a
mosaic mitochondria' gene-A tool to investigate the mechanism of splicing.
R. J. SCHWEYEN, H. BECHMANN, A. HAID, G. GROSCH, and F. KAUDEWITZ, Genetisches Institut der UniversitUt
Munchen, Germany: The COB/BOX region on mitDNA-Mutants and gene products.
T. D. Fox, Biozentrum, University of Basel, Switzerland: DNA sequence analysis of mitochondria! mutations
at the oxi 1 locus.
R. M. SYNENKI, S. MERTEN, T. CHRISTIANSEN, J. LOCKER, and M. RABINOWITZ, Franklin McClean Memorial
Research Institute, University of Chicago, Illinois: Processing and mapping of mitochondrial transcripts in
yeast.
R. D. VINCENT,* P. S. PERLMAN,* R. L. STRAUSBERG,t and R. A. BUTOW,t *Developmental Biology Program and
Department of Genetics, Ohio State University, Columbus; +Biochemistry Department, University of
Texas Health Science Center, Dallas: Physical mapping of determinants affecting the size of the var1
protein.
H. P. ZASSENHAUS and P. S. PERLMAN, Developmental Biology Program and Department of Genetics, Ohio
State University, Columbus: Respiration deficient mutants in the earl region.
L. A. M. HENSGENS,* A. C. ARNBERG,t L. A. GRIVELL,* A. SONNENBERG,* and G. J. B. VAN OMMEN,* *Laboratory
of Biochemistry, University of Amsterdam; +Biochemical Laboratory, State University at Groningen, The
Netherlands: The expression of the mitochondria! gene for the ATPase subunit 9.
L. A. GRIVELL,* A. C. ARNBERG,t G. J. B. VAN OMMEN,* E. F. J. VAN BRUGGEN,± and P. BORST,* *Laboratory of
Biochemistry, University of Amsterdam; +Biochemical Laboratory, State University at Groningen, The
Netherlands: Some yeast mitochondria' RNAs are circular.
E. P. SENA, Case Western Reserve University, Cleveland, Ohio; Molecular basis of mitochondrial transmis-
sional types.
Session 5: Mitochondria.
Chairperson: P. PERLMAN, Ohio State University, Columbus
B. DUJON, The Biological Laboratories, Cambridge, Massachusetts: DNA sequence of the co and ribosomal
region of the yeast mitochondrial genome.
H. F. TABAK, J. L. Bos, and G. J. B. VAN OMMEN, Laboratory of Biochemistry, University of Amsterdam, The
Netherlands: Studies on the yeast mitochondria' rRNA genes.
N. C. MARTIN and C. SIGURDSON, Department of Biochemistry, University of Minnesota, Minneapolis: Studies
on yeast mitochondria' tRNA genes and transcripts.
M. MONNEROT* and M. WESOLOWSKI,T *Laboratoire de Biologie Generale, Universite d'Orsay; tlnstitut
Curie, Orsay, France: Genetic and physical maps of tRNA genes of yeast mitochondria.
R. D. TODD, P. C. MCADA, and M. G. DOUGLAS, Department of Biochemistry, University of Texas Health
Science Center, San Antonio: A nuclear mutation altering the assembly of the yeast mitochondria' inner
membrane.
Session 6: Extrachromosomal Elements
Chairperson: W. FANGMAN, University of Seattle, Washington
R. B. WICKNER, NIAMDD, National Institutes of Health, Bethesda, Maryland: Control of exclusion of the K2
killer plasmid.
J. R. BROACH, J. N. STRATHERN, and J. B. HICKS, Cold Spring Harbor Laboratory, New York: Analysis of 2µ
circle replication by transformation in yeast.
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J. B. McNEIL, R. K. STORMS, P. S. KHANDEKAR, and J. D. FRIESEN, Department of Biology, York University,
Downsview, Ontario, Canada: Transformation of yeast with chimeric plasmids containing different
portions of the yeast plasmid 2 micron circle.
D. M. LIVINGSTON, Department of Biochemistry, University of Minnesota, Minneapolis: Isolation of a
condensed, intracellular form of the 21.,cm DNA plasmid.
S. M. JAZWINSKI, M. TAKETO, and G. M. EDELMAN, Department of Developmental and Molecular Biology,
Rockefeller University, New York, New York: Replication in vitro of the 2/..cm DNA plasmid of yeast.
L. BELL and B. BYERS, Department of Genetics, University of Washington, Seattle: Detection of crossed-strand
exchange forms in yeast 2/..,trn DNA during meiosis.
Session 7: Poster Session
H. BUSSEY and D. SAVILLE, Department of Biology, McGill University, Montreal, Quebec: Binding of
radioactive killer toxin to cell wall receptors of sensitive yeast.
K. A. BOSTIAN, J. A. STURGEON, and D. J. TIPPER, Brandeis University, Waltham, Massachusetts, and
University of Massachusetts Medical Center, Worcester: Establishment of a functional relationship within
the segmented dsRNA virus-like-particle genome of S. cerevisiae.
J. D. WELSH and M. J. LEIBOWITZ, Department of Microbiology, College of Medicine and Dentistry of New
Jersey-Rutgers Medical School, Piscataway: Transcription of yeast double-stranded RNA in vitro.
W. P. KANE and J. BRUENN, Division of Cell and Molecular Biology, State University of New York, Buffalo:
Structure and evolution of defective interfering double stranded RNAs of virus-like particles of yeast.
S. G. OLIVER and J. J. CLARE, Biological Laboratory, University of Kent at Canterbury, United Kingdom: The
effect of starvation on the synthesis and maintenance of yeast double-stranded RNAs.
L. DEL GIUDICE* and K. WOLF' *International Institute of Genetics and Biophysics, Consiglio Nazionale del le
Ricerche, Naples, Italy; tGenetisches Institut der Universitat Munchen, Germany: 21.km Covalent ly closed
non-mitochondrial circular DNA in the petite-negative yeast Schizosaccharomyces pombe.
H. GOLD and C. SHALITIN, Technion-Israel Institute of Technology, Haifa: Transcription of 2p.m circular DNA
from S. cerevisiae.
A. BRUNNER-L., Centro de Investigaciones Universidad Nacional Autonoma de Mexico, en Fisiologia Celular,
Mexico City: Chromosomal and extrachromosomal inheritance to antimycin resistance in the petite-
negative yeast Kluyveromyces lactis.
M. F. TUITE, B. S. Cox, and M. J. DOBSON, Botany School, Oxford, United Kingdom: Induced mutation of the
cytoplasmically-inherited [psi+] factor and other plasmids of S. cerevisiae.
R. G. BUCKHOLZ and B. G. ADAMS, Department of Microbiology, University of Hawaii, Honolulu: Control
and processing of yeast a-galactosidase.
P. ALEXANDER and B. G. ADAMS, Department of Microbiology, University of Hawaii, Honolulu: Isolation and
characterization of a-galactosidase mutants of S. cerevisiae.
H. FEDEROFF,* R. ECCLESHALL,* R. NEEDLEMAN,' and J. MARMUR,* *Department of Biochemistry, Albert Einstein
College of Medicine, Bronx, New York; 'Department of Biochemistry, Wayne State University, Detroit,
Michigan: Synthesis of maltase by S. carlsbergensis.
A. P. BOLLON, Department of Biochemistry, University of Texas Health Science Center, Dallas: Analysis of
the ilv 1-OP control region.
M. L. GREENBERG and S. A. HENRY, Department of Genetics, Albert Einstein College of Medicine, Bronx, New
York: Isolation of a regulatory mutant constitutive for inositol-l-phosphate synthase.
B. SNICKER and S. A. HENRY, Department of Genetics, Albert Einstein College of Medicine, Bronx, New York:
Yeast mutant defective in the conversion of phosphatidylethanolamine to phosphatylcholine.
K. D. ATKINSON,* B. JENSEN,* A. I. KOLATJ E. M. STORM,' S. A. HENRY,' and S. FOGEL,* *Department of
Genetics, University of California, Berkeley; 'Department of Genetics, Albert Einstein College of Medi-
cine, Bronx, New York: Yeast mutants defective in phosphatidylserine synthesis.
D. GRIMAL and R. LABBE-BOIS, Laboratoire Biochimie des Porphyrines, Universite Paris VII, France: Mutants
of S. cerevisiae deficient in heme synthesis.
A. P. MITCHELL and B. MAGASANIK, Department of Biology, Massachusetts Institute of Technology, Cam-
bridge: Mutations affecting glutamine synthetase regulation.
A. PIERARD, F. MESSENGUY, A. FELLER, and F. HILGER, Laboratoire de Microbiologie, Universite Libre de
Bruxelles; Institut de Recherches du CERIA, Brussels; Chaire de Microbiologie, Faculte des Sciences
Agronomiques de I'Etat, Gembloux, Belgium: Regulation of the synthesis of the arginine pathway
carbamoylphosphate synthase of S. cerevisiae-General and specific control mechanisms.
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J. MCKELVEY and T. G. COOPER, University of Pittsburgh, Pennsylvania: Oxalurate transport and its relation to
nitrogen repression.
V. TUROSCY and T. G. COOPER, University of Pittsburgh, Pennsylvania: Allantoic acid transport in S.
cerevisiae.
C. J. PANCHAL and G. G. STEWART, Labatt Brewing Company, London, Ontario, Canada: Uptake of monosac-
charides by a brewing yeast strain of Saccharomyces uvarum (carlsbergensis).
M. BORBOLLA and A. PENA, Departmento de Microbiologia, Centro de Investigaciones en Fisiologia Celular
and Departmente de Bioquimica, Facultad de Medicina, Universidad Nacional Autonoma de Mexico,
Mexico City: Calcium uptake and binding by S. cerevisiae.
E. DUBOIS and M. GRENSON, Laboratoire de Microbiologie, University Libre de Bruxelles and Institut de
Recherches du CERIA, Belgium: Multiplicity and regulation of methylamine/ammonia permeases in
yeast.
C. GAILLARDIN and H. HESLOT, Institut National de la Recherche Agronomique, Paris: Mutations affecting
lysine specific or general control of saccharopine dehydrogenase in Saccharomycopsis
T. G. COOPER and C. LAM, University of Pittsburgh, Pennsylvania: Structural organization of the dur1,2 gene
in yeast.
R. SUMRADA, C. LAM, and T. G. COOPER, University of Pittsburgh, Pennsylvania: An inducible multifunctional
protein degrades urea in yeast.
T. ACHSTETTER and W. BUSCH, Institut fur Biologie, Universitat Tubingen, Germany: Multiple forms of two
different esterases in laboratory strains of S. cerevisiae.
W. A. FONZI and D. J. OPHEIM, Texas A & M University, College Station: Inducible alkaline phosphatase from
S. cerevisiae.
A. M. SCHWEINGRUBER and M. E. SCHWEINGRUBER, Institute for General Microbiology, Altenbergrain, Bern,
Switzerland: Posttranslational control of acid phosphatase in S. cerevisiae.
J. S. TKACZ, H. R. ONISHI, T. MIZUNAGA, and J. 0. LAMPEN, Waksman Institute of Microbiology, Rutgers
University, Piscataway, New Jersey: Glycosylated enzymes of yeast-Continued synthesis of the protein
moieties when glycosylation is blocked by tunicamycin.
J. H. SCOTT and R. SCHEKMAN, Department of Biochemistry, University of California, Berkeley: Lyticase-
Endoglucanase and protease activities that act together in yeast cell lysis.
L.-L. S. CHIA and C. S. MCLAUGHLIN, Department of Biological Chemistry, University of California, Irvine:
Effect of translation inhibitors on the synthesis of individual proteins-Discriminatory synthesis of pro-
teins in the presence of initiation inhibitors as potential evidence for translational control in yeast.
L. MCALLISTER and D. B. FINKELSTEIN, Department of Biochemistry, University of Texas Health Science Center,
Dallas: Transient changes in translational patterns induced by heat shock of S. cerevisiae.
M. J. MILLER,* N.-H. XUONG,St and E. P. GEIDUSCHEK,* Departments of *Biology, *Physics, and *Chemistry,
University of California, San Diego: Analysis of the response of protein synthesis to temperature shift in S.
cerevisiae.
P. FARABAUGH, C. ILGEN, and G. R. FINK, Department of Biochemistry, Cellular and Molecular Biology,
Cornell University, Ithaca, New York: The structure of the his4 region.
S. HOLMBERG,* M. C. KIELLAND-BRANDT,* T. NILSSON-TILLGREN," and J. G. L. PETERSEN,* *Department of
Physiology, Carlsberg Laboratory, Copenhagen;* Institute of Genetics, University of Copenhagen, Den-
mark: Genetic transformation of his4 deletion mutants in yeast without the involvement of bacterial
plasmids.
J. SCHWARTZ, W. Loos, and H. GREER, Biology Department, Harvard University, Cambridge, Massachusetts:
Regulatory mutations of the his4 promoter and of genes involved in general control of amino acid
biosynthesis.
T. NILSSON-TILLGREN,* J. G. L. PETERSEN,' S. HOLMBERG,' and M. C. KIELLAND- BRANDT,5 *Institute of Genetics,
University of Copenhagen; *Department of Physiology, Carlsberg Laboratory, Copenhagen, Denmark:
Stabilization by chromosomal integration of his4 from an unstable yeast transformant.
G. MCKNIGHT and F. SHERMAN, Department of Radiation Biology and Biophysics, University of Rochester
School of Medicine, New York: A deletion causing overproduction of yeast iso-2-cytochrome c.
G. FAYE, K. TATCHELL, K. NASMYTH, and B. HALL, Department of Genetics, University of Washington, Seattle:
Transformation of yeast by plasmids containing the iso-1-cytochrome c gene.
R. S. ZITOMER,* D. L. MONTGOMERY,' D. L. NICHOLS,* and B. D. HALL,' *Department of Biological Sciences,
State University at Albarty, New York; *Genetics Department, University of Washington, Seattle: Trans-
criptional regulation of the yeast iso-l-cytochrome c gene.
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M. CRABEEL,* F. MESSENGUY,t F. LACROUTE,' and N. GLANSDORFF,* *Vrije Universiteit Brussels, Belgium;
tCERIA, Institut de Recherches, Brussels; tIBMC, Centre National de la Recherche Scientifique, Stras-
bourg, France: Cloning of ar3, the structural gene for ornithine carbamoyltransferase (OTCase) in S.
cerevisiae.
D. GALLWITZ, Institut fur Physiologische Chemie, Universitat Marburg, Germany: Molecular coloning of the
actin gene from yeast (S. cerevisiae).
V. M. WILLIAMSON, K. NASMYTH, J. BENNETZEN, B. D. HALL, and E. T. YOUNG, Department of Biochemistry and
Department of Genetics, University of Washington, Seattle: Cloning the constitute alcohol dehydro-
genase gene by transformation of yeast.
P. SHALIT, K. LOUGHNEY, M. V. OLSON, and B. D. HALL, Department of Genetics, University of Washington,
Seattle: Isolation and characterization of the DNA corresponding to the CYO -SUP4 interval in S.
cerevisiae.
Session 8: Regulation. I.
Chairperson: F. LACROUTE, Centre National de la Recherche Scientifique, Strasbourg, France
L. RODRIGUEZ, T. MIZUNAGA, V. L. MACKAY, J. S. TKACZ, and J. 0. LAMPEN, Waksman Institute of Microbiol-
ogy, Rutgers University, Piscataway, New Jersey: SUC1 is a structural gene for invertase.
D. PERLMAN and H. 0. HALVORSON, Brandeis University, Waltham, Massachusetts: Regulation of the SUC
genes in S. cerevisiae.
M. CARLSON and D. BOTSTEIN, Department of Biology, Massachusetts Institute of Technology, Cambridge:
Genetic studies of sucrose utilization in yeast.
K. A. Bos-nAN, R. C. LEE, and H. 0. HALVORSON, Brandeis University, Waltham, Massachusetts: Genetic
regulation of multiple mRNAs coding for repressible yeast acid phosphatase polypeptide.
M. E. SCHWEINGRUBER and A. M. SCHWEINGRUBER, Institute for General Microbiology, Bern, Switzerland:
Repressible acid phosphatase is developmentally modulated in S. cerevisiae.
A. P. BOLLON, Department of Biochemistry, University of Texas Health Science Center, Dallas: Analysis of
ilv 1 functional domains.
B. ERREDE,* F. SHERMAN,* E. DUBOIS, t J. DESCHEMPS,t and J. M. WIAME,, *Department of Radiation Biology
and Biophysics, University of Rochester School of Medicine, New York; Institut de Recherches du
CERIA, Brussels, Belgium: Concomitant control of a class of regulatory mutations and mating functions in
S. cerevisiae.
M. CIRIACY, Institut fur Mikrobiologie der Technischen Hochschule, Darmstadt, Germany: Cis- and trans-
acting regulatory elements of glucose-repressible alcohol dehydrogenase (ADHII) synthesis.
L. BISSON and J. THORNER, Department of Microbiology and Immunology, University of California, Berkeley:
Thymidylate synthetase from S. cerevisiae and its overproduction.
Session 9: Regulation. II.
Chairperson: G. FINK, Cornell University, Ithaca, New York
D. CHALEFF, S. ROEDER, and G. R. FINK, Department of Biochemistry, Molecular and Cell Biology, Cornell
University, Ithaca, New York: An insertion mutation in the his4 region.
T. P. ST. JOHN, S. SCHERER, M. MCDONELL, and R. W. DAVIS, Department of Biochemistry, Stanford University
School of Medicine, California: A transcriptional and genetic analysis of galactose inducible yeast genes.
K. STRuiii. and R. W. DAVIS, Department of Biochemistry, Stanford University School of Medicine, California:
DNA sequence analysis of his3 promoter mutants.
M. R. CHEVALLIER, R. JUND, and F. LACROUTE, Institut de Biologie Moleculaire et Cellulaire, Strasbourg,
France: Study on specific mRNAs produced in yeast by a chimeric yeast-E. coli plasmid.
J. P. HOLLAND, G. THILL, and M. J. HOLLAND, Department of Biochemistry, University of Connecticut Health
Center, Farmington: Structural analysis of repeated yeast glyceraldehyde 3-phosphate dehydrogenase and
enolase genes.
D. L. MONTGOMERY,* D. W. LEUNG,, M. SMITH:, G. FAYE,* P. SHALIT,* and B. D. HALL,* *Department of
Genetics, University of Washington, Seattle; tDepartment of Biochemistry, University of British Colum-
bia, Vancouver, Canada: Cloning and sequencing the iso-2-cytochrome c gene.
J. I. STILES, C. HELMS, T. S. CARDILLO, and F. SHERMAN, Department of Radiation Biology and Biophysics,
University of Rochester School of Medicine, New York: A transposition of the CYC1 gene causing
overproduction of iso-l-cytochrome c in yeast.
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J. M. Boss, M. D. DARROW, and R. S. ZrromEK, Department of Biological Sciences, State University of New
York, Albany: Characterization of the iso-1-cytochrome c mRNA.
T. DONAHUE and S. HENRY, Department of Genetics, Albert Einstein College of Medicine, Bronx, New York:
Biochemical and genetic analysis of inosito1-1-phosphate synthase mutants of yeast.
Session: 10 Poster Session
M. D. MENDENHALL, C. CUMMINS, and M. R. CULBERTSON, Laboratories of Genetics and Molecular Biology,
University of Wisconsin, Madison: Properties of yeast cloning vectors.
K. NASMYTH and B. HALL, Department of Genetics, University of Washington, Seattle: A simple method for
constructing random DNA fragment libraries.
R. NEEDLEMAN, J. COHEN, H. FEDEROFF, and J. MARMUR, Albert Einstein College of Medicine, Bronx, New
York: Isolation of yeast genes by shotgun transformation of yeast-Cloning of the genes ILVI and LYS1.
B. HOHN and A. HINNEN, Friedrich Miescher-Institut, Basel, Switzerland: Yeast "transfusion" with a cosmid
type cloning vector.
J. F. SCOTT, Molecular Biology Institute, University of California, Los Angeles: Construction and character-
ization of a high-copy-number circular yeast minichromosome containing the trpl gene.
M. SALVATO, T. ETCHEVERRY, and C. GUTHRIE, Department of Biochemistry and Biophysics, University of
California, San Francisco: Isolation of the gene for the tRNAucG of S. cerevisiae.
J. R. BROACH, Cold Spring Harbor Laboratory, New York: Identification and recovery of specific alleles by
transformation in yeast.
D. Y. THOMAS and A. P. JAMES, Division of Biological Sciences, National Research Council, Ottawa, Canada:
Transformation of yeast with suppressor tRNA genes.
J. OLAH and H. FELDMAN, Institut fur Physiologische Chemie, Physikalische Biochemie and Zellbiologie der
Universitat Miinchen, Germany: Analysis of tRNA genes in yeast.
R. C. DICKSON, Department of Biochemistry, University of Kentucky, Lexington: Expression of a foreign
eukaryotic gene in S. cerevisiae.
H. FEDEROFF and H. FRIED, Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New
York: Behavior of the mouse /3- globin gene in S. cerevisiae.
J. VAN DEN BERG* J. D. BEGGS,t A. VAN DOYEN,* and C. WEISSMANN,* *Institut fur Molekularbiologie 1,
Universitat Zurich, Switzerland; ',Plant Breeding Institute, Cambridge, England: Transcription of a rabbit
/3- globin gene in yeast cells.
J. COHEN,* R. NEEDLEMAN,t R. ECCLESHALL,* H. FEDEROFF,* and J. MARMUR,* *Albert Einstein College of
Medicine, Bronx, New York; tWayne State Medical School, Detroit, Michigan: Functional expression of
an E. coli plasmid gene, cam' in the yeast S. cerevisiae.
A. KLAR, J. HICKS, M. DUBOW, J. BROACH, and J. STRATHERN, Cold Spring Harbor Laboratory, New York:
Expression of bacterial genes in yeast.
D. KASUNIC and S. R. KUSHNER, Department of Biochemistry, University of Georgia, Athens: Factors affecting
the expression of yeast genes in E. coli K-12.
A. STOTZ and P. PHILIPPSEN, Biozentrum, University of Basel, Switzerland: Analysis of expression of cloned
yeast suppressor tRNA genes in E. coli and S. cerevisiae.
M. ROSE and D. BOTSTEIN, Department of Biology, Massachusetts Institute of Technology, Cambridge:
Expression of the yeast ura3 gene on phage A in E. coli.
K. STRUHL and R. W. DAVIS, Department of Biochemistry, Stanford University School of Medicine, California:
Expression and regulation of the his3 gene in yeast and in E. coli.
J. A. JAEHNING, L. POLDER, and R. W. DAVIS, Department of Biochemistry, Stanford University, California:
Selective interactions of E. coli RNA polymerase with the yeast his gene.
D. COLBY, T. ETCHEVERRY, and C. GUTHRIE, Department of Biochemistry and Biophysics, University of
California, San Francisco: Nucleotide modification in ochre specific suppressor tRNAs.
T. ETCHEVERRY and C. GUTHRIE, Department of Biochemistry and Biophysics, University of California, San
Francisco: Analysis of recessive lethality caused by an ochre suppressor tRNA in S. cerevisiae.
D. D. WOMBLE, J. H. CRAMER, and R. H. ROWND, Laboratory of Molecular Biology and Department of
Biochemistry, University of Wisconsin, Madison: Analysis of variant ribosomal DNA types in yeast.
T. J. ZAMB and T. D. PETES, Department of Microbiology, University of Chicago, Illinois: Characterization of
junction fragments in Saccharomyces.
123
S. SMOLIK-UTLAUT and T. PETES, Department of Microbiology, University of Chicago, Illinois: A comparison
of the restriction patterns for two forms of ribosomal DNA in S. cerevisiae.
R. ROTHSTEIN, Department of Microbiology, New Jersey School of Medicine, Newark: Deletions of SUP4 are
promoted by 5 sequences.
H. FRIED and H. FEDEROFF, Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New
York: The reverse transcription of yeast rRNA.
G. E. WILLICK,* M. YAGUCHI,* and R. N. MAZAR,t *Division of Biological Sciences, National Research
Council, Ottawa, Canada; 'Department of Botony and Genetics, University of Guelph, Canada: The 5S
RNA protein complex from S. cerevisiae.
A. RUET, F. IBORRA, J. HUET, M. SAWADOGO, A. SENTENAC, and P. FROMAGEOT, Commissariat N l'Energie
Atomique, Centre d'Etudes Nucleaires de Sac lay, Departement de Biologie, Service de Biochimie,
Gif-sur-Yvette, France: Subunit function in yeast RNA polymerases.
J. WALLIS,* K. E. DIAMOND,* L. HEREFORD,' and M. GRUNSTEIN,* *Molecular Biology Institute and Depart-
ment of Biology, University of California, Los Angeles; tRosenstiel Institute, Brandeis University,
Waltham, Massachusetts: Histone gene activity in S. cerevisiae.
A. SINGH, Department of Biochemistry, University of Wisconsin, Madison: Hygromycin B resistant mutants
of S. cerevisiae.
J. PLESSET, M. TUITE, C. S. MCLAUGHLIN, and K. MOLDAVE, Department of Biological Chemistry, University of
California, Irvine: Characterization of a yeast in vitro protein synthesizing system.
M. TUITE, J. PLESSET, C. S. MCLAUGHLIN and K. MOLDAVE, Department of Biological Chemistry, University of
California, Irvine: Faithful translation of natural mRNAs in a yeast cell-free system.
P. BAUM, R. KUNISAWA, and J. THORNER, Department of Microbiology and Immunology, University of
California, Berkeley: A new method for the preparation of nuclei from S. cerevisiae.
G. IDE and C. SAUNDERS, Department of Biochemistry and Biophysics, Oregon State University, Corvallis:
Rapid isolation of yeast nuclei.
H. KOCH* and J. KIEFER,' *Max-Planck-Institut fiir Biologie, Tilbingen; tStrahlenzentrum /Biophysik, Giessen,
Germany: Transcript sizes in yeast as determined by UV-induced premature termination of transcription.
H. DAVIS,* B. CROSBY,' L. PRAKASH," and D. HINKLE,* Departments of .*Biology and 'Radiation Biology and
Biophysics, University of Rochester, New York: Purification and characterization of a uracil-DNA
glycosylase from yeast.
C. MOORE, Department of Biology and Department of Radiation Biology and Biophysics, University of
Rochester, New York: DNA damage and cell-killing by phleomycin and bleomycin.
B. MONTELONE,* L. PRAKASH," and S. PRAKASH,* Departments of *Biology and 'Radiation Biology and
Biophysics, University of Rochester, New York: Effects of the m ms2 1 gene on recombination and
spontaneous and induced mutations in S. cerevisiae.
D. LOHR,* K. TATCHELL," and J. MARDIAN,t *Department of Chemistry, Arizona State University, Tempe;
'Department of Genetics, University of Washington, Seattle; tBiology Division, Oak Ridge National
Laboratory, Tennessee: The capability of yeast histone to reconstitute a native core particle.
U. WINTERSBERGER and D. BLUTSCH, Institute for Cancer Research, University of Vienna, Austria: Identifica-
tion of a multifunctional DNA binding protein from yeast?
S. G. LABONNE and L. B. DUMAS, Department of Biochemistry and Molecular Biology, Northwestern
University, Evanston, Illinois: A DNA helix-destabilizing protein from baker's yeast.
M. F. TUITE, L. DICAPRIO, B. S. Cox, and B. FUTCHER, Botany School, Oxford, England: Suppression of alleles
of rad 6, S-phase repair-The theory of mutation induction.
R. J. REYNOLDS and E. C. FRIEDBERG, Department of Pathology, Stanford University, California: UV-induced,
endogenous single-strand breaks in excision deficient rad mutants of S. cerevisiae.
Session 1 1: Regulation. III.
Chairperson: E. JONES, Carnegie-Mellon University, Pittsburgh, Pennsylvania
T. G. COOPER, University of Pittsburgh, Pennsylvania: Control and coordination of nitrogen metabolism in
yeast-A model.
B. A. HEMMINGS, NHLBI, National Institutes of Health, Bethesda, Maryland: Regulation of nitrogen metabo-
lism in yeast by proteolysis and protein phosphorylation.
M. C. BRANDRISS and B. MAGASANIK, Department of Biology, Massachusetts Institute of Technology, Cam-
bridge: One enzyme, two pathways, two inducers.
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M. S. COHN, C. W. TABOR, and H. TABOR, National Institutes of Health, Bethesda, Maryland: Mutations
affecting expression of yeast ornithine decarboxylase.
F. LACROUTE, R. LOSSON, and G. LOISON, Institut de Biologie Moleculaire at Cellulaire, Centre National de la
Recherche Scientifique, Strasbourg, France: Regulatory mutations constitutive for OMPdecase, product of
the yeast ura 3 gene.
G. IDE, Department of Biochemistry and Biophysics, Oregon State University, Corvallis: In vitro initiation of
transcription in isolated yeast nuclei.
S. LILLIE, M. BANUELOS, and J. R. PRINGLE, Division of Biological Sciences, University of Michigan, Ann Arbor:
Roles and control of reserve carbohydrate metabolism during the yeast life cycle.
J. WOOLFORD, L. HEREFORD, K. FARHNER, and M. ROSBASH, Department of Biology and Rosenstiel Center,
Brandeis University, Waltham, Massachusetts: Ribosomal protein genes of yeast.
D. R. KIEF and J. R. WARNER, Departments of Cell Biology and Biochemistry, Albert Einstein College of
Medicine, Bronx, New York: Coordinate control of synthesis of rRNA and ribosomal protein during a
nutritional shift-up.
Session 12: rDNA and tRNA
Chairperson: F. SHERMAN, University of Rochester, New York
J. W. SZOSTAK, Division of Genetics, Sidney Farber Cancer Institute, Boston, Massachusetts: Replication and
sequence rectification of the rDNA of yeast.
T. D. PETES, Department of Microbiology, University of Chicago, Illinois: Unequal meiotic recombination of
yeast ribosomal DNA genes.
A. K. HOPPER, L. SCHULTZ, and R. SHAPIRO, University of Massachusetts Medical School, Worcester: Yeast
mutants defective in tRNA biosynthesis.
J. KURJAN,* B. D. HALL,* and M. SMITH,t *Department of Genetics, University of Washington, Seattle;
+Department of Biochemistry, University of British Columbia, Vancouver, Canada: A fine structure
genetic and sequence analysis of the SUP4 locus.
C. GUTHRIE, D. COLBY, T. ETCHEVERRY, and M. SALVATO, Department of Biochemistry and Biophysics,
University of California, San Francisco: Processing of S. cerevisiae tRNA precursors containing interven-
ing sequences.
J. KOHLI, S. SHARP, and D. SOLL, Department of Molecular Biophysics and Biochemistry, Yale University,
New Haven, Connecticut: UGA suppressor tRNAs in Schizosaccharomyces pombe.
C. CUMMINS,* R. GABER,* I. EDELMAN,* M. MENDENHALL,* M. CULBERTSON,* R. MANN,t and G. FiNict
*Laboratories of Genetics and Molecular Biology, University of Wisconsin, Madison; +Department of
Botany, Genetics, and Development, Cornell University, Ithaca, New York: Isolation and properties of
group III frameshift suppressors.
M. MASUREKAR,* E. PALMER,t ). M. WILHELM,t and F. SHERMAN,* Departments of *Radiation Biology and
Biophysics and +Microbiology, University of Rochester School of Medicine and Dentistry, New York:
Altered 40 S ribosomal subunits from an omnipotent suppressor strain.
Session 13: Chromosome Structure
Chairperson: D. BOTSTEIN, Massachusetts Institute of Technology, Cambridge
L. HEREFORD and K. FAHRNER, Rosenstiel Center, Brandeis University, Waltham, Massachusetts: Yeast histone
genes.
D. B. KABACK* and L. HEREFORD,t *Department of Chemistry, California Institute of Technology, Pasadena;
tRosenstiel Center, Brandeis University, Waltham, Massachusetts: Organization of yeast histone 2A and
2B genes and other transcribed sequences as investigated by R-loop mapping.
U. WINTERSBERGER and B. MARIAN, Institute for Cancer Research, University of Vienna, Austria: Uncoupling
of histone synthesis from premeiotic DNA replication in sporulating yeast, S. cerevisiae.
D. H. WILLIAMSON and D. J. FENNELL, National Institute for Medical Research, Mill Hill, England: Non-
random assortment of sister chromatids in mitotically dividing cells of S. cerevisiae.
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D. LoHR* and K. E. VAN HOLDE,t *Department of Chemistry, Arizona State University, Tempe; tDepartment
of Biochemistry/Biophysics, Oregon State University, Corvallis: The arrangement of nucleosomes in yeast
chromatin.
A. J. KINGSMAN,* A. C. CHINAULT,t L. CLARKE,* R. HITZEMAN,* and J. CARBON,* *Department of Biological
Sciences, University of California, Santa Barbara; tDepartment of Medicine, Baylor College, Houston,
Texas: Organization of sequences surrounding the centromere of chromosome III in S. cerevisiae.
L. DAVIDOW, L. GOETSCH, and B. BYERS, Department of Genetics, University of Washington, Seattle: Genetic
basis and consequences of a reversible thermal arrest of yeast meiosis at pachytene.
J. GAFNER,* H. EIBEL,* M. BRENNAN,* B. HOHN,t and P. PHILIPPSEN,* *Department of Microbiology, Biozen-
trum, University of Basel; tFriedrich Miescher Institut, Bawl, Switzerland: Analysis of integration sites of
mobile elements in yeast.
H. GREER and D. PHEASANT, Biology Department, Harvard University, Cambridge, Massachusetts: A yeast
transposable element which carries the his4C gene.
C. NEWLON, J. N. STRATHERN, and J. B. HICKS, Cold Spring Harbor Laboratory, New York: Isolation of a
circular derivative of yeast chromosome III.
G. P. JANSEN, M. C. BARNEY, and J. R. HELBERT, Miller Brewing Company, Milwaukee, Wisconsin:
Nonvector-associated genetic transformation of flocculence in yeast.
Session 14: Recombination, Repair, and DNA Synthesis
Chairperson: S. FOGEL, University of California, Berkeley
S. GOLTZ,* M. BELFORT,t L. DUMAS,* and D. BENESH,* *Department of Biochemistry and Molecular Biology,
Northwestern University, Evanston, Illinois; iDivision of Laboratories and Research, New York State
Department of Health, Albany: Isolation and characterization of A-yeast recombinant phages able to
replicate in DNA primase defective E. coli.
M. N. CONRAD and C. S. NEWLON, Department of Zoology, University of Iowa, Iowa City: Characterization
of DNA synthesis in cdc2.
B. K. TYE and C. S. M. CHAN, Section of Biochemistry, Molecular and Cell Biology, Cornell University,
Ithaca, New York: Chromosomal replication origins in yeast.
D. STINCHCOMB, M. THOMAS, and R. DAVIS, Department of Biochemistry, Stanford University School of
Medicine, California: Isolation and characterization of yeast chromosomal replicators.
B. CROSBY,* L. PRAKASH,* and D. HINKLE,t Departments of *Radiation Biology and Biophysics and tBiology,
University of Rochester, New York: Isolation of a DNA binding protein from yeast.
B. MONTELONE,* L. PRAKASH,t and S. PRAKASH,* Departments of *Biology and tRadiation Biology and
Biophysics, University of Rochester, New York: Characteristics of spontaneous mitotic recombination in
S. cerevisiae.
J. E. WAGSTAFF, J. E. GOLIN, and M. S. ESPOSITO, Department of Biology and Committee on Genetics,
University of Chicago, Illinois: Spontaneous mitotic recombination in a/a and cdot diploids of S. cere-
visiae.
V. L. MACKAY and L. Buss, Waksman Institute of Microbiology, Rutgers University, Piscataway, New Jersey:
Mating-type dependent repair of MMS damage is a constitutive function.
M. FRANKENBERG-SCHWAGER, D. FRANKENBERG, D. BL?OCHER, and C. ADAMCZYK, Gesellschaft fur Strahlen and
Umweltforschung, Munchen, and Abteilung Biophysikalische Strahlenforschung, Frankfurt, Germany:
Repair of DNA double-strand breaks under nongrowth conditions.
W. J. JACHYMCZYK" and R. C. VON BORSTEL,* *Department of Genetics, University of Alberta, Edmonton,
Canada; tInstitute of Biochemistry and Biophysics, Polish Academy of Science, Warsaw: Removal of
interstrand cross-links from DNA of S. cerevisiae-Comparison of two pathways for DNA repair.
This meeting was supported in part by contributions from the Miller Brewing Co., Labatt Breweries of
Canada, Ltd., and the Upjohn Co.
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233 participants
Session 1: DNA Replication
M. LUSKY and G. HOBOM, Institut fur Biologie III, Universitat Freiburg, Germany: Inceptor and origin of DNA
replication in bacteriophage lambda.
K. GEIDER and T. F. MEYER, Abteilung Molekulare Biologie, Max-Planck-Institut, Heidelberg, Germany: Replica-
tion of fd RF with purified proteins.
T. F. MEYER and K. GEIDER, Abteilung Molekulare Biologie, Max-Planck Institut, Heidelberg, Germany: Proper-
ties of isolated phage fd gene II-protein.
R. A. GRANT and R. E. WEBSTER, Department of Biochemistry, Duke University, Durham, North Carolina: Studies
on the gene V protein/DNA complex of the filamentous bacteriophage Fl.
S. WICKNER, NCI, National Institutes of Health, Bethesda, Maryland: Phage P22 gene 12 protein functions in
vitro in oligonucleotide synthesis catalyzed by dnaG protein.
R. MAURER and D.BOTSTEIN, Department of Biology, Massachusetts Institute of Technology, Cambridge: Interac-
tion between host- and phage-specified replication proteins during growth of Salmonella phage P22.
L. W. BORQUE and J. R. CHRISTENSEN, Department of Microbiology, University of Rochester, New York: DNA
synthesis of bacteriophage T1.
G. L. STETLER, G. J. KING, and W. M. HUANG, Department of Cellular, Viral, and Molecular Biology, University of
Utah, Salt Lake City: T4 DNA-delay proteins, required for specific T4 DNA replication, form a complex
which untwists superhelical DNA in an ATP-dependent reaction.
D. GHOSAL, G. MOSIG, and S. BOCK, Department of Molecular Biology, Vanderbilt University, Nashville,
Tennessee: Genetic instability in gene 32 (DNA binding protein, HDP) of phage T4.
S. BENEDICT and G. MOSIG, Department of Molecular Biology, Vanderbilt University, Nashville, Tennessee:
Analysis of replicating T4 DNA by Southern hybridization.
M. E. HALPERN, Department of Human Genetics, University of Pennsylvania, Philadelphia: The origins of T4
DNA replication-the first two.
M. J. STEPHEN,* D. VAPNEK,* and J. R. SCOTT:, *Department of Microbiology, University of Georgia, Athens;
'Department of Microbiology, Emory University, Atlanta, Georgia: Localization of the origin(s) or
replication of bacteriophage
F. TAMANOI and C. C. RICHARDSON, Department of Biological Chemistry, Harvard Medical School, Boston,
Massachusetts: Site specific initiation of DNA replication in vitro on a cloned segment of T7 DNA.
K. J. BARRETT,* A. BLINKOWA,' and G. ARNOLD,* *Max-Planck-Institut fur Virusforschung, Tilibingen, Ger-
many; 'Institute of Microbiology, University of Warsaw, Poland: Isolation and characterization of
temperature-sensitive mutants in the a gene of phage P4.
Session 2: Morphogenesis
R. HAMATAKE,* R. MUKAbt and M. HAYASHI,* *Department of Biology, University of California, San Diego;
'Institute of Basic Medical Science, University of Tsukuba, Nihari-gun, Japan: Morphogenesis of bac-
teriophage cloX174.
Y. NAKASHIMA,* R. L. WISEMAN,T B. FRANGIONE,' and W. H. KONIGSBERG,§ *National Institute of Environ-
mental Health Sciences, Research Triangle Park, North Carolina; 'Department of Biochemistry, Public
Health Research Institute of the City of New York, Inc.; 'Irvington House Institute, New York University
Medical Center, New York; §Department of Molecular Biophysics and Biochemistry, Yale University,
New Haven, Connecticut: Structure of the major coat protein of the filamentous bacteriophages.
Y. C. NG and A. K. DUNKER, Chemistry Department, Washington State University, Pullman: Effects of
oxidative phosphorylation uncouplers on the assembly of the filamentous phage fd.
M. F. SHEMYAKIN and S. K. ZAVRIEV, Shemyakin Institute of Bioorganic Chemistry, USSR Academy of
Sciences, Moscow, and Beritashvili Institute of Physiology, Georgian SSR Academy of Sciences, Tbilisi:
Blocking of DNA transfer from T7 virion into host cell by inhibitors of bacterial RNA polymerase.
M. ONTELL and D. NAKADA, Department of Biochemistry, University of Pittsburgh School of Medicine,
Pennsylvania: Involvement of T7 phage gene 2 DNA packaging.
B. KEMPER, Institut fur Genetik, Univesrsitat Köln, Germany: Action of purified gene 49-controlled nuclease
on very fast sedimenting DNA and its role in the development of phage T4.
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D. W. BOWDEN and P. MODRICH, Department of Biochemistry, Duke University, Durham, North Carolina: In
vitro studies on the P2 ter reaction.
J. SEDIVY, B. WALSH, R. GOLDSTEIN, and J. GEISSELSODER, Department of Microbiology and Molecular
Genetics, Harvard Medical School, Boston, Massachusetts: Triangulation numbers of the phages P2 and
P4.
M. B. ADAMS and S. CASIENS, Department of Cellular, Viral, and Molecular Biology, University of Utah
Medical Center, Salt Lake City: On the autogenous regulation of P22 scaffolding protein.
M. FULLER and J. KING, Department of Biology, Massachusetts Institute of Technology, Cambridge: Assembly
of active P22 proheads in vitro from purified coat and scaffolding protein.
D. GOLDENBERG, D. SMITH, and J. KING, Department of Biology, Massachusetts Institute of Technology,
Cambridge: Temperature sensitive mutants blocking maturation of the thermostable P22 tailspike protein.
J. KOCHAN and H. MURIALDO, Department of Medical Genetics, University of Toronto, Canada: Biologically
active intermediates in X prohead assembly.
M. SUMNER-SMITH, A. BECKER, and H. MURIALDO, Department of Medical Genetics, University of Toronto,
Canada: In vitro complementation between XNul- and XAam extracts.
J. 0. THOMAS and M. E. KERSHAW, Department of Biochemistry, New York University School of Medicine,
New York: The in situ arrangement of phage DNA.
Session 3: Bacteriophage Mu
P. VAN DE PUTTE, Laboratory of Biochemistry, University of Leiden, The Netherlands: The G area of
bacteriophage Mu.
R. CLAYTON, W. SCHUMANN, and E. G. BADE, Universitat Konstanz, Germany: In vitro insertions and
deletions in the G segment of phage Mu DNA do not abolish the inversion process.
D. KWOH, T. J. KwoH, and D. ZIPSER, Cold Spring Harbor Laboratory, New York: Analysis of the cloned
genome of phage Mu.
C. CHASE and R. BENZINGER, Department of Biology, University of Virginia, Charlottesville: Identification of a
protein which protects bacteriophage Mu DNA against host cell nuclease.
J. WILLIAMS and C. RADDING, Department of Molecular Biophysics and Biochemistry, Yale University, New
Haven, Connecticut: Partial purification of an exonuclease inhibitor induced by bacteriophage Mu.
V. N. KRYLOV, V. G. BocusH, A. S. YANENKO, and N. B. KIRSANOV, All-Union Research Institute for Genetics
and Selection of Industrial Microorganisms, Moscow, USSR: Bacteriophages of Pseudomonas aeruginosa
with Mu-like DNA structure.
Session 4: Replication and Transposition of Mu
L. T. CHOW, J. M. SCOTT, and R. LA PORTA, Cold Spring Harbor Laboratory, New York: The relationship
between phages Mu and D108.
D. KAMP and R. KAHMANN, Cold Spring Harbor Laboratory, New York: Structural aspects of bacteriophage
Mu integration.
G. CHACONAS and A. I. BUKHARI, Cold Spring Harbor Laboratory, New York: Association of Mu containing
plasmids with the E. coli chromosome upon prophage induction.
R. M. HARSHEY and A. I. BUKHARI, Cold Spring Harbor Laboratory, New York: Electron microscopic study of
Mu DNA transposition.
J. W. SCHUMM and M. M. HOWE, Department of Bacteriology, University of Wisconsin, Madison: Properties
of X phages containing both ends of Mu.
R. Y05HIDA and M. M. HOWE, Department of Bacteriology, University of Wisconsin, Madison: Lysogeniza-
tion and development of Mu and Mu nu phages in E. coli and him mutant strains.
A. TOUSSAINT, M. FAELEN, L. DESMET, and A. RESIBOIS, Faculte de Medecine, Universite Libre de Bruxelles,
Belgium: Physiological relationship between mutator phages Mu and D108.
R. FITTS and A. L. TAYLOR, University of Colorado Health Sciences Center, Denver: Integration of Mu DNA at
host chromosomal replication forks.
B. WAGGONER,* A. TOUSSAINT,' and M. PATO,* *National Jewish Hospital and Research Center, Denver,
Colorado; tFree University of Brussels, Belgium: A new function required for normal Mu DNA replica-
tion.
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H. BIALY, B. WAGGONER, and M. PATO, National Jewish Hospital and Research Center, Denver, Colorado:
The fate of an RP4: :Mu plasmid after induction of the prophage.
K. H. WESTPHAL, and E. G. BADE, Fachbereich Biologie, Universitat Konstanz, Germany: Early replication of
temperate bacteriophage Mu.
Session 5: Integrative Recombination
R. HOESS,* K. BIDWELL,* C. FOELLER,t and A. LANDY,t *Cancer Biology Program, Frederick Cancer Research
Center, Maryland; +Division of Biology and Medicine, Brown University, Providence, Rhode Island:
DNA sequence analysis of the lambda int-xis region.
M. MIZUUCHI and K. MIZUUCHI, Laboratory of Molecular Biology, National Institutes of Health, Bethesda,
Maryland: In vitro study of the integrative recombination of X.
K. ABREMSKI and S. GOTTESMAN, NCI, National Institutes of Health, Bethesda, Maryland: A comparison
between A integration and excision in vitro.
C. GRITZMACHER, L. ENQUIST, and R. WEISBERG, National Institutes of Health, Bethesda, Maryland: Xis-
independent excision of bacteriophage X-Isolation and characterization of an xin mutant.
L. W. ENQUIST and M. J. MADDEN, NCI, National Institutes of Health, Bethesda, Maryland: Does A have a
preferred secondary integration site?
M. L. PEARSON,* C. EPP,* and L. W. ENQUIST,t *Department of Medical Genetics, University of Toronto,
Canada; +NCI, National Institutes of Health, Bethesda, Maryland: Cis-dominant inhibition of A INT
synthesis by the /3-region.
D. MASCARENHAS, M. BENEDIK, and A. CAMPBELL, Department of Biological Sciences, Stanford University,
California: DNA sequence of trp-int fusions in the integrase regulatory region of bacteriophage lambda.
M. J. BENEDIK and A. M. CAMPBELL, Department of Biological Sciences, Stanford University, California:
Genetic analysis of integrase regulation in bacteriophage X.
S. AUSTIN and N. STERNBERG, Cancer Biology Program, Frederick Cancer Research Center, Maryland: A novel
role for site-specific recombination in the maintenance of the P1 plasmid prophage.
T. J. FOSTER, K. TAKESHITA, and N. KLECKNER, The Biological Laboratories, Harvard University, Cambridge,
Massachusetts: The role of Tn10-encoded functions and sites in transposon-related recombination events.
V. LUNDBLAD and N. KLECKNER, The Biological Laboratories, Harvard University, Cambridge, Massachusetts:
Precise excision and nearly-precise excision of Tn10.
R. A. FISHER, K. KRIZSANOVICH-WILLIAMS, and M. FEISS, Department of Microbiology, University of Iowa, Iowa
City: Packaging of the bacteriophage lambda chromosome -Isolation and characterization of the cos 1
mutation and the analysis of cos+ revertants.
C. PARSONS,* P. TOMICH,* R. DEANS,' and D. FRIEDMAN,* Departments of *Microbiology and +Biological
Chemistry, University of Michigan, Ann Arbor: ARF -A phage that rescues "silent" copies of P22 genes
in an E. col/ K12 strain.
Session 6: A Promoters and Operators
J. ABRAHAM, R. FISCHER, and H. ECHOLS, Department of Molecular Biology, University of California, Berkeley:
Sequence analysis of the P, promoter region of bacteriophage lambda.
G. LAUER and R. PASTRANA, The Biological Laboratories, Harvard University, Cambridge, Massachusetts:
Interactions of the bacteriophage 434 repressor with operator DNA.
A. JOHNSON, B. J. MEYER, and M. PTASHNE, The Biological Laboratories, Harvard University, Cambridge,
Massachusetts: Specific cooperative interactions between DNA-bound repressors govern regulation by
the A phage repressor.
B. J. MEYER, R. MAURER, and M. PTASHNE, The Biological Laboratories, Harvard University, Cambridge,
Massachusetts: Molecular mechanisms for the regulation of the c/ and cro genes of phage A mediated by
A repressor and by cro product.
U. SCHMEISSNER, D. COURT, H. SHIMATAKE, and M. ROSENBERG, NCI, National Institutes of Health, Bethesda,
Maryland: Promoter for the establishment of repressor synthesis in bacteriophage X.
D. HAWLEY and W. MCCLURE, Department of Biochemistry and Molecular Biology, Harvard University,
Cambridge, Massachusetts: In vitro comparison of the initiation properties of bacteriophage lambda
wild-type PR and x3 mutant promoters.
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E. C. ROSENVOLD, E. CALVA, R. R. BURGESS, and W. SZYBALSKI, McArdle Laboratory, University of Wisconsin,
Madison: In vitro initiation of decanucleotide and longer transcripts at the leftward promoter pi,. in the b2
region of bacteriophage X DNA.
E. CALVA and R. R. BURGESS, McArdle Laboratory, University of Wisconsin, Madison: End-labeled in vitro
transcripts of bacteriophage lambda-Characterization of a rho-dependent 5S RNA.
S. ADI-IYA and M. GOTTESMAN, NO, National Institutes of Health, Bethesda, Maryland: Promoter competition
in bacteriophage X.
E. D. SVERDLOV, E. M. HODKOVA, L. I. PATRUSHEV, and M. F. SHEMYAKIN, Shemyakin Institute of Bioorganic
Chemistry, USSR Academy of Sciences, Moscow: The cloning of fragments of phage A imm434 DNA,
which contain some regulator sequences.
Session 7: A- Regulation of Gene Expression
N. C. FRANKLIN, Department of Biological Sciences, Stanford University, California: The N protein of lambda
defined by its DNA sequence.
J. GREENBLATT and J. Li, Banting and Best Department of Medical Research, University of Toronto, Canada:
The gene N protein of bacteriophage A- Purification, properties, and specific interactions and host-
coded proteins.
S. GOTTESMAN, P. TRISLER, and M. GOTTESMAN, NCI, National Institutes of Health, Bethesda, Maryland: The
functional decay of lambda N protein.
J. SHAW,* M. L. PEARSON,* and S. GOTTESMAN,' *Department of Medical Genetics, University of Toronto,
Canada; 'NCI, National Institutes of Health, Bethesda, Maryland: Stability of bacteriophage lambda N,
0, and cll proteins in Ion_ and rho_ bacteria.
H. SHIMATAKE, C. QUEEN, B. PATERSON, and M. ROSENBERG, NCI, National Institutes of Health, Bethesda,
Maryland: Multiple forms of X cll protein.
D. FORBES and I. HERSKOWITZ, Institute of Molecular Biology, University of Oregon, Eugene: Relief of polarity
in the gal operon by the action of Q in trans.
E. J. GRAYHACK, M. G. SCHECHTMAN, and J. W. ROBERTS, Department of Biochemistry, Cornell University,
Ithaca, New York: Late gene regulation in phage lambda.
J. N. ALEGRE, M. G. SCHECHTMAN, and J. W. ROBERTS, Department of Biochemistry, Cornell University, Ithaca,
New York: Phage 082 late gene regulation.
M. A. MOZOLA and D. I. FRIEDMAN, Department of Microbiology, University of Michigan, Ann Arbor: A X
mutant displaying a temperature-sensitive growth defect in himA_ strains.
E. L. FLAMM and D. I. FRIEDMAN, University of Michigan, Ann Arbor: Characterization of a X nutR mutant.
J. SWINDLE and C. GEORGOPOULOS, Department of Cellular, Viral, and Molecular Biology, University of Utah,
Salt Lake City: Studies with the groNB E. coli mutants.
K. TILLY and C. GEORGOPOULOS, Department of Cellular, Viral, and Molecular Biology, University of Utah,
Salt Lake City: Studies on groE mutants of E. coli.
H. MURIALDO, W. FIFE, A. BECKER, M. FEISS, and J. YOCHEN, Department of Medical Genetics, University of
Toronto, Canada, and Department of Microbiology, University of Iowa, Iowa City: Isolation and charac-
terization of Fl-independent mutants of X.
Session 8: Poster Session
M. M. HOWE,* J. W. SCHUMM,* J. A. ENGLER,' W. SCHUMANN,' and E. G. BADE,' *Department of
Bacteriology, University of Wisconsin, Madison; 'Cold Spring Harbor Laboratory, New York;
BFachbereich Biologie, Universitat Konstanz, Germany: Correlation of the genetic and physical maps of
bacteriophage Mu.
M. DUBOW, D. EVANS, N. SARVETNICK, and A. I. BUKHARI, Cold Spring Harbor Laboratory, New York:
Utilization of /3- lactamase as a measure of amp-encoding DNA replication.
J. E. MOTT and J. F. SPEYER, Department of Biological Sciences, University of Connecticut, Storrs: Character-
ization of 1.7 mutants able to overcome restriction by P2 lysogens.
S. HILLIKER, M. SCHLEIN, and M. DECou, Department of Biology, Bucknell University, Lewisburg, Pennsylva-
nia: Characterization of Salmonella phages P22 and L by means of A -P22 and A -L hybrid phages.
M. KAHN,* D. Ow,t B. SAUER," R. CALENDAR,' and A. RABINOWITZ,* *Department of Biology, University of
California at San Diego, La Jolla; tMolecular Biology Department, University of California, Berkeley:
Physical genetic map of the P4 phage genome.
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T. C. LIN and W. H. KONIGSBERG, Department of Molecular Biophysics and Biochemistry, Yale University
School of Medicine, New Haven, Connecticut: Isolation and characterization of a low molecular weight
viral coat protein from bacteriophage fd.
W. GERALD and J. KARAM, Department of Biochemistry, Medical University of South Carolina, Charleston:
Separate transcripts for T4 genes 45 and 44.
B. LABEDAN and E. B. GOLDBERG, Tufts University School of Medicine, Boston, Massachusetts: Role for a
membrane potential in phage T4 DNA injection (protonmotive force/inhibitors/phage/adsorption).
A. LUDER and G. MOSIG, Department of Molecular Biology, Vanderbilt University, Nashville, Tennessee:
Effects of mutations in gene 58-61 on T4 DNA metabolism.
L. GOLD, M. A. NELSON, D. PRIBNOW, B. SINGER, G. STORMO, M. COLKITT, and L. HUNTER, Department of
Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder: What's new in HI, and
some old stuff too.
G. H. WEVER and J. S. WIBERG, Department of Radiation Biology and Biophysics, University of Rochester
School of Medicine and Dentistry, New York: regA constraint on expression of recombinant DNA in
early genes of bacteriophage T4.
M. COUTURIER, F. BEX, J. JANSSENS, and A. DESMYTER, Department of Molecular Biology, Universite Libre de
Bruxelles, Belgium: Construction in vitro and properties of "phage-plasmid" chimerae.
Session 9: P1, P2, P4, and P22
P. YOUDERIAN and R. GOLDSTEIN, Department of Microbiology and Molecular Genetics, Harvard Medical
School, Boston, Massachusetts: Control of satellite P4 protein synthesis.
P. YOUDERIAN,* G. DENO,* M. CHIDAMBARAM,* G. GROVER,* L. TINELLI,* D. SHORE,* J. GEISSELSODER,* R.
GOLDSTEIN,* and E. LJUNGQUIST," *Department of Microbiology and Molecular Genetics Harvard Medi-
cal School, Boston, Massachusetts; tDepartment of Microbial Genetics, Karolinska Institutet, Stockholm,
Sweden: A conditional lethal mutant of satellite bacteriophage P4 unable to derepress its provirus helper.
B. H. LINDQVIST, Institute of Medical Biology, University of Tromso, Norway: Isolation of viable recombi-
nants between satellite phage P4 and its helper P2.
D. Ow and F. AUSUBEL, The Biological Laboratories, Harvard University, Cambridge, Massachusetts: Co li-
phage P4 as a cloning vector in Klebsiella pneumoniae.
A. R. POTEETE, Department of Biochemistry and Molecular Biology, Harvard University, Cambridge, Mas-
sachusetts: Control of P22 PR and PRM promoters by repressor.
F. WINSTON and D. BOTSTEIN, Department of Biology, Massachusetts Institute of Technology, Cambridge:
Lysogeny and anti-immunity in phage P22.
M. M. SUSSKIND, Department of Microbiology, University of Massachusetts Medical School, Worcester:
Identification of the P22 PANT in vitro transcript and of P22 PANT mutations.
K. R. LEASON, T. F. WEIGHOUS, and E. N. JACKSON, Department of Microbiology, University of Michigan, Ann
Arbor: Regulation of transcription of the late gene region of bacteriophage P22.
E. JACKSON and J. RUTILA, Department of Microbiology, University of Michigan, Ann Arbor: Genetic analysis
of cloned fragments of P22 DNA-Definition of a P22 physical gene map.
B. R. BAUMSTARK and J. R. SCOTT, Department of Microbiology, Emory University, Atlanta, Georgia: cl
repressor of phage P1.
H. HEILMANN,* A. PUNTER,* H. J. BURKARDT,* and J. N. REEVE,' *Institut fib' Mikrobiologie der Univesitat
Erlangen; tMax-Planck-Institut fur Molekulare Genetik, Berlin, Germany: Molecular analysis of the
restriction gene of phage P1.
R. J. MURAL, N. STERNBERG, and M. POWERS, Cancer Biology Program, Frederick Cancer Research Center,
Maryland: Isolation and characterization of X-P1 miniplasmids and their use in generating mutations in
plasmid maintenance functions.
Session 10: T-phage Chromosome Structure and Function
M. D. ROBERTS and H. DREXLER, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem,
North Carolina: A transducing mutant of T1 which cannot degrade E. coli DNA.
G. WILSON,* K. YOUNG,* G. EDLIN,* and W. KONIGSBERG,' *Department of Genetics, University of
California, Davis; Department of Molecular Biophysics and Biochemistry Yale University, Connecticut:
Generalized transduction by bacteriophage T4.
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G. WILSON,* R. NEVE,* G. EDLIN,* and W. KONIGSBERG,t *Department of Genetics, University of California,
Davis; +Department of Molecular Biophysics and Biochemistry, Yale University, Connecticut: The
genetic location of the Barn HI restriction site in the chromosome of bacteriophage T4.
K. CARLSON, Institute of Medical Biology, University of Tromso, Norway: Mapping of T4 DNA with
restriction endonucleases.
V. I. TANYASHIN, L.I. Li, A. I. KRUTILINA, G. G. PRYTISIUK, V. F. ZINKEVICH, V. N. BOLEZNINA, and A. A. BAYEV,
Institute of Biochemistry and Physiology of Microorganisms, USSR Academy of Sciences, Pushchino,
Moscow: T4 DNA structure and function-Genes 42-46 and 50-48 regions.
R. MARSH, M. MAHER, and J. YEE, Biology Program, University of Texas, Dallas: Restriction map of
bacteriophage T4.
C. G. GOFF, Biology Department, Haverford College, Pennsylvania: Cloning T4 genes which affect E. coli
RNA polymerase.
K. JACOBS, D. SHIBATA, and E. P. GEIDUSCHEK, Department of Biology, University of California, San Diego:
Regulation of expression of cloned T4 late genes by infecting T4 bacteriophage.
D. H. HALL, C. E. SMITH, and A. J. DERSHOWITZ, School of Biology, Georgia Institute of Technology, Atlanta:
Gene expression by bacteriophage T4 on mutants of E. coli with defective ribosomes.
B. GOMEZ, L. NUALART, and J. DEL BOSQUE, Departmento de Ecologia Humana, Facultad de Medicina,
Universidad Nacional Autonoma de Mexico: Abortive infection by bacteriophages T7 of an E. coli strain
in which no viral proteins are synthesized.
E. P. AMANN and J. N. REEVE, Max-Planck-Institut fur Molekulare Genetik, Berlin, Germany: The expression
of B. subtilis phage SPP1 genes in E. coli.
F. BRUNEL, J. DAVISON, and M. MERCHEZ, Unit of Molecular Biology, International Institute of Cellular
Pathology, Brussels, Belgium: Partial correlation of the physical and genetical maps of bacteriophage T5.
A. ZACHARY* and L. A. McNicot+ *Department of Biological Chemistry, University of Maryland Medical
School, Baltimore; +Department of Microbiology, University of Maryland, College Park: T-even bac-
teriophage from the marine environment.
K. HABERER*t and J. MANILOFF,* *Department of Microbiology, University of Rochester Medical Center, New
York; tAbteilung Mikrobiologie, Universitat Ulm, Germany: Structure and replication of mycoplas-
mavirus MVL3-A unique cytocidal virus infecting prokaryotes.
Session 11: Recombination; cloning
W. BRADLEY, L. BEATTY, D. VETTER, and P. D. SADOWSKI, Department of Medical Genetics, University of
Toronto, Ontario, Canada: Further characterization of a biological assay for recombination of bac-
teriophage T7 DNA in vitro.
D. K. CHATTORAJ, Institute of Molecular Biology, University of Oregon, Eugene: Recombinational inter-
mediates of phage lambda.
R. ZAGURSKY, T. JORDAN, and J. HAYS, Department of Chemistry, University of Maryland Baltimore County,
Catonsville: Recombination of lambda tandem duplication phages-Intramolecular recombination and
interclonal mixing.
I. S. SALSTROM, The Biological Laboratories, Harvard University, Cambridge, Massachusetts: New of -like
mutants of the recA gene of E. coli.
R. BRENT, The Biological Laboratories, Harvard University, Cambridge, Massachusetts: The lexA gene and its
protein product.
C. DAMBLY, Z. TOMAN, and M. RADMAN, Department of Molecular Biology, Free University of Brussels,
Belgium: A A test system detecting mutational and epigenic changes.
L. D. VALES, J. B. MURPHY, and J. W. CHASE, Department of Molecular Biology, Albert Einstein College of
Medicine, Bronx, New York: Studies of lambda prophage induction in E. coli K-12 strains containing
defects in the single-strand DNA binding protein.
N. E. MELECHEN and G. Go, Department of Microbiology., St. Louis University School of Medicine, Missouri:
Induction of lambdoid phages by amino acid deprivation-Questions about the role of RecA.
B. E. KORBA and J. B. HAYS, Department of Chemistry, University of Maryland Baltimore County, Can-
tonsville: arl mutants of E. coli generate recombinogenic A phages.
N. L. CRAIG, E. M. PHIZICKY, C. W. ROBERTS, and J. W. ROBERTS, Department of Biochemistry, Cornell
University, Ithaca, New York: Function of the E. coli RecA protein in phage induction.
E. JEDLICKI, J. P. KUSNIERZ, and 0. REYES, Institut Pasteur, Lille, France: Inhibition of P2 interference.
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J. DAVISON, F. BRUNEL, and M. MERCHEZ, Unit of Molecular Biology, International Institute of Cellular
Pathology, Brussels, Belgium: XgtWES.T5 -622 an improved vector allowing positive selection for recom-
binants having foreign DNA inserts.
K. MCKENNY, H. SHIMATAKE, D. COURT, and M. ROSENBERG, NCI, National Institutes of Health, Bethesda,
Maryland: A plasmid vector to examine transcription regulatory signals.
Session 12: RNA Polymerases and Transcription
H. STRAUSS, R. BURGESS, and M. T. RECORD, JR. McArdle Laboratories, University of Wisconsin, Madison: The
selective binding of E. coli RNA polymerase.to promoters on phage T7 DNA.
J. S. HEILIG, J. G. SCAIFE, and R. CALENDAR, Molecular Biology Department, University of California, Berkeley:
Genetic studies of the sigma subunit of E. coli RNA polymerase-Suppressor mutations and cloned
genes.
U. HANSEN and W. MCCLURE, Department of Biochemistry and Molecular Biology, Harvard University,
Cambridge, Massachusetts: Release of sigma from E. coli RNA polymerase after initiation of transcription.
G. LEE, C. TALKINGTON, and J. PERO, The Biological Laboratories, Harvard University, Cambridge, Mas-
sachusetts: Distinctive nucleotide sequences of promoters recognized by RNA polymerase containing a
phage-coded "sigma-like" protein.
J. ROMEO, B. CHELM, S. BRENNAN, and E. P. GEIDUSCHEK, Department of Biology, University of California, San
Diego: (At least) 25 early SPO1 promoters.
S. BRENNAN, P. U. GiAcomoNi, B. K. CHELM, and J. ROMEO, Department of Biology, University of California,
San Diego: In vitro transcription of SPO1 early RNA.
B. BROWNSTEIN, S. USALA, H. AGRAWAL, and R. HASELKORN, Department of Biophysics and Theoretical
Biology, University of Chicago, Illinois: In vitro transcription by virion RNA polymerase of bacteriophage
S6.
R. ZIVIN, W. ZEHRING, K. VANDER LAAN, and L. B. ROTHMAN-DENES, Departments of Biophysics and Theoreti-
cal Biology, and Microbiology, University of Chicago, Illinois: Involvement of E. coli RNA polymerase in
coliphage N4 transcription.
B. SAUER, D. Ow, L. LING, and R. CALENDAR, Department of Molecular Biology, University of California,
Berkeley: Mutants of satellite phage P4 which are defective in the suppression of transcriptional polarity.
J. S. FASSLER and I. TESSMAN, Department of Biological Sciences, Purdue University, West Lafayette, Indiana:
Parallel effects of ultraviolet irradiation and rho deficiency in relieving polarity in OX174.
J. S. CASHMAN, R. E. WEBSTER, and D. A. STEEGE, Department of Biochemistry, Duke University Medical
Center, Durham, North Carolina: In vivo transcription of bacteriophage fl .
B. S-rirr* and H. R. REVEL,' *Public Health Research Institute of the City of New York, Inc., New York;
,Department of Microbiology and Molecular Biology, Tufts University Medical School, Boston, Mas-
sachusetts: The role of the host in phage T4 development-E. coli mutants with a pleiotropic effect.
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335 participants
Session 1: DNA Structure
Chairpersons: B. FLECKENSTEIN, Universitat Erlangen, Germany
W. SUMMERS, Yale University, New Haven, Connecticut
J. CEBRIAN,* C. KASCHKA-DIERICH," N. BERTHELOT* and P. SHELDRICK,* *InStitUt de Recherches Scientifiques sur
le Cancer, Villejuif, France; ,Institut fur Klinische Virologie der Universitat Erlangen, Germany: Inverted
repeats in the genomes of Marek's disease virus and turkey herpesvirus.
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J. SKARE, Sidney Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts: Restriction map-
ping of infectious bovine rhinotracheitis virus DNA.
G. S. HAYWARD and R. LAFEMINA, Department of Pharmacology, Johns Hopkins Medical School, Baltimore,
Maryland: Comparison of the genome structure in two subgroups of primate cytomegalovirus.
J. L. M. C. GEELEN and M. W. WESTSTRATE, Laboratorium voor de Gezondheidsleer, Universiteit van
Amsterdam, The Netherlands: Structure of human cytomegalovirus DNA-Analysis of strain variation by
"cross-blot" hybridization and RNA transcription.
M. W. WESTRATE and J. L. M. C. GEELEN, Laboratorium voor de Gezondheidsleer, Universiteit van Amster-
dam, The Netherlands: Human cytomegalovirus DNA-Mapping of restriction endonucleases sites for
Bg/II, Hind III, and Xba I.
E. HUANG,* S. STAGNo,* R. PASS,' and C. ALFORD,T *Department of Medicine, University of North Carolina
School of Medicine, Chapel Hill; *Department of Pediatrics, University of Alabama Medical School,
Birmingham: Molecular epidemiology of perinatal cytomegalovirus infection in man.
B. E. HENRY, S. A. DAUENHAUER, J. H. WHARTON, and D. J. O'CALLAGHAN, University of Mississippi Medical
Center, Jackson: Molecular structure of the genomes of standard virus and DI particles of equine
herpesvirus type 1 (equine abortion) and type 2 (equine cytomegalovirus).
H. LOCKER, B. BURCKART, and N. FRENKEL, Department of Biology, University of Chicago, Illinois: Structure
and expression of defective herpes simplex virus genomes.
K. DENNIs-roN-THomPsoN, L. W. ENQUIST, and G. F. VANDE WOUDE, Laboratory of Molecular Virology, NCI,
National Institutes of Health, Bethesda, Maryland: Characterization of EcoR1 fragments from defective
HSV-1 (Patton) cloned in phage X.
J. M. KOOMEY,* C. MULDER,* M. D. DANIEL,' L. A. FALK,t R. C. DESROSIERS,t and B. FLECKENSTEIN,' *University
of Massachusetts Medical School, Worcester; *New England Regional Primate Research Center, Harvard
Medical School, Southboro, Massachusetts; *Universitat Erlangen-Nuernberg, Germany: Genome altera-
tions of two attenuated strains of herpesvirus saimiri.
Y. S. LEE, A. TANAKA, R. Y. LAU, M. NONOYAMA, and H. RABIN, Laboratory of Molecular Virology, Life
Sciences Biomedical Research Institute, St. Petersburg, Florida, and Biological Carcinogenesis Program,
Frederick Cancer Research Center, Maryland: The DNA of herpesvirus papio (baboon herpesvirus)
induced by the tumor promoter (12-0-tetradecanoylphorbol-13-acetate).
Session 2: DNA Structure and Replication
Chairpersons: B. ROIZMAN, University of Chicago, Illinois
T. BEN-PORAT, Vanderbilt University, Nashville, Tennessee
N. RAAB-TRAUB, T. DAMBAUGH, W. KING, D. GIVEN, M. HUMMEL, C. BEISEL, and E. KIEFF, University of
Chicago, Illinois: DNA of Epstein-Barr virus.
C. KINTNER and B. SUGDEN, McArdle Laboratory for Cancer Research, University of Wisconsin, Madison: The
structure of the terminal repeats of Epstein-Barr viral DNA in the virion and the arrangement of these
sequences in the transformed cell.
L. NOGEE, C. ANDREWS, G. S. HAYWARD, and S. D. HAYWARD, Department of Pharmacology, Johns Hopkins
University School of Medicine, Baltimore Maryland: Organization of repeated regions within the
Epstein-Barr virus genome.
J. R. ARRAND,* L. RYMO,t J. WALSH,* E. BJORCK,t T. LINDAHL,t and B. GRIFFIN,* *Imperial Cancer Research
Fund, Lincoln's Inn Fields, London, England; *Departments of Medical Chemistry and Clinical Chemistry,
University of Gothenburg, Sweden: Cloning of EBV DNA fragments in the E. coli plasmid pBR322.
J. SKARE, C. EDSON, and J. STROMINGER, Sidney Farber Cancer Institute, Harvard Medical School, Boston,
Massachusetts: Cloning of EBV Barn H1 restriction fragments.
M.-S. CHO, K. -O. FRESEN, and H. ZUR HAUSEN, Institut fur Virologie, Zentrum fur Hygiene der Universitat,
Freiburg, Germany: Characterization of the DNA and of biological functions of EBV synthesized after
superinfection.
K. -O. FRESEN and M.-S. CHO, Institut fur Virologie, Zentrum fLir Hygiene der Universitat, Freiburg, Germany:
Rescue of recombinant Epstein-Barr virus DNA from superinfected NC37 cells.
J. E. SHAW, Cancer Research Center, University of North Carolina School of Medicine, Chapel Hill: Analysis
of EBV DNA in a somatic cell hybrid line.
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B. M. COLBY, J. E. SHAW, and J. S. PAGANO, Department of Bacteriology and Immunology, and Department of
Medicine, University of North Carolina School of Medicine, Chapel Hill: Comparative studies of the EBV
episomes from producer and nonproducer lymphoblastoid cell lines.
B. F. LADIN, M. L. BLANKENSHIP, and T. BEN-PORAT, Department of Microbiology, Vanderbilt University,
Nashville, Tennessee: Maturation of concatemeric DNA of pseudorabies virus to genome length is
related to capsid formation.
C. V. JONGENEEL and S. L. BACHENHEIMER, Department of Bacteriology and Immunology, University of North
Carolina, Chapel Hill: Molecular anatomy of the replicating DNA of HSV-1.
R. DESROSIERS,* C. MULDER,t and B. FLECKENSTEIN,t *New England Regional Primate Research Center,
Harvard Medical School, Southboro, Massachusetts; *Departments of Pharmacology and Microbiology,
University of Massachusetts Medical School, Worcester; *Institut fur Klinische Virologie, Erlangen,
Germany: Methylation of Herpesvirus saimiri DNA in lymphoid tumor cell lines.
M. Wu,* R. W. HYMAN,t and N. Davidson,* *Department of Chemistry, California Institute of Technology,
Pasadena; *Department of Microbiology, Pennsylvania State University College of Medicine, Hershey:
Electron microscopic mapping of proteins bound to herpes simplex virus DNA.
Y. BECKER, S. RABKIN, and Y.- SHTRAN, Laboratory for Molecular Virology, Hebrew University-Hadassah
Medical School, Jerusalem, Israel: Synthesis of wild type and defective herpes simplex virus (HSV) DNA
by a subnuclear fraction extracted from infected cells.
Session 3: Poster Session-DNA Structure and Replication: RNA
D. A. GALLOWAY, Fred Hutchinson Cancer Research Center, Seattle, Washington: Cloning of herpes simplex
virus type 2 DNA fragments in a plasmid vector.
G. J. RUSSELL, N. M. WILKIE, and J. H. SUBAK-SHARPE, MRC Virology Unit, Institute of Virology, Glasgow,
Scotland: Doublet frequency analysis of DNA restriction fragments of herpes simplex virus.
A. M. DUMAS,* J. L. M. C. GEELEN,t and W. MARIS,' *Municipal Laboratory for Virology, Rotterdam, The
Netherlands; tLaboratorium voor de Gezondheidsleer, Universiteit van Amsterdam, The Netherlands:
Isolation and characterization of varicella-zoster virus DNA.
R. W. HYMAN, J. C. RICHARDS, and F. RAPP, Department of Microbiology, Pennsylvania State University
College of Medicine, Hershey: Analysis of varicella-zoster virus DNA.
A. TANAKA, Y. S. LEE, and M. NONOYAMA, Life Science Research Laboratories, St. Petersburg, Florida:
Presence of defective virus particle in Marek's disease virus.
N. HORAIST,* S. CHOUSTERMANN,t N. BERTHELOT,t P. SHELDRICK,t and J.-C. GUILLON,* *Institut Pasteur, Paris,
France; *Institut de Recherches Scientifique sur le Cancer, Villejuif, France; *Characterization of herpes-
virus eidolon (HVE), a new virus isolated from African bats and study of its genome.
S. S. LEINBACH and W. C. SUMMERS, Radiobiology Laboratories, Yale University School of Medicine, New
Haven, Connecticut: DNA-protein interactions during replication of herpes simplex virus type 1.
M. E. MOUTTET and J. M. BECHET, Institut Pasteur, Paris, France: Structure of intranuclear viral chromatin late
in infection with herpes simplex virus type 1.
D. S. PARRIS* and P. A. SCHAFFER,t *Department of Medical Microbiology, Ohio State University College of
Medicine, Columbus; *Sidney Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts:
Dependence of herpes simplex virus type 1 recombination on viral DNA replication.
C. MooRE, J. E. SHAW, and J. GRIFFITH, Cancer Research Center, University of North Carolina, Chapel Hill;
Electron microscope analysis of chromatin structural changes in superinfected Raji cells.
I. W. HALLIBURTON, K. E. QUINN, S. C. SMITH, and L. FRASER, Department of Microbiology, University of
Leeds, England: Mapping of herpes simplex virus glycoproteins and antigenic sites involved in neu-
tralization.
J. K. MCDOUGALL, E. J. TOLLENTINO, and T. H. MASSEY, Fred Hutchinson Cancer Research Center, Seattle,
Washington: Location of the HSV-2 thymidine kinase gene and its expression in transformed cells.
D. J. BZIK and S. PERSON, Biophysics Program, Pennsylvania State University, University Park: The capacity
of different cells and viruses to promote and inhibit HSV-1 induced cell fusion.
L. RYMO, Sahlgren's Hospital, University of Gothenburg, Sweden: Identification of transcribed regions of
Epstein-Barr virus DNA in Burkitt lymphoma-derived cells.
R. M. STENBERG,* D. J. SPECTOR,t and L. I. PIZER,* *Department of Microbiology/Immunology, University of
Colorado Medical Center, Boulder; *Washington University, St. Louis: HSV infection alters RNA metabo-
lism in adenovirus transformed cells.
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F. BIA, W. C. SUMMERS, C. K. Y. FONG, and G. D. HSIUNG, Yale University School of Medicine, New Haven,
Connecticut: Biological and molecular characterization of a new herpesvirus of guinea pigs.
G. DARAI, L. ZOLLER, U. GRAMLICH, B. MATZ, R. M. FLUGEL, U. BERGER, C. KUHN, S. MODROW, H. WOLF, H.
GELDERBLOM, A. KRIEG, J. M. CAMERON, and H. DELIUS, Institut fur Medizinische Virologie, Universitat
Heidelberg; Institut fur Virusforschung, Heidelberg; Fachschule Biologie, Universitat Konstanz; Robert-
Koch-Institut, Berlin; Biologische Bundesans, Land-und Forstwirtschaft, Darmstadt; Max-von-
Pettenkofer-Institut, Universitat Munchen; Department of Virology, University of Glasgow, Scotland;
European Molecular Biology Laboratory, Heidelberg, Germany: Characterization of a new DNA virus
detected in various human cytomegalo-and herpeszoster virus stocks.
R. DESROSIERS and L. FALK, New England Regional Primate Research Center, Harvard Medical School,
Southboro, Massachusetts: Characterization of herpesvirus platyrrhinae, a herpes simplex related virus of
new world primates.
Session 4: Genetics
Chairpersons: P. SCHAEFFER, Sidney Farber Cancer Institute, Boston, Massachusetts
N. M. WILKIE, Institute of Virology, Glasgow, Scotland
R. A. F. DIXON and P. A. SCHAFFER, Sidney Farber Cancer Institute, Harvard Medical School, Boston,
Massachusetts: The relationship of genome structure to the genetic map of HSV-1.
A. J. DAVISON and N. M. WILKIE, MRC, Institute of Virology, Glasgow, Scotland: Fine analysis of HSV intertypic
recombinants-Homology for "a" sequences suffices for normal inversion of the long region.
A. J. DAVISON, H. S. MARSDEN, and N. M. WILKIE, MRC Virology Unit, Institute of Virology, Glasgow,
Scotland: Expression of only one copy of the genes coding for the immediate-early polypeptide I.E. 110 is
sufficient for a productive infection of BHK cells by HSV.
D. KNIPE,* W. RUYECHAN,t R. HONESS,t and B. RolzmAN,§ *Department of Microbiology and Molecular
Genetics, Harvard Medical School, Boston, Massachusetts; *Department of Biochemistry, Uniformed
Services University, Bethesda, Maryland; *National Institute of Medical Research, London, England;
S-University of Chicago, Illinois: A sequence repeated at the ends of the L and S components of HSV-1
DNA is part of
J. R. SMILEY, M. WAGNER, J. A. SHARP, W. P. SUMMERS, and W. C. SUMMERS, Yale University School of
Medicine, New Haven, Connecticut: Genetic and physical fine structure of the thymidine kinase gene of
herpes simplex virus 1.
U. B. DASGUPTA and W. C. SUMMERS, Yale Medical School, New Haven, Connecticut: Study of recombina-
tion in mammalian cells using herpes simplex virus type 1.
F. COLB'ERE-GARAPIN,* S. CHOUSTERMAN,t F. HORODNICEANU,* P. KOURILSKY,* and A. GARAPIN,* *Institut
Pasteur, Paris; *Institut de Recherches Scientifiques sur le Cancer, Villejuif, France: Cloning of the active
thymidine kinase gene of herpes simplex virus type 1 in E. coli K12.
P. CHARTRAND,* C. CRUMPACKER,* P. SCHAFFER,t and N. M. WILKIE,* *Institute of Virology, Glasgow,
Scotland; 1-Sidney Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts: A physical
and genetic analysis of markers associated with the DNA polymerase activity of herpes simplex virus.
D. M. COEN and P. A. SCHAFFER, Sidney Farber Cancer Institute, Harvard Medical School, Boston, Mas-
sachusetts: Genetics of acycloguanosine resistance in HSV-1-Evidence for two distinct loci.
C. CRUMPACKER," L. SCHNIPPER,* P. CHARTRAND,t *Harvard Medical School, Boston, Massachusetts; 1-Insti-
tute of Virology, Glasgow, Scotland: Resistance of herpes simplex virus to acycloguanosine-Role of viral
thymidine kinase and viral DNA polymerase.
S. P. LITTLE and P. A. SCHAFFER, Sidney Farber Cancer Institute, Harvard Medical School, Boston, Mas-
sachusetts: Two loci control the expression of the syncytial (syn) phenotype in HSV-1, strain KOS.
V. C. BOND and S. PERSON, Biophysics Program, Pennsylvania State University, University Park: Isolation and
partial characterization of mutants of HSV-1 which cause cell fusion.
R. M. SANDRI, M. LEVINE, and J. C. GLORIOSO, University of Michigan, Ann Arbor: A method for the isolation
of mutations in physically defined regions of the herpes simplex virus genome.
Session 5: RNA
Chairpersons: E. K. WAGNER, University of California, Irvine
B. CLEMENTS, University of Glasgow, Scotland
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K. P. ANDERSON, L. E. HOLLAND, and E. K. WAGNER, Department of Molecular Biology and Biochemistry,
University of California, Irvine: Characterization of messenger RNA encoded by specific regions of the
HSV-1 genome.
L. E. HOLLAND,* K. P. ANDERSON,* C. SHIPMAN, Jr.,t and E. K. WAGNER,* *Department of Molecular Biology
and Biochemistry, University of California, Irvine; +Dental Research Institute, University of Michigan,
Ann Arbor: Viral DNA synthesis is required for the expression of specific herpes simplex virus type 1
mRNA species on polyribosomes.
J. B. CLEMENTS, F. J. RIXON, A. EASTON, and R. J. WATSON, Institute of Virology, Glasgow, Scotland: Immediate
early transcription of herpes simplex virus types 1 and 2.
S. TALLEY-BROWN and R. MILLETTE, Department of Immunology and Microbiology, Wayne State University
School of Medicine, Detroit, Michigan: Characterization of the immediate early mRNA of herpes simplex
virus 1.
T. BECK and R. MILLETTE, Department of Immunology and Microbiology, Wayne State University School of
Medicine, Detroit, Michigan: In vitro transcription of HSV-1 DNA by RNA polymerase from HEp-2 cells.
B. JACQUEMONT, R. DANTE, A. GARCIA, and J. HUPPERT, Unite de Virologie, INSERM, Lyon, France: Selective
nuclear cleavage of viral high molecular weight RNA in cells infected by herpes simplex type 1.
L. FELDMAN, A. CHEN, T. BEN-PORAT, and A. S. KAPLAN, Department of Microbiology, Vanderbilt University,
Nashville, Tennessee: Fine mapping of the immediate-early transcripts of pseudorabies (Pr) virus.
M. F. STINSKI, D. R. THOMSEN, M. W. WATHEN, and T. R. LOEPFE, Department of Microbiology, University of
Iowa, Iowa City: Transcription of the human cytomegalovirus genome.
C. C. CHUA and S. C. ST. JEOR, Department of Microbiology, Pennsylvania State University College of
Medicine, Hershey: Synthesis of virus specific messenger RNA in cells productively infected with human
cytomegalovirus.
W. KING, A. POWELL, N. RAAB-TRAUB, T. DAMBAUGH, and E. KIEFF, University of Chicago, Illinois: Epstein-Barr
virus RNA in growth transformed (restringently infected) cells.
R. Y. LAU, A. TANAKA, and M. NONOYAMA, Laboratory of Molecular Virology, Life Sciences Biomedical
Research Institute, St. Petersburg, Florida: Transcription and replication of viral genome in lymphoblas-
toid cells (super)infected with Epstein-Barr virus.
Session 6: Poster Session-Enzymes, Proteins, and Immunology
G. PAULI, B. NORRILD, and H. LUDWIG, Institut fur Virologie der Freien Universitat, Berlin, Germany:
Expression of common antigenic determinants on HSV-1 and BHM virus infected cells.
S. PERSON, K. G. KOUSOULAS, and S. C. WARNER, Biophysics Program, Pennsylvania State University,
University Park: The synthesis and processing of glycoproteins specified by syncytial mutants of HSV-1.
S. WELLING-WESTER, Laboratorium voor Medische Microbiologie Rijksuniversiteit Groningen, The Nether-
lands: Herpesvirus induced proteins obtained after limited proteolysis of infected Vero cells.
H. A. BLOUGH, C. B. BARON, and J. IVANOFF, University of Pennsylvania, Philadelphia: The fusion factor of
herpesvirus.
T. BLOCK and R. HUGHES, Department of Viral Oncology, Roswell Park Memorial Institute, Buffalo, New
York: Possible co-transfer of unlinked markers to Ltk-aprt- cells biochemically transformed by HSV.
A. MINSON, K. BASTOW G. DARBY, and P. WILDY, Department of Pathology, University of Cambridge,
England: Properties of cells which carry the HSV-2 thymidine kinase gene.
M. HELLER and E. KIEFF, Kovler Viral Oncology Laboratory, University of Chicago, Illinois: The transfer of
portions of the EBV genome into L TK- cells.
R. J. FEIGHNY and J. S. PAGANO, Cancer Research Center, University of North Carolina School of Medicine,
Chapel Hill: Sequential synthesis of virus-induced proteins after superinfection of Raji cells with EBV.
D. L. WERNER and W. GIBSON, Johns Hopkins University School of Medicine, Baltimore, Maryland: Identifi-
cation and characterization of a matrix-like protein in cells infected with human cytomegalovirus.
M. P. FARRELL, C. MOORE, J. D. GRIFFITH, and E.-S. HUANG, Cancer Research Center, University of North
Carolina, Chapel Hill: Subivrion nucleoprotein complex of human cytomegalovirus.
B. WAHREN* and B. ()BERG* *Department of Virology, Karolinska Institute, Stockholm; +Astra Lakemedel
AB, Sodertalje, Sweden: Inhibition and induction of CMV late antigens during and after PFA.
M. I. SIQUEIRA-LINHARES, N. FAUCON-BIGUET, Y. CHARDONNET, and J. P. REVILLARD, INSERM, Lyon, France:
Comparative polypeptides of cytomegalovirus isolated from renal transplanted patients and from young
children.
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A. E. BOURKAS and J. MENEZES, University of Montreal, Ste. Justine Hospital, Canada: Comparative studies on
the immunobiology of Fc receptors induced by human herpesviruses in different lymphoid cell types.
M. BARTKOSKI, Department of Microbiology, Uniformed Services University School of Medicine, Bethesda,
Maryland: The effect of actinomycin D and cordycepin on the pattern(s) of protein synthesis in herpes
simplex virus type 1 (HSV-1) infected cells.
Y. LANGELIER,* S. QUALIZZA,* and tG. BUTTIN, *Institut du Cancer, Montreal, Canada; +Unite de Genetique
Cellulaire, Institut de Recherche en Biologie Moleculaire, Paris, France: Characterization of ribonucleo-
tide reductase inducation in BHK-21/C13 syrian hamster cell line upon infection by herpes simplex virus(HSV).
B. ERIKSSON, E. HELGSTRAND, and B. OBERG, Astra Lakemedel AB, Research and Development Laboratories,
Sodertalje, Sweden: Pyrophosphate analogs as inhibitors of herpesvirus DNA polymerase.
J. J. McGowAN and G. A. GENTRY, Department of Microbiology, University of Mississippi Medical Center,
Jackson: Differences in the evolutionary status of deoxythymidine kinases of herpesviruses and host cells.
G. FLAMINIO, G. TARRO, G. GALA TRINCHERA, W. FOSTER, and G. PAPA, University of Naples, Cotugno
Hospital, Italy: HSV-induced nonvirion antigen in guinea pig cells multiplying in spinner flasks.
D. GROSSBERGER and W. CLOUGH, Molecular Biology Department, University of Southern California, Los
Angeles: Epstein-Barr virus induced DNA polymerase.
W. CLOUGH, Molecular Biology Department, University of Southern California, Los Angeles: Epstein-Barr
virus-associated nuclease activity.
J. E. OAKES, W. B. DAVIS, and W. A. WEPPNER, Department of Microbiology and Immunology, University of
South Alabama College of Medicine, Mobile: Role of antibody as a host defense mechanism against
primary herpes simplex virus type 1 infection of the cornea.
J. HILFENHAUS and H. MOSER, Behringwerke Research Laboratories, Marburg, Germany: Comparison of
various methods of determining antibodies against herpes simplex virus type 1 proved ELISA as the only
assay for selecting seronegative patients.
H. MOSER, E. WEINMANN, and J. HILFENHAUS, Behringwerke Research Laboratories, Marburg, Germany:
Protection of mice infected with herpes simplex virus type 1 or type 2 by immunization witha herpes
simplex virus type 1 particle or envelope antigen vaccine.
S. S. MORSE and P. S. MORAHAN, Department of Microbiology, Medical College of Virginia, Richmond:
Inhibition of herpes simplex virus (HSV) by macrophages.
D. WESTMORELAND, Department of Medical Microbiology, Welsh National School of Medicine, Cardiff, S.
Wales, United Kingdom: Lymphoblastoid response to herpes simplex virus type II by human fetal
lymphocytes.
J. SCHIRM and T. H. THE, Clinical Immunology Division, University Hospital, Gronigen, The Netherlands: In
vitro lymphocyte transformation induced by cytomegalovirus infected human fibroblasts.
K. S. ROSENTHAL and J. L. STROMINGER, Sidney Farber Cancer Institute, Harvard Medical School, Boston,
Massachusetts: An EBV induced antigenic determinant on EHRB-RAMOS which cross reacts with T cell
antigens.
R. VELTRI, J. MCCLUNG, A. HENDRICKS, J. HICKS, and P. SPRINKLE, Departments of Otolaryngology and
Medicine, West Virginia University, Morgantown: Consequences of activation of Epstein-Barr virus in
lymphoproliferative diseases.
Session 7: Structural Proteins
Chairpersons: P. SPEAR, University of Chicago, Illinois
M. STINSKI, University of Iowa, Iowa City
M. PARA, R. BAUCKE, and P. G. SPEAR, University of Chicago, Illinois: An Fc-binding glycoprotein induced by
herpes simplex virus (HSV)-It's presence in the virion envelope and introduction into cells by input
virus.
R. COURTNEY, R. EBERLE, E. WENSKE, and R. Dix, Department of Microbiology, University of Tennessee,
Knoxville: The major glycoprotein region of herpes simplex virus (HSV), types 1 and 2-Biochemical and
immunological studies.
R. J. EISENBERG* and G. H. COHEN,t *School of Veterinary Medicine and tSchool of Dental Medicine,
University of Pennsylvania, Philadelphia: Structural studies of glycoproteins A, B, and D of herpes
simplex virus type 1.
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G. H. COHEN,* M. PONCE DELEON,* and R. J. EISENBERG,' *School of Dental Medicine and *School of
Veterinary Medicine, University of Pennsylvania, Philadelphia: Tryptic peptide analysis of the type
common glycoprotein D of HSV-1 and HSV-2.
D. H. WATSON, R. A. KILLINGTON, E. J. OULDRIDGE, P. R. KINCHINGTON, and B. E. DUNCAN, Department of
Microbiology, University of Leeds, England: Strain variation in particle surface antigens of herpes simplex
virus type 1.
D. A. THORLEY-LAWSON and D. E. SHALLOWAY, Sidney Farber Cancer Institute, Harvard Medical School,
Boston, Massachusetts: The membrane/neutralizing antigen complex of Epstein-Barr virus-I. Identifica-
tion of the components and their immunogenicity.
C. M. EDSON and D. A. THORLEY-LAWSON, Sidney Farber Cancer Institute, Harvard Medical School, Boston,
Massachusetts: The membrane/neutralizing antigen complex of Epstein-Barr virus-II. Characterization of
the components and their assembly.
B. C. STRNAD, R. H. NEUBAUER, and H. RABIN, Biological Carcinogenesis Program, Frederick Cancer Research
Center, Maryland: Three high molecular weight surface glycoproteins associated with Epstein-Barr virus
membrane antigen.
K. GEILINGER and D. A. TFIORLEY-LAWSON, Sidney Farber Cancer Institute, Harvard Medical School, Boston,
Massachusetts: Monoclonal antibodies against Epstein-Barr virus membrane antigens.
G. J. HOFFMAN* and S. D. HAYWARD' Departments of *Pathology and tPharmacology, Johns Hopkins
University School of Medicine, Baltimore, Maryland: Monoclonal antibodies against Epstein-Barr virus
(EBV).
N. MUELLER-LANTZSCH, N. YAMAMOTO, B. GEORG, and H. ZUR HAUSEN, Institut fur Virologie der Universitat
Freiburg, Germany: Analysis of early and late EBV associated polypeptides by immunoprecipitation.
H. WOLF,* G. BORNKAMM,t and A. GRAESSMANN,t *Max von Pettenkofer-Institut, Munich; tlnstitut fLir
Hygiene, Freiburg; *Institut fur Molekularbiologie and Biochemie, Berlin, Germany: Expression of
Epstein-Barr virus genes in different cell types after microinjection of viral DNA.
P. O'HARE and R. W. HONESS, Division of Virology, National Institute for Medical Research, Mill Hill,
London, England: Structural and nonstructural polypeptides of a simian oncogenic herpesvirus-
Herpesvirus saimiri.
Session 8: Enzymes and Nonstructural Proteins
Chairpersons: S. SILVERSTEIN, Columbia University, New York, New York
J. HAY, Uniformed Services University of Health Sciences, Bethesda, Maryland
L. HAARR and H. MARSDEN, MRC Virology Unit, Institute of Virology, Glasgow, Scotland: Separation of
HSV-1 induced polypeptides by 2-dimensional gel electrophoresis.
K. Witcox,* A. KOHN,t E. SKLYANSKAYA," and B. ROIZMAN,t *Department of Microbiology, Medical College
of Wisconsin, Milwaukee; tKovler Viral Oncology Laboratories, University of Chicago, Illinois: Evidence
that phosphorylation regulates the function of virus-specific proteins in cells infected by herpes simplex
virus.
D. MACDONALD, M. SUH, and H. S. MARSDEN, MRC Virology Unit, Institute of Virology, Glasgow, Scotland:
Polypeptide processing in HSV-infected cells.
H. C. KAERNER, K.-W. KNOPF, and H. FISCHER, Institut fur Virusforschung, Heidelberg, Germany: Virus
specific basic phosphoproteins associated with herpes simplex virus type 1 (HSV-1) infected cells
W.-C. LEUNG, Department of Pathology, McMaster University, Hamilton, Ontario, Canada: Control of
repression of HSV alpha polypeptide synthesis.
S. LEMASTER and B. ROIZMAN, Department of Microbiology, University of Chicago, Illinois: Some properties
of the protein kinase and the ATPase associated with HSV-1 and HSV-2.
F. WOHLRAB and B. FRANCKE, Department of Human Genetics, Yale University Medical School, New Haven,
Connecticut: A deoxyprimidine triphosphatase present in HSV-1 infected but absent from uninfected
BHK cells.
K.-W. KNOPF, Institut fiir Virusforschung, Heidelberg, Germany: Herpes simplex virus type 1 DNA
polymerase exhibits a proof-reading exonucleolytic activity.
W. GIBSON, T. MALONE, and K.-T. JEANG, Johns Hopkins University School of Medicine, Baltimore, Mary-
land: An "early" human cytomegalovirus protein binds to DNA.
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S. MICHELSON,* F. HORODNICEANU,t M. TARDY- PANIT,t and M. KRESS,' *Laboratoire de Medecine Exper-
imentale, College de France, Paris; +Unite de Virologie Medicale, Institut Pasteur, Paris; +Institut de
Recherches sur le Cancer, Villejuif, France: Characterization of human cytomegalovirus (HCMV)-induced
immediate early antigen.
Y. C. CHENG,* J. Y. CHEN,* P. J. HOFFMAN,' and R. GLASER,' *Pharmacology Department, University of North
Carolina School of Medicine, Chapel Hill; +Department of Medical Microbiology, College of Medicine
and Comprehensive Cancer Center, Ohio State University, Columbus: Studies on the activity of DNAse,
DNA polymerase, and thymidine kinase associated with EBV replication.
R. J. FEIGHNY, A. K. DATTA, B. COLBY, and J. S. PAGANO, Cancer Research Center, University of North
Carolina School of Medicine, Chapel Hill: Acycloguanosine and Epstein-Barr virus associated DNA
polymerase.
Session 9: Poster Session-Latency, Transformation, and Biology
J. RAJCANI,* J. MATIS,* and H. FIELD,' *Institute of Virology, Slovak Academy of Sciences, Bratislava,
Czechoslovakia; +Department of Pathology, Cambridge University, England: Immediate early and early
herpesvirus antigens were not seen in serial sections of ganglia with established latent infection.
R. W. PRICE, Sloan-Kettering Institute, New York, New York: Outcome of acute ganglionic HSV infection in
vivo-Modification by systemic resistance and axonal injury.
H. J. ZWEERINK,* D. MARTINEX,* and L. COREY,' *Merck Institute for Therapeutic Research, West Point,
Pennsylvania; +University of Washington School of Medicine, Seattle: Immunological and virological
studies of recurrent herpetic infections.
G. DARAI, U. GRAMLICH, L. ZOLLER, B. MATZ, A. SCHWAIER, R. M. FLUGEL, and K. MUNK, Institut fur
Medizinische Virologie der Universitat Heidelberg; Battelle-Institut Frankfurt am Main; Institut fur Virus-
forschung am Deutschen Krebsforschungzentrum Heidelberg, Germany: Experimental infection and the
state of viral latency in adult tupaia with herpes simplex virus type 1 and 2-Infection of juvenile tupaia
with temperature sensitive mutants of HSV type 2.
M. SUH, N. POIRIER, A. KESSOUS, and R. SIMARD, Institut du Cancer de Montreal, Centre Hospitalier
Notre-Dame, Canada: Immunoprecipitation of polypeptides from hamster cells transformed by herpes
simplex virus type 2.
E. J. SHILLITOE, J. S. GREENSPAN, L. S. HANSEN, and S. SILVERMAN, Department of Oral Medicine, University of
California, San Francisco: Herpes simplex virus neutralization by serum from oral cancer patients.
L. KUCERA,* A. HALE,* L. DANIEL,' and M. WAITE,' Departments of *Microbiology and Immunology, and
+Biochemistry, Bowman Gray School of Medicine, Winston-Salem, North Carolina: Parameters distin-
guishing herpes simplex virus type 2 transformed tumorigenic and nontumorigenic rat cells.
D. SCHNEIDER and D. FALKE, Division of Experimental Virology, Institute for Medical Microbiology, University
of Mainz, Germany: Investigations on the mechanism of induction of the alkaline phosphatase by BdU
and hydrocortisone in HSV-transformed cells.
R. J. REISS-GUTFREUND, V. DOSTAL, and K. LETNANSKY, Institute for Cancer Research, University of Vienna,
Austria: HSV infection as a co-factor in tumor formation.
C. H. SCHRODER and G. URBACZKA, Deutsches Krebsforschungszentrum Institut fur Virusforschung, Heidel-
berg, Germany: Homologous interference in serial high multiplicity passages of herpes simplex virus
(HSV).
P. A. FURMAN, P. V. McGuiR-r, and G. B. ELION, Wellcome Research Laboratories, Research Triangle Park,
North Carolina: Effect of acyclovir on the DNA synthesis of cells transformed with herpes virus genetic
information.
V. DOSTAL, E. TRAVNICZEK, and R. REISS-GUTEREUND, Institute for Cancer Research, University of Vienna,
Austria: Enhanced DNA repair after UV irradiation in human lymphocytes infected with HSV-1 and
HSV-2.
H. HAMPL, J. R. SCHLEHOFER, and K. -0. HABERMEHL, Institut fur Klinische und Experimentelle Virologie der
Freien Universitht Berlin, Hindenburgdamm, Germany: Type specific differences in the release of newly
synthesized herpes simplex viruses from HEp-2 cells.
J. -R. SCHLEHOFER, H. HAMPL, and K. -0. HABERMEHL, Institut fill' Klinische und Experimentelle Virologie der
Freien Universitat Berlin, Hindenburgdamm, Germany: Cell-line and virus-strain depending differences
in the morphology and permeability of herpesvirus-infected cells.
140
S. ALENIUS,* and B. OBERG,t *Department of Virology, College of Veterinary Medicine, Uppsala, Sweden;
tAstra Lakemedel AB, Research and Development Laboratories, Sodertalje, Sweden: Mechanism and
therapeutic effect of trisodium phosphonoformate on experimental herpes simplex virus infections.
M. J. Toco and S. C. ST. JEOR, Department of Microbiology, Pennsylvania State University College of
Medicine, Hershey: The replication of human cytomegalovirus in lymphoblastoid cells.
L. L. WILLIAMS,* and J. R. BLAKESLEE, JR.,t *Department of Pediatrics and tDepartment of Veterinary
Pathobiology, Ohio State University, Columbus: New human cytomegalovirus isolated from cultured skin
fibroblasts of a familial neuropathy.
J. F. BASKAR and E. -S. HUANG, Cancer Research Center and Department of Medicine, University of North
Carolina School of Medicine, Chapel Hill: Effect of murine cytomegalovirus on pre-and post-implantation
mouse embryos.
J. NEDRUD, J. S. PAGANO, and A. M. COLLIER, Cancer Research Center and Departments of Pediatrics,
Bacteriology and Immunology, and Medicine, University of North Carolina School of Medicine, Chapel
Hill: Persistent murine cytomegalovirus infections in epithelial cells of tracheal organ culture-Possible
mechanism of chronicity.
H. GADLER,* and C.-G. GROTH,t *Department of Virology, National Bacteriological Laboratory, Stockholm;
tTransplanation Unit, Huddinge Hospital, Sweden: In vitro activation of human cytomegalovirus.
J. JONCAS, M. LEYRITZ, J. GAGNON, P. BROCHU, and P. PAYER, University of Montreal, Ste.-Justine Hospital,
Canada: Dual congenital infection with the Epstein-Barr virus (EBV) and the cytomegalovirus (CMV).
T. GOTLIEB-STEMATSKY,* J. ZONIS,t A. ARLOZOROFF,*" T. MOSES,' and M. SIGAL,' *Central Virus Laboratory,
Ministry of Health, Tel-Aviv-Yafo; tDepartment of Neurology, Assaf Harofeh Government Hospital,
Zerifin; +Ness-Ziona Government Hospital, and *Tel-Aviv University Sackler School of Medicine,
Ramat-Aviv, Israel: Association between psychotic disorders and antibody titers to Epstein-Barr virus
(EBV) and herpes simplex type 1 (HSV-1).
L. A. PAQuiN,* H. S. MAURER,t D. T. PuRTito,* *University of Massachusetts Medical Center, Worcester;
tNorthwestern University Medical School, Chicago, Illinois: Cytogenetic abnormalities in the X-linked
lymphoproliferative syndrome.
W. MARK,* M. PHELPS,* J. DOMORADZKI,t and B. SUGDEN,* *McArdle Laboratory for Cancer Research,
University of Wisconsin, Madison; tDow Chemical Corporation, Midland, Michigan: The DNA of
Epstein-Barr virus is amplified in transformed lymphocytes.
Y. YABMA and R. GLASER, Department of Medical Microbiology and Comprehensive Cancer Center, Ohio
State University College of Medicine, Columbus: The interaction of nontransforming Epstein-Barr virus
(HR-1 EBV) with EBV positive and negative lymphoblastoid cell lines.
B. KAYIBANDA and C. ROSENFELD, Institute of Cancer and Immunogenetics, Villejuif, France: Presence of
Epstein-Barr virus DNA and nuclear antigen in cell lines spontaneously established from peripheral blood
leukocytes from normal and leukemic donors.
N. YAMAMOTO and H. ZUR HAUSEN, Institut far Virologie der Universitat, Freiburg, Germany: Induction of
EBV early antigens by TPA is not affected by inhibition of DNA synthesis.
T. GOTLIEB-STEMATSKY,*t A. VoNsovEK,* K. PERK,' and A. VANN' *Central Virus Laboratory, Ministry of
Health, Tel-Aviv-Yafo; tDepartment of Human Microbiology, Sackler School of Medicine, Tel-Aviv
University, Ramat-Aviv; tDepartment of Animal Science, Hebrew University of Jerusalem, Rehovot,
Israel: Characterization of a type C virus derived from Burkitt's lymphoma cell line
H. K. ADLDINGER and D. A. BENFIELD, Department of Microbiology, University of Missouri, College of
Veterinary Medicine, Columbia: Latent herpesvirus of turkeys and fertility.
M. GALLATIN and B. M. LONGENECKER, Department of Immunology, University of Alberta, Edmonton, Canada:
Expression of Genetic resistance to Marek's disease at the target cell level.
E. C. HAHN and A. J. KENYON, Walker Laboratory, Memorial Sloan-Kettering Cancer Center, Rye, New York:
Antibody activity to tumor cell antigens in sera from Marek's disease virus-infected chickens.
M. JERKOFSKY, Department of Microbiology, University of Maine, Orono: Replication of Marek's disease virus
and herpesvirus of turkeys in a newly established stable line of chick cells.
K. HIRAI,* N. KITAMOTO,t K. IKUTA,t and S. KATO,t *Department of Molecular Biology, Tokai University
School of Medicine, Isehara, Japan; tDepartment of Pathology, Research Institute for Microbial Diseases,
Osaka University, Suita, Japan: Persistance of both herpesvirus of turkey and Marek's disease virus
genomes in a chicken lymphoblastoid cell line.
R. A. ROBINSON, B. E. HENRY, and D. J. O'CALLAGHAN, Department of Microbiology, University of Mississippi
Medical Center, Jackson: Quantitation and identification of equine herpesvirus type 1 (EHV-1).
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D. R. JOHNSON and G. KLEIN, Department of Tumor Biology, Karolinska Institute, Stockholm, Sweden:
Herpesvirus ateles (HVA) infection of marmoset (saguinus) lymphocytes-Evidence for viurs receptors
and stimulation of DNA synthesis after infection.
L. GEDER, M. DAWSON, R. HYMAN, and F. RAPE, Department of Microbiology, Pennsylvania State University
College of Medicine, Hershey: Properties of mouse cell lines transformed in vitro by the HMC-strain of
infectious bovine rhinotracheitis virus.
G. DARAI, L. ZOLLER, U. GRAMLICH, B. MATZ, R. M. FLUGEL, C. SCHRODER, K. MUNK, W. HOFFMANN, P. MOLLER,
and H. GELDERBLOM, Institut fur Medizinische Virologie, Universitat Heidelberg, Germany: Tupaia
herpesvirus--Isolation and characterization of a third herpesvirus of tupaia; oncogenic properties of
tupaia herpesviruses in rabbits.
Session 10: Immunology
Chairpersons: A. NAHMIAS, Emory University, Atlanta, Georgia
G. MILLER, Yale University, New Haven, Connecticut
A. M. ARVIN, R. B. POLLARD, L. E. RASMUSSEN, and T. C. MERIGAN, Stanford University Medical Center,
California: A prospective study of cell-mediated and humoral immunity to varicella-zoster (VZ), herpes
simplex (HSV), and cytomegalymphoma.
M. D. HILTY, D. R. MANN, and P. J. HOFFMANN, Departments of Pediatrics and Medical Microbiology, Ohio
State University, Columbus: Analysis of antibodies to herpes simplex virus (HSV) polypeptides in sera of
patients with HSV infection.
B. T. ROUSE,* A. S. GREWAL,t and L. A. BABIUK,' *Department of Microbiology, College of Veterinary
Medicine, University of Tennessee, Knoxville; +Department of Veterinary Microbiology, University of
Saskatchewan, Saskatoon, Canada: Destruction of herpesvirus infected cells by neutrophils and
complement-A new mechanism of antiviral immunity.
R. N. LAUSCH* and K. A. HAY,' *Department of Microbiology and Immunology, University of South
Alabama, Mobile; +Department of Microbiology, Pennsylvania State University College of Medicine,
Hershey: Cytotoxic activity of lymphoid cells from hamsters sensitized to HSV-1.
M. COON JORDAN, Department of Medicine and Reed Neurological Research Center, University of California
Medical School, Los Angeles: Adverse effects of cytomegalovirus vaccination in mice.
G. QUINNAN and J. MANISCHEWITZ, Bureau of Biologics, Food and Drug Administration, Bethesda, Maryland:
Virus specific antibody dependent cell-mediated cytotoxicity (ADCC) during murine cytomegalovirus
(MCMV) infection.
L. M. HUTE-FLETCHER and C. J. GILBERT, Cancer Research Center, University of North Carolina School of
Medicine, Chapel Hill: Induction of cytotoxic cells by Epstein-Barr virus antigens.
C. A. BIRON, L. M. HUTT-FLETCHER, and J. S. PAGANO, Cancer Research Center, University of North Carolina
School of Medicine, Chapel Hill: Interferon production and effector cell activation concurrent with
lymphoblastoid cell line stimulation in vitro.
L. E. WALLACE, A. B. RICKINSON, and M. A. EPSTEIN, Department of Pathology, University of Bristol Medical
School, England: T cell-mediated immunity to Epstein-Barr virus in virus-infected individuals.
Y. HINUMA and K. SUGAMURA, Department of Microbiology, Kumamoto University Medical School, Japan: In
vitro induction of cytotoxic T cells specific for Epstein-Barr virus (EBV)-transformed cells.
I. S. MISKO, D. J. Moss, and J. H. POPE, Queensland Institute of Medical Research, Brisbane, Australia: The
specificity of cytotoxic T lymphocytes generated in vitro in response to EB virus.
Session 11: Latency
Chairpersons: D. WATSON, Leeds University, England
J. STEVENS, University of California, Los Angeles
C. CABRERA, E. CANTIN, A. L. NOTKINS, H. OPENSHAW, A. PUGA, J. D. ROSENTHAL, T. SEKIZAWA, and C.
WOHLENBERG, National Institute of Dental Research, National Institutes of Health, Bethesda, Maryland:
HSV-1 latency in nervous tissue.
D. A. GALLOWAY,* C. FENOGLIO,' and J. K. MCDOUGALL,* *Fred Hutchinson Cancer Research Center, Seattle,
Washington; +Department of Pathology, Columbia University College of Physicians and Surgeons, New
York, New York: Detection of herpes simplex RNA in human sensory ganglia.
142
R. TENSER, Departments of Medicine and Microbiology, Pennsylvania State University College of Medicine,
Hershey: The role of herpes simplex virus (HSV) thymidine kinase (TK) expression in acute and latent
infection of the trigeminal ganglion.
A. L. GOLDIN, M. LEVINE, and J. C. GLORIOSO, University of Michigan, Ann Arbor: Persistence of viral genes
in neuronal cells surviving HSV-1 infection.
A. M. COLBERG-POLEY, H. C. Isom, and F. RAPP, Department of Microbiology, Pennsylvania State University
College of Medicine, Hershey: Stimulation of herpes simplex virus type 2 replication from a quiescent
state by superinfection with human cytomegalovirus.
J. F. SHERIDAN, A. D. DONNENBERG, R. B. BELL, and L. AURELIAN, Divisions of Comparative Medicine and
Biophysics, Johns Hopkins Medical Institutions, Baltimore, Maryland: Mechanism of HSV-induced
latency-A transient defect of HSV-specific cell-mediated immunity in recurrent disease.
J. M. DEMARCHI, C. A. SCHMIDT, and A. S. KAPLAN, Department of Microbiology, Vanderbilt University,
Nashville, Tennessee: Analysis of the interactions of various strains of human cytomegalovirus (HCMV)
with permissive and nonpermissive cells.
F. J. DUTKO, W. C. SPEERS, and M. B. A. OLDSTONE, Department of Immunopathology, Scripps Clinic and
Research Foundation, La Jolla, California: Replication of murine cytomegalovirus (MCMV) in differ-
entiated and undifferentiated murine teratocarcinoma cells.
J. S. PEPOSE, M. L. COOK, and J. G. STEVENS, University of California School of Medicine, Los Angeles:
Marek's disease as an animal model for the Guillain-Barre syndrome.
C. LENOIR,* T. OOKA,T M. TOVEY,t M. DE TURENNE,t and J. DAILLIE,t *International Agency for Research on
Cancer, Lyon; +Universite Claude-Bernard, Villeurbanne; *Institut de Recherches sur le Cancer, Villejuif,
France: Activation of Epstein-Barr virus in human lymphoid cell lines.
1. -C. LINI and J. S. PAGANO, Cancer Research Center and Department of Biochemistry and Nutrition,
University of North Carolina School of Medicine, Chapel Hill: Chromosomal proteins and the reactiva-
tion of latent Epstein-Barr virus genome.
B. KALLIN, J. LUKA, and G. KLEIN, Department of Tumor Virology, Karolinska Institute, Stockholm, Sweden:
Immunochemical analysis of EBV-related polypeptides in latently infected P3H3 cells after induction of
the productive cycle by n-butyrate.
Session 12: Transformation and Biology
Chairpersons: S. BACHENHEIMER, University of North Carolina, Chapel Hill
F. RAPP, Pennsylvania State University, Hershey
S. KIT,* H. QAVI,* M. HAZEN,*. D. R. DUBBS,* and S. PATHAK,t *Division of Biochemical Virology, Baylor
College of Medicine, Houston, Texas; +Department of Biology, University of Texas System Cancer
Center, M.D. Anderson Hospital, Houston: Sites of integration of herpes simplex virus type 1 (HSV-1)
thymidine kinase (TK) gene in human chromosomes.
G. R. REYES and G. S. HAYWARD, Department of Pharmacology, Johns Hopkins Medical School, Baltimore,
Maryland: Morphological and biochemical transformation with fragments of HSV-2 DNA.
A. CAMACHO and P. G. SPEAR, University of Chicago, Illinois: The expression of specific proteins in cells
transformed by a fragment of the herpes simplex virus (HSV) genome.
R. J. JARIWALLA, L. AURELIAN and P.O.P. Ts'o, Divisions of Biophysics and Comparative Medicine, Johns
Hopkins Medical Institutions, Baltimore, Maryland: Tumorigenic transformation of Syrian hamster em-
bryo (SHE) cells by a specific fragment of herpes simplex virus type 2 DNA.
F. RAPP and Y. NISHIYAMA, Department of Microbiology, Pennsylvania State University College of Medicine,
Hershey: Inhibition of herpes simplex virus type 2 (HSV-2) induced transformation by interferon.
J. M. LEIDEN and N. FRENKEL, Department of Biology, University of Chicago, Illinois: Mapping of the viral
DNA sequences present in herpes simplex virus thymidine kinase transformed cells.
J. C. M. MACNAB, M. PARK, D. M. LONSDALE, and J. H. SUBAK-SHARPE, Institute of Virology, Glasgow,
Scotland: Genetic information retrieval from herpes simplex virus transformed rat embryo cells by
recombination with superinfecting herpes simplex virus.
M. K. HOWETT,* A. E. PEGG:, and F. RAPP,* Departments of *Microbiology and +Physiology, Pennsylvania
State University College of Medicine, Hershey: Cocarcinogenesis of viruses and chemicals-
Nitrosomethylurea treatment of mouse cells enhances DNA repair.
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M. M. MANAK, L. AURELIAN, and P.O.P. Ts'o, Divisions of Biophysics and Comparative Medicine, Johns
Hopkins University, Baltimore, Maryland: Inactivation of HSV-2 by BUdR and nUV light during the
course of the infectious cycle-Time of appearance of transforming activity.
A. VAHLNE, B. SVENNERHOLM, and E. LYCKE, Department of Virology, Institute of Medical Microbiology,
University of G6teborg, Sweden: Evidence for herpes simplex virus type-selective receptors on cellular
plasma membranes.
F. GERVAIS, A. WILLs, M. LEYRrrz, and J. JoNcAs, Pediatric Research Center and Department of Microbiology,
University of Montreal, Ste. Justine Hospital, Canada: Lack of Epstein-Barr virus (EBV) receptors on B
cells from persistently EBV seronegative adults.
E. VESTERINEN, J. NEDRUD, A. COLLIER, and J. S. PAGANO, Cancer Research Center, University of North
Carolina School of Medicine, Chapel Hill: Epstein-Barr virus infection of human cervical epithelial cells
in vitro.
T. L. STANWICK and A. J. NAHMIAS, Emory University School of Medicine, Atlanta, Georgia: Inhibition of
interferon activity on HSV types 1 and 2 by cyclic GMP enhancing compounds.
Session 13: Transformation
Chairpersons: J. PAGANO, University of North Carolina, Chapel Hill
G. KLEIN, Karolinska Institute, Stockholm, Sweden
G. MILLER, J. ROBINSON, and E. GROGAN, Yale University School of Medicine, New Haven, Connecticut:
Transfection of human lymphoid cells with the DNA of herpes simplex virus.
D. T. PURTILO, H. J. FREED, K. SAKAMOTO, and L. A. PAQUIN, University of Massachusetts Medical School,
Worcester: Immunopathology of the X-linked lymphoproliferative syndrome.
K. SAKAMOTO, H. J. FREED, and D. T. PURTILO, University of Massachusetts Medical School, Worcester:
Epstein-Barr virus antibodies in X-linked lymphoproliferative syndrome.
J. LUKA and G. KLEIN, Department of Tumor Biology, Karolinska Institute, Stockholm, Sweden: Purification
and biochemical studies on Epstein-Barr virus determined nuclear antigen (EBNA).
D. HENTZEN,* J. DAILLIE,* and G. LENOIR,t *Universite Claude-Bernard, Villeurbanne, France; +International
Agency for Research on Cancer, Lyon, France: Characterization of the Epstein-Barr virus determined
antigen.
R. H. NEUBAUER, H. RABIN, and B. C. STRNAD, Biological Carcinogenesis Program, Frederick Cancer Research
Center, Maryland: Nuclear antigens of Epstein-Barr virus (EBV) and EBV -like simian viruses-
Demonstration of multiple antigenic determinants.
I. ERNBERG,* G. KLEIN,* J. ZEUTHEN,t and B. GIOVANELLA,t *Department of Tumor Biology, Karolinska
Institutet, Stockholm, Sweden; University of Aarhus, Denmark; ,Stehlin Foundation for Cancer Research,
Houston, Texas: Epstein-Barr virus primary infection of lymphocytes and subsequent selection on soft
agarose.
J. ROBINSON, Departments of Pediatrics and Epidemiology and Public Health, Yale University School of
Medicine, New Haven, Connecticut: Kinetics of EBNA expression, DNA synthesis, and cellular prolifera-
tion in human lymphocytes infected with Epstein-Barr virus.
K. TAKADA, K. YAMAMOTO, and T. OSATO, Cancer Institute, Hokkaido University School of Medicine,
Sapporo, Japan: Abortive response to the transforming Epstein-Barr virus of leukemic lymphocytes.
J. S. PAGANO,* J. E. SHAW,* and G. PEARSON,t *Cancer Research Center, University of North Carolina
School of Medicine, Chapel Hill; tDepartment of Microbiology, Mayo Clinic, Rochester, Minnesota:
Analysis of nasopharyngeal carcinoma and infectious mononucleosis cell lines of American origin for
Epstein-Barr virus DNA content.
E. F. KALETA,* and K. PRESSLER,t *Klinik fur Gefliigel, Tierarztliche Hochschule Hannover; tAstawerke AG,
Bielefeld, Germany: Prevention of Marek's disease virus inducedtumors and nerve lesions by Impacarzin
R.
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Introduction: D. BALTIMORE, Massachusetts Institute of Technology, Cambridge
Session 1: DNA Viruses I-Polyoma Viruses
Chairperson: T. BENJAMIN, Harvard Medical School, Boston, Massachusetts
K. K. TAKEMOTO, NIAID, National Institutes of Health, Bethesda, Maryland: Human polyomaviruses-
Evaluation of their possible association with human cancer.
B. L. PADGET and D. L. WALKER, Department of Medical Microbiology, University of Wisconsin, Madison:
Human papovavirus, JC-Natural history, tumorigenicity, and interaction with human cells in culture.
M. PATER, A. PATER, and G. DI MAYORCA, Department of Microbiology, New Jersey Medical School, Newark:
BK virus--A human papovavirus.
E. GEISSLER,* H.-j. HEROLD,' L. LONE,* M. RUDOLPH,' S. SCHERNECK,* H. WAHLTE,* F. WEICKMANN,t and W.
ZIMMERMANN,* *Central Institute of Molecular Biology, +Central Institute of Cancer Research, Academy of
Sciences of the GDR; *Neurosurgical Clinic, Municipal Clinicum, Berlin-Buch, Germany: Further studies
on the relation of SV40-like viruses to human tumors.
S. S. TEVETHIA, Department of Microbiology, Pennsylvania State University College of Medicine, Hershey:
Immunological controls in papovavirus SV40 induced neoplasia.
H. ZUR HAUSEN and L. GISSMANN, Institut fur Virologie, Universitat Freiburg, Germany: Characterization of a
lymphotropic papovavirus.
M. GREEN, W. S. M. WOLD, K. H. BRACKMANN, M. A. CARTAS, T. MATSUO, Q. KAPOOR, J. MACKEY, K. OLSON,
and T. LEE, Institute for Molecular Virology, St. Louis University Medical Center, Missouri: Human
adenovirus transforming genes-Group relationships, integration into transformed cells and expression of
candidate transformation proteins, and analyses of human cancers and tonsils.
Session 2: RNA Viruses I-Murine Retroviruses
Chairperson: D. YOHN, Ohio State University, Columbus
M. B. GARDNER, S. RASHEED, B. K. PAL, J. SCOTT, and J. D. ESTES, Department of Pathology, University of
Southern California School of Medicine, Los Angeles: The natural history of cancer and retroviruses in
wild mice.
P. J. FISCHINGER,* J. N. IHLE,+ J. P. LEVY,' D. P. BOLOGNESI,§ J. ELDER,** and W. ScHAftR,++ *NCI, National
Institutes of Health, Bethesda, Maryland; +Frederick Cancer Research Center, Frederick, Maryland;
,Hospital Cochin, Paris, France; §Duke University, Medical Center, Durham, North Carolina; **Scripps
Clinic, La Jolla, California; ttMax- Planck Institute, Tubingen, Germany: Recombinant murine leukemia
viruses and protective factors in disease.
R. SCHWARTZ, S. WAKSAL, and P. MORRISSEY, Cancer Research Center, Tufts University School of Medicine,
Boston, Massachusetts: Abnormal cellular differentiation predisposes to viral leukemia.
J. N. IHLE, J. C. LEE, and L. ENJUANES, Cancer Biology Program, Frederick Cancer Research Center, Frederick,
Maryland: Chronic immune stimulation as a possible mechanism in murine C-type virus-induced lym-
phomas.
T. MATTHEWS, G. ROLOSON, J. THIEL, J. COLLINS, and D. BOLOGNESI, Department of Surgery, Duke University
Medical Center, Durham, North Carolina: Unique properties of protective antibodies against a trans-
plantable murine tumor.
U. RAPP and G. J. TODARO, NCI, National Institutes of Health, Bethesda, Maryland: Generation of sarcoma
and carcinoma producing viruses by selection from endogenous mouse type C virus stocks.
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R. JAENISCH and D. JAHNER, Heinrich-Pette-Institut fur Experimentelle Virologie and Immunologie, Universitat
Hamburg, Germany: Germ line integration of Moloney leukemia virus-Characterization of indepen-
dently derived mouse sublines.
I. HILKENS,* J. HILGERS,* R. MICHALIDES,* and B. VAN DER ZEIJST," *Divisions of Genetics and Virology,
Netherlands Cancer Institute, Amsterdam; tlnstitute for Virology, Rijksuniversiteit, Utrecht, The Nether-
lands: Analysis of murine retroviral genes and genes for viral membrane receptors by somatic cell
genetics.
P. J. FIALKOW, Veterans Administration Medical Center and Department of Medicine, University of Washing-
ton, Seattle: G6PD studies to determine the uni- or multicellular origin of neoplasms.
E. KLEIN, Department of Tumor Biology, Karolinska Institute, Stockholm, Sweden: Immune response to
naturally occurring tumors.
Session 3: DNA Viruses II-EBV and Related Viruses
Chairperson: J. STROMINGER, Sidney Farber Cancer Institute, Boston, Massachusetts
W. HENLE and G. HENLE, Division of Virology, Children's Hospital, and University of Pennsylvania School of
Medicine, Philadelphia: Epstein-Barr virus in human malignancies.
G. DE-THE, Faculty of Medicine A. Carrel, Lyon, and Cancer Institute, Centre National de la Recherche
Scientifique, Villejuif, France: Environment and cancer-The role of the Epstein-Barr virus in initiation,
promotion, and onset of malignancies.
E. GUSSANDER* and A. ADAMS,' *Institute of Medical Microbiology, University of Gothenburg, Sweden;
tWallenberg Laboratory, University of Uppsala, Sweden: The state of the Epstein-Barr virus genome in
transformed cells.
L. FALK, New England Regional Primate Research Center, Harvard Medical School, Southborough, Mas-
sachusetts: Lymphotropic herpesviruses of new world monkeys.
B. FLECKENSTEIN,* G. KEIL,* I. MULLER,* M. COOMEY," and C. MULDER,' *Institute fur Klinische Virologie,
Universitat Erlangen-Nurnberg, Germany; tUniversity of Massachusetts Medical School, Worcester:
Generation of recombinants between different strains of Herpesvirus saimiri.
M. A. EPSTEIN,* D. H. CRAWFORD,* G. W. BORNKAMM,t B. G. ACHONG,* S. FINERTY,* and J. L. THOMPSON,*
fur Virologie, Albert-Ludwigs-
Universitat, Freiburg im Breisgau, Germany: Biological and biochemical observations on isolates of EB
virus from the malignant epithelial cells of two nasopharyngeal carcinomas.
R. NATEGH,* A. ATTARZADEH,* K. DOWLATSHAHI," D. MOITABAI,t SH. AMITI,t B. ARAMESH,* J. WANER,§ J.
KMET,.. and F. MODABBER,*"" *Department of Pathobiology, Tehran University School of Public Health;
tCentral Hospital, National Cancer Institute, Tehran; *Taj Pahlavi Cancer Institute, Tehran University;
§Department of Tropical Public Health, Harvard School of Public Health, Boston, Massachusetts; **Inter-
national Agency for Research on Cancer, Lyon, France; ttlnstitute of Biophysics and Biochemistry,
Tehran University, Iran: Antibody to viral capsid antigens of Epstein-Barr and cytomegalo viruses in
patients with carcinoma of esophagus.
K. -O. FRESEN and M.-S. CHO, Institut hir Virologie, Zentrum fur Hygiene der Universitat, Freiburg, Germany:
Complementation and recombination between Epstein-Barr virus (EBV) genomes.
J. ROBINSON, N. BROWN, W. ANDIMAN, M. ROBERT, U. FRANCKE, K. HALLIDAY, D. M. HORSTMANN, and G.
MILLER, Yale University School of Medicine, New Haven, Connecticut: Diffuse malignant lymphoma
associated with primary Epstein-Barr virus infection.
G. KLEIN, Karolinska Institute, Stockholm, Sweden: The relative role of EBV transformation and chromosomal
changes in the causation of Burkitt's lymphoma.
Session 4: RNA Viruses II--Avian Retroviruses
Chairperson: P. DUESBERG, University of California, Berkeley
D. P. FRISBY,* R. A. WEISS,* R. MAcCoRmicK,* D. STEHELIN,t and M. ROUSSEL,' *Imperial Cancer Research
Fund Laboratories, London, England; tlnstitut Pasteur, Lille, France: Distribution of RAV -O related
sequences in the DNA of galliform birds.
R. L. ERIKSON, A. F. PURCHIO, E. ERIKSON, and M. S. COLLETT, Department of Pathology, University of
Colorado Health Sciences Center, Denver: Comparative biochemical properties of the avian sarcoma
virus transforming gene product and its homolog in normal avian cells.
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P. NEIMAN,*t L. N. PAYNE," R. WEISS,* L. JORDAN,* and R. N. EISENMAN,t *Imperial Cancer Research Fund
Laboratories, London, England; 1-Houghton Poultry Research Station, Huntingdon, England; *Fred Hutch-
inson Cancer Research Center, Seattle, Washington: Analysis by restriction endonuclease digestion of
viral DNA in bursal lymphomas induced by avian leukosis virus (ALV).
L. B. CRITTENDEN, Regional Poultry Research Laboratory, US Department of Agriculture, East Lansing,
Michigan: Viral induction of lymphoid leukosis in chickens.
H. L. ROBINSON,* M. N. PEARSON,* P. N. TSICHLIS," and J. M. COFFIN,' *Worcester Foundation for Exper-
imental Biology, Shrewsbury; 1"Tufts University School of Medicine, Boston, Massachusetts: Role of
envelope antigens in non-acute avian leukosis virus associated disease.
J. L. SPENCER* and J. S. GAVORA," *Animal Diseases Research Institute, Agriculture Canada, Nepean,
Ontario; +Animal Research Institute, Agriculture Canada, Ottawa, Ontario: Lymphoid leukosis-Natural
transmission and non-neoplastic effects.
H. BAUER, Y. YOSHIKAWA, J. IcNiATovic, and M. HAYAMI, Institut fur Virologie FB Humanmedizin, Giessen,
Germany: Onco-fetal antigens as markers for retrodifferentiation in malignant transformation.
P. K. VOLT, S. S. F. Hu, M. M. C. LAI, and J. NEIL, Department of Microbiology, University of Southern
California School of Medicine, Los Angeles: The genetic structure of avian erythroblastosis virus, strain
ES-4.
D. STEHELIN, S. SAULE, M. ROUSSEL, A. SERGEANT, C. LAGROU, M. B. RAES, and C. ROMMENS, INSERM, Pasteur
Institute, Lille, France: Three new types of transforming genes in avian acute defective leukemia viruses
correlate with distinct phenotypes of virus-transformed cells.
Session 5: DNA Viruses 111-Hepatitis B
Chairperson: R. SHEININ, University of Toronto, Canada
B. S. BLUMBERG, Institute for Cancer Research, Philadelphia, Pennsylvania: Hepatitis B virus and primary
cancer of the liver.
P. L. MARION and W. S. ROBINSON, Department of Medicine, Stanford University School of Medicine,
California: Hepatitis B virus in a human hepatocellular carcinoma cell line.
P. H. HOFSCHNEIDER, V. ZASLAVSKY, T.-K. WONG, and 0. MARQUARDT, Max-Planck-Institut fur Biochemie,
Martinsried, Germany: Studies on a DNA-polymerase complex specific for A HBs-antigene producing
hepatoma cell-line.
R. L. SNYDER* and JESSE SUMMERS,' *Penrose Research Laboratory, Zoological Society of Philadelphia;
+institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania: Strong association
between woodchuck hepatitis virus (WHV) and primary liver cancer.
J. SUMMERS,* J. M. SMOLEC,* B. WERNER,* T. J. KELLY, Jr.,1- G. TYLER,* and R. SNYDER,t *Institute for Cancer
Research, Philadelphia, Pennsylvania; lohns Hopkins University, Baltimore, Maryland; *Penrose Re-
search Laboratory, Philadelphia, Pennsylvania: Hepatitis B- and woodchuck hepatitis virus are members
of a novel class of DNA viruses.
T. T. SUN, JIH T'AN Cancer Hospital, Chinese Academy of Medicine, Peking, China: Immunological
investigations on growth pattern-early diagnosis and etiology of human PHC.
P. MAUPAS,* A. GOUDEAU,* P. COURSAGET,* J. DRUCKER,* F. BARIN," I. PERRIN,' J. P. CHIRON,' F. DENIS,' I. DIOP
MAR,' and J. SUMMERS,t *Institut de Virologie, Tours, France; tFaculte de Medecine, Dakar, Senegal;
*Institute for Cancer Research, Philadelphia, Pennsylvania: HBV infection and hepatoma-
Epidemiological, clinical and virology study in Senegal. Perspective of prevention by active immuniza-
tion.
K. NISHIOKA, Tokyo Metropolitan Institute of Medical Science, Honkomagome, Bunkyo-ku, Tokyo, Japan:
Persistent infection of hepatitis B virus and hepatoma.
W. SZMUNESS, Lindsley F. Kimball Research Institute, New York Blood Center, New York: The relationship
between hepatocellular carcinoma (HCC) and hepatitus B virus (HBV) infections.
Session 6: RNA Viruses 111-Feline Retroviruses
Chairperson: A. HURVITZ, Animal Medical Center, New York, New York
M. ESSEX, A. H. SLISKI, M. WORLEY, C. K. GRANT, H. SNYDER, Jr., W. D. HARDY, Jr., and L. B. CHEN,
Department of Microbiology, Harvard School of Public Health, Boston, Massachusetts; and Laboratory of
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Veterinary Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York: Significance of the
feline oncornavirus-associated cell membrane antigen (FOCMA) in the natural history of feline leukemia.
0. JARRETT, University of Glasgow Veterinary School, Scotland: The natural occurrence of subgroups of
feline leukemia virus.
C. J. SHERR, L. A. FEDELE, L. DONNER, L. TUREK, and G. VANDE WOUDE, NCI, National Institutes of Health,
Bethesda, Maryland: Structures of the DNA proviruses of Snyder-Theilen feline leukemia and sarcoma
viruses.
F. WONG-STAAL, R. KOSHY, and R. C. GALLO, NCI, National Institutes of Health, Bethesda, Maryland:
Retrovirus genomes associated with the domestic cat-A survey of tissues from leukemic and normal
animals.
E. A. HOOVER,* J. L. ROJKO,* and R. G. OLSEN,*t *Department of Veterinary Pathobiology, Ohio State
University, Columbus; tDepartment of Microbiology, Ohio State University and Comprehensive Cancer
Center, Columbus: Host-virus interactions in progressive vs regressive feline leukemia virus infection in
cats.
H. LUTZ,* N. C. PEDERSEN,t J. HIGGINS,* F. A. TROY,' and G. H. THEILEN,* *Department of Surgery, University
of California School of Veterinary Medicine, Davis; Departments of tMedicine and *Biological Chemis-
try, University of California School of Medicine, San Francisco: Long term immune response to feline
leukemia virus components in cats after natural infection.
R. OLSEN,*t' L. MATHES,* M. TARR,* M. STIFF,* S. NICHOLAS,g S. KRAKOWKA,* and E. HOOVER,* *Department of
Veterinary Pathobiology; tDepartment of Microbiology; *Comprehensive Cancer Center; §Department of
Pathology, Ohio State University, Columbus: Abrogation of lymphocyte functions by feline retrovirus
protein-A model for immunosuppression.
W. D. HARDY, Jr.,* E. E. ZUCKERMAN,* A. J. MCCLELLAND,* H. W. SNYDER, Jr.,* M. ESSEX,t and D. FRANCIS,t
*Memorial Sloan-Kettering Cancer Center, New York, New York; +Harvard School of Public Health,
Boston, Massachusetts: The immunology and epidemiology of FeLV non-producer feline lymphosar-
comas.
N. GUTENSOHN, D. P. FRANCIS, W. D. HARDY, Jr., and M. ESSEX, Departments of Epidemiology and Microbiol-
ogy, Harvard School of Public Health, Boston, Massachusetts, and Laboratory of Veterinary Oncology,
Memorial Sloan-Kettering Cancer Center, New York, New York: Risk to humans from exposure to feline
leukemia virus-Epidemiologic considerations.
Session 7: RNA Viruses IV-MTV and Primate Viruses
Chairperson: C. FRIEND, Mount Sinai School of Medicine, New York, New York
P. BENTVELZEN, Radiobiological Institute TNO, Rijswijk, The Netherlands: Natural history of the murine
mammary tumor virus.
R. D. CARDIFF and L. J. T. YOUNG, Department of Pathology, University of California Medical School, Davis:
Mouse mammary tumor biology-A new synthesis.
J. SCHLOM, J. M. YOUNG, and W. N. DROHAN, NCI, National Institutes of Health, Bethesda, Maryland: The
occurrence of spontaneous mammary cancer correlates with the Mendelian segregation of specific
murine mammary tumor proviral sequences.
G. SCHOCHETMAN, L. 0. ARTHUR, G. G. LOVINGER, and R. J. MASSEY, Biological Carcinogenesis Program,
Frederick Cancer Research Center, Frederick, Maryland: Expression of mouse mammary tumor virus
(MMTV) proteins in mammary tumor cells and the development of type-specific cytotoxic and neutraliz-
ing antibodies to exogenous and endogenous MMTVs.'
S. SPIEGELMAN,* R. MESA-TEJADA,** I. KEYDAR,* T. OHNO,* M. RAMANARAYANAN,* R. NAYAK,* J. BAUSCH,* and
C. FENOGLIO,t *Institute of Cancer Research; tDepartment of Pathology, College of Physicians and
Surgeons, Columbia University, New York, New York: The presence and clinical implications of a
viral-related protein in human breast cancer.
T. G. KAWAKAMI, Comparative Oncology Laboratory, University of California, Davis: Infectious primate
type-C virus.
G. J. TODARO, NCI, National Institutes of Health, Bethesda, Maryland: Origins and distribution of genetically
transmitted retroviruses of primates.
E. HEFTI, J. T. REYNOLDS, S. PANEM, and W. H. KIRSTEN, Departments of Pathology, Microbiology, and the
Committee on Virology, University of Chicago, Illinois: Characterization of unique nucleotide sequences
and antigenic determinants of a type C virus isolated from normal human cells (HEL-12 virus).
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R. S. GOODENOW, R. LEVY, and H. S. KAPLAN, Cancer Biology Research Laboratory, Stanford University
School of Medicine, California: Partial characterization of the virion proteins of a C-type RNA virus
produced by a human histiocytic lymphoma cell line.
R. GALLO, F. WONG-STAAL, M. REITZ, P. JACQUEMIN, R. RUSCETTI, I. WITZ, C. SAXINGER, A. GANGULY, and R.
DALLA FAVERA, NCI, National Institutes of Health, Bethesda, Maryland: Recent studies with retroviruses
and primate-human leukemogenesis.
Session 8: DNA Viruses IV-Herpesviruses
Chairperson: G. HENLE, Children's Hospital, Philadelphia, Pennsylvania
R. RAPP, Department of Microbiology, Pennsylvania State University, College of Medicine, Hershey: Trans-
formation by herpes simplex virus.
L. AURELIAN, I. I. KESSLER, R. J. JARIWALLA, and M. M. MANAK, Divisions of Biophysics and Comparative
Medicine, Johns Hopkins Medical Institutions, and Department of Epidemiology, University of Maryland
School of Medicine, Baltimore: Herpes simplex virus type 2 and cervix cancer-Structure/function of
transforming gene(s).
J. K. McDouGAtt,* C. M. FENOGLIO' and D. A. GALLOWAY,* *Fred Hutchinson Cancer Research Center,
Seattle, Washington; tColumbia University College of Physicians and Surgeons, New York, New York:
Detection of herpes simplex virus RNA in latently infected ganglion cells and in cervical neoplasia.
W. E. RAWLS, Department of Pathology, McMaster University, Hamilton, Ontario, Canada: Specific anti-
bodies to HSV-2 among women with cervical cancer.
T. MACK, Cancer Surveillance Program, University of Southern California, Los Angeles: Epidemiology of
young adult Hodgkin's disease-Compatibility with various infectious disease models.
H. C. HINZE and K. W. LEE, Department of Medical Microbiology, University of Wisconsin, Madison:
Secretory antibody and persistent oral shedding of the rabbit mononucleosis agent, Herpesvirus syl-
vilagus.
K. NAZERIAN, Regional Poultry Research Laboratory, US Department of Agriculture, East Lansing, Michigan:
Malignant transformation of lymphoid cells by the herpesvirus of Marek's disease.
B. W. CALNEK and K. A. SCHAT, New York State College of Veterinary Medicine, Cornell University, Ithaca:
Early pathogenesis in Marek's disease.
T. MIKAMI,* K. SUZUKI,* H. KODAMA,* I. OKADA," M. ONUMA,* and H. IzAwA,* *Faculty of Veterinary
Medicine, Hokkaido University, Sapporo; +Faculty of Fisheries and Animal Husbandry, Hiroshima
University, Fukuyama, Japan: Antigenic difference of Marek's disease tumor-associated surface antigens
of MSB-1 and RPL-1 line cells derived from Marek's disease lymphoma.
C. G. FABRICANT,* I. FABRICANT,* C. R. MINICK," and M. M. LITRENTA,t *New York State College of Veterinary
Medicine, Cornell University, Ithaca; tCornell University Medical College, New York, New York:
Herpesvirus induced atherosclerosis.
Session 9: RNA Viruses V-Bovine and Primate Viruses
Chairperson: R. GILDEN, Frederick Cancer Research Center, Frederick, Maryland
J. F. FERRER, School of Veterinary Medicine, University of Pennsylvania, Philadelphia: Bovine leukemia-
Importance as a model for viral leukemogenesis.
J. M. MILLER, National Animal Disease Center, US Department of Agriculture, Ames, Iowa: The biology of
bovine leukemia virus infection in cattle.
M. MUSSGAY,* B. FRENZEL,' O. -R. KAADEN," R. LORENZ,* H. D. MATHEKA,* W. MATTHAEUS,* F. WEILAND,* and
J. W. WILESMITH,* *Federal Research Institute for Animal Virus Diseases, Tiibingen; +School of Veterinary
Medicine, Hannover, Germany: Some properties of bovine leukosis virus and its eradication from
infected herds.
R. KET-rmANN,*, M. MEUNIER-ROTIVAL,, G. MARBAIX,* J. CORTADAS,' Y. CLEUTER,* M. MAMMERICKX,§ A.
BURNY, *+ and G. BERNARDI,§ *Departement de Biologie Moleculaire, University Libre de Bruxelles,
Rhode St.-Genese, Belgium; laculte des Sciences Agroriomiques, Gembloux, Belgium; 5Institut de
Recherche en Biologie Moleculaire, University Paris, France; §Institut National de Recherches Vet-
erinaires, Uccle, Belgium: Integration of bovine leukemia virus DNA in the bovine genome.
S. G. DEVARE, NCI, National Institutes of Health, Bethesda, Maryland: Bovine leukemia virus-An etiologic
agent associated with lymphosarcoma of domestic cattle.
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J. CLEMENTS,* F. S. PEDERSEN,t and W. A. HASELTINE," *Johns Hopkins Medical School, Baltimore, Maryland;
+Sidney Farber Cancer Institute, Boston, Massachusetts: Antigenic drift of a retrovirus-Analysis of the
genome structure of antigenic variants of visna virus isolated from persistently infected sheep.
P. CHANDRA, L. K. STEEL, H. LAUBE, S. BALIKCIOGLU, B. MILONER, U. EBENER, K. WELTE, M. REZZONICO, and R.
KREINBERG, Center of Biological Chemistry, University Medical School, Frankfurt, Germany: Immunologi-
cal characterization of reverse transcriptases from human tumors-Evidence for the sub-group-specific
interspecies antigenic determinants on the reverse transcriptase molecule.
D. L. FINE and L. 0. ARTHUR, Biological Carcinogenesis Program, Frederick Cancer Research Center,
Frederick, Maryland: Prevalence of natural immunity to retroviruses in primates.
S. 0. WARNAAR, P. HERBRINK, G. N. P. VAN MUIJEN, J. E. T. MOEN, and J. BROUWER, Department of Pathology,
University of Leiden, The Netherlands: Evidence for type C-viral related antigens and antibodies cross-
reactive with type C-viral antigens in human tissues and sera.
R. KURTH,* R. LOWER,* J. LOWER,* H. FRANK,' R. HARZMANN,' *Friedrich-Miescher Laboratorium, Max Planck
Institut; +Max Planck Institut fur Virusforschung, Tubingen, +Universitatskliniken, Tubingen, Germany:
Three groups of patients with certain malignant diseases react specifically with C-type tumor virus
antigens.
J. THIEL and D. IGLEHART, Department of Surgery, Duke University Medical Center, Durham, North Carolina:
Serological reactivities of an antiserum against SSV non-producer cells.
H. W. SNYDER, Jr., M. Fox, and E. FLEISSNER, Laboratory of Viral Oncology, Memorial Sloan-Kettering Cancer
Center, New York, New York: Natural human antibodies reactive with retrovirus glycoprotein.
Session 10: DNA Viruses V-Papillomaviruses
Chairperson: C. OLSON, University of Wisconsin, Madison
W. F. H. JARRETT, University of Glasgow Veterinary School, Scotland: Papillomaviruses and bracken fern in
high incidence area of bovine alimentary cancer.
W. D. LANCASTER* and C. OLSON,' *Department of Surgery, Case Western Reserve University, Cleveland,
Ohio; +Department Veterinary Science, University Wisconsin, Madison: Bovine papillomavirus and
connective tissue tumors.
P. M. HOWLEY,* M. F. LAW,* C. A. HEILMAN,* W. D. LANCASTER,' D. R. LOWY,* and M. A. ISRAEL,' *NCI and
+NIAID, National Institutes of Health, Bethesda, Maryland; + Department of Surgery, Case Western
Reserve University, Cleveland, Ohio: Molecular characterization of papillomavirus genomes.
H. PEISTER, Institut hir Virologie, Zentrum fiir Hygiene, Freiburg, Germany: Characterization of human and
bovine papillomaviruses and antibody response of the host.
G. ORTH,* S. JABLONSKA,T M. FAVRE,* and 0. CROISSANT,* *Unite des Papillomavirus, Institut Pasteur,
Paris, France; +Department of Dermatology, School of Medicine, Warsaw, Poland: Epidermodysplasia
verruciformis-A model for viral carcinogenesis in man.
J. W. KREIDER, Departments of Pathology and Microbiology, Milton S. Hershey Medical Center, Hershey,
Pennsylvania: Factors determining progression of Shope rabbit papilloma-carcinoma complex.
F. 0. WETTSTEIN and J. G. STEVENS, Department of Microbiology and Immunology, University of California
School of Medicine, Los Angeles: Distribution and state of viral nucleic acid in Shope papilloma virus
induced tumors.
Summary: G. TODARO, National Cancer Institute, Bethesda, Maryland
This meeting was supported in part by the National Cancer Institute, the Federal Drug Administration





Since its inception, the postgraduate program at Cold Spring Harbor
Laboratory has been aimed at meeting the rather special need for
training in interdisciplinary subjects that are either so new or so
specialized that they are not adequately treated by universities. Our
intention is to provide intensive training in the most recent devel-
opments and techniques in each of the subjects so that, upon comple-
tion, the students will be able to enter directly into research in the
particular area. To ensure this up-to-date coverage of current research
work, we bring together a workshop staff from many laboratories
around the world and supplement this staff with a series of seminar
speakers.
ADVANCED BACTERIAL GENETICS, June 10 - June 30
INSTRUCTORS
Davis, Ron, Ph.D., Stanford University, California
Botstein, David, Ph.D., Massachusetts Institute of Technology, Cambridge
Roth, John, Ph.D., University of Utah, Salt Lake City
ASSISTANTS
Koshland, Doug, B.A., Massachusetts Institute of Technology, Cambridge
Sherer, Stewart, B.S., Stanford University, California
Lam, Steve, B.A., University of Utah, Salt Lake City
Starting with a random pool of A phages carrying cloned inserts of
Salmonella DNA, students identified phages carrying portions of the
histidine operon. These phages were identified by lytic selection,
lysogenic selection, and plaque hybridization. Phages were charac-
terized by restriction analysis, complementation tests, and electron
microscopy.
A series of deletion mutants of the his operon were mapped
genetically by transductional crosses. The physical size of each of
these same deletions was then determined by rfsh (restriction fragment
spectrum hybridization). By this procedure it was also possible to map
the position of restriction sites genetically.
Students performed a variety of genetic manipulations involving
use of the Tn 70 insertion element. Auxotrophs were made by Tn10
insertion, and Tn10 insertions were selected near particular genes.
Tn10 was used as a selective marker to perform localized
mutagenesis of a particular region of the chromosome.
Mutagenesis of cloned DNA was performed using the Tn3 /3
lactamase gene carried by phage A. Students selected deletion and
point mutations in this gene and characterized these mutants by
genetic crosses, restriction analysis, and electron microscopy
heteroduplex analysis.
PARTICIPANTS
Balbinder, Elias, Ph.D., University of Colorado, Denver
Bear, David, Ph.D., University of Oregon, Eugene
Buckel, Peter, Ph.D., Boehringer Mannheim Biochemical Plant, Tutzing, Germany
Chang, Simon H., Ph.D., Louisiana State University, Baton Rouge
Clarke, Catherine M., Ph.D., University of Pittsburgh, Pennsylvania
Dahl, Gary A., B.S., University of Wisconsin, Madison
DeBouck, Christine M., B.S., Universite Libre de Bruxelles, Belgium
Gottlieb, Paul D., Massachusetts Institute of Technology, Cambridge
Grana, Dolores, M.S., Centro de Investigacion del IPN, Mexico City, Mexico
lyer, V.N., Ph.D., Carleton University, Ottawa, Canada
Kilbane, John J., B.S., Tufts University, Boston, Massachusetts
Rutledge, Barbara J., B.A., University of Georgia, Athens
Schild, David, Ph.D., University of California, Berkeley
Skold, Ola E., M.D., University of Uppsala, Sweden
Skolnick, Mark, Ph.D., LDS Hospital, Salt Lake City, Utah
Treisman, Richard H., B.A., Imperial Cancer Research Fund, Cambridge, England
SEMINARS
Silhavy, T., Harvard Medical School. Signal peptides that position proteins in cell.
Wensink, P., Brandeis University. Cloning and analysis of some Drosophila middle repetitive DNA sequences.
Bukhari, A., Cold Spring Harbor Laboratory. Phage M: A transposable genetic element.
Parkinson, S., University of Utah. Genetic analysis of chemotaxis in E. coli.
Kleckner, N., Harvard University. Analysis of the transposable element Tn10.
Weisberg, R., National Institutes of Health. Mechanism of A integration into the E. coli chromosome.
Ptashne, M., Harvard University. Activities of X. Cl repressor protein.
Roberts, J., Cornell University. The recA protein is too a protease!
Wigler, M., Cold Spring Harbor Laboratory. Random joining of DNA fragments in animal cells.
Zinder, N., Rockefeller University. My life with single-stranded DNA phages.
Kaiser, D., Stanford University. What we've learned about myxo-motility.
THE TRANSFORMED CELL, June 10 - June 30
INSTRUCTORS
Hynes, Richard, Ph.D., Massachusetts Institute of Technology, Cambridge
Graessmann, Adolph, M.D., Freie Universitet, Berlin, Germany
Risser, Rex, Ph.D., University of Wisconsin, Madison
ASSISTANT
Destree, Antonia, B.S., Massachusetts Institute of Technology, Cambridge
The course consisted of an integrated series of lectures, demonstrations, discussions, and laboratory exper-
iments designed to introduce students to the concepts and techniques involved in the study of oncogenic
transformation. The lecture topics covered initiation of transformation by tumor viruses, the parameters of
the transformed phenotype, and the nature of the immune response to tumors. Established cell lines and
primary cultures were transformed by SV40 virus, by SV40 DNA and avian sarcoma viruses, and by
microinjection of SV40 DNA.
Growth properties of transformed cells were analyzed and the transformed phenotype was studied by a
variety of techniques: immunofluorescence for T and V antigens, cell-surface fibronectin and cytoskeletal
proteins; SDS-polyacrylamide gels; immunoprecipitation; plasminogen activator assays; and mutant trans-
port. Mice were injected with an Abelson lymphoma and with Friend virus, and development of tumors and
spleen foci were scored. Cytotoxicity tests were performed for a variety of cell-surface antigens.
Additional discussions covered technical aspects of surface labeling, antibody production, characteriza-
tion and use, and microinjection methods.
PARTICIPANTS
Abrams, Frederick E., B.A., University of California, Berkeley
Armelin, Mari C.S., Ph.D., University of Sao Paulo, Brazil
Fung, Brenda P., B.S., University of California, Los Angeles
Gardner, John M., B.S., Carnegie Institution, Washington, DC
Jonak, Gerald J., Ph.D., Temple University, Philadelphia, Pennsylvania
Kaschka-Dierich, Christine, M.D., University of Gottingen, Germany
Kirschmeier, Paul T., B.S. Douglass College, New Brunswick, New Jersey
Kitagawa, Takayuki, Ph.D., Cornell University, Ithaca, New York
Kline, Stanley A., Ph.D., New York University, New York
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Neumann-Haefelin, Dieter, M.D., University of Freiburg, Germany
Petit, Carol Ann, M.S., Institut de Recherches Scientifiques, Villejuif, France
Prasad, Rajendra, Ph.D., New York Medical College, Valhalla
Preston, Christopher M., Ph.D., Medical Research Council Virology Unit, Glasgow, Scotland
Segura, Magdalena, M.S., Instituto Politecnico Nacional, Mexico City, Mexico
Skolnik, Hagit, M.S., Weizmann Institute, Rehovot, Israel
Steck, Peter A., B.A., Michigan State University, East Lansing
SEMINARS
Demars, R., University of Wisconsin. The transformed phenotype and chemical carcinogens.
Sambrook, J., Cold Spring Harbor Laboratory. DNA tumor viruses.
Topp, W., Cold Spring Harbor Laboratory. Cellular transformation by DNA tumor viruses.
Boettiger, D., University of Pennsylvania. Transformation of differentiated cell types.
Sugden, W., University of Wisconsin. Transformation by herpesviruses.
Graessmann, A., Freie U n ve Ts i tet of Berlin. Regulation of SV40 gene expression.
Quigley, J., State University of New York Downstate Medical Center. Proteases and transformation.
Burridge, K., Cold Spring Harbor Laboratory. Antibody and lectin staining of gels.
Todaro, G., National Institutes of Health. Growth factors produced by transformed cells.
Lane, D., Cold Spring Harbor Laboratory. Hybridomas.
Hynes, R., Massachusetts Institute of Technology. Cell surfaces and transformation.
Feramisco, J., Cold Spring Harbor Laboratory. Microinjection studies of cytoskeleton.
Goldman, R., Carnegie-Mellon Institute. Cytoskeleton, cell structure, and movement.
Poste, G., Roswell Park Memorial Institute. Invasion and metastasis.
Stockert, E. Sloan-Kettering Institute. Cell surface antigens in mouse leukemia.
Risser, R., University of Wisconsin. Abelson and Friend virus-induced antigens.
Rowe, W., National Institutes of Health. Viruses and spontaneous leukemia.
Rosenberg, N., Tufts University. Transformation in vivo and in vitro by acute defective leukemia viruses.
CENTRAL NERVOUS SYSTEM OF THE LEECH, June 10 - June 30
INSTRUCTORS
Nicholls, John, Ph.D., M.D., Stanford Medical School, California
Muller, Kenneth J., Ph.D., Carnegie Institution of Washington, Baltimore, Maryland
Parnas, Itzhak, Ph.D., Hebrew University, Jerusalem, Israel
Zipser, Birgit, Ph.D., Cold Spring Harbor Laboratory, New York
The aim of this workshop was to provide students with an intensive lab and seminar course that would
enable them to pursue independent work on the leech. To this end, we hoped to provide the students with
techniques for recording from leech cells, now considered straightforward and relatively easy, that took
much time and effort to be refined. With this knowledge, they might avoid many of the trivial technical
difficulties that bedevil anyone starting on the nervous system of the leech or other animals.
The initial work was devoted mainly to recognizing the individual cells, learning how to record from them
with intracellular and extracellular electrodes, getting familiar with the equipment, and performing dissec-
tions. The students the progressed to more difficult experiments, such as recording synaptic potentials while
changing the fluid bathing the prepa6tion or injecting individual cells with marker substances to study their
geometry.
The final phase of the course consisted of devising and performing original experiments, some of which
proved to be of sufficient interest to be pursued in greater detail. For example, the nervous systems of
various hitherto unexplored leeches were studied. In addition, the properties of a new fluorescent dye,
Lucifer yellow, were tested by intracellular injection into identified cells, and individual cells were killed by
injection of proteotype enzymes.
PARTICIPANTS
Boyle, Mary B., B.A., Yale University, New Haven, Connecticut
Fett, Michael J., M.B.B.S., Monash University, Clayton, Australia
Henderson, Leslie P., B.A., Stanford Medical School, California
Hounsgaard, barn, M.D., University of Copenhagen, Denmark
Mason, Adrian J.R., B.A., Portsmouth Polytechnic, England
Nusbaum, Michael P., B.A., University of California, San Diego
Obaid, Ana L., Ph.D., University of Pennsylvania, Philadelphia
Pellegrino, Mario, Ph.D., University of Pisa, Italy
Pine, Jerome, Ph.D., Washington University, St. Louis, Missouri
Zackson, Saul L., B.A., University of California, Berkeley
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SEMINARS
Nicholls, LG., Stanford Medical School. Introduction to the leech.
Sensory and motor cells.
Pumps and glial cells in the leech.
Conduction block and potassium accumulation.
Synaptic transmission-chemical and electrical.
Quantal analysis of synaptic transmission.
Cultured ganglia and individual cells.





Zipser, B., Cold Spring Harbor Laboratory. Control of sexual function by neurons in the leech CNS.
Parnas, I., Hebrew University. Conduction block.
Killing single cells.
Weisblat, D., University of California, Berkeley. Biology of leeches.
Development.
Kristan, W., University of California, San Diego. Swimming.
Demonstration of swimming.
Sleet, G., University of California, Berkeley. Swimming.
Photoreceptors.
Control of heartbeat.
Stewart, W., National Institutes of Health. Lucifer yellow for staining leech cells.
NEUROBIOLOGY OF BEHAVIOR, June 10 - June 23
INSTRUCTORS
Kandel, Eric. R., M.D., Columbia University, New York, New York
Koester, John, Ph.D., Columbia University, New York, New York
Nottebohm, Fernando, Ph.D., Rockefeller University, New York, New York
Pearson, Kier, Ph.D., University of Alberta, Edmonton, Canada
A lecture course on the Neurobiology of Behavior was presented this year for the first time. Thiscourse was
designed to introduce students to cellular approaches to the study of behavior and learning. Rather than
being exhaustive, the lectures provided an intensive coverage of four main areas: 1) general principles of
behavior and cellular neurobiology; 2) simple forms of behavior, learning, and motivation; 3) initiation and
maintenance of complex locomotor sequences, including voluntary movement and motor learning; and 4)
communication. To illustrate general principles, suitable systems for study were selected from both inverte-
brate and vertebrate behavior. To put the cellular work into perspective, selected exampleswere also taken
from human behavior and its abnormalities. This course, designed for advanced graduate and research
workers, had an enrollment of 19 students.
PARTICIPANTS
Anderson, Patricia A., M.A., New York University, New York
Beres, Linda S., B.S., University of Maryland, College Park
Blank, Paul S., B.A., Johns Hopkins University, Baltimore, Maryland
Bricker, Connie S., B.S., Michigan State University, East Lansing
Buchanan, James T., B.A., Washington University, St. Louis, Missouri
Cleary, Len, M.S., Columbia University, New York, New York
Cornejo-Anze, Hector J., Ph.D., University of Chicago, Illinois
Deutsch, Dale G., Ph.D., State University of New York, Stony Brook
Einstein, Jill, B.A., University of Pennsylvania, Philadelphia
Farrow, Simon J., MA., University of Chicago, Illinois
Fox, Steven E., B.S., Downstate Medical Center, New York, New York
Grega, Debra, M.S., University of Kentucky, Lexington
Irvin, Gregg, BA., Syracuse University, New York
Lafferman, Jeffrey A., B.S., National Institutes of Health, Bethesda, Maryland
McElligott, Sandra, Ph.D., University of Pennsylvania, Philadelphia
McGlade, Ellen K., B.S., University of Maryland, College Park
Mitchell, Susan I., Ph.D., Johns Hopkins University, Baltimore, Maryland
Niles, Walter D., B.S., University of Wisconsin, Madison
Schmidt, Rupert, Ph.D., Harvard Medical School, Boston, Massachusetts
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SEMINARS
Kandel, E.R., Columbia University. Introduction to the cellular study of behavior.
Learning. I. Habituation.
Learning. II. Sensitization.
Koester, J., Columbia University. Introduction to biophysics of behavior.
Repetitive firing properties and the control of behavior.
Krasne, F., University of Southern California. Nerve circuitry for simple behavioral acts and their control.
Kupfermann, I., Columbia University. Hormones and behavior. I.
Motivation.
Truman, f., University of Washington. Hormones and behavior. II.
Deadwyler, S., Bowman-Gray Medical School. Long-term plasticity in the CNS.
Wurtz, R., National Institutes of Health. Attention.
Pearson, K., University of Alberta. Introduction to motor sequences.
Central and reflex control of movements in motor systems.
Walking the cat.
Kristan, W., University of California. Leech swimming.
Ghez, C., Columbia University. Voluntary movements in mammals.
Thach, W. T., Jr., Washington University. Does the cerebellum learn motor programs?
Fuchs, A., University of Washington. Behavioral modification of vestibulo-ocular reflex.
Nottebohm, F., Rockefeller University. Introduction to communication.
Communication in birds. I. Predispositions brought to the learning of a complex motor task.
Communication in birds. II. Brain pathways for vocal learning.
Hoy, R., Cornell University. Communication in crickets.
Milner, B., McGill University. Language and the brain.
Geschwind, N., Beth Israel Hospital. The apraxias: Neural mechanisms of disorders of learned movement.
Zigmond, R., Harvard Medical School. Neurotransmitters: Role in behavioral abnormalities.
THE MAMMALIAN CENTRAL NERVOUS SYSTEM, June 10 - July 5
INSTRUCTOR'S
Hubel, David, Ph.D., Harvard Medical School, Boston, Massachusetts
Kirkwood, Peter, Ph.D., Institute of Neurology, London, England
Malpeli, Joseph, Ph.D., University of Illinois, Champaign
Sherk, Helen, Ph.D., Harvard Medical School, Boston, Massachusetts
This workshop offered laboratories and lectures on the mammalian central nervous system. It began with a
week of lectures by David Hubel on general neuroanatomy, the ontogeny of the nervous system, the spinal
cord, motor control, and the visual system. These lectures were supplemented by demonstrations of
recording from cat thoracic motoneurons, medullary respiratory neurons, and lateral geniculate neurons.
The remaining three weeks were devoted to four series of laboratory experiments on the cat CNS, with the
eight participants working in pairs, spending four to five days on each series. In all labs, they learned the
appropriate surgical techniques, the preparation of microelectrodes, and histological procedures for recon-
structing micro electrode tracks. In one lab participants studied the reflex activity of motoneurons in the
spinal cord using both intracellular and extracellular recording techniques. Motoneurons were injected
intracellularly with horseradish peroxidase (HRP) to enable their dendritic morphology to be reconstructed.
In another lab, the participants recorded extracellularly from neurons in areas SI and SIII of the somatosen-
sory cortex, observed their response properties to somatic stimuli, and mapped the somatotopic organization
of these areas. The other two labs focussed on extracellular recording from visual cortex (area 17 and 18)
and subcortical visual structures (the lateral geniculate nucleus and the superior colliculus). The single-cell
responses to visual stimuli, retinotopic organization, and functional cytoarchitecture of these structures were
examined. Retrograde transport of HRP was used in the somatosensory and vision experiments to study the
connections between cortical and subcortical structures. The workshop ended with participants applying
techniques learned in the spinal cord and vision labs to record intracellularly from neurons in the visual
cortex. At intervals throughout the workshop seminars on current research topics were given by five invited
speakers and the instructors.
PARTICIPANTS
Campbell, Norma C., B.S., University of Bristol, England
Cleland, Corey L., B.A., Northwestern University, Evanston, Illinois
Fah le, Manfred W., M.D., Max Planck Institute, Tiibingen, Germany
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Fischer, K. Ludwig, M.A., University of Konstanz, Germany
Lidov, Hart G.W., B.A., Johns Hopkins School of Medicine, Baltimore, Maryland
Lockton, John W., B.S., University of Glasgow, Scotland
Walsh, Christopher, B.S., University of Chicago, Illinois
Wetzel, Daniel M., B.A., Princeton University, New Jersey
SEMINARS
Gilbert, C.D., Harvard University. Morphology of physiologically identified cells in the visual cortex.
Kitai, S.T., Michigan State University. Connectivity between the substantia nigra and the basal ganglia.
LeVay, S., Harvard University. Development and malleability of ocular dominance columns in the visual cortex.
Moore, G.P., University of Southern California. Theory and use of cross correlation techniques in the mammalian
nervous system.
Simpson, J.I., New York University. Physiology and anatomy of the accessory optic system.
SYNAPTIC STRUCTURE AND FUNCTION, June 25 - July 18
INSTRUCTORS
Rahamimoff, Rami, M.D., Hebrew University Medical School, Jerusalem, Israel
McMahan, U. Jack, Ph.D., Stanford University, California
Purves, Dale, M.D., Washington University, St. Louis, Missouri
Stevens, Charles F., M.D., Ph.D., Yale University, New Haven, Connecticut
This course was designed for graduate students and research workers interested in the structure and function
of synapses. It consisted of lectures; readings of papers; group discussions; presentations of selected topics by
participants; seminars by instructors, faculty, and participants; and demonstrations. After the course ended,
some of the participants stayed on for a workshop.
PARTICIPANTS
Anglister, Lili, Ph.D., Weizmann Institute, Rehovot, Israel
Bader, David M., Ph.D., University of Michigan, Ann Arbor
Brett, Roger S., Ph.D., Case Western Reserve University, Cleveland, Ohio
Brown, David L., B.S., University of Virginia, Charlottesville
Eatock, Ruth A., M.S., California Institute of Technology, Pasadena
Feder, Ned, M.D., National Institutes of Health, Bethesda, Maryland
Gordon, Herman, B.A., California Institute of Technology, Pasadena
Hayashi, Jon H., B.A., Bekesy Laboratory of Neurobiology, Honolulu, Hawaii
Heinonen, Erkki A., M.D., University of Helsinki, Finland
Johnson, Jon M., B.S., Stanford University, California
Kauvar, Lawrence M., Ph.D., California Institute of Technology, Pasadena
Laureano, Manuel, B.S., University of Puerto Rico, San Juan
Maehlen, Jan, University of Oslo, Norway
Maron, Ron, M.S., Hebrew University Medical School, Jerusalem, Israel
McManus, Owen B., B.A., University of Utah, Salt Lake City
Rivera, Amelia J., M.S., University of Puerto Rico, San Juan
Stewart, Walter W., B.A., National Institutes of Health, Bethesda, Maryland
Towle, Andrew C., M.S., University of Connecticut, Storrs
SEMINARS
Rahamimoff, R., Hebrew University Medical School. Principles of signaling in the nervous system.
Forces and fluxes in the generation of membrane potentials.
The resting potential.
The generation of the action potential.
The conduction of the action potential.
Ionic basis of the action potential: The currents.
The conductances and the action potential: Analysis and reconstruction.
The Hodgkin and Huxley model of the action potential.
Quantal transmitter release.
The role of calcium in transmitter liberation from motor nerve terminals.
Frequency modulation of quantal transmitter release.
Leakage of neurotransmitter.
McMahan, U. J., Stanford University. The structure of synapses. I. The neuromuscular junction.
The structure of synapses. II. CNS synapses.
Localization of acetylcholine receptors and acetycholinesterase in muscle.
Vesicle recycling at the presynaptic nerve terminal.
Rein nervation.
Sequence of steps in the development of the neuromuscular junction.
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Purves, D., Washington University. Introduction to excitatory synaptic transmission.




Formation and maintenance of synaptic connections: Axon guidance, nerve growth factor, cell death,
synapse elimination, selectivity, maintenance.
Denervation.
Synapse elimination.
Stevens, C. F., Yale University. Steps in the opening of the postsynaptic channel andbinding of agonists to receptors.
Eyring rate theory and voltage dependency of channel opening.
Signal channel currents.
Fluctuation analysis: Principles and application.
Gating currents.
Nicholls, J., Stanford University. Properties, connections, and regeneration of the nervous system of the leech.
Demonstration of the nervous system of the leech.
Goodenough, D., Harvard University. Structure and function of gap junctions.
X-ray diffraction and its application to gap-junction structure.
Muller, K., Carnegie Institution. Denervation and reinnervation in the nervous systemof the leech.
Demonstration of the nervous system of the leech.
Parnas, I., Hebrew University. Demonstration of the nervous system of the leech.
Hall, Z., University of California, San Francisco. Structure and activity of cholinesterase in the electric organ and
mammalian tissue.
Properties of the acetylcholine receptor.
Regulation of the acetylcholine receptor.
Mains, R., University of Colorado, Denver. An introduction to the role of peptides inneuronal function: Bioassays and
radioimmunoassays of peptides.
Immunostarving and immunoprecipitation of peptides; biosynthesis of peptides; signal peptides.
Biosynthesis and localization of peptides.
VIP as a tentative inhibitory transmitter.
Is substance P a neurotransmitter at the spinal cord?
Black, I., Cornell University Medical College. The catecholamine synapse.
Growth and development in the sympathetic system.
Clinical disorders of the catecholaminergic system: Parkinson's disease, idiopathic hypotension, familiar
dysautonomia.
Patterson, P., Harvard Medical School. The influence of the environment on neuronaldifferentiation.
Kanner, B., Hebrew University. Neurotransmitters uptake into isolated presynaptic terminals and membrane vesicles.
Yoshikami, D., University of Utah. Slow synaptic potentials.
The microphysiology of the postsynaptic membrane.
Kehoe, J., Ecole Normale Superieure. Transmitter effects in molluskan neurons: Ionic and pharmacological charac-
teristics.
LaVail, J., University of California, San Francisco. Retrograde transport.
Circadian metabolism in photoreceptors.
Stefani, E., lnstituto Politecnico Nacional. Calcium currents in muscle.
Zipser, D., Cold Spring Harbor Laboratory. Computer models in neurobiology.
Sex neurons in the leech.
Albrecht-Buehler, G., Cold Spring Harbor Laboratory. Cell motility and the centriole.
Zigmond, R., Harvard Medical School. Long-term biochemical changes in neurons as a result of activity.
Erulkar, S., University of Pennsylvania. Functional organization of the spinal cord.
Neurotransmitters in the CNS.
Neurotoxins.
Frank, E., Harvard Medical School. Quantal transmission at the spinal cord.
Inhibition at the spinal cord and the crayfish neuromuscular junction.
Development of the spinal cord.
Ascher, P., Ecole Normale Superieure. Acetylcholine antagonists.
Basbaum, A., University of California, San Francisco. Pain mechanisms.
Raviola, E., Harvard Medical School. An overview on the structure of the retina.
Structure of photoreceptors and synapses at the outer and inner layers.
Transmitter release and recycling at photoreceptor synapses.
Baylor, D., University of California, San Francisco. Signal flow in the retina.
Transduction in photoreceptors.
Electrical microanalysis of transduction in retinal' rods.
Cell interactions in the retina.
Lass, Y., Tel-Aviv University. The effect of the microenvironment on the acetylcholine receptor.
Hudspeth, J., California Institute of Technology. Morphological organization and function of acousticolateralis sensory
systems.
The transduction process of vertebrate hair cells.
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ELECTROPHYSIOLOGICAL METHODS FOR CELLULAR NEUROBIOLOGY, July 3 - July 23
INSTRUCTORS
Kehoe, Jac Sue, Ph.D., Ecole Norma le Superieure, Paris, France
Chiarandini, Dante, M.D., New York University, New York
Stefani, Enrique, M.D., Instituto Politecnico Nacional, Mexico City, Mexico
GUEST LECTURER
Kado, Ray, Ph.D., Centre National de la Recherche Scientifique, Gif-sur-Yvette, France
In this neurobiology course the neuromuscular junction of the frog and the central ganglia of the mollusk
Aplysia were used as experimental preparations for training students in basic electrophysiological methods
for cellular neurobiology. Examination of certain characteristics of the resting, action and synaptic potentials
of these two preparations served as a basis for introducing the following techniques: microdissection,
fabrication of single and multibarreled capillary microelectrodes; intracellular recording of membrane
voltage changes (in so-called current clamp) and membrane currents (using a slow voltage clamp); intracel-
lular and extracellular' application of ions and drugs (by ionophoresis and pressure injections); and intracel-
lular staining of Aplysia neurons.
The first 3 days of the course were devoted to lectures and exercises on electronics for cellular
neurobiologists given by Ray Kado. The last 2 days of the course were devoted to individual experimental
projects chosen by the students. These projects permitted them to try techniques not taught in the course
and to use biological preparations that they intended to study when they returned to their own laboratories.
PARTICIPANTS
Beres, Linda S., B.S., University of Maryland, College Park
Burke, Michael J., B.S., Medical College of Wisconsin, Wauwatosa
Carrow, Grant M., B.A., Harvard University, Cambridge, Massachusetts
Denburg, Jeffrey L., Ph.D., University of Iowa, Iowa City
Eberly, Lewis B., B.A., University of Texas, Galveston
Garb, Frances C., M.S., North Dakota State University, Fargo
1p, Nancy Y., B.S., Harvard Medical School, Boston, Massachusetts
McDonald, Virginia N., B.A., University of California, Davis
Mellin, Theodore N., Ph.D., Merck Institute, Rahway, New Jersey
Obaid, Any L., Ph.D., University of Pennsylvania, Philadelphia
THE MOLECULAR BIOLOGY AND DEVELOPMENTAL GENETICS OF DROSOPHILA, July 3 - July 23
INSTRUCTORS
Pardue, MaryLou, Ph.D., Massachusetts Institute of Technology, Cambridge
Gelbart, William, Ph.D., Harvard University, Boston, Massachusetts
ASSISTANT
Mohler, James, B.S., Massachusetts Institute of Technology, Cambridge
Drosophila melanogaster is an especially favorable organism for use in studies of gene control in higher
animals. The course on The Molecular Biology and Developmental Genetics of Drosophila consisted of
laboratory work, lectures, and discussions on current problems and approaches to the study of the molecular
basis of developmental phenomena in this organism. Emphasis was placed on integration of the classical
genetic, cytogenetic, and developmental biological techniques with microtechniques for molecular analysis.
Topics covered included: chromosome mechanics, chromosome structure, intragenic organization, gene-
enzyme systems, neurogenetics, embryology and early determinative events, pattern formation and regula-
tion, regulation in specific gene systems, genetics of mutable elements, and speciation in Drosophila.
Students came from many parts of the United States as well as Germany and Italy. Some of the students were
new to the field, having worked previously on bacteria or vertebrates. Other students were already working
on some aspect of Drosophila development.
PARTICIPANTS
Cheney, Clarissa M., Ph.D., University of Pennsylvania, Philadelphia
Clark, Ellen M., B.A., University of Virginia, Charlottesville
Dwyer, Kathleen G., B.S., Princeton University, New jersey
Kramer, Angela, M.S., University of Heidelberg, Germany
Maine, Eleanor M., B.A., Princeton University, New Jersey
Myers, Paul L., B.A., Harvard Uniyersity, Cambridge, Massachusetts
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rerer, brandeis University, Waltham, Massachusetts
Polito, Cate llo, M.D., International Institute of Genetics and Biophysics, Naples, ItalyRosen, Jonathan I., B.A., State University of New York, Stony BrookSchmidt, Otto, Ph.D., Yale University, New Haven, Connecticut
Spoerel, Nikolaus, Ph.D., Institut fur Genetik, Karlsruhe, Germany
Stevens, Bryn, B.A., University of California, Los Angeles
Toole, John J., B.A., Roswell Park Memorial Institute, Buffalo, New York
SEMINARS
Hall, J. C., Brandeis University. Neurogenetics.
Strub, S., Stony Brook University. Pattern formation and regulation.Cherbas, P., Harvard University. Cell culture techniques.
Ashburner, M., Cambridge University. Insect endrochronology.
Young, M., Rockefeller University. Transposable elements.
RNA TUMOR VIRUSES, July 3
- July 23
INSTRUCTORS
Hopkins, Nancy, Ph.D., Massachusetts Institute of Technology, Cambridge
Weinberg, Robert, Ph.D., Massachusetts Institute of Technology, Cambridge
Villa-Komaroff, Lydia, Ph.D., University of Massachusetts Medical School, WorcesterWhite, Ray, Ph.D., University of Massachusetts Medical School, Worcester
The course included daily lectures by visitors from across the country. An extensive series of laboratoryexercises was performed to develop familiarity with the most recent molecular and biological techniquesthat are applied to retroviruses. These exercises included titering of leukemia and sarcoma viruses by plaqueand focus titers, transfection of
sarcoma and leukemia virus DNAs, Southern gel-filter transfer blotting, andrecombinant DNA techniques. Among the most important of the latter were screening of a phage library of
mouse cellular DNA clones to detect clones
containing endogenomes, genetically-transmitted viralgenomes, and subcloning of cloned retrovirus DNAs into plasmids.
PARTICIPANTS
Alkaitis, Saulius A., Ph.D., University of Wisconsin, Madison
Feingold, Jay M., B.S., University of Virginia, Charlottesville
Jaehner, Detlev, M.S., University of Hamburg, Germanyjongstra, Ian, M.S., Friedrich Meischer Institute, Basel, Switzerland
Khan, Arifa S., Ph.D., Frederick Cancer Research Center, Maryland
Kitamura, Naomi, Ph.D., State University of New York, Stony Brook
Liou, Ruey-Shyan, Ph.D., Oak Ridge National Laboratory, Tennessee
Logan, Jonothan L., Ph.D., Harvard University, Cambridge, MassachusettsMol, Joseph N.M., Ph.D., Erasmus University, Rotterdam, The Netherlands
Nerenberg, Michael, I., B.A., Yale University, New Haven, Connecticut
Nissen-Meyer, Jon, Ph.D., Norwegian Radium Hospital, Oslo
Seymore, Beverly D., M.S., University of Texas, Dallas
Triadou, Patrick, M.S., Institut Pasteur, Paris, France
Van der Putten, M.H., Ph.D., University of Nijmegen, Holland
Wang, Tse-Wei, Ph.D., Oak Ridge National Laboratory, Tennessee
SEMINARS
Erikson, R., University of Colorado. The avian-sarcoma-virus-transforming gene (src) product.Todaro, G., National Institutes of Health. Endogenousviruses and their mode of transmission.
Rowe, W., National Institutes of Health. The natural history of murine leukemia viruses.Taylor, J., Institute of Cancer Research, Philadelphia. Synthesis and structure of retrovirus DNAs.
Hanafusa, H., Rockefeller University. Origin of the src gene of avian sarcoma viruses.Lilly, F., Albert Einstein College of Medicine. Interaction of host and viral genetic factors in mouse leukemia.
Fischinger, P., National Institutes of Health. The transforming genes of murine and feline sarcoma viruses.
Risser, R., University of Wisconsin. Viral oncogenesis in hematopoietic tissues.Hager, G., National Institutes of Health. Cloning of retrovirus genomes.
Robinson, H., Worcester Foundation. Endogenous viruses and cancer.
Bishop, M., University of California, San Francisco. Origins of retrovirus-transforming genes.!hie, J.N., Frederick Cancer Research Center. Irnmunobiology of endogenous c-type virus expression.O'Donnell, P., Memorial Sloan-Kettering Cancer Center. MuLV-related cell-surface antigens as serological markers ofendogenous AKR viruses.
Famulari, N., Memorial Sloan-Kettering Cancer Center. Expression of MuLV env gene products in fibroblasts andlymphoid cells.
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August, T., Johns Hopkins University. Derivation and use of monoclonal antibodies against viral antigens.
Wig ler, M., Cold Spring Harbor Laboratory. DNA transfection of eukaryotic cells in culture.
Hicks, J., Cold Spring Harbor Laboratory. Development and properties of a yeast cloning vehicle.
Gelinas, R., Cold Spring Harbor Laboratory. DNA sequencing.
Gingeras, T., Cold Spring Harbor Laboratory. Computer analysis of DNA sequences.
Fermisco, J., Cold Spring Harbor Laboratory. Microinjection of cultured mammalian cells.
BASIC NEUROANATOMICAL METHODS, July 8 - July 28
INSTRUCTORS
LaVail, Matthew, Ph.D., University of California, San Francisco
LaVail, Jennifer, Ph.D., University of California, San Francisco
Basbaum, Allan, Ph.D., University of California, San Francisco
ASSISTANTS
Sugino, Ilene, M.A., University of California, San Francisco
Lord, Bonnie, B.A., University of California, San Francisco
This workshop is designed for graduate students and research workers interested in learning basic
neuroanatomical techniques. The course is primarily a series of laboratory exercises by the participants, with
lectures and demonstrations by the instructors and visiting faculty.
The classic neuroanatomical methods that were covered in this laboratory workshop include: perfusion
fixation; embedding in various media; cell-staining methods that highlight neuronal and glial cell nucleic
acids; silver-salt-impregnation -methods in the intact nervous system and in selectively interrupted nerve-
fiber bundles; bright-field, dark-field, and fluorescence light microscopy; electron microscopy; and data
gathering with camera lucida and photomicrography.
Among the new methods covered were the following: various histochemical, radiochemical, and im-
munocytochemical techniques that demonstrate the structure and location of specific neurons or synaptic
terminals, based on their characteristic neurotransmitters or state of electrical activity; tracing axonal
pathways using the anterograde axoplasmic transport of radioactively labeled protein; and determining the
sources of neuronal pathways using the retrograde axonal transport of suitable markers.
PARTICIPANTS
Aceves-Pina, Efrain 0., M.S., Princeton University, New Jersey
Dennis, Michael J., M.S., Clinical Research Institute, Montreal, Canada
Gibson, Daniel J., B.S., Johns Hopkins University, Baltimore, Maryland
Goldman, Steven A., B.A., Rockefeller University, New York, New York
Pong, Sheng-Shung, Ph.D., Merck Institute, Rahway, New Jersey
Ranscht, Barbara B., Ph.D., Max-Planck-Institute, Tubingen, Germany
Tran, Vinh T., B.A., Johns Hopkins University, Baltimore, Maryland
Tedeschi, Bruce W., MA., Yale University, New Haven, Connecticut
Zigmond, Richard E., Ph.D., Harvard Medical School, Boston, Massachusetts
Zipser, Birgit, Ph.D., Cold Spring Harbor Laboratory, New York
SEMINARS
Hendrickson, A., University of Washington. Light and electron microscopy.
Autoradiographic methods.
Raviola, E., Harvard Medical School. Freeze-fracture methods.
Hand, P., University of Pennsylvania. The 2-deoxyglucose method.
Gershon, M., Columbia University. Fluorescence microscopy and aminergic systems.
Glazer, E., University of California, San Francisco. lmmunocytochemical methods.
Weiner, R., University of California, San Francisco. CNS receptors.
MOLECULAR BIOLOGY AND GENETICS OF YEAST, July 25 - August 14
INSTRUCTORS
Fink, Gerald R., Ph.D., Cornell University, Ithaca, New York
Sherman, Fred, Ph.D., University of Rochester, New York
Hicks, James B. Ph.D., Cold Spring Harbor Laboratory, New York
ASSISTANT
Zaret, Kenneth, B.A., University of Rochester, New York
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This program emphasized the major laboratory techniques used in the genetic analysis of yeast-tetrad
analysis, mitotic recombination, and fine-structure mapping. The isolation and characterization of both
chromosomal and cytoplasmic mutants were undertaken. Biochemical studies were performed with
chromosomal and mitochondrial mutants. Analysis of eukaryotic gene structure used digestion with restric-
tion endonucleases and gel electrophoresis. Several aspects of this yeast transformation system were also
investigated.
PARTICIPANTS
Achstetter, Tilman T., M.S., University of TObingen, Germany
Astell, Caroline, Ph.D., University of British Columbia, Vancouver
Campbell, Judith, M.S., California Institute of Technology, Pasadena
Douglas, Michael G., Ph.D., University of Texas, San Antonio
Dumas, Lawrence B., Ph.D., Northwestern University, Evanston, Illinois
Edwards, John C., B.S., University of Chicago, Illinois
Grimal, Danielle, M.S., University of Paris, France
Grunstein, Michael, Ph.D., University of California, Los Angeles
Johnson, Alexander D., B.A., Harvard University, Cambridge, Massachusetts
Laughon, Allen S., B.S., University of Utah, Salt Lake City
Lobo, Zita, M.S., Tata Institute, Bombay, India
Muller, Heinz K., D.V.M., University Hospital, Zurich, Switzerland
Nall, Barry T., Ph.D., University of Texas, Houston
Philippsen, Peter, Ph.D., University of Basel, Switzerland
Procter, Alan R., Ph.D., Pfizer Central Research, Groton, Connecticut
Wills, Norma M., B.A., University of Utah, Salt Lake City
SEMINARS
Byers, B., University of Washington, Seattle. Cytology of the yeast life cycle.
Hartwell, L.H., University of Washington, Seattle. Control of cell division. 1.
Control of cell division. II.
Lawrence, C., University of Rochester. Radiation mutagenesis and repair in yeast.
Petes, T.D., University of Chicago. Structure and replication of yeast DNA.
Genetic analysis of repeating ribosomal DNA genes.
Broach, J., Cold Spring Harbor Laboratory. The yeast plasmid Scpl.
Mortimer, R.K., University of California, Berkeley. Genetic mapping in yeast.
Gene conversion and post meiotic segregation.
Tzagoloff, A., Columbia University Medical School. The mitochondria! genetic code.
Dujon, B., Centre National de la Recherche Scientifique. Genetics of mitochondrial function.
Holland, M., University of Connecticut, Farmington. Isolation and analysis of yeast glycolytic genes.
Hicks, J., Cold Spring Harbor Laboratory. Regulation of mating types in yeast.
Fink, G.R., Cornell University. Transformation of yeast with hybrid DNA.
Regulation of HIS4 in yeast.
Sherman, F., University of Rochester. Regulation of the iso-cytochromes c.
Nonsense suppression in yeast.
IMMUNOGENETICS AND TUMOR IMMUNOLOGY, July 30 - August 12
INSTRUCTORS
Cantor, Harvey, M.D., Harvard Medical School, Boston, Massachusetts
Paul, William, M.D., National Institutes of Health, Bethesda, Maryland
Woodland, Robert, Ph.D., University of Massachusetts Medical Center, Worcester
ASSISTANT
Chun, Linda, Ph.D., Harvard Medical School, Boston, Massachusetts
The course was intended for graduate students and research workers who are interested in studying the
lymphocyte population of the mouse as material for analysis of the molecular biology of cell differentiation
in higher organisms. Some of the general areas that were considered included (1) studies of lymphocyte
development and the molecular basis of lymphocyte differentiation, (2) genetic and biochemical analysis of
recognition structures expressed by different sets of lymphocytes, (3) the special requirements for activation
of lymphocytes by antigen, (4) the role of interactions between different sets of lymphocytes in regulating the
immune response to viruses and other antigens, (5) the use of monoclonal antibodies.
PARTICIPANTS
Basta, Patricia V., A.B., University of Alabama, Birmingham
Bender, Timothy P., M.S., University of Michigan, Ann Arbor
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Bottom ly, Kim, Ph.D., Fox Chase Cancer Center, Philadelphia, Pennsylvania
Calman, Francoise, M.D., Institut d'Embryologie, Nogent-sur-Marne, France
Devlin, James J., B.S., University of California, Irvine
DiMarzo, Sheila A., B.A., University of Rochester, New York
Finnegan, Alison, B.S., Tufts University, Boston, Massachusetts
Fleischer, Bernhard, M.D., University Giessen, Germany
Gold, Dan P., B.A., Tufts University, Boston, Massachusetts
Herrlich, Peter A., M.D., Ph.D., Universitat Karlsruhe, Germany
Hiernaux, Jacques R., Ph.D., National Institutes of Health, Bethesda, Maryland
Hong, David T., A.B., Texas Technology University, Lubbock
Jakway, James P., B.S., University of Colorado, Denver
Jorgensen, Trond 0., M.S., University of Tromso, Norway
Kaschka, Wolfgang P., M.D., University of Erlangen, Germany
Lugo, James P., B.S., Massachusetts Institute of Technology, Cambridge
Mastro, Andrea M., Ph.D., University of Pennsylvania, Philadelphia
Oppenheim, Stephen, B.A., University of California, Los Angeles
Pames, Jane R., M.D., Massachusetts Institute of Technology, Cambridge
Quan, Zoe S., B.A., University of Chicago, Illinois
Rock, Kenneth L., M.D., Peter Bent Brigham Hospital, Boston, Massachusetts
Schrier, Rachel D., B.S., University of Colorado, Denver
Zack, Donald J., A.B., Albert Einstein College of Medicine, Bronx, New York
Zlotnik, Albert, B.S., University of Colorado, Denver
SEMINARS
Davie, J., Washington University Medical School, St. Louis. Organization of immunoglobulin genes.
Doherty, P., Wistar Institute. T-cell reactions to viruses.
Germain, R., Harvard Medical School. Biochemical analysis of specific suppressive factors.
Goodman, J., University of California Medical School, San Francisco. Definition of the T-cell receptor.
Nathenson, S., Albert Einstein Medical School. Chemistry of MHC gene products.
Pernis, B., Columbia University. Network models of the immune system.
Raff, M., University College, London. Definition of the T-cell receptor.
Rosenthal, A., Merck Institute. T-cell recognition of antigen.
Scharff, M., Albert Einstein Medical School. Cell-cell hybridization techniques-Use of variants of myeloma cells to
analyze the immune system.
Shreffler, D., Washington University Medical School, St. Louis. Genetics of the major histocompatibility complex.
Seidman, J., National Institutes of Health. Arrangement and rearrangement of immunoglobulin genes.
on T-cell recognition.
Weissman, I., Stanford University Medical School. Development of thymocytes and T cells.
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IN-HOUSE SEMINARS
Cold Spring Harbor in-house seminars were initiated to provide a
semiformal avenue for communication between the various research
groups at the laboratory. They are particularly useful for research
personnel who have joined the laboratory during the summer. The
seminars also afford a necessary opportunity for the graduate students
and postgraduate staff to develop their skills in defending, organizing,
and presenting their research. In addition to those listed below, semi-
nars were given by many others involved in research at this laboratory.
1978-1979
Drs. Ian Buckley and John Smart
prepare for seminar in James Laboratory
October
Ivar Giaever, General Electric Research & Developmental Center, Schenectady, New York: Protein adsorption to
surfaces.
Francis Galibert, Hospital-St-Louis, Paris, France: The sequence of the EcoRl F fragment of Ad2 and its mRNAs.
Gregory Goldberg, Roche Institute, Nutley, New Jersey: The regulation of synthesis of ribosomal protein L12 in vitro.
November
Charles Shoemaker, University of Iowa, Iowa City: An H3 histone specific protein kinase from bovine thymus
chromatin.
Minoru Hirama, Basel Institute for Immunology, Switzerland: Do immunoglobulin genes on both chromosomes
translocate?
loran Akuspryi, Uppsala University, Sweden: Structure of the spliced 5' region of the hexon messenger RNA.
Andrew Badley, Unilever Research Laboratory, Bedford, England: Specific fibroblast-substrate adhesions - their
formation, structure, and possible role as modulators of cell behavior.
Pradip Bandyopadhyay, Albert Einstein College of Medicine, Bronx, New York: Structure and dynamics of DNA
binding proteins.
December
Mark Achtman, Max-Planck-Institut fur Molekulare Genetik, Berlin, Germany: Cell-cell interactions between conjugat-
ing Escherichia coll.
Eliezer Huberman, Oak Ridge National Laboratory, Tennessee: Induction of somatic mutations and cell transformation
in cultured mammalian cells by chemical carcinogens.
January
Frank Solomon, Massachusetts Institute of Technology, Cambridge: Detailed neurite morphologies of sister neuroblas-
toma cells are related.
Malcolm J. Casadaban, Stanford University School of Medicine, California: Gene fusion.
February
Tauseef R. Butt, Georgetown University School of Medicine, Washington, D.C. Structure of HeLa cell chromatin as
probed by nucleases and nucleoprotein modifications.
Masayori Inouye, State University of New York, Stony Brook: Molecular mechanism of biosynthesis and assembly of
the outer membrane proteins.
March
Marilyn Kozak, New York University chool of Medicine, New York: How do eukaryotic ribosomes select initiation
regions in messenger RNA?
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Carol Prives, National Institutes of Health, Bethesda, Maryland: DNA binding properties of SV40 T antigen synthesized
in vivo and in vitro.
Sherie Morrison, Columbia University, New York: Isolation and characterization of mouse myeloma cells mutant in
their production of immunoglobulin.
Philip Musich, Albert Einstein College of Medicine, Bronx, New York: Resolution of discrete nucleosome subsets in
mammalian genomes.
Edward Wagner, University of California, Irvine: Pinning down herpes simplex transcripts.
Sheldon Penman, Massachusetts Institute of Technology, Cambridge: Cell architecture and macromolecular metabo-
lism.
April
Martin Gellert, National Institutes of Health, Bethesda, Maryland: DNA gyrase and the biological significance of DNA
supercoiling.
Gianni Cesareni, MRC Laboratory of Molecular Biology, Cambridge, England: Plasmid as a tool for DNA cloning and
plasmid genetics.
Rex Risser, University of Wisconsin, Madison: Cell surface antigens of Abelson or Friend murine leukemia virus.
Mark Willingham, National Institutes of Health, Bethesda, Maryland: Cataloging human gene products by two-
dimensional gel electrophoresis and computerized data reduction.
Mark Willingham, National Institutes of Health, Bethesda, Maryland: Ultrastructural distribution of contractile and
cytoskeletal proteins in cultured fibroblasts.
Leigh Anderson, Argonne National Laboratory, Illinois: Cataloging human gene products by two-dimensional gel
electrophoresis and computerized data reduction.
May
Mark Ptashne, Harvard University, Cambridge, Massachusetts: Turning genes on and off with repressors - The role of
reiterated binding sites and protein cooperativity.
Bruce Anderson, University of Miami, Florida: Biochemistry and genetics of 4-methylphthalic acid utilization in soil
pseudomonads.
Larry Feldman, Vanderbilt University, Nashville, Tennessee: Transcriptional control of the pseudorabies virus genome.
June
Dan Skup, McGill University, Montreal, Canada: Regulation of protein synthesis during reovirus infection.
July





Another aspect of the summer program at the Laboratory is the participation of college undergraduate students in
active research projects under the supervision of full-time laboratory staff members. The program was initiated
in 1959. Since that year, 205 students have completed the course, and many have gone on to creative careers in
biological science.
The objectives of the program are to provide (1) a greater understanding of the fundamental principles of
biology, (2) an increased awareness of major problem areas under investigation, (3) better understanding of the
physical and intellectual tools for modern research and the pertinence of this information to future training, and
(4) a personal acquaintance with research, research workers, and centers for study.
The following students, selected from a large number of applicants, took part in the program, which was
supported by The Camille and Henry Dreyfus Foundation, Inc. They are listed below with their laboratory
sponsors and topics of research.
Martha S. Cyert, Harvard University
Research Advisor: B.S. Zain
Samuel M. Kunes, University of Oregon
Research Advisor: G.P. Thomas
Joachim Li, University of Chicago
Research Advisor: A.I. Bukhari
Leona Ling, University of California,
Berkeley
Research Advisor: Y. Gluzman
Suzanne L. Mansour, Radcliffe College
Research Advisor: M.B. Mathews
Mark E. Minie, Wesleyan University
Research Advisor: K. Burridge
David Schriger, Amherst College
Research Advisor: M. Wigler
Brook Chase Soltvedt, Wellesley College
Research Advisor: Y.-S. E. Cheng
Elizabeth Spatola, Wheaton College
Research Advisor: J.B. Hicks
Ina Sporecke, Smith College
Research Advisor: D.Y. Kwoh
Olney Fellowship
Timothy Mitchison Oxford
Research Advisor: M. Botchan
Nucleotide sequence analysis of the
REC/INT sites of Ac12+ND,-dp2 viral DNA.
Studies on the control of adenovirus
gene expression.
Sequencing of the products left after
excision of Mu DNA from the lacZ
gene: Adaptation of Sanger's dideoxy-
method and the M13 phage system.
Sequence determination of the junctions
between Ad2 and SV40 genomes in the
Ad2-SV40 (HEY and LEY) hybrids.
Selection of adenovirus mRNAs using
the separated strands of viral DNA
fragments.
An attempt to isolate mouse lymphocyte
IgG "caps" or "patches."
Cloning and characterization of deletion
mutants of the HSV-1 thymidine kinase
gene.
Restriction endonuclease analysis of the
cloned IacZ carrying an ochre mutation.
Isolation of mutations in the mating
type locus of S. cerevisiae.
Nitrous acid mutagenesis of recombinant
plasmids carrying the Mu gin gene.







The Nature Study Program is designed for elementary and high school students who wish to achieve a greater
understanding of their environment. During Summer and Fall a total of 408 students participated in these
activities. Most classes were held outdoors, when weather permitted,or at Uplands Farm Nature Preserve of The
Nature Conservancy, where the Laboratory has equipped and maintains classroom laboratories for the study of
field specimens collected by students.
In addition to courses, a series of one-day Marine Biology Workshops was offered, with special workshops for
adults. Studies were conducted on Long Island Sound aboard a 55-foot schooner chartered from Schooner, Inc.
of New Haven, Connecticut. This vessel is equipped with a variety of instrumentation and is staffed by a captain,
mate, and marine biologist. Students participated in biological studies and in the actual sailing of the vessel.
This past Summer, a new course, Nature Bugs, was given, extending the program to five year-olds and offering
an early introduction to environmental sciences.
In the Fall, Observational Astronomy, for eight-to-eleven year-olds, was again offeredas an introduction to all
facets of astronomy. Photography as related to Astronomy was included, with students utilizing our fully
equipped darkroom. Telescopes for the observational sessions were loaned by Ehrenreich Photo-Optical, and
technical assistance was provided by the Astronomical Society of Long Island and the Long Island Observers
Association.
Program Director: Sanford Kaufman, M.S., M.P.A., science teacher, Hewlett High School
INSTRUCTORS
Don Dunn, art and photography teacher, Hewlett High School
Judith Calloway, M.S., math and biology teacher, East Islip High School
Mary Jane Fitzgibbon, M.S., science teacher, East Northport High School
Carolyn Hess, M.A. candidate, State University of New York, Stony Brook
James Romansky, M.S., biololgy teacher, Bay Shore High School








They Walk, Swim, and Crawl
Aquatic Biology
Marine Biology








Somewhat to the surprise of all concerned, the Banbury Center pro-
gram of conferences and books on biological risk assessment ap-
proached its anticipated scope during only the second year of opera-
tion. The first two Banbury Reports were published (and the first of
these, Assessing Chemical Mutagens: The Risk to Humans, sold out in
the first 6 months after publication). Fobr technical conferences drew
distinguished specialists to discuss mammalian cell mutagenesis tests,
less hazardous cigarettes, health data from human populations at low
risk of cancer, and ethylene dichloride. Each meeting disclosed inter-
esting recent findings, such as the rapid maturation of the Chinese
hamster ovary test for chemical mutagens; signs of a sharp reduction in
lung-cancer risk to smokers, related to progressive changes in com-
position of cigarettes; progress in codifying genetic information about
such well-defined populations as the Mormons; and a fascinating
contradiction in the results of different tests designed to discover if
ethylene dichloride, a major chemical industry intermediate, is car-
cinogenic. With the help of professionally prepared transcripts of the
technical conferences, the pace of book production effectively dou-
bled. Meanwhile, a beginning was made on a second major program:
informational meetings for nontechnical groups having key roles in
policy-making, with a session in June for scientists and congressional
staff from Washington.
Support
Financial support of the Center's program, so generously begun in
1978 by the Alfred P. Sloan Foundation and the Esther A. and Joseph
Klingenstein Fund, continued to be encouraging. Payment was re-
ceived from the Environmental Protection Agency under a contract for
its support of our May 1978 conference on assessing chemical muta-
gens and the publication of its proceedings. After months of uncer-
tainty about the form of support from the National Cancer Institute for
the 1979 program of technical conferences, a resolution appeared at
year-end in a proposal to purchase volumes of proceedings of the
meetings, based on the model of the Institute's purchase of many sets
of the now-classic Cold Spring Harbor Laboratory work of 1978,
Origins of Human Cancer. In November, the Banbury Center informa-
tional program received a splendid vote of confidence when the Sloan
Foundation trustees appropriated halt the projected cost of a 3-year
program of meetings designed for groups of journalists and groups of
legislative and congressional staff. As 1980 opened, we began plan-
ning sessions for the staffs of individual news organizations, inspired in
part by the pioneering work of Fred W. Friendly of the Ford Founda-
tion, who has staged a series of meetings for journalists and lawyers to
thrash out legal issues that lately have beset the news-gathering pro-
fession.
Visitors
With the addition of five Banbury conferences to the 1979 schedule, which also included staging three summer
courses in the neurosciences at Banbury and accommodating participants in no less than eight major confer-
ences at the Cold Spring Harbor Laboratory, the use of Banbury facilities was heavier than ever. A roll of
Robertson House guests that we sent to Mr. Charles S. Robertson, donor of the Banbury estate, carried the names
of 295 scientists, including 60 from 17 foreign countries. As is traditional, the Banbury pool was the site of the
annual outing of the Lloyd Harbor Village Police Department. The estate was also the site of two meetings of the
Laboratory's Board of Trustees, of a special workshop on virus research organized by Dr. Joseph Sambrook, and
dinners bidding farewell to several scientists and a member of the buildings and grounds department. An
especially welcome event was the use of the Robertson House living room for a music recital by scientists
participating in the summer course on RNA tumor viruses. Of great help to the entire program was the generous
loan by the Wood family of the housing facilities of the dramatically sited Fort Hill estate on Lloyd Neck.
Physical Changes
Improvement of the Banbury property proceeded briskly. Two concealed parking areas were created near the
new garage and the tennis court, and excavation began for Sammis Hall (scheduled for completion in 1980),
which will provide 16 single bedrooms for Banbury guests. The start on Sammis Hall was made possible by
generous grants from the Kresge and Fleischmann foundations.
Staff
There was a series of welcome additions to the staff, joining the director, Victor McElheny; the administrative
assistant, Beatrice Toliver; the Robertson House housekeeper, Mary Hill; and the grounds keepers, Fred Pfeiffer
and Peter Stahl. The new staff included two Banbury editors, Lynda Moran and Judith Cuddihy; an editorial
assistant, Kathleen Kennedy; a resident hostess and cook at Robertson House, Katya Davey; and a resident
watchman, Chris McEvoy of the Laboratory's buildings and grounds staff. It is a pleasure to record once again the
Banbury Center's gratitude for support from every department of the Laboratory and, of particular importance in




QUANTITATIVE MAMMALIAN CELL MUTAGENESIS AND MUTAGEN SCREENING, May 6
- May 9
Proceedings published in December 1979 as Banbury Report 2, Mammalian Cell Mutagenesis: The Matura-
tion of Test Systems.
The conference heard new evidence concerning such mammalian cell systems as the hypoxanthine-guanine
phosphoribosyl transferase (HGPRT) locus in Chinese hamster ovaries (CHO) and the thymidine kinase (TK)
locus in mouse lymphoma cells, which revealed that mutations can be experimentally induced and
quantitatively analyzed. Unresolved questions were also explored, such as the actual range of mutational
events being assayed and whether the events in cell culture reflect the cellular responses in intact animals
and humans. Although the conference participants wrestled with a host of questions about means of
activating cell systems for screening environmental mutagens, there was conviction that the systems have
proved themselves workable, as evidenced by wide use in industrial toxicology and screening programs.
The conference brought together leading developers of animal and human cell systems, geneticists using
such systems for fundamental biological studies, and participants in industrial and government screening
programs. Leading the organization of the meeting were Abraham Hsie and J. Patrick O'Neill of Oak Ridge
National Laboratory.
Session 1: Gene Mutation-Exploring the Evidence for Mutation Events in Cultured Mammalian Cells, and
the Criteria Utilized to Define Such Events
Chairperson: E. A. ADELBERG, Yale University School of Medicine, New Haven, Connecticut
T. T. PUCK, University of Colorado Medical Center, Denver: Historical perspective of mutation studies with
somatic mammalian cells.
L. SIMINOVITCH, University of Toronto, Canada: Studies of mutation in CHO cells.
C. T. CASKEY, Baylor College of Medicine, Houston, Texas: HGPRT mutants in Chinese hamster V79 cells.
Roundtable: Definition of Criteria to Define a Genetic Event
Chairperson: R. L. DAVIDSON, Children's Hospital Medical Center, Boston, Massachusetts
E. A. ADELBERG, Yale University School of Medicine, New Haven, Connecticut
R. J. ALBERTINI, University of Vermont College of Medicine, Burlington
T. T. PUCK, University of Colorado Medical Center, Denver
L. SIMINOVITCH, University of Toronto, Canada
Session 2: Quantitative Mutagenesis with Rodent Cells
Chairperson: L. SIMINOVITCH, University of Toronto, Canada
J. P. O'NEILL, Oak Ridge National Laboratory, Tennessee: CHO/HGPRT mutation assay-Experimental
procedure.
M. M. MOORE-BROWN* and D. CLIvE,t *Environmental Protection Agency, Research Triangle Park, North
Carolina; tBurroughs Wellcome Co., Research Triangle Park, North Carolina: The L5178Yrilei- muta-
gen assay system: In situ results.
C. C. CHANG, Michigan State University, East Lansing: The use of Chinese hamster V79 cells for the
detection of mutagens and tumor promoters or anti-promoters.
Roundtable: Quantitative Mutational Systems, Evidence for Genetic Events
Chairperson: L. A. CHASIN, Columbia University, New York, New.York
A. W. HSIE and J. P. O'NEILL, Oak Ridge National Laboratory, Tennessee
M. M. MOORE-BROWN, Environmental Protection Agency, Research Triangle Park, North Carolina
D. CLIVE, Burroughs Wellcome Co., Research Triangle Park, North Carolina
C. C. CHANG, Michigan State University, East Lansing
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Session 3: Roundtable-Criteria for a Mutagen Screening System
Chairperson: D. A. CASCIANO, National Center for Toxicological Research, Jefferson, Arkansas
J. A. BRADLAW, Food and Drug Administration, Washington, DC
B. E. BUTTERWORTH, Chemical Industry Institute of Toxicology, Research Triangle Park, North Carolina
L. D. KIER, Monsanto Chemical Company, St. Louis, Missouri
D. F. KRAHN, E. I. du Pont de Nemours & Company, Newark, Delaware
M. D. WATERS, Environmental Protection Agency, Research Triangle Park, North Carolina
E. ZEIGER, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina
Session 4: Genetic, Biochemical and Molecular Analysis of Mutation
Chairperson: P.O.P. Ts'o, Johns Hopkins University, Baltimore, Maryland
E. A. ADELBERG, Yale University School of Medicine, New Haven, Connecticut: Selection methods for
membrane transport mutants.
L. H. THOMPSON, Lawrence Livermore Laboratory, Livermore, California: Analysis of temperature-sensitive
mutants and quantitative assay of purine analog resistance in CHO cells.
L. A. CHASIN, Columbia University, New York, New York: Selection of recessive mutants at diploid loci by
titration of the gene product-CHO mutants deficient in dihydrofolate reductase activity.
M. W. TAYLOR, Indiana University, Bloomington: An analysis of mutation at the APRT locus.
R. L. DAVIDSON, Children's Hospital Medical Center, Boston, Massachusetts: Mechanisms of resistance to
thymidine analogs in mammalian cells.
R. M. BAKER, Massachusetts Institute of Technology, Cambridge: Nature and use of ouabain resistant
mutants.
Session 5: Use of Mutagen Screening Systems
Chairperson: E. ZEIGER, National Institute of Environmental Health Sciences, Research Triangle Park, North
Carolina
D. F. KRAHN, E. I. du Pont de Nemours & Company, Newark, Delaware: Utilization of the CHO/HGPRT
system-Metabolic activation and a method for testing gases.
J. D. !RR, E. I. du Pont de Nemours & Company, Newark, Delaware: Statistical evaluation of mutagenicity
with the CHO/HGPRT system.
D. E. AMACHER, Pfizer, Inc., Groton, Connecticut: Utility of the mouse lymphoma 1_5178Y/TK assay for the
detection of chemical mutagens.
J. G. DENT, Chemical Industry Institute of Toxicology, Research Triangle Park, North Carolina: Choice of
activating systems for in vitro mutagenesis assays.
D. B. COUCH, Chemical Industry Institute of Toxicology, Research Triangle Park, North Carolina: The
influence of activation systems on the metabolism of 2,4-dinitrotoluene and its mutagenicity to CHO
cel Is.
J. P. O'NEILL, Oak Ridge National Laboratory, Tennessee: The CHO/HGPRT mutation assay-Adaptation for
mutagen screening.
Session 6: Quantitative Mutagenesis of Human Cells
Chairperson: J. P. O'NEILL, Oak Ridge National Laboratory, Tennessee
R. DEMARS, University of Wisconsin, Madison: Suggestions for increasing the scope of direct testing for
mutagens and carcinogens in intact humans and animals.
W. G. THILLY, Massachusetts Institute of Technology, Cambridge: Study of mutagenesis in diploid human
lymphoblasts.
V. M. MAHER, Michigan State University College of Osteopathic Medicine, East Lansing: Comparing the
frequency of mutations induced in strains and diploid human fibroblasts with different capacities for
DNA repair.
R. J. ALBERTINI, University of Vermont College of Medicine, Burlington: Direct mutagenicity testing with
peripheral blood lymphocytes.
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Session 7: Mutation, Cancer, and Progress with Mutagen Testing
Chairperson: J. A. BRADLAW, Food and Drug Administration, Washington, DC
P. 0. P. Ts'o, Johns Hopkins University, Baltimore, Maryland: Current progress in the study of basic
mechanisms of neoplastic transformation.
A. W. HSIE, Oak Ridge National Laboratory, Tennessee: The CHO/HGPRT mutation assay-Progress with
quantitative mutagenesis and mutagen screening.
D. CLIVE* and M. M. MOORE-BROWN,' *Burroughs Wellcome Co., Research Triangle Park, North Carolina;
tEnvironmental Protection Agency, Research Triangle Park, North Carolina: The L5178Y/TK+/- mutagen
assay system-Mutant analysis.
M. HOLLSTEIN, University of California, Berkeley: Evaluation of rapid screening methods that detect carcino-
gens and mutagens-Collation and comparison of test results.
M. D. WATERS, Environmental Protection Agency, Research Triangle Park, North Carolina: The Gene-Tox
Program.
Conference Summary: L. A. CHASIN, Columbia University, New York, New York
WORKSHOP ON ENVIRONMENTAL HEALTH RISKS, June 8 - June 10
Staff from the offices of individual members of Congress, Congressional committees, research agencies of
Congress and the legislative affairs office of an Executive Branch scientific agency heard and questioned
intently a distinguished group of scientists who discussed techniques of detecting and assessing risks, the
relationship between risk assessment and fundamental biological research, and such specific problems of
risk assessment as food safety and the management of wastes from advanced technological industries.
Attendees at the meeting, recruited over nearly a year, flew up from Washington during a busy legislative
season for the weekend workshop, and promptly sent back comments that were both enthusiastic and
helpful for future workshops, planned to be held at least once a year.
Session I: Introduction
B. N. AMES, University of California, Berkeley: Identifying chemicals causing cancer and mutations.
Session 2: Risk Assessment in its Scientific Context
J. HIGHLAND, Environmental Defense Fund, Washington, DC: Neglected risks.
J. LEDERBERG, Rockefeller University, New York, New York: Intellectual and technical limits of risk assess-
ment.
D. BALTIMORE, Massachusetts Institute of Technology, Cambridge: The relevance of fundamental biological
studies of genes and viruses.
Session 3: Food Safety and Broader Concerns
P. N. MAGEE, Temple University School of Medicine, Philadelphia, Pennsylvania: Possibilities of cancer
prevention.
S. R. TANNENBAUM, Massachusetts Institute of Technology, Cambridge: Unavoidable exposure to
carcinogens-Nitrates, nitrites, pyrolysis products, and carcinogenic spices.
I. RODRICKS, Food and Drug Administration, Rockville, Maryland: Usefulness and pitfalls of using risk
assessment in regulation.
Session 4: The Burden of Wastes
B. J. PAIGEN, Roswell Park Memorial Institute, Buffalo, New York: Lessons of Love Canal.
H. WHITESIDE, Environmental Protection Agency, Washington, DC: Low-level radiation from the nuclear fuel
cycle-A political and scientific problem.
R. WILSON, Harvard University, Cambridge, Massachusetts: Chemical and nuclear wastes; their differences
and similarities.
TOWARD A LESS HAZARDOUS CIGARETTE, October 14
- October 16
Proceedings to be published in May 1980 as Banbury Report 3, A Safe Cigarette?
The conference heard presentations of evidence, such as declining lung cancer incidence among younger
age groups in the United Kingdom, and United States studies reporting lower rates of lung cancer among
filter-cigarette smokers and a reduced frequency of bronchial lesions in hospital patients of recent years(with known smoking frequencies) compared with similar groups of patients 15 years earlier. All of this
evidence indicates that the risk of smoking-related lung cancer is being reduced by multiple changes in
cigarettes whose combined effect has been to reduce the delivery of tar of the average cigarette by more
than half in the last 20 years. Among other topics discussed was the recent sharp increase in the market
share of cigarettes with less than 15 mg of tar (defined in the United States as low-tar cigarettes) from 24% in
the first quarter of 1977 to more than 40% in the second quarter of 1979. Also discussed were studies of
such possible continuing smoking risks as carbon monoxide, polonium 210, nitrosamines, and nicotine; and
studies indicating that the tendency of smokers to compensate for reduced tar and nicotine by smoking more
cigarettes is very moderate. Leading in the organization of the meeting was Gio B. Gori of the NationalCancer Institute.
Session 1: Introduction and Epidemiological Trends
Chairperson: E. C. HAMMOND, American Cancer Society, New York, New York
E. L. WYNDER, American Health Foundation, New York, New York: Epidemiological perspectives.
E. C. HAMMOND, American Cancer Society, New York, New York: The long-term benefits of reducing tar
and nicotine in cigarettes.
L. GARFINKEL, American Cancer Society, New York, New York: Changes in the cigarette consumption of
smokers in relation to changes in tar and nicotine content of cigarettes smoked.
M. KUNZE, Hygiene-Institut, University of Vienna, Austria: Thresholds of tar exposure-Analysis of smoking
histories of male lung cancer cases and controls.
C. LYNCH, Enviro Control, Inc., Rockville, Maryland: Non-detectable risk levels in cigarette smoking.
Session 2: Toxicological Dimensions
Chairperson: F. G. BOCK, Roswell Park Memorial Institute, Orchard Park, New York
S. P. BATTISTA, Arthur D. Little, Inc., Cambridge, Massachusetts: Inhalation studies of toxicity of tobacco
smoke.
M. C. BATTIGELLI, University of North Carolina, Chapel Hill: Reversible versus fixed obstructive disorder ofthe airways.
L. DIAMOND, University of Kentucky College of Pharmacology, Lexington: Pulmonary toxicity of nitrogen
oxides.
P. ASTRUP, Rigshospitalet, Copenhagen, Denmark: Carbon monoxide as a contributor to the health hazards
of cigarette smoking.
C. J. SCHWARTZ, University of Texas Health Science Center, San Antonio: Cigarette smoking and cardiovas-
cular diseases.
N. HARLEY, Institute of Environmental Medicine, New York University Medical Center, New York: Polonium
210-A questionable risk factor in smoking-related carcinogenesis.
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B. L. VAN DUUREN, Institute of Environmental Medicine, New York University Medical Center, New York:
Co-carcinogens in tobacco smoke.
D. HOFFMANN, Naylor Dana Institute, American Health Foundation, Valhalla, New York: The role of
volatiles and nonvolatiles and nitrosamines in tobacco carcinogenesis.
F. G. BOCK, Roswell Park Memorial Institute, Orchard Park, New York: Co-carcinogenic properties of
nicotine.
L. GARFINKEL, American Cancer Society, New York, New York: Changes in bronchial epithelium in relation
to cigarette smoking: 1955-60 versus 1970-77.
Session 3: Cigarette Engineering
Chairperson: G. B. GORI, Division of Cancer Cause and Prevention, National Cancer Institute, Bethesda,
Maryland
T. C. Tso, Beltsville Agricultural Research Center, Maryland: Chemistry of tobacco, and the effects of
agronomy and curing.
M. R. GUERIN, Oak Ridge National Laboratory, Tennessee: Chemistry of tobacco smoke.
W. SELKE, Schweitzer Division, Kimberly-Clark Corporation, Lee, Massachusetts: Reconstituted tobacco
sheet.
T. EICHER and F. MULLER, Bayer Industries, Dormagen, West Germany: A co-tobacco material, RCN.
C. KEITH, Celanese Fibers Company, Charlotte, North Carolina: Physical methods in modification of tobacco
smoke (filters, papers and ventilation).
W. S. CAIN, Yale University School of Medicine, New Haven, Connecticut: Sensory attributes of cigarette
smoking.
E. J. LAVoiE, Naylor Dana Institute, American Health Foundation, Valhalla, New York: The less harmful
cigarette and tobacco smoke flavors.
G. B. GORI, Division of Cancer Cause and Prevention, National Cancer Institute, Bethesda, Maryland:
Overview of changes in the cigarette product.
Session 4: Behavioral and Economic Issues
Chairperson: J. H. JAFFE, New York State Psychiatric Institute, New York
S. M. SHIFFMAN, University of California, School of Medicine, Los Angeles: Reduced smoking, withdrawal
symptoms, and cessation-A cautionary note.
M. A. H. RUSSELL, Addiction Research Unit, Institute of Psychiatry, London, England: Dependency on
nicotine-Relation of nicotine yield and blood nicotine levels.
J. H. JAFFE, New York State Psychiatric Institute, New York: Preliminary observations of switchers-Some
physiological and biological findings.
J. C. MAXWELL, JR. Lehman Brothers Kuhn Loeb, Inc., New York, New York: Trends in cigarette consumption.
J. E. HARRIS, Massachusetts Institute of Technology, Cambridge: Taxation of cigarettes according to tar and
nicotine contents.
B. RICHTER, Enviro Control, Inc., Rockville, Maryland: Macro-economics of the prevention of tobacco-related
diseases.
Conference Summary: G. B. GORI, Division of Cancer Cause and Prevention, National Cancer Institute,
Bethesda, Maryland
HUMAN HEALTH DATA FROM DEFINED POPULATIONS, October 28 October 31
Proceedings to be published in June 1980 as Banbury Report 4, Cancer Incidence in Defined Populations
Combined genetic and epidemiological investigations of defined groups, a number of them with cancer rates
markedly different from that of the general population (according to presentations at the conference) form an
important tool for quantifying the impact on cancer rates of such factors as variations in food in the diet,
content of water or other drinks, or cigarettes. The conference also heard much evidence that new tools,
such as computerized construction of pedigrees of such groups as the Mormons, molecular biological
techniques of constructing libraries of stretches of human genetic material, and operation of national death
registries, show great promise for deepening knowledge of well-defined populations in search of preventive
measures against cancer. Leading in the organization of the conference were John Cairns of the Imperial
Cancer Research Fund, Mill Hill Laboratories; J. L. Lyon of the Utah Cancer Registry; and Mark Skolnick of
the University of Utah Medical Center.
Session 1: Cancer in Utah, Mortality Among Seventh Day Adventists
Chairperson: G. D. COPLEY, National Cancer Institute, Bethesda, Maryland
J. L. LYON, University of Utah Medical Center, Salt Lake City: Overview of studies of cancer in Utah
populations.
D. WEST, Utah Cancer Registry, Salt Lake City: An assessment of cancer risk factors in Mormons and
non-Mormons in Utah, with particular reference to cervix and colon cancer.
A. SORENSON, University of Utah Medical Center, Salt Lake City: Methods and strategies in nutritional
epidemiology studies, using a colon cancer study as a model.
T. LOTZ, Loma Linda University, California: Death ascertainment among a defined population of California
Seventh Day Adventists (SDAs) by computer-assisted matching to the California State Mortality File; and
the problem of selection for comparison of mortality experience of SDAs to that of the general popula-
tion.
R. L. PHILLIPS, Loma Linda University, California: Mortality from cancer of the large bowel, breast, and
stomach among SDAs with differing dietary habits.
Session 2: Cancer Among Mormons and Other Defined Populations
Chairperson: C. DAVERN, University of Utah, Salt Lake City
J. E. ENSTROM, University of California, School of Public Health, Los Angeles: Health and dietary practices
and cancer mortality among active California Mormons.
M.-C. KING, University of California, Berkeley: Genetic epidemiology of breast cancer in Mormon kindreds.
E. J. GARDNER, Utah State University College of Science, Logan: Prevention and cure for hereditary cancers.
A. 0. MARTIN, Prentice Women's Hospital and Maternity Center, Northwestern University Medical School,
Chicago, Illinois: Use of a genealogically linked data base in the analysis of cancer in a human isolate.
H. SIGVALDASON, Icelandic Cancer Registry, Reykjavik: Human health data in Iceland.
Session 3: Epidemiology and Cancer Prevention
Chairperson: J. CAIRNS, Imperial Cancer Research Fund, London, England
R. W. RAwSON, University of Utah Research Institute, Salt Lake City: The total environment in the
epidemiology of neoplastic disease-The obvious "ain't necessarily so."
Discussion led by J. CAIRNS.
Session 4: Studies in Several Defined Populations, and an Examination of Associations between Radiation
and Leukemia in Utah
Chairperson: R. W. RAWSON, University of Utah Research Institute, Salt Lake City
L. J. KINLEN, Cancer Research Campaign, Radcliffe Infirmary, Oxford, England: Abstinence from meat in
relation to mortality among sisters in contemplative orders in the United Kingdom.
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W. NANCE, Medical College of Virginia, Richmond: The value of population-based twin registries
for genetic
and epidemiologic research.
R. WARD, University of Washington, Seattle: Pedigrees and blood pressure-Genetic
epidemiology in a
migrant isolate, Tokelau.
K. M. WEISS, Center for Demographic and Population Genetics, University of Texas, Houston:
Studies in
Laredo, Texas.
J. L. LYON, University of Utah Medical Center, Salt Lake City: Childhood leukemias associated
with fallout
from nuclear testing.
J. E. ENSTROM, University of California, School of Public Health, Los Angeles: The nonassociation of
fallout
radiation with childhood leukemia in Utah.
Session 5: Genealogical Studies
Chairperson: A. 0. MARTIN, Prentice Women's Hospital and Maternity Center, Northwestern University
Medical Center, Chicago, Illinois
J. PET°, Imperial Cancer Research Fund, Oxford, England: The epidemiological study of hereditary cancer
risks.
J.-M. LALOUEL, University of Hawaii at Manoa, Honolulu: Relative merits and pitfalls of some strategies in
genetic epidemiology.
M. SKOLNICK, LDS Hospital, Salt Lake City, Utah: Genetic studies of Utah genealogy.
J. R. HILL, LDS Hospital, Salt Lake City, Utah: Studies of coefficients of kinship for cancer in Utah Mormon
genealogy.
T. BISHOP, LDS Hospital, Salt Lake City, Utah: Analysis of the genetic predisposition to cancer in individual
pedigrees.
R. WILLIAMS, University of Utah Medical Center, Salt Lake City: Analysis of Mormon genealogical data for
factors relating to heart disease.
R. M. FINEMAN, University of Utah Medical Center, Salt Lake City: Utah registry for birth defects and genetic
diseases.
Session 6: Problems of Genetic Epidemiology
Chairperson: E. JORDAN, National Institute of General Medical Sciences, Bethesda, Maryland
R. L. WHITE, University of Massachusetts Medical School, Worcester: In search of DNA polymorphism in
humans.
M. SKOLNICK, LDS Hospital, Salt Lake City, Utah: Number of families needed to establish tight linkagesfor
polymorphisms.
T. BISHOP, LDS Hospital, Salt Lake City, Utah: Mathematical aspects of locating genes on chromosomes.
R. S. SPARKES, University of California, School of Medicine, Los Angeles: Gene-mapping with retinoblas-
toma.
Session 7: National Death Registries
Chairperson: J. PETO, Imperial Cancer Research Fund, Oxford, England
L. J. KINLEN, Cancer Research Campaign, Radcliffe Infirmary, Oxford, England: The National Health Service
and death registration in the United Kingdom.
J. PATTERSON, National Center for Health Statistics, Hyattsville, Maryland: Establishment of a National Death
Registry in the United States.
Conference Summary: C. DAVERN, University of Utah, Salt Lake City
ETHYLENE DICHLORIDE: ECONOMIC IMPORTANCE AND POTENTIAL HEALTH RISKS, November 14 -
November 17
Proceedings to be published in July 1980 as Banbury Report 5, Ethylene Dichloride: Economic Importance
and Potential Health Risks.
Examination at the conference of the manufacture and uses of this major chemical industry intermediate, of
which some 10 billion pounds is manufactured annually in the United States and most of which is converted
to vinyl chloride monomer, showed that although there is a high volume of potential exposures to ethylene
dichloride, largely within the chemical industry, the level of exposure is low from the industry point of view,
whereas it is worrisome to researchers studying the mutagenicity of the compound (who hold that the
ambient air levels likely to be inhaled by workers match up with levels sufficient to induce cancer in
laboratory animals). The conference explored variations in the results of carcinogenicity tests on ethylene
dichloride and other chlorinated hydrocarbons, particularly between tests by tube-feeding and by inhalation
of ethylene dichloride. It also considered new information on the effects of metabolism and binding of
chlorinated hydrocarbons in cells and animals, and also of age, on the outcome of short-term tests of the
mutagenicity of such compounds. Leading in the organization of the conference were Bruce Ames and Kim
Hooper of the University of California at Berkeley, Peter Infante of the Occupational Safety and Health
Administration, and Richard Reitz of the Dow Chemical Company.
Session 1: Mutagenicity and Carcinogenicity of Ethylene Dichloride
Chairperson: R.- REITZ, Dow Chemical Company, Midland, Michigan
C. MALTONI, Istituto di Oncologia e Centro Tumori, Bologna, Italy: Long-term carcinogenicity bioassays on
ethylene dichloride, administered by inhalation to rats and mice.
J. M. WARD, National Toxicology Program, National Cancer Institute, Bethesda, Maryland: The National
Cancer Institute bioassay of ethylene dichloride.
B. N. AMES, University of California, Berkeley: Carcinogenic potency.
K. HOOPER, University of California, Berkeley: Ethylene dichloride as a mutagen.
U. RANNUG, Wallenberg Laboratoriet, Stockholms Universitet, Sweden: The use of different metabolising
systems in the elucidation of the mutagenic effects of 1,2 dichloroethane in Salmonella.
V. F. SIMMON, Genex Corporation, Rockville, Maryland: Review of nonbacterial tests of the mutagenicity of
ethylene dichloride.
Session 2: Toxicology and Other Topics
Chairperson: P. INFANTE, Office of Carcinogen Identification and Classification, Occupational Safety and
Health Administration, Washington, DC
F. SPREAFICO, Istituto di Ricerche Farmacologiche "Mario Negri," Milan, Italy: Clinical chemistry of animals
inhaling ethylene dichloride.
R. REITZ, Dow Chemical Company, Midland, Michigan: Pharmacokinetics and macromolecular interactions
of ethylene dichloride; comparison of oral and inhalation exposures.
K. S. RAO, Dow Chemical Company, Midland, Michigan: Teratogenic and reproductive effects of ethylene
dichloride in rats.
G. TER HAAR, Ethyl Corporation, Baton Rouge, Louisiana: An investigation of possible sterility and health
effects of ethylene dibromide.
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Session 3: Uses of Ethylene Dichloride; Worker Exposure
Chairperson: R. K. HINDERER, B. F. Goodrich Company, Cleveland, Ohio
L. GOLD, University of California, Berkeley: Uses of ethylene dichloride.
L. FISHBEIN, National Center for Toxicological Research, Jefferson, Arkansas: Uses and environmental fate of
ethylene dichloride.
E. S. JACOBS, E. I. du Pont de Nemours & Company, Wilmington, Delaware: Scavengers for use in leaded
gasoline.
M. N. JOHNSON, B. F. Goodrich Company, Akron, Ohio: Medical aspects of ethylene dichloride in the
workplace.
R. KELLAM, Environmental Protection Agency, Research Triangle Park, North Carolina: Human exposure to
ethylene dichloride-Potential for regulation as an airborne carcinogen.
B. L. VAN DUUREN, Institute of Environmental Medicine, New York University Medical Center, New York:
Carcinogenicity and metabolism of halogenated olefinic and aliphatic hydrocarbons.
Session 4: Related Chemicals
Chairperson: K. HOOPER, University of California, Berkeley
W. M. BUSEY, Experimental Pathology Laboratories, Inc., Herndon, Virginia: The inhalation carcinogenesis
of vinyl bromide.
H. B. PLOTNICK, Center for Disease Control, National Institute for Occupational Safety and Health, Cincin-
nati, Ohio: The effect of dietary disulfuram upon the toxicity of 1,2 dibromoethane.
P. INFANTE, Office of Carcinogen Identification and Classification, Occupational Safety and Health Adminis-
tration, Washington, DC: Evidence for the carcinogenicity of some structural analogs of ethylene
dichloride.
J. D. FABRICANT, University of Texas Medical Branch, Galveston: Evidence of the mutagenicity of 1,2
dichloroethane and related structural analogs.
P. MARLow, Office of Carcinogen Identification and Classification, Occupational Safety and Health Admin-
istration, Washington, DC: Assessment of animal studies of ethylene dichloride and related compounds.
M. W. ANDERS, University of Minnesota Twin Cities Medical School, Minneapolis: Metabolism of dihalides
to ethylene.
Conference Summary: R. K. HINDERER, B. F. Goodrich Company, Cleveland, Ohio
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year ended December 31, 1979





Cash $ 1,041,245 $ 312,756
Accounts Receivable 260,806 174,199
Prepaid expenses 16,339 23,742
Inventory of books 123,202 135,838
Due from restricted fund 180,485 101,653
Due from Banbury Center 87,939 14,984
Total unrestricted 1,710,016 763,172
Restricted
Grants and contracts receivable 2,265,333 2,063,598
Total restricted 2,265,333 2,063,598







Total Robertson Research Fund 8,185,048 8,003,799




Accounts payable $ 94,971 $ 149,608
Mortgage Payable 133,200 166,500
Due to plant funds 1,001,089 377,531
Fund balance 480,756 69,533
Total unrestricted 1,710,016 763,172
Restricted
Due to unrestricted funds 180,485 101,653
Fund balance 2,084,848 1,961,945
Total restricted 2,265,333 2,063,598







Total Olney Memorial Fund 27,410 24,535
Total endowment funds $ 8,212,458 $ 8,028,334 Fund balance $ 8,212,458 $ 8,028,334
PLANT FUNDS PLANT FUNDS
Investments 230,725 219,358
Due from unrestricted fund 1,001,089 377,531
Land and improvements 960,530 935,530
Buildings 5,735,358 5,493,511
Furniture, fixtures and equipment 1,103,409 857,891
Books and periodicals 365,630 365,630
Construction in progress 88,630 65,012
9,485,371 8,314,463
Less allowance for depreciation
and amortization 1,951,625 1,545,396
Total plant funds $ 7,533,746 $ 6,769,067 Fund balance $ 7,533,746 $ 6,769,067
BANBURY CENTER BANBURY CENTER
Current funds Current funds
Cash 600 300 Due to CSHL unrestricted fund $ 87,939 $ 14,984
Prepaid expenses 95 95 Fund balance (87,244) (14,589)
Total current funds 695 395 Total current funds 695 395
Endowment Funds




$1,726,973; 1978-$1,539,539) 1,586,667 1,493,754
Total endowment funds 1,524,076 1,502,663 Endowment funds balance 1,524,076 1,502,663
-co Plant funds
4,. Land 772,500 772,500 Plant funds
Buildings 412,672 412,672
Furniture, fixtures and equipment 164,416 160,700
Construction in progress 49,510 8,856
1,399,098 1,354,728
Less allowance for depreciation 129,340 86,886
Total plant funds 1,269,758 1,267,842 Plant funds balance 1,269,758 1,267,842
Total Banbury Center $ 2,794,529 $ 2,770,900 Total Banbury Center $ 2,794,529 $ 2,770,900
Total-All funds $22,516,082 $20,395,071 Total-All funds $22,516,082 $20,395,071
CURRENT REVENUES, EXPENSES AND TRANSFERS
year ended December 31, 1979








Grants and contracts $ 3,269,582 $ 2,826,545 Endowment income $ 82,604 $ 83,424
Indirect cost allowances on grants and Grants & contributions 123,000 100,000
contracts 1,499,040 1,299,409 Conference fees 970
Contributions Rooms and apartments 16,890 16,700
Unrestricted 81,624 100,660 Publications 40,768
Restricted and capital 774,264 10,000 Transfer from Cold
Long Island Biological Association 6,753 31,000 Spring Harbor Laboratory 40,655 12,900
Robertson Research Fund Distribution 350,000 379,167 Total revenues 303,917 213,994
Summer programs 288,380 207,838










Publications sales 837,763 649,041 Operation and maintenance of plant 89,777 81,929













Total revenues 7,817,745 6,126,375 Total expenditures 432,212 267,736
EXPENSES Excess (deficit) of
Research* 3,002,771 2,583,374 revenues over expenses $ (128,295) $ (53,742)
Summer programs* 633,270 518,570
Library 129,752 111,479
Operation and maintenance of plant 1,011,822 796,998
General and administrative 716,487 598,880
Depreciation 405,180 366,630
Publications sales* 510,805 530,834
Dining hall* 324,093 228,767
Total expenses $ 6,734,180 $ 5,735,532
C5`
TRANSFERS
Capital building projects 1,036,867 759,855
Banbury Center 40,655 12,900
Total transfers 1,077,522 772,755
Total expenses and transfers 7,811,702 6,508,287
Excess (deficit) of revenues
'over expenses and transfers $ 6,043 $ (381,912)**
*Reported exclusive of an allocation for operation and maintenance of plant,
general and administrative, library, and depreciation expenses.
"1978 deficit primarily caused by conversion of current funds to plant funds for
capital building projects.
Note: Copies of our complete, audited financial statements, certified by our independent auditors, Peat, Marwick, Mitchell & Co., are available
upon request from the Comptroller, Cold Spring Harbor Laboratory.
COLD SPRING HARBOR LABORATORY
SOURCES OF REVENUE
Year ended December 31, 1979
Federal Grants and Contracts
53.8%
Endowments
5.4% 411%4mo mmoutorammot Ltitomiso0
Auxiliary Activities
21.5%








The Cold Spring Harbor Laboratory is a publicly supported educational institution chartered by the University of
the State of New York and may receive contributions which are tax exempt under the provisions of the Internal
Revenue Code, particularly Section 501C. In addition, the Laboratory has been formally designated a "public
charity" by the Internal Revenue Service. Accordingly, it is an acceptable recipient of grants which would result
from the termination of "private" foundations.
The Laboratory depends upon the generous contributions of its sponsors, participating institutions, and friends
for central institutional needs and capital improvements. In addition, the development of any new programs,
such as year-round research in neurobiology and the marine sciences, can be undertaken only with substantial
support from private sources.
Methods of contributing to Cold Spring Harbor Laboratory
Gifts of money can be made directly to Cold Spring Harbor Laboratory.
Securities
(1) Your broker or bank may sell the securities and remit the proceeds directly to the Laboratory.
(2) If you wish to send stock directly to the Laboratory either (a) endorse the certificate(s) by signing your name
on the back, leave the space for the transferee's name blank, have your signature guaranteed on the
certificate(s) by your bank or broker, and send the certificate(s) by registered mail to the Laboratory, or (b)
send unsigned certificate(s) with a covering letter and send under separate cover a stock power executed
in blank, with signature guarantee, for each certificate, and also a copy of the covering letter (use first-class
mail). Depreciated securities should be sold to establish a tax loss, then the contribution to the Laboratory
should be made by check.
Bequests
Probably most wills need to be updated. Designating Cold Spring Harbor Laboratory as beneficiary ensures
that a bequest will be utilized as specified for continuing good.
Appreciated real estate or personal property
Sizable tax benefits can result from such donations; the Laboratory can use some in its program and can sell
others.
Life insurance and charitable remainder trusts can be structured to suit the donor's specific desires as to extent,
timing, and tax needs.
Conversion of private foundation to -public" status on termination
This may be done by creating a separate fund within Cold Spring Harbor Laboratory whereby the assets of the
private foundation could be accounted for as a separate fund and used for the purposes specified by the
donor. Alternatively, the private foundation can be established as a "supporting organization of Cold Spring
Harbor Laboratory."
For additional information, please contact the Administrative Director, Cold Spring Harbor Laboratory, P.O.
Box 100, Cold Spring Harbor, N.Y. 11724, or call 516-367-8300.
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GRANTS
January 1, 1979- December 31, 1979
NEW GRANTS
Grantor
COLD SPRING HARBOR LABORATORY






The Camille and Henry Dreyfus
Foundation
Institute of Molecular Biology
Division of Bethesda
Research Laboratory





Dr. Watson-neurobiology course support
Dr. Watson-membrane biogenesis meeting
Dr. Watson-C. elegans meeting
Dr. Watson-herpes virus meeting
Dr. Watson-advanced bacterial
genetics course







Dr. Watson-herpes virus meeting
Dr. Watson-C. elegans meeting




Dr. B. Zipser-neurobiology course support









Dr. Watson-neurobiology course support



























































COLD SPRING HARBOR LABORATORY
Principal Investigator Duration
Grantor and program Total award of grant
Dr. E. Lane-fellowship





Alfred P. Sloan Foundation Dr. D. Zipser-computer workshops 31,000 6/1/79-12/31/81
Whitehall Foundation Dr. Roberts-research 34,500 4/1/79 3/31/80
Helen Hay Whitney Foundation Dr. Drickamer-fellowship 24,125 9/1/79 5/31/81
Damon Runyon-Walter Winchell
Cancer Fund Dr. Lin-fellowship 28,000 7/1/79 6/30/81
Dr. Stillman-fellowship 28,000 4/1/79 3/31/81
CONTINUING GRANTS
COLD SPRING HARBOR LABORATORY
Principal investigator Duration
Grantor and program Total award of grant
National Institutes of Health Dr. Watson-Cancer Research Center $13,500,000 1/1/77-12/31/81
Dr. Watson-general research support 173,612 4/1/76 3/31/80
Dr. Watson-Symposium support 96,000 4/1/74 3/31/79
Dr. Watson-summer workshops 470,340 4/1/77 3/31/82
Dr. Watson-advanced bacterial
genetics course 40,000 6/30/78 4/30/79
W. Udry-cancer research facility 1,411,000 9/15/77indefinite
Dr. Albrecht-Buehler-research 73,612 9/1/78 8/31/80
Dr. Blose-research 167,702 12/1/78-11/30/81
Dr. Broach-research 144,320 8/1/77 7/31/79
Dr. Bukhari-career development 148,961 5/1/75 4/30/80
Dr. Bukhari-research 121,351 9/9/77 8/31/80
Dr. Chow-research 238,186. 4/1/77 3/31/80
Dr. Gingeras-fellowship 26,400 1/1/78 12/31/79
Dr. Hicks-research 384,703 7/1/78 6/30/81
Dr. Klar-research 253,000 7/1/78 6/30/81
Dr. Zain-research 34,572 9/30/77 7/31/79
Dr. D. Zipser - fellowship training 754,000 7/1/78 6/30/81
Dr. D. Zipser-research 355,657 5/1/74 4/30/79
National Science Foundation Dr. Burridge-research and equipment 182,494 7/1/78 12/31/80
Dr. Bukhari-research 130,000 8/1/76 7/31/79








Total award of grant
Dr. Roberts-research 130,000 4/1/77-10/31/79
Dr. Zain-research 65,000 8/15/77 1/31/80
Dr. B. Zipser-research 120,000 11/1/78 4/30/82
Dr. D. Zipser-research 136,000 2/15/78 7/31/81
Rita Allen Foundation Dr. Lewis-research 150,000 8/1/76 7/31/81
American Cancer Society Dr. Garrels-fellowship 10,575 9/1/78 8/31/79
Dr. Lewis-research 53,250 7/1/78 6/30/79
Dr. Zain-research 48,528 1/1/78-11/30/79
Canadian Medical Research
Council Dr. Chanonas-fellowship 24,000 8/1/78 7/31/80
Jane Coffin Childs Dr. Gluzman-fellowship 24,333 9/16/77 9/15/79
The Camille and Henry Dreyfus
Foundation Dr. Watson-undergraduate research
participation 20,000 12/1/78 9/30/79
Leukemia Society of America Dr. Engler-fellowship 25,000 11/1/78-10/31/80
Muscular Dystrophy Association Dr. Burridge-research 25,142 7/1/78 6/30/79
Alfred P. Sloan Foundation Dr. D. Zipser-Biological Information
Processing Workshop 17,800 5/1/78 4/30/79
Damon Runyon-Walter Winchell
Cancer Fund Dr. Brooks-fellowship 28,560 1/1/78-12/31/79
Dr. Hu-fellowship 26,070 7/1/78 6/30/80
Dr. Kilpatrick-fellowship 30,000 1/1/78-12/31/79
Dr. Sciaky-fellowship 28,980 3/1/77 2/28/79
Dr. Stow-fellowship 30,000 10/1/78 9/30/80
Dr. Strathern-fellowship 14,990 4/1/78 3/31/79
BANBURY CENTER
Environmental Protection Agency-Conference on Chemical Mutagens 29,000 5/11/78 5/1/79
Esther A. and Joseph
Klingenstein Fund program support 100,000 3/1/78 2/29/80
Alfred P. Sloan Foundation program support 100,000 8/1/78 7/31/80
190
SPONSORS




Ely Lilly & Company
Merck, Sharpe & Dohme
Pfizer, Inc.
Smith, Kline & French Laboratories
Upjohn & Company
CONTRIBUTORS
















David & Getta Denhardt
Digital Equipment Corp.
Russell & Janet Doubleday Fund
Dr. & Mrs. Lester Dubnick
Duke University
Mr. & Mrs. James Ebert
Fleischmann Foundation
Mr. & Mrs. Murray Forman
Walter N. Frank, Jr.
Bentley Glass
Dr. & Mrs. Maurice Green
Roger W. Hendrix
Bernhard Hirt
Mr. & Mrs. 011ie Hoagland
Alexander Hollaender
Mrs. David Ingraham
Estate of Lillian Keily
Kresge Foundation
Labatt Breweries
Gordon & Anita Lamb
L.S. Lee
Dr. & Mrs. Monroe L. Levin
Mrs. Mary Lindsay
Mrs. V.S. Littauer
Long Island Biological Association
Paul Margolin
Julius & Mildred Marmur
Massachusetts Institute of Technology
Mr. & Mrs. Angus D. McIntyre
Ms. Leila Laughlin McKnight
Dr. Calvin S. McLaughlin















Dr. & Mrs. Fred Rapp
Willis L.M. Reese













Dr. & Mrs. Samuel Teich
Dr. Charles A. Thomas, Jr.
Joan Tilney






THE LONG ISLAND BIOLOGICAL ASSOCIATION (LIBA)
and Its Relation to the Cold Spring Harbor Laboratory
Biological research at Cold Spring Harbor began in
1890 when the Brooklyn Institute of Arts and Sciences
was looking for a place to set up a summer laboratory
as the headquarters of its Department of Zoology.
Representatives of the Institute were invited by Eugene
S. Blackford, at that time the First Commissioner of the
State of New York, to inspect a site on Bungtown Road
across Northern Boulevard (25A) from the Fish
Hatchery. The site was found to be ideal, and so the
original Laboratory was organized with Mr. Blackford
as president of the Board of Trustees. The land was
leased from Mr. John D. Jones, whose family since
1819 had operated various industries including ship-
building, coopering, and textile manufacture (later
whaling, also) at the head of Cold Spring Harbor.
Bungtown Road, which runs through the Lab property,
got its name from the factory that specialized in mak-
ing bungs-or stoppers-for barrels.
In 1892 the Laboratory's land was leased for a dollar
a year from the Wawepex Society, which Mr. Jones
had organized as a corporation for holding real estate
and for investing funds for the propagation of fishes
and for scientific research. In 1904 the Wawepex So-
ciety leased additional land to the Carnegie Institution
of Washington, which wanted to locate a Department
of Experimental Evolution in the Cold Spring Harbor
area. Charles B. Davenport, who had been directing
the Laboratory since 1896, assumed the additional
duties of director of the Carnegie Institution's exper-
imental station. It is interesting to note that Mr. Daven-
port lived in what came to be known later as the
Carnegie Dormitory, the Victorian house on 25A built
by John D. Jones before the turn of the century, and
recently repainted in its original colors.
The Long Island Biological Association was estab-
lished in 1924 when the Brooklyn Institute decided to
discontinue its research at Cold Spring Harbor and
offered its laboratory to two universities. Fortunately, a
local group of interested neighbors decided to assume
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responsibility for the Lab, and thus LIBA came into
being. For 38 years LIBA actually operated the Labora-
tory in conjunction with the Carnegie Institution, but
in 1962 it seemed advisable for the Laboratory to be
reorganized as an independent unit. Therefore, the
property on which it now stands was conveyed to it by
LIBA, which, however, still retains reversionary rights.
Today LIBA is one of thirteen institutions participating
in the support of the Laboratory, each institution being
represented on the Laboratory's Board of Trustees.
What has happened, in effect, is that LIBA has be-
come an expanding group of local "Friends of the
Laboratory" who help support it through annual con-
tributions. Also, from time to time, the Association
undertakes campaigns to finance special important
projects for which the Lab cannot obtain funds from
the Federal Government or from other sources. For
instance, in 1974, LIBA made possible building the
James Laboratory Annex and the renovation of
Blackford Hall; in 1976 the re-building of Williams
House. Currently (in 1979-80) funds are being raised
for the Lab's purchase from the Carnegie Institution (at
a cost of $200,000) of some 20 acres of land essential
for the preservation of the Laboratory's property which
the Institution no longer wishes to use.
The affairs of LIBA are handled by a board of 28
directors who are elected to office by the membership
at an annual meeting. At least twice a year LIBA mem-
bers are invited to bring their friends to a lecture or an
open house at the Lab.
Membership in LIBA requires a minimum annual
contribution (tax deductible) of $25 for a husband and
wife, $15 for a single adult, $5 for a junior member
(under 21). Further information can be obtained from
the Long Island Biological Association, Box 100, Cold
Spring Harbor, N.Y. 11724, or by telephoning the
Laboratory's administrative director, Mr. William R.
Udry, at (516) 367-8300.
OFFICERS
DIRECTORS
Mrs. Charles 0. Ames
Dr. Alfred A. Azzoni
Mr. Edmund Bartlett
Mr. Samuel R. Callaway
Mr. David C. Clark
Mrs. Miner D. Crary, Jr.






Mr. Norris W. Darrell, Jr.
Mr. Joseph C. Dey, Jr.
Mr. James A. Eisenman
Mr. Walter N. Frank, Jr.
Mr. Clarence E. Galston
Mr. Charles S. Gay
Mr. George J. Hossfeld, Jr.
Mr. Edward Pulling
Mr. Walter H. Page
Mr. James A. Eisenman
Mrs. James J. Pirtle, Jr.
Mr. William R. Udry
Mr. James A. McCurdy
Mr. Richard Olney 3rd
Mr. Walter H. Page
Mr. Samuel D. Parkinson
Mr. William Parsons, Jr.
Mrs. James J. Pirtle, Jr.
Mrs. Edward Everett Post
REPORT OF THE CHAIRMAN FOR 1979
LIBA's most important activity in 1979 was that of
launching a campaign to raise $200,000 from its
members over a two-year period to purchase 20 acres
of land essential for the preservation of the Lab's
property. At the end of the year contributions and
pledges totaled more than half the amount needed to
reach our goal.
The custom of giving dinner parties for the visiting
scientists at the Lab's summer Symposium was suc-
cessfully continued and greatly appreciated. On June
3rd, eighteen of our directors and members gave par-
ties for over a hundred guests. This year's hosts and
hostesses were:
Mr. and Mrs. Charles 0. Ames
Mr. and Mrs. Edmund Bartlett
Mrs. John K. Colgate
Mr. and Mrs. Roderick H. Cushman
Mr. and Mrs. George W. Cutting, Jr.
Mr. and Mrs. Norris W. Darrell, Jr.
Mr. and Mrs. James A. Eisenman
Mrs. B. Tappen Fairchild
Mr. and Mrs. George N. Lindsay
Mr. and Mrs. Richard Olney III
Mr. and Mrs. Walter H. Page
Mr. and Mrs. Samuel D. Parkinson
Mr. and Mrs. Edward Everett Post
Mrs. H. Irving Pratt
Mrs. Ethelbert Warfield
Mr. and Mrs. Richard J. Weghorn
Mrs. Alex M. White
Mr. & Mrs. William A. Woodcock
Mrs. Richardson Pratt
Mr. Edward Pulling
Mr. Stanley S. Trotman, Jr.
Dr. James D. Watson
Mr. Richard J. Weghorn
Mrs. Alex M. White
Mr. Theodore Wickersham
There were two LIBA meetings open to the whole
membership. At the first on May 13th, Dr. Rene Dubos
of Rockefeller University, the famous biologist and
conservationist, gave the annual lecture in
our former director Mrs. Dorcas Cummings. At the
second (our annual) meeting on January 27th, 1980
we were addressed by Dr. Philip Sharp (Massachusetts
Institute of Technology), who told us about a wonder-
ful new discovery (in which he has played a prominent
role) that seems to have great potential for curing a
number of diseases caused by viruses. The title of his
lecture was Genetically Engineering Bacteria to Pro-
duce the Human Interferon. This meeting, which was
scheduled for December 9th, had been postponed
because Dr. Lewis Thomas, who was to have ad-
dressed us then, was incapacitated by an accident. He
hoped to come for our deferred meeting but compli-
cations resulting from his accident put him back in the
hospital. We were greatly indebted to Dr. Walter Gil-
bert of Harvard University who, at the urgent request
of his friend Dr. Watson, agreed upon less than a
week's notice to come to speak to us. We were even
more indebted to his associate, Dr. Sharp, who came
on 24 hours' notice in Dr. Gilbert's place when the
latter had succumbed to flu! Summaries of both lec-
tures are printed below.
On November 11th a special meeting was held for
directors and their guests. The evening began with a
lecture by Dr. Guenter Albrecht-Buehler describing
his work on cell motility. He took his audience down
to the microscopic world of the cell, describing the
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Dr. Phillip Sharp and Mr. Edward Pulling at LIBA's Annual Williams House, rebuilt with LISA funds
Meeting.
strange forces encountered there and how the cell
responds intelligently to its environment. After the
talk, tours were conducted through the new laboratory
and computer facility set up by Dr. James Garrets for
analysis of the proteins in the cell by two-dimensional
gel electrophoresis. Dr. Garrels gave a demonstration
in the Lab while Carter Burwell showed how the com-
puter can analyze the data and display the results on
the color TV screen. The tour, which also led the
visitors through the newly reconstructed Hershey
building, was followed by dinner in Blackford Hall,
which was attended also by members of the Lab's
scientific staff.
At the annual meeting of members and the subse-
quent meeting of directors, all previous directors and
officers were re-elected, with the exception of Mrs.
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Edward M. Shepard (the former Mrs. Joan Flanigan).
Her recent marriage and new residence in Wood-
stock, Vermont, made her unavailable for re-election.
A resolution of regret and of appreciation of her valu-
able services to LIBA for several years was adopted.
Then Mrs. Miner D. Crary was elected to fill Mrs.
Shepard's place on the Board.
I am pleased to report that the LIBA membership
continues to expand and that the interest and support
of the community in the Lab-our basic objective-
seems also to be increasing.
January 28, 1980 Edward Pulling, Chairman
Long Island Biological Association
Dr. James Carrels giving lab demonstration to LISA directors and guests
DORCAS CUMMINGS
MEMORIAL LECTURE
At the May 1979 Dorcas Cummings Memorial Lec-
ture, members of the Long Island Biological Associa-
tion were privileged to hear a talk by Dr. Rene Dubos,
who achieved worldwide fame 30 years ago for dis-
covering the first commercially produced antibiotic.
Dr. Dubos, who won a Pulitzer Prize in 1969 for his
book, So Human an Animal, is a renowned environ-
mentalist as well as microbiologist.
Dr. Dubos spoke of the need for mankind to estab-
lish a symbiotic relationship with the earth in order to
survive. Departing from the orthodox ecologists' posi-
tion that "Nature knows best," Dr. Dubos pointed out
that if man interacts, rather than interferes, with Na-
ture, both will benefit. Nature's solutions to ecological
problems are sometimes clumsy, shortsighted, and
inadequate. Man's reason and imagination are needed
to facilitate the processes of recycling and to establish
an equilibrium between population size and local
resources.
"The earth is to be seen neither as a static system to
be preserved unchanged, nor as a quarry to be
exploited for purely economic reasons, but rather as a
garden to be cultivated." This feat man has accom-
plished through the recycling of deposits of peat, coal,
oil, and shale; by employing drainage and irrigation
techniques; by terracing and developing new land
from the seas; through the genetic modification of
flora and the cultivation of crops from one continent to
another.
Emphasizing his optimistic view of man's relation to
nature, Dr. Dubos told the audience:
"We can manipulate the raw stuff of nature to
shape it into environments which are ecologically
sound, economically profitable, esthetically re-
warding, and favorable to human health. We can
insert our dreams into ecological determinism and
thus enrich the earth and diversify its manifesta-
tions by bringing out its hidden potentialities.
We can be ecologically sound while humaniz-
ing the earth."




to Produce the Human Interferon
Dr. Phillip A. Sharp
Center for Cancer Research
Massachusetts Institute of Technology
With the development of recombinant-DNA technol-
ogy in the 1970s, mankind obtained the capacity to
design, isolate, and construct genes. This ability,
coupled with the well-developed genetics and
molecular biology of bacteria, has made it possible to
use these simple organisms to produce large amounts
of complicated proteins. Biogen, a company whose
goal is to utilize this rapidly developing technology in
order to produce useful products, several years ago
began supporting Professor Charles Weissmann's
work on the cloning and synthesis in bacteria of
human leukocyte interferon.
Human leukocyte interferon was discovered in
1957 by Isaacs and Lindenman by its ability to render
human cells resistant to a broad spectrum of different
types of viruses. For example, interferon has been
shown to block the growth of viruses such as hepatitis,
influenza, poxvirus, and poliovirus. There is also hope
that interferon will be of clinical use as an antitumor
agent. At the moment, most of the available human
leukocyte interferon is produced from white blood
cells separated from blood donations in Finland by Dr.
Kari Cantell's group. Even though this is the most
efficient means of obtaining interferon, the process is
very expensive and the source so limited that pure
interferon is not available for clinical studies.
To isolate the gene for interferon, Professor
Weissmann's group took messenger RNA from human
leukocytes and constructed a library of 20,000 sepa-
rate bacteria cultures. Each member of this library
contained one type of gene from the human cell, and
somewhere in this library there should have been a
bacteria culture containing the interferon gene. Iden-
tifying a bacteria culture containing the interferon
gene involved testing pools of members of this library.
By first detecting the interferon gene in a pool of 512,
then a subset of 64, then a subset of 8, and finally as a
gene in a single bacteria culture, Professor Weiss-
mann's group was able to isolate the gene specifying
human leukocyte interferon. His laboratory further
found that bacteria containing a complete copy of this
gene synthesized a protein with interferon activity at a
level of 1 to 2 molecules per cell. Even at this minus-
cule level, production of interferon activity in bacteria
is much less expensive than from human sources.
Hopefully, in the near future, there will be sufficient
pure interferon produced by bacterial fermentation to
bring this promising pharmaceutical compound to the




of the Long Island Biological Association
Mr. & Mrs. Thomas Ackerman
Mr. & Mrs. Warren S. Adams II
Mr. & Mrs. Amyas Ames
Mrs. Charles E. Ames
Mr. & Mrs. Charles 0. Ames
Dr. & Mrs. Oakes Ames
Mr. & Mrs. Hoyt Ammidon
Mr. Robert W. Anthony
Mr. & Mrs. J. S. Armentrout
Mr. & Mrs. Donald Arthur
Dr. & Mrs. Joseph T. August
Mr. & Mrs. Robert W. Ayer
Dr. & Mrs. Alfred Azzoni
Mr. Henry D. Babcock, Jr.
Mr. & Mrs. Benjamin H. Balkind
Mrs. Gilbert Ball
Mr. & Mrs. George C. Barclay
Dr. Henry H. Bard
Mr. & Mrs. D. R. Barr
Mr. & Mrs. Edmund Bartlett
Mr. & Mrs. Robert E. Belknap, Jr.
Dr. & Mrs. Stephen Belman
Dr. & Mrs. Alan Bernheimer
Mr. & Mrs. Loren C. Berry
Mr. & Mrs. R. Beuerlein
Mr. & Mrs. Nicholas Biddle, Jr.
Mr. & Mrs. William Binnian
Mr. F. Roberts Blair
Mr. & Mrs. Bache Bleecker
Rev. & Mrs. Lyman C. Bleecker
Mrs. R. DeWitt Bleecker
Mr. & Mrs. A. L. Boorstein
Dr. & Mrs. George Bowen
Mr. & Mrs. William Braden
Dr. & Mrs. Arik Brissenden
Mr. Horace Brock
Mr. F. Sedgwick Browne
Mr. & Mrs. James Bryan, Jr.
Mr. & Mrs. Julian Buckley
Mr. & Mrs. R. P. Burr
Mr. & Mrs. John Busby
Mr. & Mrs. Albert Bush-Brown
Mr. & Mrs. Sidney G. Butler
Mr. & Mrs. S. R. Callaway
Mrs. Eunice Campbell
Mr. & Mrs. John P. Campbell
Mr. & Mrs. Ward C. Campbell
Mr. & Mrs. John Carr
Mr. & Mrs. T. C. Cattrall, Jr.
Mr. & Mrs. Lionel Chaikin
Mr. & Mrs. Harry Charlston
Mr. & Mrs. Beverly Chew
Miss Joan Chodkowski
Mr. & Mrs. Charles M. Clark
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Mr. & Mrs. David C. Clark
Dr. & Mrs. Bayard Clarkson
Mr. & Mrs. Thomas N. Cochran
Mrs. C. Payson Coleman
Mr. & Mrs. John H. Coleman
Mrs. John K. Colgate
Mr. Bradley Collins
Mr. & Mrs. Patrick Collins
Mrs. Ralph C. Colyer
Dr. & Mrs. Crispin Cooke
Mr. & Mrs. Howard Corning, Jr.
Mr. Duncan B. Cox
Mr. E. V. Cox, Jr.
Mr. & Mrs. Charles L. Craig
Mr. & Mrs. Miner D. Crary, Jr.
Mr. & Mrs. Arthur M. Crocker
Mr. Robert L. Cummings
Dr. & Mrs. Paul Cushman, Jr.
Mr. & Mrs. Roderick H. Cushman
Mr. & Mrs. George W. Cutting, Jr.
Mr. Theodore H. Danforth
Mr. & Mrs. Norris Darrell, Jr.
Mr. & Mrs. Lawrence Davis
Mrs. F. Trubee Davison
Mr. & Mrs. Jay DeBow
Mr. & Mrs. Raymond deClairville
Mr. & Mrs. Donald L. Deming
Mrs. William Denby
Mr. & Mrs. Douglas Despard, Jr.
Mr. & Mrs. Joseph C. Dey, Jr.
Mr. David Dowd
Mr. & Mrs. Clark M. Drasher, Jr.
Dr. A. Drazan
Dr. & Mrs. Lester Dubnick
Mr. & Mrs. Hutchinson DuBosque
Mr. & Mrs. James C. Dudley
Dr. & Mrs. John L. Duffy
Mr. & Mrs. Edgar P. Dunlaevy
Mr. & Mrs. William T. Dunn, Jr.
Dr. & Mrs. James D. Ebert
Mr. & Mrs. Paul S. Eckhoff
Mrs. Joseph R. Eggert, Jr.
Mr. & Mrs. James A. Eisenman
Mr. & Mrs. Fred J. Eissler
Mr. & Mrs. Duncan Elder
Mr. Ashton G. Eldredge
Mr. & Mrs. Martin Elias
Mr. Henri Ey1
Mr. & Mrs. Raymond Z. Fahs
Mrs. B. Tappen Fairchild
Mr. & Mrs. H. L. Fates
Mrs. Allston Flagg
Mr. & Mrs. Henry L. Fox
Mr. Joseph C. Fox
Mr. Walter N. Frank, Jr.
Mr. & Mrs. George S. Franklin
Mr. & Mrs. Jack B. Friedman
Mr. D. Kent Gale
Mr. & Mrs. Clarence E. Galston
Mr. John W. Galston
Mr. & Mrs. Charles S. Gay
Mr. & Mrs. Robert A. Gay
Mr. & Mrs. Louis F. Geissler, Jr.
Mrs. Ruth Reed Gillespie
Dr. & Mrs. H. Bentley Glass
Mr. & Mrs. Bernard Gloisten
Mr. & Mrs. E. Rawson Godfrey
Mr. & Mrs. Joseph Goeschl
Dr. E. Raymond Goodrich
Mr. & Mrs. Kilbourn'Gordon, Jr.
Mrs. Charles V. Graham
Mr. & Mrs. William R. Grant
Mr. & Mrs. Alfred T. Gregory
Dr. & Mrs. Donald Gromisch
Mrs. Joanna Hadden
Mrs. Morris Hadley
Mr. & Mrs. Lawrence Hahn
Mrs. Beverly Hanson
Mr. & Mrs. Henry U. Harris
Dr. & Mrs. C. Hartenstein
Mr. & Mrs. R. D. Hartman
Mr. & Mrs. Horace Havemeyer, Jr.
Mr. Huyler C. Held
Mr. & Mrs. James E. Hellier
Heritage Federal Savings & Loan
Dr. & Mrs. William W. Heroy
Mr. & Mrs. Charles L. Hewitt
Mrs. Herman A. Heydt
Miss Cynthia Hopkins
Mr. & Mrs. Frederick G. Hoppin
Mr. & Mrs. George J. Hossfeld
Mr. & Mrs. George J. Hossfeld, Jr.
Mr. & Mrs. Chandler Hovey, Jr.
Mrs. J. Taylor Howell
Mr. & Mrs. Charles J. Hubbard
Mr. & Mrs. Philip G. Hull
Mrs. John C. Ingersoll
Mrs. David Ingraham
Mr. & Mrs. Frederic B. Ingraham
Mr. & Mrs. Valdemar F. Jacobsen
Mr. Irving D. Jakobson
Walter B. James Fund
Dr. N. Mitchel Jason
Mr. & Mrs. Robert D. Jay
Mrs. B. Brewster Jennings
Mr. & Mrs. L. S. Johnson
Mr. & Mrs. John J. Juda
Mr. & Mrs. Henry J. Kaftel
Dr. & Mrs. Irving H. Kagan
Mr. & Mrs. Morris I. Karpen
Mr. & Mrs. Francis E. Kelly, Jr.
Mrs. Walter A. Kernan
Mr. Brian King
Mrs. Samantha King
Mr. & Mrs. Francis S. Kinney
Mr. & Mrs. John P. Kipp
Mr. & Mrs. Richard L. Kline
Mr. & Mrs. Robert P. Koenig
Mr. & Mrs. Edward W. Kozlik
Mr. & Mrs. Paul Kramer
Mrs. Carol Lamb
Mr. & Mrs. Gordon Lamb
Mr. & Mrs. Edward M. Lamont
Mrs. Joanne Landon
Mr. & Mrs. Orin T. Leach
Mrs. Randall J. LeBoeuf, Jr.
Mrs. Burton J. Lee
Mr. & Mrs. Henry C. Lee
Rev. & Mrs. T. Carleton Lee
Dr. & Mrs. R. V. Lewis
Mrs. Elizabeth A. Lindsay
Mr. & Mrs. George N. Lindsay, Jr.
Mr. & Mrs. Robert V. Lindsay
Mr. & Mrs. Bernard Lippman
Mr. & Mrs. V. S. Littauer
Mr. & Mrs. John H. Livingston
Dr. S. E. Luria
Mr. & Mrs. John F. MacKay
Mrs. Malcolm MacKay
Mr. & Mrs. Marshall MacLeod
Mrs. Henry R. Macy
Mr. & Mrs. Ralph J. Maffei
Mr. & Mrs. J. R. Mahoney
Mr. & Mrs. John Mariani
Mrs. John B. Marsh
Mr. & Mrs. John M. Martin
Mr. & Mrs. William H. Mathers
Mr. & Mrs. John D. Maxwell
Dr. Ernst Mayr
Mr. & Mrs. J. A. McCurdy II
Miss Diana Mcllvaine
Mr. & Mrs. Angus P. McIntyre
Mr. & Mrs. Randall P. McIntyre
Dr. & Mrs. Walter Meier
Dr. & Mrs. Leo M. Meyer
Mr. & Mrs. Kennedy B. Middendorf
Mr. & Mrs. William H. Miller
Mr. Dudley H. Mills
Mr. & Mrs. George G. Montgomery, Jr.
Mr. & Mrs. F. Franklin Moon
Mrs. William G. Moore
Mr. & Mrs. Henry S. Morgan
Mr. & Mrs. George Morgese
Mr. & Mrs. Grinnell Morris
Mr. & Mrs. Allan F. Munro
Mr. & Mrs. Francis W. Murray III




Mr. & Mrs. John W. Nields
Mr. & Mrs. William S. Niven
Mr. Lawrence W. Northam
Mr. & Mrs. Charles P. Noyes
Mr. & Mrs. David C. Noyes, Jr.
Mr. & Mrs. Richard Olney III
Mr. & Mrs. George D. O'Neill
Mr. & Mrs. Grover O'Neill, Jr.
Mr. & Mrs. Arthur W. Page, Jr.
Dr. & Mrs. David A. Page
Mr. & Mrs. John H. Page
Mr. & Mrs. Walter H. Page
Mr. & Mrs. Fred W. Pain
Mr. & Mrs. Samuel D. Parkinson
Mr. & Mrs. William Parsons
Mr. & Mrs. William Parsons, Jr.
Mr. & Mrs. Charles F. Paul
Mr. & Mrs. William H. Peck, Jr.
Mr. & Mrs. Ernest Penchuk
Mrs. Paul G. Pennoyer
Mr. & Mrs. Paul Pennoyer, Jr.
Mr. Bernard Peyton
Miss Linda Peyton
Mr. & Mrs. Lewis G. Phillips
Mr. & Mrs. Howard Phipps, Jr.
Mr. John Pickett
Mrs. Richard N. Pierson
Mr. & Mrs. James J. Pirtle
Mr. & Mrs. Collier Platt
Mr. & Mrs. Francis T. P. Plimpton
Mr. & Mrs. Martin Pollak
Mr. & Mrs. Edward Everett Post
Mrs. William S. Post
Mrs. H. Irving Pratt
Mr. & Mrs. Richardson Pratt
Mr. & Mrs. William Preston
Mr. Edward Pulling
Mr. & Mrs. Thomas L. Pulling
Mr. & Mrs. James T. Pyle
Mr. & Mrs. William Rand
Mr. & Mrs. Roland 0. Rasch
Dr. John H. Ray III
Mrs. Sara Redmond
Mr. & Mrs. John R. Reese
Mr. & Mrs. Willis L. M. Reese
Mr. & Mrs. Cornelius J. Reid
Olney House, purchased in 1973 with LIBA funds, provides on-ground residences for Laboratory's
scientific staff
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Dr. Robert M. Reiss
Mr. & Mrs. lose I. Reissig
Mr. & Mrs. Bernard J. Reverdin
Mr. & Mrs. John T. Ricks
Mr. & Mrs. Samuel B. Rogers
Mrs. Philip J. Roosevelt
Mrs. Quentin Roosevelt
Mr. & Mrs. Charles W. Root
Mrs. Donald W. Rose
Mr. & Mrs. Arthur W. Rossiter, Jr.
Mr. & Mrs. Walter N. Rothschild, Jr.
Mr. & Mrs. Francis J. Rue, Jr.
Mr. & Mrs. Harold B. Salembier
Mr. & Mrs. Bernard Salzberg
Mr. & Mrs. John K. Sands
Mr. John M. Schiff
Dr. & Mrs. Carl J. Schmidlapp II
Mr. & Mrs. Frederick P. Schmitt
Mr. & Mrs. Franz Schneider
Dr. Irving M. Schneider
Mr. & Mrs. Hermann C. Schwab
Mr. & Mrs. David R. Schwarz
Mr. & Mrs. Frederick E. Seymour
Mr. & Mrs. Dale Sharp
Mr. & Mrs. Paul C. Sheeline
Mrs. Edward M. Shepard
Mr. & Mrs. Douglas A. Shepardson, Jr.
Dr. & Mrs. Paul Siminoff
Mr. & Mrs. Richard Simmons
Mr. & Mrs. W. 0. Simpson
Mrs. James C. Skiff
Mr. & Mrs. Rowland G. Skinner
Mr. & Mrs. William S. Smoot
Mr. W. 0. Stanton
Mr. & Mrs. James F. Stebbins
Mr. & Mrs. Theodore E. Stebbins
Mrs. J. Rich Steers
Mr. & Mrs. Norman W. Stewart
Mr. Dudley W. Stoddard
Mr. & Mrs. F. Page Storment
Mr. & Mrs. Richard S. Storrs
Mr. & Mrs. Joseph S. Stout
Mr. & Mrs. Joseph S. Stout, Jr.
Mr. Theodore C. Streibert
Mrs. Terry Sullivan
Mr. & Mrs. Robert Swiggert
Dr. Basil Tangredi
Mrs. E. W. Taylor
Mr. & Mrs. Frederick Taylor
Mrs. Henry C. Taylor
Mr. & Mrs. John W. Taylor
Mr. & Mrs. Daniel G. Tenney, Jr.
Mr. & Mrs. D. B. Tenney
Mr. & Mrs. Fred Thielking
Mr. & Mrs. Barry E. Thors
Dr. & Mrs. Robert Tilney
Mr. Alexander C. Tomlinson
Mr. & Mrs. Perry D. Trafford, Jr.
Mr. & Mrs. Stanley Trotman
Mr. & Mrs. Godfrey G. Truslow
Mr. & Mrs. E. T. Turner
Mr. & Mrs. William R. Udry
Mr. & Mrs. Stephen Van R. Ulman
Dr. & Mrs. Thornton Vandersall
Mr. & Mrs. Martin Victor
Mr. & Mrs. Eric Von Raits
Mr. & Mrs. Colton P. Wagner
Ms. Christine M. Walker
Mrs. George Walker
Mrs. Robert P. Walton
Dr. & Mrs. David E. Warden
Mrs. Ethelbert Warfield
Mr. & Mrs. Bradford A. Warner
Mr. & Mrs. Harold L. Warner, Jr.
Dr. & Mrs. James D. Watson
Mr. & Mrs. Arthur D. Weekes, Jr.
Mr. & Mrs. B. G. Weekes
Mrs. F. Carrington Weems
Mr. John C. Weghorn
Mr. & Mrs. Richard J. Weghorn
Mr. & Mrs. Taggart Whipple
Mrs. Alex M. White
Mrs. James R. White
Whitehall Foundation
Mr. & Mrs. William F. Whitman, Jr.
Mr. & Mrs. Theodore S. Wickersham
Mr. & Mrs. Douglas Williams
Mr. & Mrs. Duane N. Williams
Mr. & Mrs. Thorndike Williams
Mrs. John C. Wilmerding
Mr. & Mrs. Henry S. Wingate
Mrs. Willis D. Wood
Mr. & Mrs. William A. Woodcock
Mrs. Ford Wright
Mr. & Mrs. Woodhull Young
LIBA funds paid for the winterization of Blackford Hall, in which Meetings Office, dining room, and dormitories
are located
198


